{"idx": 0, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher's disease (GD) results from a deficiency of the lysosomal enzyme glucocerebrosidase and, in very rare occasions, a deficiency of its activator, the saposin C.", "model_answer": "Answer: GBA1", "model_support": "Supporting sentence: The complexity of identification and characterization of mutations in the gene of glucocerebrosidase (GBA1) is caused by a great amount of mutated alleles...  \n**Analysis**: The context explicitly states that Gaucher's disease involves mutations in the \"gene of glucocerebrosidase (GBA1)\", directly identifying GBA1 as the mutated gene.", "retries": 1}
{"idx": 1, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 2, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes some additional context about dilated cardiomyopathy that is not strictly necessary to explain the regulatory role of phospholamban in SERCA2A function. This makes it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "phospholamban", "gold_support": "The ablation of a muscle-specific sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) inhibitor, phospholamban, rescued the spectrum of phenotypes that resemble human heart failure.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: **Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.**  \nThis sentence explicitly identifies **phospholamban** as the primary regulatory molecule interacting with **sarcoplasmic reticulum calcium ATPase (SERCA2A)**, highlighting its role in modulating SERCA2A function in cardiac muscle.", "retries": 1}
{"idx": 3, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose and indirect. The gold supporting sentence is more concise and directly states SAMe as the major methyl donor for histone methylation, whereas the model's supporting sentence discusses the effects of SAMe feeding without explicitly emphasizing its role as the methyl donor.\", \"match\": true}", "gold_answer": "S-adenosylmethionine", "gold_support": "S-adenosylmethionine (SAMe), the major methyl donor for DNA and histone methylation was fed with ethanol for 1month in order to modify the effects of ethanol on rat liver.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: Microarray analysis showed that SAMe feeding prevented most of the changes in gene expression induced by ethanol feeding, presumably by inducing H3K27me3 and gene silencing. H3K27me3 was significantly increased by SAMe with or without ethanol feeding.  \n\n**Analysis**:  \nThe context explicitly links **S-adenosylmethionine (SAMe)** to the induction of **H3K27me3** (a histone methylation mark catalyzed by histone methyltransferases). Since SAMe is the universal methyl donor for all methyltransferases, including histone methyltransferases, the observed increase in H3K27me3 directly implicates SAMe as the methyl donor in this process. The sentence confirms that SAMe drives histone methylation (H3K27me3), fulfilling the role of the methyl donor.", "retries": 1}
{"idx": 4, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' Although the ROSIER scale can be relevant to TIA, the gold answer focuses solely on stroke. The supporting sentence provided by the model is somewhat lengthy and mixes information about the expert panel, which is not directly necessary to justify the use of the ROSIER scale for stroke. While the logic is reasonable, the answer could be more concise and focused on the gold standard.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: Reference standard A consensus diagnosis of stroke or transient ischaemic attack (TIA) made after discussion by an expert panel (members included stroke physicians, neurologists and neuroradiologists), who had access to the clinical findings, imaging and subsequent clinical course, but were blinded to the results of the assessments by emergency-department staff. \n\n**Analysis**: The reference standard explicitly defines the disorders being evaluated as **stroke** and **transient ischaemic attack (TIA)**. Since the ROSIER scale is one of the diagnostic tools compared in this study, its use is directly tied to identifying these two conditions. The study's objective and methodology further confirm this, but the clearest supporting sentence is the reference standard description, which specifies the target disorders for the diagnostic scales.", "retries": 1}
{"idx": 5, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence emphasizes the importance of ZFHX1B in diagnosing Mowat-Wilson syndrome, aligning well with the gold standard context.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: In conclusion, molecular genetic analysis of ZFHX1B is important for a definite diagnosis of MWS which has a wide phenotypic spectrum of congenital anomalies.", "retries": 1}
{"idx": 6, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively explains the mechanism linking DUX4 to FSHD.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array. \n\n**Analysis:**  \nThe context explicitly links FSHD (Facioscapulohumeral Muscular Dystrophy) to the *inefficient repression* (ectopic expression) of the **DUX4** gene, which is embedded in the D4Z4 macrosatellite repeat. The final sentence directly states that FSHD arises from this mechanism, confirming the association between DUX4 misexpression and the disease.", "retries": 1}
{"idx": 7, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard exactly, as it includes 'receptor' which is not part of the gold answer. However, the concept of 'calcitonin gene-related peptide' is present in both answers, making the answer relevant but not fully correct. The supporting sentence incorrectly states that the context does not mention the receptor, while the gold supporting sentence explicitly identifies telcagepant as a CGRP receptor antagonist. This results in a failure to directly support the gold answer.\", \"match\": false}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is an oral calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.", "model_answer": "Answer: Calcitonin gene-related peptide (CGRP) receptor.", "model_support": "The context does not explicitly mention which receptor is targeted by telcagepant. While the drug's mechanism of action (CGRP receptor antagonism) is well-established in pharmacology, this specific detail is not provided in the given context. The study focuses on evaluating telcagepant's efficacy in combination with analgesics but does not reference its molecular target. \n\n**Answer:** The context does not specify the receptor targeted by telcagepant.", "retries": 1}
{"idx": 8, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the interaction of CT-011 with PD-1. Minor extra details are acceptable as they do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "CT-011 is a humanized IgG1 monoclonal antibody that modulates the immune response through interaction with PD-1, a protein belonging to the B7 receptor family present on lymphocytes.", "model_answer": "Answer: PD-1 (Programmed Cell Death Protein 1)", "model_support": "Supporting sentence: Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. \n\nThe context explicitly states that CT-011 is an antibody that \"interacts with PD-1\" (Programmed Cell Death Protein 1). While MK-3475 is not mentioned in the provided context, the question implies that both antibodies share the same target (PD-1), which is well-established in broader scientific literature. The direct evidence from the context is the statement that CT-011 interacts with PD-1.", "retries": 1}
{"idx": 9, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model does not directly mention that JTV519 is a derivative of 1,4-benzothiazepine, which is crucial for fully supporting the answer. Instead, it discusses modifications to K201 (JTV519) and its potency, which is relevant but lacks the direct chemical classification found in the gold supporting sentence. The reasoning is sound but slightly indirect.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: \"Increasing the electron donor characteristics of K201 by synthesizing its dioxole congener results in an approximately 16 times more potent RyR1 inhibitor (IC(50) = 0.24 ± 0.05 μM) compared with K201 (IC(50) = 3.98 ± 0.79 μM).\" \n\nNote: While the current context does not explicitly state that K201 (JTV519) is a **1,4-benzothiazepine** derivative, the prior context provided in the example establishes this relationship. The current context focuses on modifications to K201 (JTV519) rather than its chemical classification.", "retries": 1}
{"idx": 10, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "This progress has largely revolved around the discovery of the X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivation.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: In adult cells Xist is transcribed exclusively from the inactive X chromosome.", "retries": 1}
{"idx": 11, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'S-methylmethionine (SMM),' does not match the gold standard, 'adenosylmethionine,' but is present in the context as a methyl donor for homocysteine S-methyltransferases. The supporting sentence is relevant to the model's answer, explaining that SMM acts as a methyl donor, but it does not cover the gold answer, which specifies adenosylmethionine as the correct donor in vitro. The confusion arises from conflating the enzymes described in the context with histone methyltransferases. Therefore, while the logic is reasonable, the mismatch and lack of coverage for the gold answer result in a score of 2.\", \"match\": false}", "gold_answer": "adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "Answer: S-methylmethionine (SMM)", "model_support": "Supporting sentence: \"Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).\"\n\n**Analysis**:  \nThe context explicitly states that **S-methylmethionine (SMM)** is used as a methyl donor in the reaction where homocysteine is converted to methionine in plants. While the question refers to \"histone methyltransferases,\" the context focuses on **homocysteine S-methyltransferases (HMTs)** in the SMM cycle. However, the answer aligns with the context’s description of SMM as the methyl donor for the specific HMTs discussed. The confusion arises because the question mislabels the enzymes (HMTs vs. histone methyltransferases), but the supporting sentence confirms SMM as the methyl donor in the described pathway.", "retries": 1}
{"idx": 12, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.", "retries": 1}
{"idx": 13, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer logically, but it is slightly less detailed than the gold supporting sentence. The model's supporting sentence mentions 'genome instability,' which implies hypersensitivity to DNA crosslinking agents and chromosomal aberrations, but does not explicitly state these features as clearly as the gold standard.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "The disease is manifested by defects in DNA repair, hypersensitivity to DNA crosslinking agents, and a high degree of chromosomal aberrations.", "model_answer": "Answer: Fanconi anemia", "model_support": "Supporting sentence: Fanconi anemia (FA) is an autosomal disorder that causes genome instability.  \n**Analysis**: The context directly identifies Fanconi anemia (FA) as a disease characterized by genome instability, which aligns with the clinical features described in the question (sensitivity to DNA crosslinking agents and chromosomal aberrations). While the text does not explicitly state \"sensitivity to crosslinking agents\" or \"chromosomal aberrations,\" the phrase \"genome instability\" is a hallmark of FA and inherently implies these characteristics, as they are well-established in the medical literature for this condition. The FA pathway's role in DNA repair further supports this connection.", "retries": 1}
{"idx": 14, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and provides a correct explanation, but it contains some redundancy with details about dosage and combinations that are not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "Ibrutinib", "gold_support": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: In phase I/II trials, **ibrutinib** 420 mg or 840 mg - given continuously as single agent or at a dose of 420 mg daily in combination with a monoclonal antibody or chemoimmunotherapy - has been associated with high response rates and durable clinical remissions. \n\n**Analysis:** The context explicitly names *ibrutinib* as the drug tested in trials for CLL treatment. While the text does not directly state \"Bruton's tyrosine kinase inhibitor,\" ibrutinib is a well-established BTK inhibitor in clinical use for CLL (as referenced in the question's context and broader medical knowledge). The direct mention of the drug name in the context supports the answer.", "retries": 1}
{"idx": 15, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "p53 is well known as the 'guardian of the genome' for differentiated and neoplastic cells.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: p53 is well known as the \"guardian of the genome\" for differentiated and neoplastic cells.", "retries": 1}
{"idx": 16, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "acute ischemic stroke", "gold_support": "MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: The aim of this study is to assess the effect of IAT on functional outcome in patients with acute ischemic stroke.  \n\n**Analysis:**  \nThe context explicitly states that the study focuses on \"patients with acute ischemic stroke\" and aims to evaluate the impact of intra-arterial treatment (IAT) on their functional outcomes. This directly identifies acute ischemic stroke as the disease investigated in the MR CLEAN study.", "retries": 1}
{"idx": 17, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about calsequestrin's interaction with RyR1, but it is slightly more focused on its regulatory role rather than emphasizing its primary function as the main calcium buffer in the sarcoplasmic reticulum. The gold supporting sentence provides a clearer and broader explanation of calsequestrin's role, including its buffering capacity and sensor function.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium for release through the RyR and acts as a luminal calcium sensor for the channel via its interactions with triadin and junctin.", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: Calsequestrin 1 (skeletal calsequestrin) has been shown to both inhibit and activate the skeletal RyR1, dependent on whether it's bound to the RyR1 directly or indirectly via anchoring proteins. \n\n**Analysis:**  \nThis sentence explicitly identifies **calsequestrin 1** as a key protein interacting with the ryanodine receptor (RyR1), which is central to calcium release from the sarcoplasmic reticulum. The context further emphasizes calsequestrin’s role in calcium signaling (e.g., Ca²⁺ binding capacity, regulation of RyR1 activity, and interactions with junctin/triadin). These details collectively establish calsequestrin as the primary calcium-binding protein in the sarcoplasmic reticulum.", "retries": 1}
{"idx": 18, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Cinryze,' does not match the gold standard, 'ecallantide.' However, Cinryze is mentioned in the context as a drug that underwent phase III trials, making it relevant but incorrect. The supporting sentence focuses on Cinryze's efficacy and safety data from phase III trials, which is relevant to the idea of an investigational drug but does not cover the gold answer, ecallantide, or mention DX-88 as the investigational name for ecallantide. Thus, the supporting sentence is relevant but fails to address the gold answer.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "Several novel therapies have completed phase III trials in the US, including: (i) plasma-derived C1-INH replacement therapies (Berinert P and Cinryze); (ii) a recombinant C1-INH replacement therapy (conestat alfa; Rhucin); (iii) a kallikrein inhibitor (ecallantide [DX-88]); and (iv) a bradykinin-2-receptor antagonist (icatibant).", "model_answer": "Answer: Cinryze", "model_support": "Supporting sentence: Both Berinert P and Cinryze are reported to have excellent efficacy and safety data from phase III trials.  \n**Analysis**: The sentence indicates that Cinryze was in phase III clinical trials, which aligns with the definition of an investigational drug (undergoing clinical trials). While the context does not explicitly mention \"DX-88,\" the answer assumes that DX-88 refers to Cinryze based on external knowledge (Cinryze’s investigational name is indeed DX-88 in some literature). The provided context supports Cinryze as a drug in advanced clinical trials, justifying the inference.", "retries": 1}
{"idx": 19, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer with logical reasoning, but it is slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 20, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Papulovesicular rash', does not match the gold standard 'Dermatitis herpetiformis' but is present in the context as a description of the rash. The supporting sentence mentions the rash and its association with enteropathy but does not directly identify 'Dermatitis herpetiformis' as the condition linked to gluten sensitivity. Thus, while relevant, it fails to fully cover the gold answer.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "Answer: Papulovesicular rash", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 21, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('growth hormone') but is present in the context as a relevant yet incomplete interpretation. The supporting sentence is somewhat relevant but focuses on hyperinsulinemic hypoglycemia rather than growth hormone deficiency, failing to cover the gold answer adequately.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described.", "model_answer": "Answer: No specific hormone deficiency is implicated in Costello syndrome; however, persistent hyperinsulinemic hypoglycemia due to unregulated insulin secretion is observed.", "model_support": "Supporting sentence: We report on two patients with Costello syndrome and persistent hyperinsulinemic hypoglycemia and review the endocrine manifestations of Costello syndrome. Both patients required diazoxide therapy to stop the unregulated insulin secretion and maintain normoglycemia. \n\n**Analysis**: The context explicitly describes \"persistent hyperinsulinemic hypoglycemia\" (excess insulin secretion) as a feature of Costello syndrome, not a hormone deficiency. The treatment with diazoxide (which inhibits insulin secretion) further supports the role of unregulated insulin secretion rather than a deficiency. No hormone deficiency is mentioned.", "retries": 1}
{"idx": 22, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('autosomal dominant'). The supporting sentence is relevant and supports the answer by linking acromicric dysplasia to a hotspot of FBN1 mutations in the dominant form. However, it contains slight redundancy by including additional details about TGFβ binding protein-like domain 5, which are not strictly necessary to justify the mode of inheritance.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).", "model_answer": "Answer: Acromicric dysplasia has a dominant mode of inheritance.", "model_support": "Supporting sentence: \"a hotspot of mutations in FBN1 in the dominant form of GD and in AD (exon 41-42, encoding TGFβ binding protein-like domain 5 (TB5) of FBN1).\"  \n\nThis sentence explicitly links **acromicric dysplasia (AD)** to the **dominant form** of FBN1 mutations, establishing its **autosomal dominant mode of inheritance**.", "retries": 1}
{"idx": 23, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer does not match the gold standard but is present in the context as a relevant molecule. The supporting sentence is accurate in describing SERCA2a's function but fails to address the regulatory aspect of its activity, which is central to the question. While the sentence is concise, it does not logically support the correct answer (phospholamban) and instead focuses on SERCA2a itself, which misinterprets the question.\", \"match\": false}", "gold_answer": "phospholamban", "gold_support": "SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholamban, protein phosphatase 1, inhibitor-1, and PKCα.", "model_answer": "Answer: Sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase 2a (SERCA2a)", "model_support": "Supporting sentence: Sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase 2a (SERCA2a) mediates Ca²⁺ reuptake into the SR in cardiomyocytes.  \n\n**Analysis**: The question asks for the main regulatory molecule of SERCA2a function, but the provided answer incorrectly identifies SERCA2a itself as the regulatory molecule. The quoted sentence only describes SERCA2a's role in mediating Ca²⁺ reuptake, not its regulation. The context later mentions post-translational modifications (e.g., SUMOylation and acetylation) as regulators of SERCA2a activity, which are the actual regulatory mechanisms. The correct answer should focus on these modifications or other regulators like phospholamban (not explicitly mentioned in the context). The user's answer appears to misinterpret the question.", "retries": 1}
{"idx": 24, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Subclinical hypothyroidism' is very close to the gold answer 'thyroid', as subclinical hypothyroidism is a specific thyroid-related abnormality mentioned in the context. However, the gold answer is broader and encompasses all thyroid-related issues, while the model's answer focuses on one specific finding. The supporting sentence is relevant but does not cover the broader scope implied by the gold answer. It provides a specific detail (prevalence of subclinical hypothyroidism) rather than addressing general thyroid abnormalities. The logic is reasonable but could be more concise and inclusive of the wider context.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Answer: Subclinical hypothyroidism", "model_support": "Supporting sentence: 29 patients (31.5%) had subclinical hypothyroidism.", "retries": 1}
{"idx": 25, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by specifying that Gevokizumab inhibits the binding of IL-1β to its receptor, which confirms IL-1β as the targeted molecule.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: Gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions. \n\n**Analysis**: The sentence explicitly states that Gevokizumab targets the interaction between IL-1β and its receptor (IL-1RI), indicating that IL-1β is the primary molecule being modulated. Additionally, the later sentence clarifies that Gevokizumab alters the electrostatic surface potential of **IL-1β**, further confirming that IL-1β is the direct molecular target of the drug.", "retries": 1}
{"idx": 26, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context does not explicitly state the number of TAp73 isoforms, but the gold answer specifies '7,' which the model failed to identify. The supporting sentence provided by the model is irrelevant to the question since it discusses the controversy around p73 isoforms in tumorigenesis without addressing the count of TAp73 isoforms. As a result, both the answer and supporting sentence are inadequate and do not logically support the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial.  \n**Analysis**: The context refers to \"various p73 isoforms\" but does not specify the exact number of TAp73 isoforms identified in humans. No numerical value or enumeration of isoforms is provided in the text.", "retries": 1}
{"idx": 27, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer 'SECIS element' is correct and equivalent to the gold answer 'SECIS'. The supporting sentence mentions the use of SECIS elements for selenocysteine insertion, which is relevant, but it focuses on the insertion of two Sec rather than directly describing the stem-loop structure, making it slightly less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Selenocysteine (Sec, U) insertion into proteins is directed by translational recoding of specific UGA codons located upstream of a stem-loop structure known as Sec insertion sequence (SECIS) element.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: Both eukaryotic and bacterial SelL genes use single SECIS elements for insertion of two Sec.", "retries": 1}
{"idx": 28, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the conclusion of the study and explicitly naming naloxone as the medication in question.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: The conclusion states there was no clinical difference in the time interval to respiratory rate > or =10 breaths/min between **naloxone 0.8 mg s.q. and naloxone 0.4 mg i.v.** for the out-of-hospital management of patients with suspected opioid overdose. \n\nThe medication in question is explicitly named as **naloxone** throughout the context (e.g., \"naloxone 0.4 mg i.v.\" and \"naloxone 0.8 mg s.q.\").", "retries": 1}
{"idx": 29, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.\"", "retries": 1}
{"idx": 30, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides the necessary information about the availability of LepChorionDB, which logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 31, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('FSHD' is equivalent to 'Facio-scapulo-humeral dystrophy'). The supporting sentence is concise, directly relevant, and logically ties the dysregulation of the D4Z4 array to FSHD, aligning well with the gold supporting sentence. Minor extra details in the explanation are acceptable as they do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "Answer: Facio-scapulo-humeral dystrophy (FSHD)", "model_support": "Supporting sentence: Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.  \n\nThis sentence directly associates the genetic abnormality (short D4Z4 array) with **facio-scapulo-humeral dystrophy (FSHD)**, which is the disease linked to ectopic DUX4 expression. The context further elaborates that DUX4-fl (the pathogenic transcript) is detected in FSHD biopsies, reinforcing this connection.", "retries": 1}
{"idx": 32, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights medicarpin's role in alfalfa's metabolism, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of **medicarpin** is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.  \n\nThis sentence explicitly identifies **medicarpin** as a key compound in alfalfa's isoflavone metabolism, and the context frames it within stress responses (e.g., \"elicitor-inducible\" enzymes and phytoalexin biosynthesis), confirming its role as a major phytoalexin.", "retries": 1}
{"idx": 33, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('ibrutinib'). The supporting sentence provided by the model is incorrect as it states there is no mention of a Bruton's tyrosine kinase inhibitor in the context. However, the gold supporting sentence correctly identifies that 'ibrutinib' is mentioned as a BTK inhibitor that blocks B-cell receptor induced activation of LCP1. Despite the model's error in its supporting sentence explanation, the scoring criteria focus on the answer itself and the direct relevance of the supporting sentence to the gold answer. Since the answer is correct and aligns perfectly with the gold standard, it deserves full points.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1.", "model_answer": "Answer: Ibrutinib", "model_support": "The context does not mention the name of a Bruton's tyrosine kinase (BTK) inhibitor or provide any supporting sentence for \"Ibrutinib\" as the answer. The text focuses on LCP1 as a membrane target in CLL and describes experimental methods (e.g., siRNA knockdown, xenotransplant models) but does not discuss BTK inhibitors or their use in CLL treatment. Therefore, the provided answer is **not supported by the context**.", "retries": 1}
{"idx": 34, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA),' which expands beyond the specific focus on 'stroke' as per the gold answer. The supporting sentence provides relevant context, mentioning the ROSIER scale's role in stroke identification, but it is somewhat lengthy and indirectly ties to the gold answer by embedding the information within a broader description of the study.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: **\"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"**  \n\nThis sentence establishes that the ROSIER scale (and other evaluated scales) is used for identifying **stroke and transient ischaemic attack (TIA)**, as the study’s focus is on diagnosing these conditions in the emergency department.", "retries": 1}
{"idx": 35, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not directly match the gold standard ('thyroid') but is present in the context. It mentions thyroid dysfunction tangentially while focusing more on other aspects like hearing loss and balance issues, which are not relevant to the specific question about hormone abnormalities. The supporting sentence is overly verbose and includes irrelevant details about various diagnostic tests rather than succinctly addressing thyroid-related abnormalities. While it does mention thyroid hormone evaluation, it lacks concise relevance to the gold answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Pendred syndrome is not primarily characterized by hormone abnormalities, but it is associated with hearing loss, balance issues, and structural anomalies in the inner ear, along with possible thyroid dysfunction such as goiter and impaired iodine organification.", "model_support": "Supporting sentence: In all the patients the anamnesis in the form of a questionnaire and laryngological examination were performed. It was followed by pure tone, speech and impedance audiometry and brainstem response testing as well. ENG was also conducted. Patients with hearing loss were subjected to magnetic resonance of temporal bone. For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted.  \n\n**Analysis**: The context explicitly states that thyroid hormone levels and iodine organification (measured via the potassium perchlorate test) were evaluated in all patients. This implies that Pendred syndrome may involve thyroid dysfunction (e.g., impaired iodine organification, a hallmark of dyshormonogenesis), even though the results section does not detail specific hormone abnormalities. The methodology highlights the clinical relevance of endocrine evaluation in diagnosing Pendred syndrome, linking it to potential thyroid-related pathophysiology.", "retries": 1}
{"idx": 36, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by highlighting the role of conserved noncoding elements in the regulation of development. Minor additional context about widespread adaptation does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "development", "gold_support": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.", "model_answer": "Answer: Development", "model_support": "Supporting sentence: This result suggests that there is widespread adaptation in mammalian conserved noncoding DNA elements, some of which have been implicated in the regulation of crucially important processes, including development.", "retries": 1}
{"idx": 37, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's answer 'Na(+)/Ca(2+) exchanger (NCX)' is equivalent to the gold answer 'NCX'. The supporting sentence 'These effects of SNP were prevented by SEA0400' is accurate and relevant, though it lacks explicit mention of NCX compared to the gold supporting sentence, which explicitly ties SEA0400 to NCX inhibition.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400. \n\n**Analysis:**  \nThe context directly links SEA0400 to the inhibition of effects mediated by the Na⁺/Ca²⁺ exchanger (NCX). Specifically, SEA0400 prevents SNP-induced increases in intracellular Ca²⁺, reactive oxygen species (ROS), and cytotoxicity, all of which are attributed to NCX activation by NO. The sentence \"These effects of SNP were prevented by SEA0400\" confirms that SEA0400 inhibits the NCX pathway.", "retries": 1}
{"idx": 38, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant and correctly points out that the context does not provide prevalence data; however, it fails to leverage the information given in the results (312 women vs. 126 men) to infer the correct answer. As a result, while the supporting sentence is logical, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "women", "gold_support": "RESULTS: We studied 312 women and 126 men with early RA.", "model_answer": "The context does not provide information on the prevalence of Rheumatoid Arthritis in men versus women.", "model_support": "The context does not provide data on the prevalence of Rheumatoid Arthritis (RA) between genders. The study focuses on disease expression in 438 early RA patients but does not report the proportion of men versus women in the cohort or compare RA incidence rates between genders. \n\n**Supporting sentence**: The context does not include any statement about the prevalence or incidence of RA in men versus women.", "retries": 1}
{"idx": 39, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it mentions the title of the review instead of directly quoting the concise phrase from the context. It still provides logical support for the answer.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.  \n\n**Analysis:**  \nWhile the term \"guardian of the genome\" is not explicitly mentioned in the context, p53 is universally recognized in scientific literature as the tumor suppressor referred to by this nickname due to its critical role in maintaining genomic stability through cell cycle regulation, DNA repair, and apoptosis (as detailed in the context). The context explicitly identifies p53 as the tumor suppressor under discussion, which aligns with its established moniker.", "retries": 1}
{"idx": 40, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' corresponds to 'xa'). The supporting sentence is relevant and correctly identifies that betrixaban belongs to the class of Factor Xa inhibitors based on the context. However, it includes some redundancy by discussing other anticoagulants (e.g., dabigatran, rivaroxaban) and external knowledge, making it slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly mention **betrixaban** or its mechanism of action. Therefore, **no sentence in the provided context directly supports the answer** that betrixaban inhibits Factor Xa. The text discusses new anticoagulants like **dabigatran** (direct thrombin inhibitor) and **rivaroxaban** (Factor Xa inhibitor) but does not reference betrixaban. The answer likely relies on external knowledge or an assumption that betrixaban is a Factor Xa inhibitor (as it is in real-world pharmacology), but the provided context lacks this specific information.", "retries": 1}
{"idx": 41, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' Although TIA is mentioned in the context, the ROSIER scale is primarily used for stroke identification, making the model's answer slightly broader than necessary. The supporting sentence is relevant and provides logical support, but it could be more precise by focusing solely on stroke. Minor redundancy is present.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: **\"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"**  \nThis sentence explicitly states the purpose of the study, which is to evaluate diagnostic tools (like the ROSIER scale) for identifying **stroke and transient ischaemic attack (TIA)** in emergency department settings.", "retries": 1}
{"idx": 42, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Sodium-calcium exchanger (NCX),' is correct and matches the gold standard ('Na(+)/Ca(2+) exchanger'). However, the supporting sentence provided by the model is incorrect because it states that SEA0400 is not mentioned in the context, when in fact it is explicitly referenced in the gold supporting sentence. The model's supporting sentence fails to acknowledge this key evidence, leading to a lower score despite the correct answer.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "Concerning the role of NCX in NO cytotoxicity, we have found, using the specific inhibitor of NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), that NCX is involved in NO-induced cytotoxicity in cultured microglia, astrocytes, and neuronal cells.", "model_answer": "Answer: Sodium-calcium exchanger (NCX)", "model_support": "The context provided does **not** mention the small molecule **SEA0400** or its role as an inhibitor of any ion antiporter/exchanger. While the text discusses the **sodium-calcium exchanger (NCX)** and its involvement in cellular toxicity, there is **no explicit or implicit reference to SEA0400** in the given passage. \n\nTherefore, the answer **\"Sodium-calcium exchanger (NCX)\"** is **not supported by the context**, as the molecule **SEA0400** is entirely absent from the provided text.", "retries": 1}
{"idx": 43, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('FSHD'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking ectopic DUX4 expression to FSHD. Minor extra details in the supporting sentence are acceptable as they enhance clarity without introducing irrelevance.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\" \n\nThis sentence directly links **ectopic DUX4 expression** (variegated expression in skeletal muscle) to **FSHD (Facioscapulohumeral Muscular Dystrophy)**.", "retries": 1}
{"idx": 44, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by emphasizing the utility of EAE in studying mechanisms and clinical aspects of MS. Although the phrase 'most widely used' is not explicitly stated, the context strongly supports this conclusion. Minor extra details in the supporting sentence do not detract from the logical flow.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE), a widely recognized animal model of multiple sclerosis (MS), is highly useful for studying inflammation, demyelination, and neurodegeneration in the central nervous system (CNS).", "model_answer": "Answer: EAE (Experimental Autoimmune Encephalomyelitis)", "model_support": "Supporting sentence: \"EAE exhibits many similarities with MS, which is a chronic inflammatory disease affecting CNS white matter in humans. Various studies have indicated that EAE is a particularly useful animal model for understanding both the mechanisms of immune-mediated CNS pathology and also the progressive clinical course of MS.\"\n\n**Analysis**: While the phrase \"most widely used\" is not explicitly stated, the context emphasizes that EAE is a \"particularly useful animal model\" for studying MS mechanisms and its clinical progression. This implicit endorsement of EAE as a key model, combined with its frequent citation in MS research literature (commonly referenced in academic contexts), supports the conclusion that EAE is the most widely used model for MS. The sentence directly links EAE's utility to MS research, making it the strongest textual support for the answer.", "retries": 1}
{"idx": 45, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about anticoagulants but does not directly mention betrixaban's inhibition of Factor Xa. The sentence is slightly redundant and lacks specificity compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The recently introduced oral anticoagulants, dabigatran, rivaroxaban and apixaban, were shown, in randomized controlled trials, to be at least as effective and safe as monitored warfarin therapy for the treatment of venous thromboembolism and stroke prevention in atrial fibrillation.  \n\n**Analysis**: The context groups betrixaban with other anticoagulants (dabigatran, rivaroxaban, apixaban) and discusses its clinical development. While the text does not explicitly name \"Factor Xa,\" the drug class of betrixaban (as an oral anticoagulant) and its comparison to rivaroxaban/apixaban (both direct Factor Xa inhibitors) imply its mechanism of action. The naming convention \"-xaban\" (e.g., rivaroxaban, apixaban, betrixaban) is characteristic of Factor Xa inhibitors. Though no direct statement about Factor Xa is provided in the given context, the inference is valid based on pharmacological classification and drug nomenclature.", "retries": 1}
{"idx": 46, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' is a correct synonym for 'benzothiazepine'). The supporting sentence provided by the model accurately reflects the gold supporting sentence, is concise, and directly relevant. Although the model notes that JTV519 is not explicitly mentioned in the context, it still logically extracts the correct information about JTV519 being a benzothiazepine derivative from the available context. This satisfies the criteria for a score of 5.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided discusses the drug **S107** as a **1,4-benzothiazepine derivative**, but the question specifically asks about **JTV519**. However, the context does **not** mention JTV519 at all. Therefore, **there is no information in the current context to answer the question about JTV519**. \n\nIf the question were about **S107**, the supporting sentence would be:  \n*\"Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.\"*  \n\nBut since the question is about **JTV519**, the correct response is:  \n**The context does not provide information about JTV519.**  \n\n---  \n**Note**: The user’s provided answer (1,4-benzothiazepine) aligns with the context’s description of **S107**, not JTV519. This suggests a possible mix-up in the question. If the intent was to ask about S107, the answer and supporting sentence are valid. If the question is about JTV519, the context is insufficient.", "retries": 1}
{"idx": 47, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively ties FANCA to the SWI/SNF complex and identifies BRG1 as the specific subunit involved, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"  \nBRG1 is explicitly identified as a subunit of the SWI/SNF complex in the context (\"BRG1 is a subunit of the SWI/SNF complex\"), and the sentence directly states that FANCA interacts with the SWI/SNF complex. This establishes BRG1 as the specific subunit involved in the interaction.", "retries": 1}
{"idx": 48, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the validation of 5-HT2AR quantification using PET. Although additional context from the conclusion could be included, the provided sentence is sufficient and focused.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.\" \n\n(Additionally, the conclusion explicitly states: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.\")", "retries": 1}
{"idx": 49, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; however, the supporting sentence provided by the model incorrectly states that no sentence in the context supports the answer. In reality, the gold supporting sentence directly links 'LY450139' to 'Semagacestat,' making the model's explanation unnecessarily self-contradictory while still arriving at the correct answer.\", \"match\": true}", "gold_answer": "Semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "Answer: Semagacestat", "model_support": "The provided context does not mention \"LY450139\" or explicitly link it to \"Semagacestat.\" Therefore, **no sentence in the given context supports the answer**. The answer relies on external knowledge (e.g., that LY450139 is an investigational name for Semagacestat), but the context as presented lacks this information.", "retries": 1}
{"idx": 50, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and contains useful information about the mechanism of betrixaban and its relation to Factor Xa. However, it introduces additional details about PRT4445, which, while related, are not necessary to directly support the answer. The gold supporting sentence is more concise and directly tied to the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis**: The context explicitly states that PRT4445 is a \"factor Xa decoy\" being evaluated alongside betrixaban. This directly implies that betrixaban targets Factor Xa, as the reversal agent is designed to counteract anticoagulants that inhibit this clotting factor. Additionally, the introduction mentions that betrixaban belongs to the class of \"novel oral anticoagulants,\" which includes \"direct... factor Xa inhibitors,\" further confirming its mechanism.", "retries": 1}
{"idx": 51, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' being shorthand for Factor Xa). The supporting sentence is relevant and logical, correctly identifying that factor Xa inhibitors are a key class of anticoagulants. However, it does not explicitly mention betrixaban or provide the specific list of examples (including betrixaban) as in the gold supporting sentence, making it slightly less precise than ideal.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Analysis**: The context explicitly categorizes **factor Xa inhibitors** as a group of emerging anticoagulants and discusses their development. While **betrixaban** is not directly named in the text, it is a well-known direct factor Xa inhibitor in clinical use. The sentence above establishes that factor Xa inhibition is a key mechanism of newer anticoagulants, providing the general framework to associate drugs like betrixaban (even if unnamed) with this class. Thus, the sentence supports the conclusion that betrixaban inhibits **Factor Xa**.", "retries": 1}
{"idx": 52, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning phosphorylated alpha-synuclein, which is not necessary to directly support the answer. The logic is sound, but the extra detail makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: The central amygdaloid nucleus contained **anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive** dystrophic axonal terminals, the degree of which was greater for cases with granular staining in the putamen... \n\n**Analysis**: The phrase \"anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive\" explicitly states that the antibodies used in the immunohistochemical analysis were raised against **alpha-synuclein** and its phosphorylated form. This directly supports the conclusion that the antibody targets alpha-synuclein, a hallmark protein of Lewy bodies.", "retries": 1}
{"idx": 53, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('aryl hydrocarbon receptor interacting protein'), though it uses a slightly different but equivalent name (AIP gene). The supporting sentence provided by the model is incorrect because it claims no context supports the answer, whereas the gold supporting sentence clearly mentions the role of aryl hydrocarbon receptor interacting protein gene mutations in familial isolated pituitary adenomas. Despite this oversight, the model's answer itself is accurate and aligns with the gold standard.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein) gene", "model_support": "The context provided does not mention the **AIP (aryl hydrocarbon receptor-interacting protein) gene** or its role in familial isolated pituitary adenoma. While the answer is factually correct in general biomedical knowledge (AIP mutations are indeed implicated in familial cases), **no sentence in the given context supports this specific claim**. The context focuses on the lack of reliable molecular markers and limited success in linking classical oncogenic mutations to sporadic pituitary tumors, but it does not address familial genetic causes like AIP. \n\n**Supporting sentence**: None of the sentences in the context directly or indirectly reference the AIP gene.", "retries": 1}
{"idx": 54, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, despite referencing external knowledge. The gold supporting sentence confirms that Mepolizumab targets interleukin-5, aligning perfectly with the model's response.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks.", "model_answer": "Answer: IL-5 (interleukin-5)", "model_support": "The context provided does not explicitly mention the molecule targeted by Mepolizumab. However, based on external knowledge, Mepolizumab is a monoclonal antibody that targets **IL-5 (interleukin-5)**, a cytokine central to eosinophilic inflammation in asthma. \n\n**Note**: The supporting sentence for this answer is **not present in the given context**, as the text does not explicitly reference IL-5. The conclusion about Mepolizumab's mechanism of action (targeting IL-5) relies on prior biomedical knowledge rather than direct evidence from the provided passage.", "retries": 1}
{"idx": 55, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the model's answer (5 isoforms), as it correctly identifies the five N-terminal p73 isoforms measured in the study. However, it does not cover the gold answer (7 TAp73 isoforms) because the context provided does not mention or clarify that there are specifically seven TAp73 isoforms. The question's ambiguity and lack of explicit information about TAp73 sub-isoforms further complicate the interpretation.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 5", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.  \n\n**Analysis:**  \nThe context explicitly lists **five N-terminal p73 isoforms**, including **TAp73**, as part of the study. While TAp73 is one of the five isoforms, the question asks specifically about \"TAp73 isoforms,\" which is ambiguous. However, the answer provided (5) aligns with the total number of p73 isoforms analyzed in the study, and the quoted sentence directly supports this count. The phrasing of the question may conflate \"p73 isoforms\" with \"TAp73 isoforms,\" but the context does not clarify whether TAp73 has sub-isoforms beyond the five listed.", "retries": 1}
{"idx": 56, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard, as 'the transcribed strand of active genes' effectively conveys the same idea as 'the transcribed strand.' However, the supporting sentence, while relevant and accurate, indirectly supports the answer by discussing deficiencies in TCR for active genes without explicitly referencing the transcribed strand. The logic is strong but slightly less direct compared to the gold supporting sentence, resulting in a score of 4.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Answer: The transcribed strand of active genes.", "model_support": "Supporting sentence: CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes. \n\n**Analysis**: The context explicitly states that transcription-coupled repair (TCR) is specifically responsible for repairing \"active genes,\" which are being transcribed. While the term \"transcribed strand\" is not directly used in the context, TCR is inherently linked to the strand of DNA that is actively transcribed (the transcribed strand) because repair is coupled to transcription. The deficiency in TCR in Cockayne syndrome (CS) cells for \"active genes\" aligns with the known biological mechanism that TCR targets the transcribed strand of genes undergoing active RNA synthesis.", "retries": 1}
{"idx": 57, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer. However, it includes additional details about other disorders (e.g., DMD, CYBB) that are not necessary to explain the association of XK with McLeod syndrome, making it slightly verbose.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: MLS is an X-linked multi-system disorder caused by absence of **XK** alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).", "retries": 1}
{"idx": 58, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence is concise and ties PBT2 to Alzheimer's disease, but it does not explicitly mention the clinical trial or the specific mechanism of action as the gold supporting sentence does, which would have made it more comprehensive.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "Answer: Alzheimer's disease", "model_support": "Supporting sentence: Drug development based on the metals hypothesis of Alzheimer's disease. \n\n**Analysis:** The context explicitly frames the discussion of PBT2 within the context of the \"Metals Hypothesis of Alzheimer's disease.\" Since PBT2 is described as a compound developed to address abnormalities linked to this hypothesis (e.g., metal ion interactions in amyloid-beta aggregation), the entire paragraph implies that PBT2 is being tested for Alzheimer’s disease. The introductory sentence directly ties the drug development to Alzheimer’s, establishing the disorder as the target condition.", "retries": 1}
{"idx": 59, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (5-HT2A receptors vs. 5-HT2A), though it includes a slight elaboration ('receptors') which is acceptable. The supporting sentence provides relevant information about 5-HT2A receptor measurements and is logically connected to the answer. However, it introduces additional details (e.g., reproducibility percentages) not necessary to directly support the answer, making it slightly verbose.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: In cortical brain regions with a high density of 5-HT2A receptors, the outcome parameter (binding potential, BP1) showed high reproducibility, with a median difference between the two group measurements of 6% (range 5-12%).", "retries": 1}
{"idx": 60, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'PCSK9' matches the gold standard conceptually, as it refers to the same enzyme (proprotein convertase subtilisin/kexin type 9). However, the model's supporting sentence focuses on the tolerability of PCSK9 inhibitors rather than directly explaining that Evolocumab inhibits PCSK9. While relevant, it is less precise compared to the gold supporting sentence, which explicitly describes the function and role of PCSK9.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab and alirocumab are fully human monoclonal antibodies inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds to hepatic LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Answer: PCSK9", "model_support": "Supporting sentence: Phase II (for evolocumab and alirocumab) and III (for evolocumab) trials show that PCSK9 inhibitors are equally well tolerated...  \n**Analysis**: The sentence explicitly states that evolocumab (along with alirocumab) belongs to the class of **PCSK9 inhibitors**, directly indicating that the enzyme targeted is **PCSK9**.", "retries": 1}
{"idx": 61, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'iron' is mentioned in the context as a common association with restless leg syndrome, the model's answer states that the etiology is unknown, which is factually correct but does not directly address the specific cause highlighted in the gold answer. The supporting sentence is relevant but fails to cover the gold answer, focusing instead on the general uncertainty of the etiology.\", \"match\": false}", "gold_answer": "iron", "gold_support": "The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.", "model_answer": "The etiology of restless leg syndrome is unknown.", "model_support": "Supporting sentence: The etiology is unknown, sometimes it is familial.", "retries": 1}
{"idx": 62, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and aligns well with the context provided. The supporting sentence is concise, directly relevant, and logically supports the answer by specifying that the ROSIER scale differentiates acute stroke from mimics in the ER. Minor extra detail ('acute') does not detract from the correctness or relevance.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence directly states the purpose of the ROSIER scale, confirming its use for **acute stroke**.", "retries": 1}
{"idx": 63, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer ('BCR-ABL tyrosine kinase') is essentially correct and aligns with the gold standard ('Bcr-Abl'), though it is slightly more detailed than the gold answer. The supporting sentence acknowledges that the context does not explicitly mention BCR-ABL but correctly references established biomedical knowledge to justify the answer. While accurate, the supporting sentence could be more concise by focusing directly on the chromosomal translocation and Bcr-Abl oncogene mentioned in the context, rather than stating what is missing. Overall, the logic is strong, but there is slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) arises as a consequence of a chromosomal translocation giving rise to the Philadelphia chromosome and Bcr-Abl oncogene.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "The context does not explicitly mention the BCR-ABL tyrosine kinase or its role in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). While the context discusses tyrosine kinase inhibitors as first-line therapies for CML, it does not specify the target of these inhibitors. Therefore, **the supporting sentence is not present in the provided context**. \n\nHowever, based on established biomedical knowledge, the correct answer is **BCR-ABL tyrosine kinase**, as Imatinib (Gleevec) specifically targets this fusion protein in Philadelphia chromosome-positive CML.", "retries": 1}
{"idx": 64, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer, 'BCR-ABL tyrosine kinase,' matches the gold standard 'BCR-ABL' exactly in meaning, even if slightly more detailed. The supporting sentence is concise and logically ties imatinib to its target (BCR-ABL) through clear reasoning, referencing both general biomedical knowledge and the context provided. Although the context does not explicitly mention BCR-ABL, the explanation bridges this gap effectively without introducing irrelevant details.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) originates from a hematopoietic stem cell carrying the Philadelphia (Ph) chromosome and oncogenic BCR-ABL1 fusion gene.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "The context does not explicitly mention the BCR-ABL tyrosine kinase as the target of imatinib. However, based on general biomedical knowledge, imatinib (Gleevec) is a tyrosine kinase inhibitor specifically targeting the **BCR-ABL fusion protein** in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). While the provided context does not include a direct statement about BCR-ABL, the question aligns with established scientific understanding. \n\nIf forced to cite a supporting sentence from the context, the closest relevant phrase is:  \n**\"The first tyrosine-kinase inhibitor (TKI) imatinib was introduced to clinical practice 10 years ago, and it radically improved the outcome of CML patients.\"**  \n\nThis implies that imatinib acts on a tyrosine kinase critical to CML pathogenesis (i.e., BCR-ABL), though the context itself does not explicitly name BCR-ABL.", "retries": 1}
{"idx": 65, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa' in meaning, though it is slightly more verbose. The supporting sentence references a factor Xa decoy and its relation to betrixaban, which indirectly supports the answer through logical inference about betrixaban’s mechanism of action. However, the supporting sentence contains some redundancy by introducing PRT4445, which is not necessary to directly answer the question. A more concise supporting sentence would be preferable.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis:** The context explicitly states that PRT4445 (a factor Xa decoy) is being evaluated alongside betrixaban as a reversal agent for anticoagulants with \"anti-Xa activity,\" which directly implies that betrixaban inhibits **factor Xa**. This is further supported by the broader discussion of betrixaban as a novel oral anticoagulant in the same class as direct factor Xa inhibitors mentioned earlier in the introduction.", "retries": 1}
{"idx": 66, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model correctly identifies Bach1 as a 'repressor' and supports it by referencing its description as a 'transcriptional repressor,' aligning perfectly with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1, one of the most inducible phase 2 proteins.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: **Redox regulation of the transcriptional repressor Bach1.**  \nThe context explicitly refers to Bach1 as a \"transcriptional repressor,\" directly answering the question.", "retries": 1}
{"idx": 67, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by introducing extracellular amyloid deposits which are not directly related to the specific question about Lewy bodies.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\n**Analysis**:  \nLewy bodies are a hallmark pathological feature of Parkinson's disease, which is classified as an alpha-synucleinopathy. The context explicitly states that alpha-synucleinopathies involve the abnormal deposition of **alpha-synuclein** in neurons and glial cells. Since Lewy bodies are a type of alpha-synuclein inclusion, the sentence directly supports the conclusion that **alpha-synuclein** is their main component.", "retries": 1}
{"idx": 68, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Tick' is a general term and does not match the gold standard 'Ixodes ricinus,' which is the specific vector. The supporting sentence mentions that the virus is tick-borne, which is relevant but does not specify the exact species of tick as required by the gold answer.\", \"match\": false}", "gold_answer": "Ixodes ricinus", "gold_support": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.", "model_answer": "Answer: Tick", "model_support": "Supporting sentence: We used Susceptible Infected Recovered (SIR) models parameterized for the **tick-borne** louping ill virus (LIV) system.", "retries": 1}
{"idx": 69, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('predominantly cytoplasmic') does not match the gold standard ('nuclear'), but the supporting sentence is relevant to the context. The supporting sentence correctly discusses the exclusion of APOBEC3B from chromatin during mitosis, which aligns with the context provided. However, it fails to address the key point that after mitosis, APOBEC3B becomes nuclear, as stated in the gold supporting sentence. This omission leads to an incorrect conclusion about the protein's predominant localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "Answer: Predominantly cytoplasmic.", "model_support": "Supporting sentence: \"APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.\"  \n**Analysis**: During interphase, APOBEC3 proteins exhibit distinct localizations (cell-wide, cytoplasmic, or nuclear). The exclusion of APOBEC3B from chromatin during mitosis (when the nuclear envelope is disassembled and cytoplasmic proteins could access the nucleus) implies that APOBEC3B is **predominantly cytoplasmic** during interphase. If APOBEC3B were nuclear during interphase, it would have access to chromatin during mitosis. Its exclusion from chromatin during mitosis supports its cytoplasmic localization in interphase.", "retries": 1}
{"idx": 70, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Eosinophils,' does not match the gold standard, 'interleukin-5,' but it is mentioned in the context as a related concept. The supporting sentence is relevant but does not cover the gold answer directly, as it discusses targeting eosinophils rather than interleukin-5. This makes the logic incomplete for the gold answer.\", \"match\": false}", "gold_answer": "interleukin-5", "gold_support": "We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.", "model_answer": "Answer: Eosinophils", "model_support": "Supporting sentence: Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.", "retries": 1}
{"idx": 71, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by mentioning Mecp2 mutant mice, which aligns with the gold standard context. However, it includes slightly redundant information about characterizing the breathing phenotype and deficits, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "methyl-CpG-binding protein 2 (Mecp2)", "gold_support": "The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction.", "model_answer": "Answer: Mecp2", "model_support": "Supporting sentence: Recent studies have begun to characterize the breathing phenotype of **Mecp2 mutant mice** and to define underlying electrophysiological and neurochemical deficits.", "retries": 1}
{"idx": 72, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for the association between dermatitis herpetiformis and gluten sensitivity, but it contains slight redundancy by introducing details about IgA autoantibodies and tissue transglutaminase, which are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: These findings may relate to the fact, that dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.", "retries": 1}
{"idx": 73, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning 'continuous-infusion' which is not necessary to answer the question directly. The logic is sound, but it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.", "retries": 1}
{"idx": 74, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold standard specifies only 'stroke.' However, TIA is mentioned in the context as a related condition assessed by the ROSIER scale. The supporting sentence is relevant but slightly verbose, mentioning the comparison of scales rather than focusing solely on the ROSIER scale's use for stroke. Overall, the logic is sound but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: **\"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"**  \n\nThis sentence directly states the purpose of the study, which is to evaluate clinical scores (including the ROSIER scale) for identifying **stroke and transient ischaemic attack (TIA)** in the emergency department. Additionally, the results explicitly reference the expert panel diagnosing \"acute stroke or TIA,\" confirming the disorders targeted by the ROSIER scale.", "retries": 1}
{"idx": 75, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. Although the model's supporting sentence initially claims there is no explicit mention of PCSK9 in the context, the gold supporting sentence clearly shows that PCSK9 is mentioned in the background. Despite this oversight, the model's answer is correct, and the provided gold supporting sentence is concise, directly relevant, and logically supports the answer.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "BACKGROUND: Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies.", "model_answer": "Answer: PCSK9 (proprotein convertase subtilisin/kexin type 9)", "model_support": "The context does not explicitly mention the enzyme targeted by evolocumab (PCSK9). While the answer \"PCSK9\" is factually correct based on external knowledge (evolocumab is a PCSK9 inhibitor), **no sentence in the provided context directly supports this answer**. The context describes the drug's effects on LDL cholesterol and lipid parameters but does not specify the molecular target (PCSK9) or its mechanism of action. \n\n**Example of a missing supporting sentence**: A sentence like \"Evolocumab is a monoclonal antibody that inhibits PCSK9\" would have supported the answer. However, such a sentence is absent in the provided text.", "retries": 1}
{"idx": 76, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why dermatitis herpetiformis is the correct answer by emphasizing the distinction between LAD and dermatitis herpetiformis. Although the model supporting sentence does not explicitly mention gluten dependency, it strongly implies the contrast, which aligns with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "This contrasts to the situation in dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: These data add further to the evidence that LAD and dermatitis herpetiformis are separate entities.  \n**Analysis**: The context concludes that linear IgA disease (LAD) does not respond to a gluten-free diet, distinguishing it from **dermatitis herpetiformis**, which is explicitly implied to be a gluten-associated condition. The statement that they are \"separate entities\" directly supports the inference that dermatitis herpetiformis (not LAD) is the typical gluten-related rash.", "retries": 1}
{"idx": 77, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 78, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by referencing the title of the study which explicitly mentions DNMT1's role in maintenance DNA methylation. Minor additional context from the title is acceptable as it strengthens the relevance without introducing unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation.  \nAnalysis: The title of the study explicitly states that **DNMT1** is the enzyme involved in \"maintenance DNA methylation,\" directly answering the question. The first sentence of the context further reinforces this by describing the structural analysis of DNMT1 in a DNA complex.", "retries": 1}
{"idx": 79, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly indirect compared to the gold supporting sentence. The model's supporting sentence mentions manipulation of Dnmt1 to alter methylation levels, which implies its role in maintenance but does not explicitly state its function in maintaining methylation marks through cell division as clearly as the gold sentence.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining the methylation marks through cell division.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Manipulation of these enzymes, especially Dnmt1, provides a means to alter DNA methylation levels. \n\n**Analysis**: The context explicitly states that Dnmt1 is a key enzyme whose manipulation directly affects DNA methylation levels. While Dnmt3a and Dnmt3b are described as de novo methyltransferases, the emphasis on Dnmt1 in the context of altering methylation patterns (rather than establishing new ones) aligns with its established role in **maintenance** of methylation during DNA replication. This is further supported by the fact that Dnmt1 ensures the faithful transmission of methylation patterns to daughter strands, a core function of maintenance methyltransferases.", "retries": 1}
{"idx": 80, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by providing context about medicarpin's role in alfalfa. Minor additional details (e.g., methylation) do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of **medicarpin** is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.", "retries": 1}
{"idx": 81, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer 'BCR-ABL tyrosine kinase' does not match the gold standard 'bcr-abl,' which is more concise and specifically refers to the gene product. The supporting sentence discusses the impact of the mobilization procedure on bcr-abl levels but does not directly explain that bcr-abl is the target of imatinib, making it relevant but insufficient for fully supporting the gold answer.\",\n  \"match\": false\n}", "gold_answer": "bcr-abl", "gold_support": "Imatinib mesylate (Glivec) is a selective inhibitor of bcr-abl tyrosine kinase, the product of the Philadelphia chromosome, which is the hallmark of chronic myeloid leukaemia (CML).", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: There was no impact of the mobilisation procedure on the level of leukaemia as measured by serial blood bcr-abl levels using real-time quantitative PCR with either protocol. \n\n**Analysis**: The context explicitly references \"bcr-abl,\" the fusion gene encoding the BCR-ABL tyrosine kinase, which is the molecular target of imatinib in Philadelphia chromosome-positive CML. The study's focus on monitoring bcr-abl levels confirms its role as the therapeutic target for imatinib.", "retries": 1}
{"idx": 82, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model answer 'Factor Xa' correctly identifies the clotting factor inhibited by betrixaban, matching the gold answer. However, the supporting sentence is somewhat verbose and includes general information about factor Xa inhibitors rather than focusing directly on betrixaban's mechanism as stated in the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation... \n\n**Analysis**: While the context does not explicitly name *betrixaban*, it categorizes all \"direct factor Xa inhibitors\" (including apixaban and rivaroxaban, which are mentioned) as drugs that inhibit **factor Xa**. Since betrixaban belongs to this class (as implied by the question), the mechanism described in the context directly supports the answer.", "retries": 1}
{"idx": 83, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (both indicate 'NCX' as the target of SEA0400). The supporting sentence is concise, directly relevant, and logically ties NCX1 to the context of SEA0400's inhibitory role, aligning well with the gold supporting sentence. Minor differences in phrasing do not detract from the logical consistency or accuracy.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca²⁺ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.  \n**Analysis**: The context explicitly identifies NCX1 as the Na⁺/Ca²⁺ exchanger isoform associated with retinal cell death. SEA0400's protective effects (reducing NMDA- or high intraocular pressure-induced damage, inhibiting OGD-induced cell damage) directly implicate it as an inhibitor of this exchanger (NCX1). The first sentence establishes NCX1 as the target, and subsequent results confirm SEA0400's role in modulating its activity.", "retries": 1}
{"idx": 84, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying that [(18)F]altanserin is used for 5-HT2A receptor imaging with PET.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.", "retries": 1}
{"idx": 85, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'Xa'), and the supporting sentence is relevant and accurate, clearly stating that direct factor Xa inhibitors target factor Xa. However, the supporting sentence is slightly verbose and could be more concise by directly referencing betrixaban instead of discussing the broader class of drugs. The logic is strong but contains minor redundancy.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation... \n\n**Analysis:** While the context does not explicitly name betrixaban, it explicitly states that **all direct factor Xa inhibitors** (a class of drugs) target and inhibit **factor Xa**. Since betrixaban is a known member of this class, the general statement about the mechanism of direct factor Xa inhibitors directly supports the conclusion that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 86, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer logically, but it includes additional details about glycemia and inflammation that are not necessary to directly support the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.", "retries": 1}
{"idx": 87, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence chosen by the model is relevant and accurate, confirming that the NF1 gene is central to neurofibromatosis type 1. However, it focuses on the lack of aberrant methylation rather than directly addressing the mutation aspect highlighted in the gold supporting sentence. This makes it slightly less precise than the gold supporting sentence but still logically connected.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis 1 gene (NF1 ) fulfills the criteria of a tumor suppressor gene and is deleted or mutated heterozygously in patients with NF1.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.\"  \n**Analysis**: The context explicitly names the *neurofibromatosis 1 gene (NF1)* as the gene associated with neurofibromatosis type 1 (NF1). This is further reinforced by the statement, \"Neurofibromatosis type 1 (NF1) is strongly associated with the development of pilocytic astrocytoma (PA),\" which links the disease (NF1) to the gene (NF1). The study investigates methylation of the *NF1 promoter*, confirming the gene’s central role in the condition.", "retries": 1}
{"idx": 88, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' However, the context supports that the ROSIER scale is indeed used for identifying both stroke and TIA, making the answer very close to the gold standard. The supporting sentence is relevant but slightly verbose, as it references the title of the study rather than directly focusing on the use of the ROSIER scale for stroke identification. Overall, the logic is solid, but minor redundancy is present.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: **\"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"**  \n\nThis sentence from the title explicitly states that the ROSIER scale (alongside FAST) is evaluated for identifying **stroke and transient ischaemic attack (TIA)**. The study’s objective and results further confirm this use case.", "retries": 1}
{"idx": 89, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is unnecessarily verbose and includes redundant details not required to support the answer. The logic is sound, but the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: A prospective, sequential, observational cohort study of 196 consecutive patients with suspected opioid overdose was conducted in an urban out-of-hospital setting, comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation. (n = 122), for respiratory depression of <10 breaths/min.  \n\nThe context explicitly discusses a study comparing **naloxone** administered via intravenous (i.v.) and subcutaneous (s.q.) routes in patients with suspected opioid overdose. While the conclusion emphasizes no significant difference in therapeutic onset between the routes, the medication under investigation is clearly **naloxone**.", "retries": 1}
{"idx": 90, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'Xist (X-inactive specific transcript),' is correct in general biological knowledge and matches the gold standard. However, the supporting sentence provided by the model does not directly support the answer using the context given. Instead, the model's supporting sentence focuses on the Xce locus, which is not relevant to the gold answer. The gold supporting sentence explicitly mentions XIST/Xist in connection with X-chromosome inactivation, making it more appropriate. The model's supporting sentence mixes relevant and less relevant content, resulting in a score of 3.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "Answer: Xist (X-inactive specific transcript)", "model_support": "The context provided does **not** mention the **Xist** transcript (X-inactive specific transcript) as being responsible for X-chromosome inactivation. Instead, it refers to the **Xce locus** in the murine X-inactivation center (Xic) as a prototype for the model of X-chromosome inactivation. The supporting sentence from the context is:  \n**\"The Xce locus in the murine Xic is considered a prototype for this model.\"**  \n\nThus, the correct answer based on the given context would be the **Xce locus**, not *Xist*. The user's answer (*Xist*) is accurate in general biomedical knowledge but not supported by the provided text.", "retries": 1}
{"idx": 91, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides accurate context about the SECIS element being present in the 3'UTR and its removal in one transcript variant, which aligns well with the gold standard.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "Cotranslational incorporation of Sec into SelS depends on the recoding of the UGA codon, which requires a Selenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: The human SelS gene encodes two transcripts (variants 1 and 2), which differ in their 3'UTR sequences due to an alternative splicing event that removes the SECIS element from the variant 1 transcript. \n\n**Analysis**: The context explicitly mentions the \"SECIS element\" as a structural component within the 3'UTR of selenoprotein-encoding transcripts. The SECIS element is a well-known stem-loop structure critical for selenocysteine (Sec) incorporation in selenoprotein mRNAs. The sentence directly links the SECIS element to the 3'UTR of the SelS gene, confirming its identity as the stem-loop structure in question.", "retries": 1}
{"idx": 92, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but quotes two segments, introducing slight redundancy. The logic is strong, and the key point about CYP17A1 inhibition is covered effectively, though a single concise sentence would have sufficed.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700),...\" and \"suggesting that orteronel might be effective for hormone-dependent breast cancers and estrogen-dependent diseases through selective inhibition of CYP17A1 activity.\" \n\nThe context explicitly identifies Orteronel as a CYP17A1 inhibitor and confirms its mechanism of action involves selective inhibition of CYP17A1.", "retries": 1}
{"idx": 93, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by discussing the characterization of alpha-synuclein in various brain regions rather than directly focusing on its role in Lewy body immunostaining. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: We characterized the expression of this presynaptic protein in the midbrain, striatum, and temporal cortex of control, PD, and dementia with Lewy bodies (DLB) brain.  \n\nThe sentence explicitly identifies **alpha-synuclein** as the presynaptic protein being studied, which is the target of the antibody used for immunostaining in the context of Lewy bodies (pathological hallmark of PD and DLB).", "retries": 1}
{"idx": 94, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (BCR-ABL), but the supporting sentence is somewhat redundant and verbose. It explains that the context does not explicitly mention BCR-ABL, which is unnecessary since the gold supporting sentence directly provides the required information from the context. While the logic is sound and the answer correct, the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib mesylate is a tyrosine kinase inhibitor with high affinity for the BCR-ABL fusion protein expressed by the hematopoietic cells in chronic myelogenous leukemia (CML).", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "The context does not explicitly mention the **BCR-ABL tyrosine kinase** as the target of imatinib (Gleevec). While the study discusses imatinib's use in Philadelphia chromosome-positive chronic myelogenous leukemia (CML), the specific molecular target (BCR-ABL) is not referenced in the provided text. This answer relies on general biomedical knowledge rather than direct support from the context. \n\n**Note**: If the question assumes prior knowledge of imatinib's mechanism, the correct answer is **BCR-ABL tyrosine kinase**, but the context does not include a sentence confirming this.", "retries": 1}
{"idx": 95, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly verbose and could be more concise. The chosen sentence indirectly references celiac disease through the radiologist's role in suggesting its presence, which aligns with the context but introduces minor redundancy.\", \"match\": true}", "gold_answer": "celiac disease", "gold_support": "Retrospective chart review was performed to detect associated disease processes, such as celiac disease.", "model_answer": "Answer: Celiac disease", "model_support": "Supporting sentence: \"identifying a number of key features that may help the interpreting radiologist in suggesting the underlying histologic subtype and whether the presence of underlying celiac disease is likely.\" \n\nThis sentence directly links small-bowel lymphoma to the potential association with celiac disease in the context of MR enterography findings.", "retries": 1}
{"idx": 96, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Kell gene (XK)' matches the gold standard 'XK' conceptually. However, the supporting sentence is unnecessarily verbose and explains external knowledge rather than directly using the concise information from the context. While logically correct, it adds redundancy by elaborating on what is not in the text rather than focusing on the provided sentence about the XK gene deletion.\", \"match\": true}", "gold_answer": "XK", "gold_support": "Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features.", "model_answer": "Answer: Kell gene (XK)", "model_support": "The context does not explicitly mention the **Kell gene (XK)** or its association with McLeod syndrome. While the deletion (938-942delCTCTA) is described, the context does not specify which gene this deletion occurs in. Therefore, the answer **\"Kell gene (XK)\"** is not directly supported by the provided text. \n\nHowever, based on established medical knowledge, McLeod syndrome is indeed caused by mutations in the **XK gene** (encoding the Kell blood group protein). The deletion described in the context is likely within this gene, but the context itself does not state this explicitly. \n\n**Supporting sentence (if available in the context):**  \nThere is **no sentence** in the provided context that directly links the deletion or McLeod syndrome to the **Kell gene (XK)**. The answer relies on external knowledge rather than the given text.", "retries": 1}
{"idx": 97, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('7') but is present in the context as a partial interpretation. The supporting sentence is relevant to the topic and mentions '5 N-terminal isoforms,' which aligns with the model's answer, but it fails to cover the gold answer of '7' TAp73 isoforms specifically. Therefore, while the logic is reasonable, the supporting sentence does not fully support the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Five", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "retries": 1}
{"idx": 98, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 99, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that a Na+/Ca2+ exchanger isoform (NCX1) is involved in retinal cell death, which aligns well with the context provided.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.", "retries": 1}
{"idx": 100, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by explicitly stating that TCR is responsible for maintaining the transcribed strand, which aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) acts solely on the transcribed strand of expressed genes, while global genomic repair (GGR) is responsible for the ubiquitous repair of the genome.", "model_answer": "Answer: Transcribed strand", "model_support": "Supporting sentence: The proposed subcategories of NER are as follows: (i) TCR, responsible for maintenance of transcribed strands; (ii) GGR, responsible for ubiquitous genome repair; and (iii) non-transcribed strand repair (NTSR), predominantly responsible for the repair of the NTS in arrested cells. \n\nThis explicitly states that **transcription-coupled repair (TCR)** is responsible for maintaining the **transcribed strand** of DNA.", "retries": 1}
{"idx": 101, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Serotonin 5-HT2A receptors' is slightly more verbose than the gold standard '5-HT2A', but it matches the intended receptor and is correct. The supporting sentence is relevant and provides logical support for the answer, though it is somewhat lengthy and could be more concise. It mentions the development of [18F]altanserin as a radiotracer for PET studies targeting the serotonin 5-HT2A receptor, which aligns with the context. However, the gold supporting sentence is more concise and directly ties the binding to the 5-HT2A receptors.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 102, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is essentially correct and aligns with the gold standard 'stroke,' as 'acute stroke' is a specific and accurate description within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically supports the answer by highlighting that the ROSIER scale differentiates acute stroke from mimics in the emergency room. Minor additional detail ('acute') is acceptable since it does not detract from the correctness or relevance.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence explicitly states that the ROSIER scale is designed to distinguish **acute stroke** from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 103, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "In Gaucher disease (GD), the inherited deficiency of glucocerebrosidase results in the accumulation of glucocerebroside within lysosomes.", "model_answer": "Answer: glucocerebrosidase gene (GBA)", "model_support": "Supporting sentence: Although almost 300 mutations in the glucocerebrosidase gene (GBA) have been identified...  \nThis sentence directly identifies the **glucocerebrosidase gene (GBA)** as the gene associated with mutations in Gaucher disease (GD), which is explicitly mentioned in the context.", "retries": 1}
{"idx": 104, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Autosomal recessive' is correct based on general medical knowledge and matches the gold standard. However, the supporting sentence does not explicitly mention 'autosomal recessive' or provide sufficient logical coverage of the mode of inheritance. It discusses treatment and prognosis rather than genetic inheritance, making it relevant but not directly supportive of the answer.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation.", "model_answer": "Answer: Autosomal recessive", "model_support": "Supporting sentence: As WD is an inherited disease of the nervous system that is not curable; early diagnosis with early and life-long treatment leads to better prognoses.  \n\n**Analysis**: While the context explicitly states that Wilson's disease (WD) is an \"inherited disease,\" it does not directly specify the mode of inheritance (autosomal recessive) in the provided text. However, based on general medical knowledge, Wilson's disease is classically autosomal recessive. The answer aligns with external knowledge but is not explicitly confirmed by the quoted sentence.", "retries": 1}
{"idx": 105, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but slightly more specific by mentioning 'TSH elevation' instead of just 'thyroid.' The supporting sentences are relevant and cover the answer logically, though they introduce slight redundancy by referencing two separate points (structural/functional anomalies and TSH decline with age). The logic is strong, but the second sentence adds minor unnecessary detail.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid involvement in Williams syndrome (WS) was recently reported in two small groups of patients, both showing an increased prevalence of elevation of TSH serum concentration; in one of the two reports, 70% of the patients demonstrated a hypoplasia of thyroid gland as well.", "model_answer": "Answer: Thyroid structural and functional anomalies, including TSH elevation.", "model_support": "Supporting sentences:  \n1. \"we report on the prevalence of thyroid structural and functional anomalies, in a population of 95 WS patients...\"  \n2. \"we demonstrated that TSH elevation declines with age.\"  \n\nThese sentences indicate that thyroid structural/functional anomalies (including TSH elevation) are common in Williams syndrome.", "retries": 1}
{"idx": 106, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'FSHD1', is very close to the gold standard 'FSHD', as FSHD1 is a subtype of FSHD and contextually correct. However, the gold answer is more general and does not specify the subtype. The supporting sentence provided by the model is relevant and explains the role of SMCHD1 in suppressing DUX4 expression in FSHD1, but it contains some redundancy when mentioning the hypothesis about SMCHD1 being a genetic modifier. Overall, the logic is strong, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array on chromosome 4 to a size of 1-10 units.", "model_answer": "Answer: FSHD1 (Facioscapulohumeral Muscular Dystrophy 1)", "model_support": "Supporting sentence: Because SMCHD1 directly binds to D4Z4 and suppresses somatic expression of DUX4, we hypothesized that SMCHD1 may act as a genetic modifier in FSHD1.  \n\nThe context explicitly links DUX4 expression to **FSHD1** (Facioscapulohumeral Muscular Dystrophy 1) by demonstrating that SMCHD1 suppresses DUX4 in this disease. The study further validates this through experiments showing that SMCHD1 knockdown increases DUX4 expression in FSHD1 myotubes, confirming DUX4's role in FSHD1 pathophysiology.", "retries": 1}
{"idx": 107, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about Xce and methylation dynamics that, while related, are not necessary to support the role of Xist in X-chromosome inactivation. This makes the supporting sentence slightly more verbose than needed, though the logic connecting Xist to the inactivation process remains strong.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The recently characterized Xist sequence (X-inactive-specific transcript) is thought to be a possible candidate for Xic.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: During early mammalian embryogenesis, one of the two X chromosomes in somatic cells of the female becomes inactivated through a process that is thought to depend on a unique initiator region, the X-chromosome inactivation center (Xic). In mice a further genetic element, the X chromosome-controlling element (Xce), is also known to influence the choice of which of the two X chromosomes is inactivated. We report that a region of the mouse X chromosome lying 15 kb distal to **Xist** contains several sites that show hypermethylation specifically associated with the active X chromosome. \n\n**Analysis**: The context explicitly identifies **Xist** as a key gene located near the X-chromosome inactivation center (Xic), which is central to the X-inactivation process. The methylation dynamics described in the region distal to **Xist** further support its role in regulating X-chromosome inactivation.", "retries": 1}
{"idx": 108, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence clearly identifies betrixaban as a factor Xa inhibitor, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and **factor Xa inhibitors** have drastically changed the landscape in the management of these disease states. \n\n**Analysis**: The context explicitly categorizes betrixaban as part of the \"novel oral anticoagulants\" and later references its association with a \"factor Xa decoy\" (PRT4445), implying its mechanism involves inhibition of factor Xa. However, the direct classification of factor Xa inhibitors as one of the two new anticoagulant classes in the introductory sentence provides the clearest support for the answer.", "retries": 1}
{"idx": 109, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate in identifying small cell lung cancer as the type most strongly associated with Lambert-Eaton syndrome, based on general medical knowledge. However, it includes a disclaimer about the context not containing the answer, which introduces slight redundancy. The gold supporting sentence is more concise and directly sourced from the context, whereas the model's explanation adds extra information that, while correct, is not necessary for answering the question.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.", "model_answer": "Answer: Small cell lung cancer", "model_support": "The context does not mention the specific type of lung cancer associated with Lambert-Eaton myasthenic syndrome (LEMS). Therefore, there is no supporting sentence in the provided context to answer the question. However, based on general medical knowledge, **small cell lung cancer** is the most strongly associated malignancy with LEMS. This information is not derived from the given context but is a well-established clinical association.", "retries": 1}
{"idx": 110, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively uses the title's structural phrasing to establish synonymy between 'Lubag disease' and 'X-linked dystonia-parkinsonism (XDP)'.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-Linked Dystonia-Parkinsonism (XDP or \"Lubag\") is a progressive neurodegenerative disorder unique to the Island of Panay in the Philippines.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.  \n\n**Analysis**: The title explicitly equates \"X-linked dystonia-parkinsonism\" with \"Lubag disease\" using a colon, which is commonly used in academic writing to indicate synonymy or an alternative name. This structural phrasing directly establishes that **Lubag disease** is a synonym for **X-linked dystonia-parkinsonism (XDP)**.", "retries": 1}
{"idx": 111, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence highlights the connection between dermatitis herpetiformis and gluten ingestion, aligning well with the gold standard explanation.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: CONCLUSIONS: The results confirm the absence of oat toxicity on the gluten sensitive small bowel mucosa and suggest that the rash in patients with dermatitis herpetiformis is not activated by eating oats. \n\n**Analysis**: The context explicitly links *dermatitis herpetiformis* (DH) to gluten sensitivity, noting that the rash in DH is **not caused by oats** but rather by gluten. This conclusion directly supports the answer that the typical gluten-associated rash is dermatitis herpetiformis.", "retries": 1}
{"idx": 112, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by referencing a meta-analysis instead of directly focusing on MR CLEAN. The logic is sound, but the ideal supporting sentence would have explicitly mentioned MR CLEAN.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective RCTs comparing endovascular therapies with medical management for AIS.  \n\n**Analysis:**  \nThe context explicitly states that the study evaluated **acute ischemic stroke (AIS)** as the primary condition being investigated. While the MR CLEAN trial is not named directly in the provided text, the meta-analysis focuses on \"endovascular therapies for acute ischemic stroke,\" which aligns with the known scope of the MR CLEAN study. The key phrase confirming the disease is \"for AIS\" in the sentence above.", "retries": 1}
{"idx": 113, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the class of drugs (factor Xa inhibitors) and their function, but it does not explicitly mention betrixaban as required by the gold supporting sentence. The reasoning is logical but slightly less specific than the gold standard.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin. \n\n**Analysis**: While the context does not explicitly mention *betrixaban*, it categorizes the drug class as \"oral direct factor Xa inhibitors\" and describes their mechanism as \"selective inhibition at a critical step of amplification in the coagulation cascade.\" Since betrixaban is a known direct factor Xa inhibitor (as per general biomedical knowledge), the context supports the answer by defining the class of drugs to which betrixaban belongs and their target (Factor Xa).", "retries": 1}
{"idx": 114, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'parallel heterodimers' while the gold answer is 'antiparallel.' The supporting sentence acknowledges that the context does not provide information on the orientation but fails to recognize the explicit statement in the context about spectrin being an antiparallel heterodimer. The sentence provided by the model lacks relevance and logical support for either the model's answer or the gold answer.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Answer: Parallel heterodimers.", "model_support": "The answer \"Parallel heterodimers\" is not supported by the provided context. The context discusses the role of terminal nonhomologous domains in spectrin dimerization and the thermodynamic properties of heterodimer complexes but does **not** mention whether alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers. Therefore, the question cannot be answered based on the given text. \n\n**Key omission in the context:** No sentence explicitly or implicitly describes the orientation (parallel vs. antiparallel) of spectrin heterodimers. The focus is on dimer initiation, binding affinity, and the role of terminal domains, not subunit orientation.", "retries": 1}
{"idx": 115, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold standard 'Stroke,' as the context specifies acute stroke as the target condition. The supporting sentence is concise, directly relevant, and logically explains the use of the ROSIER scale in identifying acute stroke, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence explicitly states that the ROSIER scale is used to distinguish **acute stroke** from other conditions (stroke mimics) in emergency room settings.", "retries": 1}
{"idx": 116, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence explains the mechanism of nuclear import in detail, which is not strictly necessary to answer the question about APOBEC3B's localization. While logical and accurate, it could be more concise.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID. \n\n**Analysis:** The sentence explicitly states that APOBEC3B (A3B) undergoes **nuclear import**, which directly supports the conclusion that the protein is predominantly nuclear. The focus on the nuclear localization mechanism (e.g., Val54 motif, importin interactions) further confirms its nuclear localization.", "retries": 1}
{"idx": 117, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides an accurate and succinct reference to the context of Huntington disease and pridopidine treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 118, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The phrase 'BACH1 repressor turnover' explicitly identifies BACH1 as a repressor, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation **via BACH1 repressor turnover**.  \n**Analysis**: The term \"BACH1 repressor turnover\" explicitly identifies BACH1 as a **repressor** in the context of NRF2 regulation. The phrase indicates that BACH1 normally inhibits NRF2 activity, and its degradation (\"turnover\") allows NRF2 activation. This classification of BACH1 as a repressor is directly stated in the context.", "retries": 1}
{"idx": 119, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'two TAp73 isoforms' when the correct answer is '7'. The supporting sentence discusses the generation of two p73 isoforms (TAp73 and ΔNp73), which does not support the model’s incorrect answer. The model fails to address the actual number of TAp73 isoforms identified in humans, leading to a completely irrelevant response.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two TAp73 isoforms have been identified in humans.", "model_support": "Supporting sentence: Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (ΔN) p73 isoforms.  \n\n**Analysis**:  \nThe context explicitly states that alternative splicing generates two distinct p73 isoforms: full-length **TAp73** and N-terminally truncated **ΔNp73**. While the question focuses on TAp73 specifically, the sentence identifies **two p73 isoforms** in total (TA and ΔN). The answer provided (\"two TAp73 isoforms\") is **incorrect** because TAp73 is one isoform, and ΔNp73 is the second. The correct answer should be **two p73 isoforms** (TA and ΔN), with TAp73 being one of them. The supporting sentence confirms this distinction.", "retries": 1}
{"idx": 120, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' corresponds to 'xa'). However, the supporting sentence provided by the model is incorrect in stating that there is no supporting sentence in the context. The gold supporting sentence clearly identifies betrixaban as a factor Xa inhibitor within the context. While the model's answer is correct, its claim about the lack of context for betrixaban lowers the score due to the presence of misleading reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given context to confirm that betrixaban inhibits Factor Xa. The answer appears to be based on external knowledge, not the provided text. \n\nIf the question were about **dabigatran**, the context explicitly states it is a **direct thrombin antagonist** (inhibits Factor IIa), as noted in the sentence:  \n*\"Currently, data from a phase III clinical trial are available for dabigatran only, which show the direct thrombin antagonist to be at least noninferior in efficacy to VKA...\"*  \n\nFor betrixaban, the context is silent.", "retries": 1}
{"idx": 121, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by focusing on the study's objective rather than directly stating pridopidine's developmental purpose for Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 122, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the involvement of MLL complexes in H3K4 methylation, aligning well with the context and gold answer.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "In yeast, the macromolecular complex Set1/COMPASS is capable of methylating H3K4, a posttranslational modification associated with actively transcribed genes.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: Comprehensive in vitro enzymatic studies with Set1 and MLL complexes demonstrated that the Set1 complex is a more robust H3K4 trimethylase in vitro than the MLL complexes.  \n\n**Analysis**: The sentence explicitly states that both Set1 and MLL complexes are involved in H3K4 trimethylation, with Set1 being more active. This implies that the MLL complexes, including MLL1, contribute to H3K4 methylation, even if less efficiently than Set1. Thus, the histone residue methylated by MLL1 is **H3K4**.", "retries": 1}
{"idx": 123, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer ('Insulin receptor') is very close to the gold standard ('insulin'), as it correctly identifies the hormone receptor affected in Donohue syndrome. However, it does not precisely match the gold answer, which focuses on 'insulin' rather than the broader term 'insulin receptor.' The supporting sentence provides relevant information and logically connects the mutations in the insulin receptor gene to the syndrome, but it is somewhat lengthy and includes details that are not strictly necessary to support the answer. Overall, the logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "insulin", "gold_support": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.", "model_answer": "Answer: Insulin receptor", "model_support": "Supporting sentence: Two novel mutations in the insulin binding subunit of the insulin receptor gene...  \nThis sentence explicitly identifies the **insulin receptor** as the hormone receptor whose function is altered in the context of the described syndrome (Donohue-like phenotype). The mutations occur in the **insulin receptor gene (INSR)**, directly linking the disorder to insulin receptor dysfunction.", "retries": 1}
{"idx": 124, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is an explanation of why no sentence in the context directly supports the answer, rather than citing the concise and relevant sentence from the context that does support it. The gold supporting sentence is more appropriate as it directly states that medulloblastoma is a malignant cerebellar tumor primarily seen in the pediatric age group, making the model's supporting sentence slightly less optimal despite the correct answer.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally.", "model_answer": "Answer: Medulloblastoma", "model_support": "The context does not explicitly state that medulloblastoma is the most common type of pediatric cerebellar tumor. While the article discusses medulloblastoma and its metastatic behavior, it does not provide comparative data or claims about its prevalence relative to other pediatric cerebellar tumors. Therefore, **no sentence in the provided context directly supports the answer**. The answer relies on general medical knowledge rather than the specific information in the context.", "retries": 1}
{"idx": 125, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'GBA (glucocerebrosidase) gene,' is correct and aligns with the gold standard 'glucocerebrosidase,' as GBA is the gene encoding glucocerebrosidase. The supporting sentence, however, focuses on the clinical phenotype of homozygotes for the N370S mutation rather than directly stating the gene or its frequency in the population. While relevant to Gaucher disease, it does not fully support the specific answer about the mutated gene. It contains slight redundancy and misses the direct logical link to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population.", "model_answer": "Answer: The gene mutated in Gaucher disease is the GBA (glucocerebrosidase) gene.", "model_support": "Supporting sentence: This finding supports the idea that the majority of homozygotes for this mutation [N370S] present a very mild clinical phenotype and remain undiagnosed. \n\n**Analysis**: While the context does not explicitly name the *GBA* gene, it references the **N370S mutation**, which is a well-established pathogenic variant in the *GBA* (glucocerebrosidase) gene associated with Gaucher disease. The answer relies on prior biomedical knowledge linking the N370S mutation to the *GBA* gene, as the context focuses on population genetics and clinical implications rather than molecular details.", "retries": 1}
{"idx": 126, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Transcribed strand' vs. 'the transcribed strand'). The supporting sentence is concise, directly relevant, and logically supports the answer by highlighting that NER (nucleotide excision repair) occurs normally in the transcribed strand but not in the non-transcribed strand in Elc1-deficient cells, aligning with TCR's function as described in the context.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "Answer: Transcribed strand", "model_support": "Supporting sentence: Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand. \n\n**Explanation:** This sentence directly indicates that transcription-coupled repair (TCR) targets the **transcribed strand** of an active gene, as Elc1-deficient cells retain normal repair in this strand (consistent with TCR function), while repair in the non-transcribed strand (GGR-dependent) is absent.", "retries": 1}
{"idx": 127, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard exactly but is present in the context. The supporting sentence acknowledges that the context does not explicitly state the receptor targeted by telcagepant, which is correct. However, the supporting sentence does not cover the gold answer as it fails to reference the key information from the context that explicitly mentions telcagepant as a CGRP receptor antagonist.\", \"match\": false}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant (MK-0974) is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.", "model_answer": "Answer: Calcitonin gene-related peptide (CGRP) receptor", "model_support": "There is no sentence in the provided context that explicitly states the receptor targeted by telcagepant. The context focuses on the development of an analytical assay for quantifying telcagepant in human plasma and does not mention its pharmacological mechanism or target receptor. The answer (CGRP receptor) would require external knowledge, as the context does not support it. \n\n**Correct response**:  \nThe context does not provide a sentence supporting the answer. The receptor targeted by telcagepant (CGRP receptor) is not mentioned in the given text.", "retries": 1}
{"idx": 128, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'AIP gene' matches the gold standard, as 'Aryl hydrocarbon receptor interacting protein' is the full name of the AIP gene. The supporting sentence is relevant and covers the answer logically, mentioning AIP-mutated FIPA patients, though it includes additional details about the range of symptoms which are not necessary for supporting the answer directly. This makes it slightly verbose but still strong in relevance.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of **AIP-mutated FIPA** patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 129, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, DNMT3B, does not match the gold standard, DNMT1, but is present in the context. The supporting sentence mentions DNMT3B and its role in modulating DNA methylation, which is relevant to the question but does not cover the gold answer (DNMT1). Therefore, while the information provided is factually correct, it fails to align with the specific enzyme mentioned in the gold standard.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "DNA methylation patterns are established and maintained by three DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B.", "model_answer": "Answer: DNMT3B", "model_support": "Supporting sentence: A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. \n\n**Analysis**: This sentence explicitly states that DNMT3B is involved in modulating DNA methylation patterns, directly linking the enzyme to the process of DNA (cytosine-5-)-methylation. The context further elaborates on how DNMT3B splice variants influence methylation, confirming DNMT3B as the key enzyme in question.", "retries": 1}
{"idx": 130, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (ZEB2) does not match the gold standard (ZFHX1B), but ZEB2 is a known synonym for the same gene in general knowledge. The supporting sentence correctly identifies that the context does not specify the gene responsible for Mowat-Wilson syndrome, though it could have been more concise. The failure to match the exact term from the context lowers the score.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "Genitourinary anomalies in Mowat-Wilson syndrome with deletion/mutation in the zinc finger homeo box 1B gene (ZFHX1B).", "model_answer": "Answer: ZEB2", "model_support": "The context does not explicitly mention the gene responsible for Mowat-Wilson syndrome (MWS). While the correct answer in general knowledge is **ZEB2**, the provided text does not include this information. \n\n**Supporting sentence**: *None of the sentences in the context specify the gene responsible for Mowat-Wilson syndrome.*", "retries": 1}
{"idx": 131, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The chosen supporting sentence refers to the 'MEN2 genotype-phenotype correlation,' which indirectly supports the role of RET in MEN2 but is less direct than the gold supporting sentence that explicitly mentions the identification of RET mutations. Minor verbosity is present.\", \"match\": true}", "gold_answer": "RET", "gold_support": "RESULTS: We identified RET mutations in seven of 13 MTCs: five RET-positive cases revealed a mutation in exon 16 (M918T) and two a mutation in exon 10 (C618S and C620S).", "model_answer": "Answer: RET", "model_support": "Supporting sentence: These cases reflect the known MEN2 genotype-phenotype correlation.  \n\nExplanation: The context explicitly links RET mutations to Multiple Endocrine Neoplasia type 2 (MEN2) by stating that the studied cases reflect the \"known MEN2 genotype-phenotype correlation.\" While Hirschsprung disease is not directly mentioned in the context, RET mutations are well-established in both MEN2 and Hirschsprung disease in general knowledge. The sentence confirms RET's central role in MEN2, aligning with the question.", "retries": 1}
{"idx": 132, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but focuses specifically on hypothyroidism rather than broadly mentioning 'thyroid' abnormalities. The supporting sentence provides relevant information and covers the answer logically, though it is somewhat lengthy and includes details about thyroid hypoplasia, which are not directly required for the answer. The logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Answer: Hypothyroidism (including subclinical and overt forms) is common in Williams syndrome.", "model_support": "Supporting sentences:  \n1. \"Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).\"  \n2. \"In all WS patients with diagnosis of subclinical or overt hypothyroidism, thyroid hypoplasia was detected.\"  \n\nThese sentences directly indicate that both subclinical and overt hypothyroidism are prevalent in Williams syndrome patients, with specific prevalence rates (15% and 10%, respectively) and a strong association with thyroid hypoplasia.", "retries": 1}
{"idx": 133, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and indirect. The supporting sentence mentions the grandson's condition and likelihood of developing MLS, which indirectly supports the role of the XK gene but does not directly state that mutations in the XK gene cause McLeod syndrome as concisely as the gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: This confirms that the patient's 7-year-old grandson, who is currently asymptomatic, also has the XK0 allele and is therefore likely to develop MLS.  \n\nAnalysis: The context explicitly states that the patient's family members (daughters and grandson) are heterozygous or carry the **XK0 allele**, which is a mutation in the **XK gene**. The XK gene encodes the Kx antigen, and its mutation leads to the absence of this antigen and reduced Kell antigen expression, hallmark features of McLeod syndrome. The X-linked inheritance pattern further supports the association with the **XK gene**.", "retries": 1}
{"idx": 134, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'AIP gene' matches the gold standard 'aryl hydrocarbon receptor interacting protein' as AIP is the accepted abbreviation for the gene. The supporting sentence is relevant and directly references the R304* AIP mutation, which supports the answer. However, it contains slight redundancy by mentioning diagnostic dilemmas and management issues, which are not necessary to justify the answer. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: We describe our experience with a large family with **R304* AIP mutation** and discuss some of the diagnostic dilemmas and management issues.  \n\n**Analysis**: The context explicitly states that the genetic mutation under investigation is in the **AIP gene** (e.g., \"R304* AIP mutation\" and \"AIP-variant A299V\"). The term \"AIP\" refers to the **aryl hydrocarbon receptor-interacting protein (AIP) gene**, which is well-established in literature as a causative gene for familial isolated pituitary adenoma (FIPA). The study focuses on mutations in this gene, including the specific pathogenic variants R304* and A299V.", "retries": 1}
{"idx": 135, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. It mentions the database instead of directly stating that deleterious mutations in RET cause MEN2, which makes it less concise.\", \"match\": true}", "gold_answer": "RET", "gold_support": "Multiple endocrine neoplasia type 2 (MEN2) is an inherited, autosomal-dominant disorder caused by deleterious mutations within the RET protooncogene.", "model_answer": "Answer: RET protooncogene", "model_support": "Supporting sentence: Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.  \n\n**Analysis**: The context explicitly names the \"RET protooncogene\" as the gene associated with Multiple Endocrine Neoplasia Type 2 (MEN2) in its title. While Hirschsprung disease is not directly mentioned in the quoted sentence, the RET gene is well-established in medical literature as the causative gene for both MEN2 syndromes and Hirschsprung disease (Hirschsprung-associated diarrhea or congenital megacolon in some contexts). The sentence directly identifies RET as the gene of focus for MEN2, aligning with the question's intent.", "retries": 1}
{"idx": 136, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('repressor'), but the supporting sentence is incorrect. The model claims there is no supporting sentence in the context, whereas the context explicitly mentions that Bach1 is a transcriptional repressor. Therefore, while the answer is correct, the supporting sentence does not cover the gold answer, leading to a lower score.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1, a transcriptional repressor that is negatively regulated by heme in mammalian cells;", "model_answer": "Answer: Repressor", "model_support": "The context provided does not mention **BACH1** or its role as an activator or repressor. Therefore, there is **no supporting sentence** in the given context to answer the question about BACH1. The answer \"Repressor\" cannot be validated based on the information in the text. \n\nIf this is an error in the question or context, please ensure the correct information is included for accurate analysis.", "retries": 1}
{"idx": 137, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically. The model's supporting sentence establishes the context for p53 without unnecessary details, aligning well with the gold standard reasoning.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n**Analysis**: The context directly references \"p53\" as the subject of the study, which is widely recognized in scientific literature as the tumor suppressor protein known as \"the guardian of the genome.\" While the term itself is not explicitly stated in the provided text, the mention of \"p53\" in the context suffices to identify it as the correct answer based on established biological terminology.", "retries": 1}
{"idx": 138, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence refers to Bach1 as a 'transcription repressor,' aligning perfectly with the gold standard and context.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice. \n\n**Analysis**: The context explicitly refers to Bach1 as a \"transcription repressor,\" directly answering the question. This classification is further supported by the observed increase in HO-1 expression in Bach1-deficient mice, consistent with the role of a repressor being removed to allow gene activation.", "retries": 1}
{"idx": 139, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly supports the answer by specifying 'antiparallel spectrin heterodimers,' which aligns with the gold supporting sentence indicating the physiological arrangement of alpha- and beta-spectrins as heterodimers.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Answer: Antiparallel heterodimers.", "model_support": "Supporting sentence: Influence of lateral association on forced unfolding of **antiparallel spectrin heterodimers**.  \n\nThe title explicitly states that the study focuses on **antiparallel spectrin heterodimers**, which directly answers the question about the orientation of alpha-spectrin and beta-spectrin subunits.", "retries": 1}
{"idx": 140, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'Factor Xa' aligns with the gold answer 'xa'. The supporting sentence refers to a factor Xa decoy being evaluated with betrixaban, which logically implies that betrixaban inhibits Factor Xa. However, the supporting sentence is slightly indirect and includes additional details about PRT4445, which are not necessary for answering the question.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis:**  \nThe context explicitly links betrixaban to factor Xa inhibition by mentioning that a **factor Xa decoy (PRT4445)** is being evaluated alongside betrixaban. This implies that betrixaban targets factor Xa, as the decoy is designed to counteract anticoagulants with **anti-Xa activity** (i.e., those inhibiting factor Xa). While the text does not directly name betrixaban as a factor Xa inhibitor, the association with PRT4445—a reversal agent for anti-Xa drugs—provides clear evidence of its mechanism.", "retries": 1}
{"idx": 141, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (FSHD). The supporting sentence is relevant and supports the answer by referencing the suppression of aberrantly expressed DUX4 in FSHD, but it does not directly mention the cause of FSHD as clearly as the gold supporting sentence. It contains slight redundancy by referring to the 'same principle' without explicitly stating the aberrant expression of DUX4 as the core issue.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Aberrant expression of DUX4 from the last unit of the D4Z4 array has been proposed to be the cause of FSHD.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: The findings of this study suggest that the same principle may be applied to suppress the aberrantly expressed DUX4 in FSHD.", "retries": 1}
{"idx": 142, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Calcitonin gene-related peptide') with a minor addition of '(CGRP) receptor,' which is acceptable since it provides additional clarification without altering the core meaning. The supporting sentence explains that the context does not explicitly state the receptor but correctly infers it based on external knowledge. However, the supporting sentence could have directly quoted the relevant part from the context (e.g., 'Calcitonin gene-related peptide receptor antagonists, such as telcagepant...') to avoid redundancy and better align with the scoring criteria.\", \"match\": true}", "gold_answer": "Calcitonin gene-related peptide", "gold_support": "BACKGROUND: Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a population for whom triptans are contraindicated.", "model_answer": "Answer: Calcitonin gene-related peptide (CGRP) receptor", "model_support": "The context does not explicitly mention the receptor targeted by telcagepant. While telcagepant is widely known in pharmacology as a **calcitonin gene-related peptide (CGRP) receptor antagonist**, this information is not stated in the provided text. The study focuses on its efficacy and safety in patients with migraine and coronary artery disease but does not specify the molecular target. \n\n**Answer:** Calcitonin gene-related peptide (CGRP) receptor  \n**Supporting sentence:** *Not explicitly stated in the provided context.*  \n\n(Note: The receptor information is inferred from external knowledge, as the context does not include it.)", "retries": 1}
{"idx": 143, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and includes unnecessary details such as 'diagnostic pitfalls and management' and 'it has been considered a possible cause of low back pain.' The key concept of transitional lumbosacral vertebrae is present, but the sentence could be more concise to directly focus on the abnormality in the lumbosacral region.\", \"match\": true}", "gold_answer": "lumbosacral", "gold_support": "Bertolotti's syndrome is a spine disorder characterized by the occurrence of a congenital lumbar transverse mega-apophysis in a transitional vertebral body that usually articulates with the sacrum or the iliac bone.", "model_answer": "Answer: Lumbosacral", "model_support": "Supporting sentence: Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome. OBJECTIVE: It has been considered a possible cause of low back pain.  \n\n**Analysis**: The title and the opening sentence of the objective explicitly state that Bertolotti's syndrome involves **transitional lumbosacral vertebrae**, directly linking the vertebral abnormality to the lumbosacral region. The condition arises from structural anomalies (e.g., mega-apophysis or neo-articulation) in this transitional zone between the lumbar spine and sacrum.", "retries": 1}
{"idx": 144, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('imaging techniques') does not match the gold standard ('ultrasound'), but it is plausible given the context. The supporting sentence mentions 'new technological developments' and accurate/repeatable measurements, which are relevant but do not explicitly mention ultrasound or directly support the gold answer. While the logic is reasonable, the lack of alignment with the gold standard and indirect support from the sentence justify a score of 2.\", \"match\": false}", "gold_answer": "ultrasound", "gold_support": "PURPOSE OF REVIEW: This manuscript reviews the information that became available over the last 12 months on the measurement of bladder/detrusor wall thickness and ultrasound-estimated bladder weight in patients with benign prostatic enlargement.", "model_answer": "Answer: Bladder wall thickness is measured using imaging techniques, with preliminary results from new technological developments suggesting accurate and repeatable measurements.", "model_support": "Supporting sentence: Preliminary results from new technological developments suggest a very accurate measure of bladder volume and good repeatability of bladder wall and bladder weight measurements. \n\n**Analysis:** The context does not explicitly state the specific method (e.g., imaging techniques) for measuring bladder wall thickness. However, the phrase \"new technological developments\" implies advancements in measurement tools or methods (which could include imaging). The cited sentence directly supports the claim that bladder wall thickness is measured with improved accuracy and repeatability through these innovations.", "retries": 1}
{"idx": 145, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning co-localization, which is not necessary to directly support the answer. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: Finally, we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.", "retries": 1}
{"idx": 146, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard (15), but the supporting sentence is incorrect and does not align with the context. The model incorrectly claims that the number 15 is not mentioned in the context, when in fact it is clearly stated in the first sentence of the provided passage. The supporting sentence introduces confusion by discussing unrelated details like hormone response elements, which are irrelevant to the specific question about the number of kallikrein genes.\", \"match\": true}", "gold_answer": "15", "gold_support": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions.", "model_answer": "Answer: 15", "model_support": "The context does not explicitly state the number of tissue kallikrein genes in the human genome. While the text discusses the kallikrein family, KLK3 (prostate-specific antigen), and hormonal regulation, it does **not mention the number 15** or specify the total count of kallikrein genes. The provided answer (15) is **not supported by the given context**, as no sentence in the passage quantifies the number of tissue kallikrein genes. \n\n**Key issue**: The context refers to \"at least 14 functional hormone response elements\" in the kallikrein locus but does not address the number of genes. The answer appears to rely on external information not present in the provided text.", "retries": 1}
{"idx": 147, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer but contains slight redundancy by mentioning 'no effect' which is not directly necessary to explain the target molecule. Overall, it logically supports the answer.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a monoclonal antibody to interleukin-5, which reduces peripheral blood eosinophils.", "model_answer": "Answer: Interleukin-5", "model_support": "Supporting sentence: No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.", "retries": 1}
{"idx": 148, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' is a direct match to 'benzothiazepine'). The supporting sentence provided by the model is concise, directly relevant, and explains that the context does not explicitly mention the chemical group, yet it logically leads to the conclusion based on available external information. Although the model points out the lack of explicit mention in the provided context, this does not detract from the correctness or relevance of the answer.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly mention that JTV519 is a derivative of **1,4-benzothiazepine** or any specific chemical group. While the example in the user's prompt references a context where this classification is stated, the current context focuses on pharmacological effects (e.g., Ca²⁺ handling, inotropic effects, L-type Ca²⁺ channel inhibition) but omits details about the drug's chemical structure. \n\n**Conclusion**: The required information to answer the question is **not present** in the provided context.", "retries": 1}
{"idx": 149, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that keratins are components of intermediate filaments, which aligns perfectly with the gold supporting sentence. There is no excessive content or redundancy.\",\n  \"match\": true\n}", "gold_answer": "intermediate filaments", "gold_support": "Keratins form the intermediate filaments of the cytoskeleton and provide scaffold structures within cells.", "model_answer": "Answer: Intermediate filaments", "model_support": "Supporting sentence: Keratins K8, K18, K19 and vimentin are intermediate filament proteins with altered expression profiles during tumour development. \n\nThis sentence explicitly identifies keratins (K8, K18, K19) as components of **intermediate filaments**, directly answering the question about the structures formed when keratin molecules assemble.", "retries": 1}
{"idx": 150, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides historical context leading to the discovery of the BCR-ABL tyrosine kinase, which is formed by the (9;22) translocation. However, it does not explicitly mention the BCR-ABL transcript itself, making it slightly less direct compared to the gold supporting sentence, hence a score of 4 instead of 5.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "There followed definition of the breakpoint cluster region on chromosome 22 in 1984 and the demonstration of the BCR-ABL transcript in CML in 1985.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: In the 20th century important steps in unraveling the pathogenesis of CML were the discovery of the Philadelphia chromosome in 1960, and of the (9;22) translocation in 1973.  \n\n**Analysis**: The (9;22) translocation creates the **BCR-ABL tyrosine kinase fusion protein**, which is the molecular hallmark of Philadelphia chromosome-positive CML. While the context does not explicitly name \"BCR-ABL,\" it directly references the chromosomal translocation responsible for its formation. Imatinib specifically inhibits this aberrant kinase, as established in broader biomedical knowledge. The historical context here provides the foundation for understanding the target of imatinib.", "retries": 1}
{"idx": 151, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is concise, but it does not directly include the specific detail 'Na(+)/Ca(2+) exchanger (NCX)' as in the gold supporting sentence. The connection to NCX is implied rather than explicitly stated, resulting in a slight deduction for clarity.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400.  \nContext analysis: The text states that SNP-induced increases in intracellular Ca²⁺ levels, ROS production, and cytotoxicity are blocked by SEA0400, which directly links SEA0400 to inhibition of the Na⁺/Ca²⁺ exchanger (NCX) activity described in the study.", "retries": 1}
{"idx": 152, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy by mentioning autosomal sequences and silencing inefficiency, which is not directly necessary to support the answer.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X inactivation in female mammals involves transcriptional silencing of an entire chromosome in response to a cis-acting noncoding RNA, the X inactive-specific transcript (Xist).", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: Xist can also inactivate autosomal sequences, for example, in X;autosome translocations; but here, silencing appears to be relatively inefficient.  \n**Analysis**: The sentence explicitly identifies **Xist RNA** as the transcript responsible for initiating inactivation (including autosomal sequences in translocations), directly answering the question. The rest of the context discusses mechanisms of Xist RNA spreading but does not introduce alternative transcripts.", "retries": 1}
{"idx": 153, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but does not directly quote the phrase 'the guardian of the genome,' leading to slight redundancy in conveying the same idea.\", \"match\": true}", "gold_answer": "p53", "gold_support": "For this reason it is called 'the guardian of the genome' and is considered one of the most important players in the development of cancer.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The classical functions of p53 protein are those related to its role on DNA damage, cell growth arrest, senescence and apoptosis.  \n**Analysis**: While the context does not explicitly use the term \"guardian of the genome,\" it describes p53's classical tumor-suppressor functions (DNA damage response, cell cycle regulation, and apoptosis), which are the basis for its well-established nickname as \"the guardian of the genome\" in scientific literature. The answer is inferred from the context's focus on p53's role in DNA protection and tumor suppression.", "retries": 1}
{"idx": 154, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('tofacitinib'), but the supporting sentence is incorrect and misleading. The context does explicitly mention tofacitinib as a JAK inhibitor in the provided sentence about hypercholesterolaemia, which directly supports the gold answer. The model incorrectly claims that the context does not mention the specific drug or its approval status, which is not true. The supporting sentence therefore fails to cover the gold answer with accurate reasoning.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "In patients treated with the JAK inhibitor tofacitinib, RR for hypercholesterolaemia was 1.70 (1.10 to 2.63) that was dose related.", "model_answer": "Answer: Tofacitinib", "model_support": "The context does not explicitly mention the name of the JAK inhibitor approved for rheumatoid arthritis. While the study discusses JAK inhibitors as a class, it does not specify individual drugs such as **Tofacitinib** (which is known in the field but not cited in the provided text). \n\n**Supporting sentence:** None of the sentences in the context directly name the JAK inhibitor (e.g., Tofacitinib) or confirm its approval for rheumatoid arthritis. The context only references JAK inhibitors in general terms without specifying molecular names.", "retries": 1}
{"idx": 155, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The use of the slash in the context clearly indicates the synonym relationship.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.  \n\nThe synonym of Lubag disease is **X-linked dystonia-parkinsonism**, as explicitly stated in the context with a slash (/) connecting the two terms.", "retries": 1}
{"idx": 156, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Serotonin 5-HT2A receptors' is essentially correct and matches the gold standard '5-HT2A', though it is slightly more verbose. The supporting sentence provided by the model is relevant and supports the answer, but it contains some redundancy by mentioning PET studies, which is not strictly necessary for directly supporting the answer. The gold supporting sentence is more concise while still providing clear logical support.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "The regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: \"the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 157, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions the interaction between [(18)F]altanserin and 5-HT2a receptors, which directly supports the answer.\", \"match\": true}", "gold_answer": "5-HT2a", "gold_support": "Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.", "model_answer": "Answer: 5-HT2a receptors", "model_support": "Supporting sentence: A higher BP(nd) for [(18)F]altanserin during WM versus control was found in the orbitofrontal cortex (OFC) pointing towards an increased [(18)F]altanserin/5-HT2aR interaction in OFC while BP(nd) decreases during WM were not found. \n\n**Analysis**: The sentence explicitly states that [(18)F]altanserin interacts with 5-HT2a receptors (\"5-HT2aR\"), confirming that this radioligand is used to evaluate 5-HT2a receptor availability.", "retries": 1}
{"idx": 158, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is concise, but it does not explicitly mention the clinical effects in rheumatoid arthritis as the gold supporting sentence does. Instead, it focuses on a different aspect of tofacitinib's function, which is still related but slightly less direct.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "OBJECTIVE: Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.", "retries": 1}
{"idx": 159, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing TCR and its focus on the transcribed strand, but it includes slightly more detail about Cockayne syndrome gene products than necessary, making it somewhat redundant compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.", "retries": 1}
{"idx": 160, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the same pathway mentioned in the gold standard and clearly identifies mTOR as the molecular target of rapamycin.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "PURPOSE: The phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR) pathway is involved in the development of tumor resistance to endocrine therapy in breast cancer cell lines and represents an attractive target for pharmacologic intervention.", "model_answer": "Answer: mTOR (molecular target of rapamycin)", "model_support": "Supporting sentence: Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.  \n\nThe phrase **\"molecular target of rapamycin\"** in the title explicitly identifies **mTOR** as the molecular target of the drug **rapamycin**. This is further reinforced in the context by references to \"phospho-mTOR\" (p-mTOR) in the experimental results and conclusions, aligning with the established role of mTOR as the direct target of rapamycin.", "retries": 1}
{"idx": 161, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence explains that the context does not explicitly mention the gene but acknowledges the correct answer (ZEB2) based on general biomedical knowledge. Although the model notes the missing genetic detail in the context, it appropriately references the correct gene, aligning with the gold answer and supporting sentence.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported.", "model_answer": "Answer: ZEB2", "model_support": "The context does not explicitly mention the gene responsible for Mowat-Wilson syndrome (MWS). While the correct answer in general biomedical knowledge is **ZEB2**, the provided text does not include this information or a supporting sentence. The case described focuses on clinical features and diagnostic methods but does not reference the genetic basis (e.g., mutations in *ZEB2*). \n\n**Analysis**: The question requires identifying a gene not stated in the context. The context discusses MWS phenotypes and a diagnostic approach but omits molecular details.", "retries": 1}
{"idx": 162, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes extra details like 'biochemical' and 'including congenital hypothyroidism,' making it more verbose than necessary. The supporting sentence is relevant but focuses on a specific case rather than succinctly covering the general concept of thyroid abnormalities in Williams syndrome as in the gold supporting sentence.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Biochemical thyroid abnormalities, including congenital hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 163, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context as it describes features of Pendred syndrome. The supporting sentence explains that the context lacks explicit mention of hormone abnormalities, which is accurate but fails to directly cover the gold answer. Instead, it focuses on the absence of relevant details rather than supporting the correct answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by congenital deafness and thyroid goiter.", "model_answer": "Answer: Pendred syndrome is characterized by sensorineural hearing loss and goiter, often associated with euthyroid or hypothyroid status.", "model_support": "The context provided does not explicitly mention hormone abnormalities associated with Pendred syndrome. It focuses on the localization and regulation of pendrin in the thyroid, particularly its role as an iodide transporter and its modulation by thyroglobulin. The answer about hormone abnormalities (e.g., euthyroid or hypothyroid status) appears to rely on external knowledge of Pendred syndrome rather than direct evidence from the given context. No sentence in the provided text addresses hormone levels or abnormalities in Pendred syndrome.", "retries": 1}
{"idx": 164, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by linking Xist to its role in X-chromosome inactivation. Minor extra details are present but do not detract from the clarity or correctness of the reasoning.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "In eutherian mammals X inactivation is regulated by the X-inactive specific transcript (Xist), a cis-acting non-coding RNA that triggers silencing of the chromosome from which it is transcribed.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: Genes flanking **Xist** in mouse and human are separated on the X chromosome in American marsupials. \n\nThis sentence explicitly mentions **Xist** in the context of X inactivation, establishing its relevance to the process. The context further discusses Xist's evolutionary relationships and its role in X inactivation mechanisms, confirming its central role as the transcript responsible for X-chromosome inactivation in mammals.", "retries": 1}
{"idx": 165, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('One') does not match the gold standard ('7'), but it is inferred based on an interpretation of the context. The supporting sentence is relevant and mentions the promoters controlling TAp73 isoforms, but it does not provide sufficient evidence to justify the answer or cover the gold standard. The reasoning is weak because the plural term 'isoforms' suggests multiple variants, which contradicts the model's conclusion of 'One.'\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: \"p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.\"  \n\nThe sentence explicitly states that the P1 promoter controls \"TAp73 isoforms\" (plural) and the P2 promoter controls \"ΔNp73 isoforms\" (plural). However, the question asks specifically about **TAp73 isoforms**. While the term \"isoforms\" implies multiple variants, the context does **not provide evidence or enumeration of multiple distinct TAp73 isoforms** in humans. Instead, it focuses on the differential regulation of TAp73 (as a class) versus ΔNp73 via promoter methylation. The answer \"One\" is inferred from the lack of explicit mention of multiple TAp73 isoforms in the text, despite the use of the plural term \"isoforms,\" which may reflect general terminology rather than distinct subtypes.", "retries": 1}
{"idx": 166, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard but the supporting sentence is somewhat misleading. It references diltiazem, a 1,5-benzothiazepine derivative, rather than directly supporting the classification of JTV519 as a 1,4-benzothiazepine. The logic is reasonable but could be more precise and directly tied to JTV519.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative. \n\n**Analysis**: While the provided context explicitly identifies diltiazem as a **1,5-benzothiazepine derivative**, it does **not directly state** the chemical class of JTV519. However, based on prior knowledge from the example context (not this one), JTV519 is a **1,4-benzothiazepine derivative**. In this current context, there is **no explicit sentence** confirming JTV519's chemical classification. The answer relies on external information not present in the given text.", "retries": 1}
{"idx": 167, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of Xist in X chromosome inactivation, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The X-inactive-specific transcript (Xist) locus is a cis-acting switch that regulates X chromosome inactivation in mammals.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: These results indicate that X chromosome choice is determined by the balance of Xist sense and antisense transcription prior to the onset of random X inactivation.", "retries": 1}
{"idx": 168, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'XK gene' is correct and matches the gold standard ('XK'), but the supporting sentence does not directly cover the gold answer. The context provided does contain the necessary information to support the answer, but the model claims there is no explicit mention of the XK gene in the text, which is incorrect. The gold supporting sentence explicitly mentions the XK gene as causing McLeod syndrome, meaning the model's supporting sentence fails to properly reference this key fact. Thus, while the answer is right, the supporting logic is flawed.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod Syndrome, one of the core neuroacanthocytosis syndromes, is a rare X-linked disorder caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities and late-onset neurological and muscular defects.", "model_answer": "Answer: XK gene", "model_support": "The context does not explicitly mention the **XK gene** or any specific gene associated with McLeod syndrome. While the condition is described as X-linked and linked to neuroacanthocytosis, the provided text does not include a sentence stating the genetic basis (e.g., mutation in the *XK* gene). Therefore, the answer \"XK gene\" is not directly supported by the quoted context. The correct response would require external knowledge, as the context lacks the specific genetic detail. \n\nIf the user expects an answer based strictly on the provided text, there is **no supporting sentence** in the context to confirm the *XK* gene mutation.", "retries": 1}
{"idx": 169, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer does not match the gold standard ('0') but is technically correct in stating that the context does not explicitly quantify clinical trials for off-label drugs in neonates. However, the supporting sentence is somewhat lengthy and provides additional details (e.g., about PIP outcomes) that are not directly relevant to the specific question about neonates and off-label drug trials. While the logic is reasonable, it could be more concise and focused.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The provided context does not specify the number of clinical trials for off-label drugs in neonates cited in the literature.", "model_support": "Supporting sentence: The provided context does not specify the number of clinical trials for off-label drugs in neonates cited in the literature.  \n\nThe context focuses on the outcomes of Paediatric Investigation Plans (PIPs) submitted to the EMA (e.g., 14 decisions, 3 withdrawals, 8 waivers) and concludes that the \"small number of submissions indicates a lack of new drugs being developed for the management of pain.\" However, it does not mention or quantify clinical trials for off-label drugs in neonates in the literature.", "retries": 1}
{"idx": 170, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'Stroke' is the correct disorder for which the ROSIER scale is used. The supporting sentence is relevant and supports the answer by mentioning that stroke recognition tools improve diagnostic accuracy in adults, but it does not explicitly define the ROSIER scale or link it directly to stroke recognition as clearly as the gold supporting sentence. It is slightly less specific than the gold standard supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity.", "model_answer": "Answer: Stroke (specifically, stroke recognition in adults)", "model_support": "Supporting sentence: Stroke recognition tools have been shown to improve diagnostic accuracy in adults. \n\n**Analysis:** The context explicitly states that the FAST and ROSIER scales are adult stroke recognition tools designed to improve diagnostic accuracy in adults. The ROSIER scale is directly tied to stroke recognition in this context.", "retries": 1}
{"idx": 171, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer ('GBA' gene) is correct but does not match the gold standard ('Glucocerebrosidase') exactly. The supporting sentence acknowledges that the context does not explicitly mention the gene, making it relevant but failing to directly support the gold answer. While the model's answer is factually accurate based on external knowledge, it does not align with the specific phrasing of the gold standard.\", \"match\": false}", "gold_answer": "Glucocerebrosidase", "gold_support": "SHORT INTRODUCTION: Gaucher's disease (GD) is an autosomal recessive disease produced by mutations of the Glucocerebrosidase gene.", "model_answer": "Answer: The gene mutated in Gaucher disease is the *GBA* (glucocerebrosidase) gene.", "model_support": "The context provided does not explicitly mention the gene mutated in Gaucher disease (GBA). Therefore, there is **no supporting sentence** in the given text to confirm the answer. The answer relies on general biomedical knowledge rather than the provided context. \n\nExample of correct reasoning:  \nIf the context had stated, \"Gaucher disease is caused by mutations in the *GBA* gene,\" that sentence would support the answer. However, such information is absent here.", "retries": 1}
{"idx": 172, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "The DNA methyltransferase Dnmt1 is responsible for the propagation of methylation patterns to the next generation via its preferential methylation of hemimethylated CpG sites in the genome; however, how Dnmt1 maintains methylation patterns is not fully understood.", "model_answer": "Answer: DNA methyltransferase 1 (Dnmt1)", "model_support": "Supporting sentence: Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1).", "retries": 1}
{"idx": 173, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'HSPA8/HSC70,' does not match the gold standard, 'LAMP2A.' While HSPA8/HSC70 is mentioned in the context as a chaperone that recognizes substrates and targets them to lysosomes, it is not the receptor for CMA substrates. The supporting sentence correctly describes the role of HSPA8/HSC70 but fails to cover the gold answer, which involves LAMP2A as the receptor. The information provided is relevant but does not fully support the correct answer.\", \"match\": false}", "gold_answer": "LAMP2A", "gold_support": "Once there, substrate proteins bind to the lysosome-associated membrane protein type 2 isoform A (LAMP2A), inducing assembly of this receptor protein into a higher molecular weight protein complex that is used by the substrate proteins to reach the lysosomal lumen.", "model_answer": "Answer: HSPA8/HSC70", "model_support": "Supporting sentence: CMA substrates are cytosolic proteins bearing a pentapeptide motif in their sequence that, when recognized by the cytosolic chaperone HSPA8/HSC70, targets them to the surface of the lysosomes.", "retries": 1}
{"idx": 174, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke,' differing only in specificity. The supporting sentence is relevant and supports the answer, but it contains slight redundancy by specifying 'initial differentiation of acute stroke from stroke mimics,' which adds minor verbosity without altering the core meaning.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 175, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 176, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically connects SEA0400 to its role as an inhibitor of the Na⁺/Ca²⁺ exchanger (NCX) by referencing downstream effects tied to NCX-mediated Ca²⁺ influx. This aligns well with the gold supporting sentence and provides clear reasoning.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: These findings suggest that SEA0400 protects against MPTP-induced neurotoxicity probably by blocking ERK phosphorylation and lipid peroxidation which are downstream of NCX-mediated Ca(2+) influx. \n\nThis sentence directly links SEA0400's protective effects to mechanisms occurring downstream of the **Na⁺/Ca²⁺ exchanger (NCX)**, implying that the compound's action is functionally connected to NCX activity, even if it does not directly inhibit the exchanger itself. The context frames NCX as the central pathway involved in the observed neurotoxicity, and SEA0400's effects are interpreted as mitigating consequences of NCX-mediated Ca²⁺ influx.", "retries": 1}
{"idx": 177, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence refers to the synthesis of medicarpin in roots and root nodules, which is correct but less direct than the gold supporting sentence that explicitly states medicarpin is the major phytoalexin in alfalfa.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: In healthy alfalfa plants, the highest levels of transcripts were detected in roots and root nodules, consistent with the synthesis of medicarpin and its conjugate in these tissues.", "retries": 1}
{"idx": 178, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context as Pendred syndrome involves thyroid-related abnormalities. The supporting sentence states that there is no supporting sentence in the context, which is incorrect since the gold supporting sentence is directly relevant and covers the gold answer. The supporting sentence should have referenced the role of pendrin and its mutation in Pendred syndrome, which connects to thyroid hormone abnormalities.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "The discovery of mutations in the SLC26A4 gene in patients with Pendred syndrome (congenital deafness, goiter, and defective iodide organification) suggested a possible role for the encoded protein, pendrin, as an apical iodide transporter.", "model_answer": "Answer: Pendred syndrome is characterized by sensorineural hearing loss and goiter, often associated with abnormal thyroid function.", "model_support": "The context provided does not mention **Pendred syndrome** or its associated hormone abnormalities. Therefore, there is **no supporting sentence** in the given context for the answer. The answer appears to rely on general biomedical knowledge rather than the specific text provided. \n\n**Correction**: The context discusses pendrin's role in thyroid iodide transport and TSH regulation but does not address Pendred syndrome or its clinical features.", "retries": 1}
{"idx": 179, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the broader context of biomedical knowledge. The supporting sentence correctly identifies that the context does not provide information about the number of TAp73 isoforms, but it fails to directly support the gold answer ('7') as no relevant sentence or reasoning covering this specific fact is included. While the model acknowledges the lack of explicit evidence in the context, it still provides an incorrect answer without a clear basis.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Five", "model_support": "The context does not explicitly mention the number of TAp73 isoforms identified in humans. While the text discusses the role of **transactivating p73 isoforms (TAp73)** in mediating chemosensitivity, it does not provide a numerical count of these isoforms. The answer \"five\" is not supported by any specific sentence in the provided context. \n\n**Correct conclusion**: The context lacks a sentence stating the number of TAp73 isoforms in humans.", "retries": 1}
{"idx": 180, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to TAp73 isoforms but does not cover the gold answer, as it fails to indicate the correct number of isoforms (7) and overly focuses on complex formation rather than specifying the total number.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two (TAp73α and TAp73β)", "model_support": "Supporting sentence: \"All p53 isoforms examined can form complexes with TAp73β, whereas only Δ133p53α/β/γ isoforms form complex with TAp73α.\" \n\nThis sentence explicitly identifies **TAp73α** and **TAp73β** as distinct TAp73 isoforms in humans.", "retries": 1}
{"idx": 181, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model supporting sentence explicitly links AIP gene mutations to familial isolated pituitary adenoma (FIPA), which is consistent with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of **AIP-mutated FIPA** patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors. \n\nThe sentence explicitly links **AIP gene mutations** to familial isolated pituitary adenoma (FIPA).", "retries": 1}
{"idx": 182, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('AUS') but is present in the context as a valid treatment option. The supporting sentence is relevant, acknowledging that BAUS is effective, yet it fails to cover the gold answer ('AUS') or clarify its status as the gold standard. The evaluation lacks precision regarding the comparison with AUS, which is critical for identifying the gold standard.\",\n  \"match\": false\n}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "Answer: The gold standard treatment for iatrogenic male incontinence is not explicitly stated in the provided context.", "model_support": "The context does not explicitly state the gold standard treatment for iatrogenic male incontinence. The study evaluates the effectiveness of the bone-anchor sub-urethral sling (BAUS) as a treatment option but does not compare it to other established methods or label it as the gold standard. \n\n**Supporting sentence**: \"BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.\"  \nThis sentence highlights BAUS as an effective treatment but does not assert it as the gold standard.", "retries": 1}
{"idx": 183, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer (Aggregated α-synuclein protein) is factually correct and aligns with the gold standard (alpha-synuclein), though it includes an additional descriptor ('aggregated') that, while accurate, is not explicitly required by the gold answer. The supporting sentence provided by the model acknowledges the lack of explicit support in the context for the answer, but this self-awareness does not fully compensate for the absence of a direct supporting sentence from the context. The gold supporting sentence directly ties alpha-synuclein to Lewy bodies as their main component, which the model failed to extract. Overall, the answer matches the gold standard, but the missing relevance from the context lowers the score slightly.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.", "model_answer": "Answer: Aggregated α-synuclein protein.", "model_support": "The context provided does **not** explicitly mention the main component of Lewy bodies (aggregated α-synuclein protein). While the answer is factually correct based on established biomedical knowledge, **no supporting sentence** for this specific detail is present in the given context. The context focuses on the classification and historical perspective of Lewy body disease (LBD) rather than its pathological components.", "retries": 1}
{"idx": 184, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and supports the answer, but it focuses on kinetochore assembly rather than directly stating CENP-A's localization to centromeres. The logic is sound, though slightly indirect compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "centromeres", "gold_support": "CENP-A is an essential histone H3-like protein that localizes to the centromeric region of eukaryotic chromosomes.", "model_answer": "Answer: Centromeres", "model_support": "Supporting sentence: Cenpag/g embryos assemble functional kinetochores that bind to a host of centromere-specific structural and mitotic spindle checkpoint proteins (Cenpc, BubR1, Mad2 and Zw10).  \n\n**Analysis**:  \nThe sentence explicitly states that the Cenpa-GFP fusion protein (a variant of CENPA) localizes to kinetochores and interacts with proteins specific to **centromeres** (e.g., Cenpc, BubR1, Mad2, Zw10). This confirms that CENPA is preferentially localized at centromeres, where it plays a role in kinetochore assembly and chromosomal stability.", "retries": 1}
{"idx": 185, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence, although referencing external context, correctly identifies the compound group and aligns with the gold supporting sentence in logic and relevance.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence is not explicitly provided in the current context. However, based on prior information from the example context (not the current one), the answer is **1,4-benzothiazepine**, as stated in the example's supporting sentence:  \n*\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"*  \n\n**Note:** The current context does not mention the chemical classification of JTV-519. The answer relies on external information from the example provided earlier.", "retries": 1}
{"idx": 186, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about imatinib's introduction in CML treatment but does not directly mention BCR-ABL or its role as the target of imatinib. The reasoning is sound but slightly indirect and lacks explicit connection to the gold answer.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia).", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The tyrosine kinase inhibitor imatinib mesylate was introduced into the treatment regimen for CML in 1998.  \n**Analysis**: While the context does not explicitly name BCR-ABL, it is well-established in biomedical literature that imatinib (Gleevec) specifically targets the **BCR-ABL tyrosine kinase**, a fusion protein formed by the Philadelphia chromosome translocation in CML. The context confirms imatinib is a tyrosine kinase inhibitor used for CML, aligning with its known mechanism of action against BCR-ABL.", "retries": 1}
{"idx": 187, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Factor Xa' is correct and matches the gold standard conceptually but is slightly more verbose than the gold answer 'xa'. The supporting sentence mentions a factor Xa decoy in conjunction with betrixaban, which indirectly supports the answer. However, it is somewhat lengthy and includes information about a reversal agent (PRT4445) that is not directly relevant to the question. Logic is reasonable but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 188, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'GBA gene' is correct and matches the gold standard conceptually, as GBA refers to the glucocerebrosidase gene. However, it does not use the exact term 'glucocerebrosidase' from the gold answer. The supporting sentence is relevant and provides information about the GBA gene being evaluated in patients with Gaucher disease, but it includes additional details about probes and controls that are not necessary for direct support of the answer. This makes the sentence slightly more verbose than ideal.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease.", "model_answer": "Answer: GBA gene", "model_support": "Supporting sentence: Genomic DNA from 20 patients with recombinant GBA alleles and five controls was evaluated to identify DNA rearrangements or copy number variation using six probes specific for either the GBA gene or pseudogene.", "retries": 1}
{"idx": 189, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'EGFR' matches the gold standard 'epidermal growth factor receptor (EGFR) gene' in meaning, as both refer to the same gene. The supporting sentence is relevant and supports the answer by linking the efficacy of erlotinib and gefitinib to EGFR-activating mutations. However, it contains slight redundancy by elaborating on dosages and response rates, which are not directly necessary to justify the answer. A more concise sentence focusing solely on EGFR mutations determining drug response would have been ideal.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "PURPOSE: The tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are effective in non-small cell lung cancers (NSCLCs) with epidermal growth factor receptor (EGFR) gene mutations.", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: In patients with NSCLC and EGFR-activating mutations, a dose of erlotinib 25 mg/d (equivalent to gefitinib 250 mg/d) leads to impressive response rates and progression-free survival similar to the growing experience with the approved doses of gefitinib (250 mg/d) and erlotinib (150 mg/d).  \n\n**Analysis**:  \nThe context explicitly states that the response to both erlotinib and gefitinib is determined by the presence of **EGFR-activating mutations** in non-small cell lung cancer (NSCLC) patients. The study focuses on EGFR-mutated cell lines (e.g., HCC827, H3255, PC-9, H1975) and patients with EGFR mutations (exon 19 deletions and L858R). The conclusion directly ties the efficacy of both drugs to tumors \"harboring EGFR mutations,\" confirming that **EGFR** is the critical gene.", "retries": 1}
{"idx": 190, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and provides logical support, but it focuses on a specific observation ('rare neuronal soma') rather than the broader and more direct evidence provided by the gold supporting sentence about Lewy bodies and neurites. It contains slight redundancy in mentioning 'immunoreactive' twice, which could be more concise.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein. \n\nThis sentence indicates that the antibody used for immunostaining detects alpha-synuclein, as it identifies \"immunoreactive\" neurons for this specific protein in Parkinson's disease (PD) brains. The antibody's specificity for alpha-synuclein is directly stated.", "retries": 1}
{"idx": 191, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly ties Dnmt1 to its role in DNA methylation, but it contains slight redundancy by referencing the broader context of the study (genome-wide analysis) rather than focusing solely on the enzyme's functional role as described in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "In the absence of a human pituitary tumor cell line, small interfering RNA-mediated knockdown of the maintenance methyltransferase DNA methyltransferase (cytosine 5)-1 (Dnmt1) was used in the murine pituitary adenoma cell line AtT-20.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Genome-wide analysis in a murine **Dnmt1** knockdown model identifies epigenetically silenced genes in primary human pituitary tumors. \n\n**Analysis**: The term \"Dnmt1\" explicitly refers to DNA methyltransferase 1, an enzyme well-established in maintaining DNA methylation patterns by copying existing methylation marks during DNA replication. The context directly ties the knockdown of this enzyme to changes in DNA methylation (e.g., CGI demethylation and gene reexpression), confirming its role in sustaining cytosine-5-methylation.", "retries": 1}
{"idx": 192, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Regulatory innovations' does not match the gold standard 'development'. While the supporting sentence is relevant and mentions regulatory innovations, it does not cover the gold answer or directly address the process that conserved noncoding elements mostly regulate according to the gold supporting sentence.\", \"match\": false}", "gold_answer": "development", "gold_support": "The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development.", "model_answer": "Answer: Regulatory innovations", "model_support": "Supporting sentence: These elements are different from other conserved noncoding elements and appear to be important regulatory innovations that became fixed following the emergence of vertebrates from the sea to the land.", "retries": 1}
{"idx": 193, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The sentence explicitly ties [18F]altanserin uptake to the evaluation of 5-HT2A receptors, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age. \n\n**Analysis:** This sentence explicitly links [18F]altanserin uptake to the evaluation of 5-HT2A receptors by stating that the drug's binding (and its age-related reduction) directly correlates with the density of these receptors. The context confirms that [18F]altanserin is used to assess 5-HT2A receptor binding in the brain.", "retries": 1}
{"idx": 194, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but it is slightly more focused on the methodology rather than the specific function of NCX. It could be more concise to directly cover the gold answer.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The sodium-calcium exchanger (NCX) is one of the transporters contributing to the control of intracellular calcium (Ca(2+)) concentration by normally mediating net Ca(2+) efflux.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: This study used the MEMRI technique to examine the temporal features of cardiac Mn(2+) efflux by implementing a T(1)-mapping method and inhibiting the NCX with SEA0400.", "retries": 1}
{"idx": 195, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer 'XK gene' is equivalent to the gold answer 'XK'. The supporting sentence discusses the E327K mutation in the XK gene and its association with McLeod syndrome, aligning well with the gold supporting sentence. However, it could be more concise by directly referencing the missense mutation without additional details about protein functionality.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional. \n\n**Analysis**: The sentence explicitly states that the E327K missense mutation (in the **XK gene**) is associated with the immunohematologic features of McLeod syndrome. This directly supports the conclusion that mutations in the **XK gene** underlie McLeod syndrome.", "retries": 1}
{"idx": 196, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it introduces additional information about FKBP12, which is not necessary to directly support the answer. This makes it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "The molecular target of rapamycin (mTOR), which is a member of the phosphoinositide 3-kinase related kinase (PIKK) family and a central modulator of cell growth, is a prime strategic target for anti-cancer therapeutic development.", "model_answer": "Answer: The molecular target of Rapamycin is the mTOR (mammalian target of rapamycin).", "model_support": "Supporting sentence: In essence, RAP gains function by binding to the immunophilin FK506 binding protein 12 (FKBP12) and the resultant complex inhibits the activity of mTOR.", "retries": 1}
{"idx": 197, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Non-small cell lung cancer (NSCLC),' is correct but too general and does not specify the EGFR-mutant subtype, which is crucial for matching the gold standard. The supporting sentence mentions afatinib in the context of NSCLC but lacks specificity regarding EGFR mutations, which are central to the gold answer. While relevant, it does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "EGFR-mutant NSCLC", "gold_support": "Reversible ATP-competitive inhibitors targeting the epidermal growth factor receptor (EGFR) have been established as the most effective treatment of patients with advanced non-small cell lung cancer (NSCLC) harboring \"activating\" mutations in exons 19 and 21 of the EGFR gene.", "model_answer": "Answer: Non-small cell lung cancer (NSCLC)", "model_support": "Supporting sentence: Clinical perspective of afatinib in non-small cell lung cancer.", "retries": 1}
{"idx": 198, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides clear evidence of tofacitinib's efficacy in treating rheumatoid arthritis, aligning with the gold answer. However, it includes additional details about the clinical trial (e.g., dosages and ACR20 response rate) that, while supportive, are not strictly necessary to justify the approval. This slight redundancy reduces the conciseness compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "The in vitro, ex vivo and in vivo effects of a JAK inhibitor CP-690,550 (tofacitinib) for the treatment of RA are reported.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"A total of 140 patients were randomised to tofacitinib 1, 3, 5, 10 mg or placebo twice daily and the American College of Rheumatology 20% improvement criteria (ACR20) response rate at week 12, a primary end point, was significant for all tofacitinib treatment groups.\"  \n\nThis sentence demonstrates the clinical efficacy of tofacitinib in rheumatoid arthritis patients, which is a critical step toward regulatory approval. While the context does not explicitly state \"approved,\" the description of a randomized clinical trial with significant outcomes for all doses (including 5 and 10 mg twice daily) directly supports its role as an approved JAK inhibitor for RA.", "retries": 1}
{"idx": 199, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa' in meaning, though it is slightly more verbose. The supporting sentence refers to factor Xa and its relation to betrixaban, but it introduces additional information about a reversal agent (PRT4445) that is not directly necessary to support the answer. This makes the supporting sentence somewhat redundant, though still relevant and logical.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 200, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's answer 'Thyroid hormone (TH) concentrations' aligns perfectly with the gold answer 'thyroid', and the supporting sentence effectively links MCT8 mutations to abnormal TH levels in AHDS.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid hormone (TH) levels.", "model_answer": "Answer: Thyroid hormone (TH) concentrations.", "model_support": "Supporting sentence: Mutations in the TH transporter, monocarboxylate transporter 8 (MCT8), are associated with AHDS.  \n**Analysis**: The abbreviation \"TH\" explicitly refers to thyroid hormone in this context, as it is described as the substrate transported by MCT8. The direct association between MCT8 mutations and AHDS (Allan–Herndon–Dudley syndrome) links the syndrome to disrupted thyroid hormone (TH) transport and concentrations.", "retries": 1}
{"idx": 201, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The title explicitly links HEXA mutations to Tay-Sachs disease, making it an appropriate supporting sentence.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "We have identified three mutations in the beta-hexoseaminidase A (HEXA) gene in a juvenile Tay-Sachs disease (TSD) patient, which exhibited a reduced level of HEXA mRNA.", "model_answer": "Answer: HEXA", "model_support": "Supporting sentence: Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing and nonsense-mediated mRNA decay.  \n\n**Analysis**: The title explicitly states that mutations in the *HEXA* gene are associated with Tay-Sachs disease (TSD), confirming that *HEXA* is the gene most commonly mutated in this condition. This is further reinforced by the context discussing specific *HEXA* mutations and their pathogenic mechanisms in Tay-Sachs disease.", "retries": 1}
{"idx": 202, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard but is not supported by the provided context. The supporting sentence discusses diltiazem as a 1,5-benzothiazepine derivative, which does not directly justify or cover the gold answer about JTV519 being a 1,4-benzothiazepine derivative.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Analysis**: The context does **not** explicitly state that JTV519 is a 1,4-benzothiazepine derivative in the provided text. Instead, it only identifies diltiazem as a 1,5-benzothiazepine derivative for comparison. The answer (1,4-benzothiazepine) likely relies on external information or a different context not included here. The quoted sentence above highlights the structural distinction between JTV519 and diltiazem but does not directly specify JTV519's chemical class in this context.", "retries": 1}
{"idx": 203, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The supporting sentence refers to a 'factor Xa decoy' which indirectly supports the model's answer but includes additional details about PRT4445 that are not necessary for answering the question.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis**: The context explicitly mentions that PRT4445 is a \"factor Xa decoy\" used with betrixaban, and that it acts as a reversal agent for anticoagulants with \"anti-Xa activity.\" This directly implies that betrixaban inhibits **factor Xa**, as its mechanism of action aligns with other factor Xa inhibitors (e.g., rivaroxaban, apixaban). The pharmacokinetic profile and clinical applications described further support its classification as a direct factor Xa inhibitor.", "retries": 1}
{"idx": 204, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about factor Xa inhibitors as a class, but it is somewhat verbose and does not explicitly mention betrixaban. The logic is sound, but the gold supporting sentence provides a more concise and direct connection.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors. Direct and indirect factor Xa inhibitors are being developed with a relative rapid onset of action and stable pharmacokinetic profiles negating the need for close monitoring...  \n\n**Analysis**: The context categorizes newer anticoagulants into **factor Xa inhibitors** and **thrombin (factor IIa) inhibitors**. While betrixaban is not explicitly named in the text, it is a well-established **direct factor Xa inhibitor** in clinical use. The context discusses the development of factor Xa inhibitors (both direct and indirect) as a class, and the question aligns with this classification. The quoted sentence supports the conclusion that betrixaban inhibits **Factor Xa**.", "retries": 1}
{"idx": 205, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'). However, the supporting sentence is unnecessarily verbose and includes information that does not directly support the specific relationship between JNK and c-Jun phosphorylation. While it acknowledges that the context doesn't explicitly mention JNK (which is incorrect as the gold supporting sentence shows), it adds excessive details about tylophorine's mechanisms that are irrelevant to the direct question. A more concise explanation could have been extracted from the context.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "The context does not explicitly mention which MAP kinase phosphorylates c-Jun. While the text discusses c-Jun's role in tylophorine's anticancer mechanisms (e.g., \"tylophorine enhanced the c-Jun downregulation of the cyclin A2 promoter activity...\"), it does not identify a specific MAP kinase (such as JNK) responsible for c-Jun phosphorylation. Therefore, **no sentence in the provided context directly supports the answer \"JNK (c-Jun N-terminal kinase)\"**. The association between JNK and c-Jun phosphorylation is based on general biochemical knowledge, not the information in this specific text.", "retries": 1}
{"idx": 206, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Rapid-onset dystonia-parkinsonism', does not match the gold standard 'X-linked dystonia-parkinsonism'. However, the context includes information about both conditions. The supporting sentence is relevant but focuses on ruling out rapid-onset dystonia-parkinsonism rather than identifying XDP (Lubag) as the correct synonym. Therefore, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Three affected siblings were found to share an identical haplotype at the X-linked dystonia-parkinsonism locus (XDP; Lubag; OMIM*314250).", "model_answer": "Answer: Rapid-onset dystonia-parkinsonism", "model_support": "Supporting sentence: Genetic testing excluded the rapid-onset dystonia-parkinsonism locus (DYT12; OMIM*128235), autosomal recessive Parkin locus (PARK2; OMIM *602544), and DYT1 dystonia.  \n\nThe sentence explicitly identifies \"rapid-onset dystonia-parkinsonism\" as the name of the DYT12 locus, confirming it as the synonym for lubag disease.", "retries": 1}
{"idx": 207, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Chiari-I malformation,' does not match the gold standard, 'craniosynostosis.' However, the supporting sentence is relevant because it accurately describes a feature specific to Shprintzen-Goldberg syndrome. The supporting sentence does not cover the gold answer, which reduces its effectiveness in this context.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Shprintzen-Goldberg syndrome is one of a group of disorders characterized by craniosynostosis and marfanoid habitus.", "model_answer": "Answer: Chiari-I malformation", "model_support": "Supporting sentence: However, radiologic investigations appear to be more specific, since an abnormality of the first and second cervical vertebrae, hydrocephalus, dilatation of the lateral ventricles, and a **Chiari-I malformation of the brain** were found only in the patients with Shprintzen-Goldberg syndrome. \n\nThe sentence explicitly lists **Chiari-I malformation** as a radiologic finding specific to Shprintzen-Goldberg syndrome, confirming it as an additional feature of the condition.", "retries": 1}
{"idx": 208, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly, identifying JNK as the protein affected by DUSP8 activation. The supporting sentence is relevant and provides a logical explanation that connects DUSP8 to JNK activation. However, it contains slight redundancy by emphasizing the attenuation of phosphatase activity, which is not central to directly supporting the answer. A more concise sentence focusing solely on JNK modulation would have been ideal.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: We propose that phosphorylation of the M3/6 phosphatase by JNK in response to stress stimuli results in attenuation of phosphatase activity and acceleration of JNK activation. \n\n**Analysis**: The context explicitly states that phosphorylation of M3/6 (a dual-specificity phosphatase, likely DUSP8) by JNK leads to \"acceleration of JNK activation.\" This indicates that JNK is the protein affected by DUSP8 (M3/6) activation, as the phosphorylation of M3/6 modulates JNK's activity. The key phrase \"acceleration of JNK activation\" directly links DUSP8's state (phosphorylation) to its impact on JNK.", "retries": 1}
{"idx": 209, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights flumazenil as a 'benzodiazepine antagonist,' which directly supports its role as an antidote in benzodiazepine overdose.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "We conclude that flumazenil is an effective and safe drug in the treatment of benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the **benzodiazepine antagonist, flumazenil**.  \n\n**Analysis**: The term \"benzodiazepine antagonist\" directly identifies flumazenil as the antidote for benzodiazepine overdose. This classification aligns with the question’s focus on the appropriate antidote. The subsequent results (e.g., improved Glasgow Coma Scale scores in flumazenil-treated patients) further validate its role, but the explicit designation as a \"benzodiazepine antagonist\" in the first sentence is the strongest supporting evidence.", "retries": 1}
{"idx": 210, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and covers the answer well, but it contains additional details about the conditions being treated, which makes it slightly more verbose than necessary.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 211, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard, as it states 'two' TAp73 isoforms instead of the correct 'seven.' However, the supporting sentence is relevant because it mentions 'TAp73 isoforms' in the plural, which implies the existence of multiple isoforms. Despite this, the supporting sentence does not provide specific information about the exact number of isoforms, and therefore it fails to fully cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two TAp73 isoforms have been identified in humans.", "model_support": "Supporting sentence: \"tazarotene modulates the expression of the p73 gene in immortalized keratinocyte cell lines by inducing the pro-apoptotic and anti-proliferative TAp73 isoforms and by repressing the anti-apoptotic and pro-proliferative DeltaNp73 isoforms.\"  \n\n**Analysis**: The sentence explicitly refers to \"TAp73 isoforms\" in the plural, indicating the presence of multiple TAp73 isoforms. While the context does not directly state the number (e.g., \"two\"), the use of the plural form supports the conclusion that at least two TAp73 isoforms exist in humans.", "retries": 1}
{"idx": 212, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying PRDX2 as an antioxidant enzyme. The supporting sentence is relevant and provides logical support by linking PRDX2 to its role in neutralizing H₂O₂, a key function of antioxidant enzymes. However, it contains slight redundancy by elaborating on the consequences of PRDX2 suppression rather than directly stating its function as an antioxidant enzyme, which makes it less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2) has been known to act as an antioxidant enzyme whose main function is H(2)O(2) reduction in cells.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme.", "model_support": "Supporting sentence: *Suppression of PRDX2 resulted in the augmentation of endogenous H₂O₂, and the ability to eliminate the exogenous H₂O₂ was attenuated.*  \n\nThis sentence demonstrates that PRDX2 is involved in neutralizing hydrogen peroxide (H₂O₂), a reactive oxygen species (ROS), which is a hallmark function of antioxidant enzymes. The inability to eliminate H₂O₂ upon PRDX2 suppression directly links its enzymatic activity to antioxidant function.", "retries": 1}
{"idx": 213, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('nuclear'), but the supporting sentence is somewhat convoluted and lacks direct citation of the key evidence. While it correctly infers the protein's localization from its function, it does not utilize the explicit sentence from the context that directly states the protein is 'predominantly nuclear.' The logic is reasonable but could be more concise and directly reference the provided evidence.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "Answer: Nuclear", "model_support": "The context does not explicitly state whether the APOBEC3B protein is predominantly cytoplasmic or nuclear. While the text describes APOBEC3B as a DNA cytosine deaminase and links it to genomic mutations (which occur in the nucleus), there is no direct sentence in the context specifying the subcellular localization of the protein. The answer \"Nuclear\" is inferred from its role in DNA modification but is not explicitly supported by a quoted sentence. \n\n**Answer:** The context does not provide a sentence explicitly stating the subcellular localization of APOBEC3B.", "retries": 1}
{"idx": 214, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"A variety of XK mutations has been reported but no clear phenotype-genotype correlation has been found, especially for the point mutations affecting splicing sites.\" \n\nThe context explicitly states that mutations in the **XK gene** are associated with McLeod syndrome, as highlighted in the background section and confirmed by the identification of a novel XK splice site mutation in the patient.", "retries": 1}
{"idx": 215, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides correct context, but it includes some redundancy by mentioning stimulation diffusion to adjacent structures, which is not necessary for directly supporting the answer. The logic is strong, but the additional details make it slightly less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "globus pallidus internus", "gold_support": "Bilateral pallidal deep brain stimulation (BP-DBS) of the globus pallidus internus (GPi) is an effective treatment for primary dystonia, but the effect of this reversible surgical procedure on dystonia-choreoathetosis CP, which is a subtype of secondary dystonia, is unknown.", "model_answer": "Answer: Globus pallidus internus (GPi)", "model_support": "Supporting sentence: \"The accuracy of surgical targeting to the GPi was assessed masked to the results of neurostimulation.\"  \n\nThis sentence explicitly identifies the **globus pallidus internus (GPi)** as the targeted nucleus for neurostimulation in the treatment of dystonia-choreoathetosis cerebral palsy. Additionally, the study's findings highlight that stimulation diffusion to adjacent structures (e.g., the globus pallidus externus [GPe]) correlated with limited improvement, further emphasizing GPi as the critical target.", "retries": 1}
{"idx": 216, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Matriptase,' does not match the gold standard, which is 'LEKTI.' However, 'Matriptase' is mentioned in the context as a contributing factor in the disease mechanism. The supporting sentence is relevant but focuses on matriptase's role rather than LEKTI's deficiency as the primary cause of Netherton syndrome, thus failing to cover the gold answer adequately.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.", "model_answer": "Answer: Matriptase", "model_support": "Supporting sentence: Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade.", "retries": 1}
{"idx": 217, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly name Rac1 as essential for lamellipodia formation. However, the supporting sentence is relevant and points to the absence of explicit information about G proteins in the provided context. The gold answer (Rac1) is present in the context, though not directly emphasized, which lowers the score.\", \"match\": false}", "gold_answer": "Rac1", "gold_support": "We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination.", "model_answer": "The question cannot be answered from the provided context.", "model_support": "The question cannot be answered from the provided context.  \n**Supporting sentence:** The context does not mention any G proteins or their roles in lamellipodia formation/function. It focuses on light-activated dimerization using *Arabidopsis* proteins (FKF1, GIGANTEA) and engineered transcription factors, without addressing G proteins or cytoskeletal dynamics like lamellipodia.", "retries": 1}
{"idx": 218, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant but does not directly mention Clostridium botulinum or provide as clear and specific reasoning as the gold supporting sentence. It is somewhat general and lacks the precision of the gold standard.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "An epidemiological investigation and laboratory detection studies showed that sausage contaminated by type A Clostridium botulinum caused this outbreak of food poisoning.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: Multilocus outbreak of foodborne botulism linked to contaminated sausage in Hebei province, China.  \n**Analysis**: While the context does not explicitly name *Clostridium botulinum*, the term \"botulism\" inherently refers to illness caused by this bacterium. Botulism is universally recognized as a disease caused by *Clostridium botulinum* due to its production of botulinum toxin, making it the most known causative agent for such outbreaks, including those linked to contaminated foods like sausage. The context implicitly supports this by describing a botulism outbreak without ambiguity.", "retries": 1}
{"idx": 219, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('iron'), but the context contains information about iron deficiency being a cause of secondary RLS. The supporting sentence is relevant but overly focused on generalities and does not directly cover the gold answer ('iron deficiency'). It discusses correction of underlying problems without explicitly mentioning iron deficiency as a specific cause.\", \"match\": false}", "gold_answer": "iron", "gold_support": "RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.", "model_answer": "Answer: The context does not mention a specific deficiency as the cause of restless leg syndrome.", "model_support": "The context does not explicitly state a specific deficiency as the cause of restless leg syndrome (RLS). While it discusses familial and secondary factors (e.g., underlying problems in secondary RLS), it does not mention a deficiency (e.g., iron, dopamine, or other nutrients) as the direct cause. \n\n**Supporting sentence**: \"Correction of underlying problem wherever possible is important in the management of secondary RLS.\"  \nThis sentence implies that secondary RLS may have identifiable underlying issues, but no specific deficiency is named in the context.", "retries": 1}
{"idx": 220, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of 'NCX currents' in the supporting sentence clearly ties SEA0400 to its role as an inhibitor of the sodium-calcium exchanger.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: Thus, we examined the effect of SEA0400 on **NCX currents** and I/R induced intracellular Ca2+ overload in mouse ventricular myocytes using patch clamp techniques and fluorescence measurements.  \n\nThe explicit mention of \"NCX currents\" (sodium-calcium exchanger currents) in the context directly identifies the ion antiporter/exchanger targeted by SEA0400.", "retries": 1}
{"idx": 221, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Stroke' vs. 'stroke'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: Emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 222, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence discusses the lack of explicit mention of 'autosomal dominant' in the context, which is incorrect since the gold supporting sentence clearly states it. Despite this, the model's supporting sentence acknowledges the general accuracy of the answer based on external knowledge, which keeps the logic sound but slightly misaligned with the provided context.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context does not explicitly state the mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD). While the text describes the genetic basis (a deletion of 3.3kb D4Z4 repeats on chromosome 4q35), it does not mention \"autosomal dominant\" inheritance. The answer provided (\"autosomal dominant\") is accurate based on general medical knowledge, but **no sentence in the given context directly supports this claim**.", "retries": 1}
{"idx": 223, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly highlights the specificity of alpha-synuclein immunostaining, which aligns well with the gold standard context.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles. \n\nThis sentence explicitly confirms that the antibody used for immunostaining is directed against **alpha-synuclein**, as it compares the specificity of alpha-synuclein immunostaining to ubiquitin immunostaining.", "retries": 1}
{"idx": 224, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard 'p53', but it is mentioned in the context. The supporting sentence is relevant to PTEN being called a 'new guardian of the genome,' but it does not logically support the gold answer, which refers specifically to p53 as the original and widely recognized 'guardian of the genome.'\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 225, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly less direct compared to the gold supporting sentence. The model's supporting sentence refers to the study's objective rather than directly stating that pridopidine is in development for Huntington disease, introducing minor redundancy.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 226, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK gene' is equivalent to 'XK'). The supporting sentence is relevant and supports the answer by referencing the analysis of the XK DNA sequence. However, it includes additional details about the study design that are not strictly necessary for supporting the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: STUDY DESIGN AND METHODS: Evaluation of two brothers carrying the McLeod phenotype with neurologic examination, immunohematology, RBC membrane protein Western blotting, analysis of **XK DNA sequence** and RNA levels, muscle histology including XK/Kell immunohistochemistry, cerebral magnetic resonance imaging (MRI), and quantified positron emission tomography (PET).  \n\nThe context explicitly states that the study analyzed **XK DNA sequence** in relation to the McLeod phenotype, confirming the association of the **XK gene** with the syndrome.", "retries": 1}
{"idx": 227, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant as it mentions the five N-terminal isoforms studied, but it does not cover the gold answer of '7'. The model likely misinterpreted the question as asking about the specific subset of N-terminal isoforms mentioned in the context, rather than all known TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 5", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.  \n\n**Analysis**: The sentence explicitly lists five N-terminal p73 isoforms, including TAp73 as one of the five. While TAp73 itself is a single isoform, the question likely intended to ask about the total number of **p73 N-terminal isoforms** (not specifically TAp73 variants). The context confirms that five distinct N-terminal p73 isoforms were studied, supporting the answer \"5.\"", "retries": 1}
{"idx": 228, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise and acknowledges the lack of direct support in the context, which aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease is a rare genetic disorder of copper metabolism with autosomal recessive inheritance.", "model_answer": "Answer: Autosomal recessive", "model_support": "The context provided does not explicitly mention the mode of inheritance of Wilson's disease. While the correct answer (autosomal recessive) is medically accurate, the context lacks a supporting sentence to justify it. \n\n**Answer:**  \nAutosomal recessive  \n\n**Supporting sentence:**  \n*There is no sentence in the context that directly addresses the mode of inheritance of Wilson's disease.*", "retries": 1}
{"idx": 229, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides direct evidence that Gevokizumab targets IL-1β by mentioning the binary complex with IL-1β. However, it contains slight redundancy as the phrase 'crystal structures of canakinumab and gevokizumab' introduces extra information not critical to the specific answer, making it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"We have analyzed the crystal structures of canakinumab and gevokizumab antibody binding fragment (Fab) as well as of their binary complexes with IL-1β.\" \n\nThis sentence explicitly states that gevokizumab forms a complex with **interleukin-1β (IL-1β)**, confirming it as the drug's target.", "retries": 1}
{"idx": 230, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('autosomal dominant'). The supporting sentence explains that while the context does not explicitly state 'autosomal dominant,' it is inferred based on standard genetic knowledge of myotonic dystrophy, which aligns with the gold supporting sentence. Although the model notes the lack of explicit mention in the context, its reasoning is clear and logically sound.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The context does not explicitly state the mode of inheritance (autosomal dominant) for myotonic dystrophy. While the text discusses genetic mutations (e.g., (CTG)n and (CCTG)n expansions) and linkage to specific chromosomal regions, it does not directly mention \"autosomal dominant\" inheritance. The answer provided relies on standard genetic knowledge about myotonic dystrophy (DM1 and DM2), which are indeed inherited in an autosomal dominant manner, but this is not explicitly stated in the given context. Therefore, **no direct supporting sentence** from the context confirms the autosomal dominant inheritance pattern.", "retries": 1}
{"idx": 231, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'Factor Xa'). The supporting sentence is relevant and provides a logical explanation by referencing the class of direct factor Xa inhibitors. However, it is slightly verbose and does not directly mention betrixaban as one of the drugs in this class, which could have made the reasoning more precise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation... \n\n**Analysis**: The context explicitly states that the entire class of \"direct factor Xa inhibitors\" targets and inhibits **factor Xa**. While betrixaban is not specifically named in the text, it belongs to this class of drugs (as per external knowledge), and the passage establishes that all members of this class inhibit factor Xa. Thus, the answer is supported by the general classification provided in the context.", "retries": 1}
{"idx": 232, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence acknowledges that the context does not explicitly state the orientation but fails to identify the correct information present in the gold supporting sentence. Instead of leveraging the provided context effectively, it dismisses the question without recognizing the clear mention of 'antiparallel chains' in the gold supporting sentence. This results in a failure to provide logical support for the correct answer.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Mapping the stress-dependent labeling kinetics of α- and β-spectrin by LC-MS/MS identifies Cys in these antiparallel chains that are either force-enhanced or force-independent in labeling, with structural analyses indicating the force-enhanced sites are sequestered either in spectrin's triple-helical domains or in interactions with actin or ankyrin.", "model_answer": "Answer: Parallel heterodimers.", "model_support": "The context provided does not explicitly state whether alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers. The analysis focuses on changes in protein labeling under shear stress and structural dynamics of the spectrin-actin network but does not address the specific orientation of spectrin subunit pairing. Therefore, the answer \"Parallel heterodimers\" is **not supported by the given context**. \n\nTo answer this question accurately, external knowledge (e.g., established structural biology of spectrin) would be required, as the context does not include a relevant sentence confirming the parallel or antiparallel arrangement.", "retries": 1}
{"idx": 233, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer 'Nf1' is the correct gene symbol and matches the gold answer 'NF1' (gene symbols are often case-insensitive in this context). The supporting sentence directly mentions Nf1 and provides additional context about its mutation being involved in astrocytomas, which aligns logically with the gold supporting sentence. However, it introduces Trp53, which, while relevant to the study, is not necessary for answering the specific question.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas.", "model_answer": "Answer: Nf1", "model_support": "Supporting sentence: We present here a mouse model of astrocytomas involving mutation of two tumour-suppressor genes, **Nf1** and Trp53.", "retries": 1}
{"idx": 234, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is unnecessarily verbose and focuses on how the context does not explicitly mention DNMT1's role in methylation maintenance, which adds redundancy. The gold supporting sentence is more concise and directly relevant, mentioning DNMT1 as the 'maintenance methyltransferase,' which supports the answer clearly and logically.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We and others have shown that DNA methyltransferase 1 (DNMT1), the maintenance methyltransferase, contributes to the cellular response to DNA damage, yet DNMT1's exact role in this process remains unclear.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: The context does not explicitly state that DNMT1 is the enzyme involved in maintaining DNA (cytosine-5-)-methylation. While DNMT1 is well-established in general knowledge as the primary enzyme for maintaining DNA methylation patterns, the provided context focuses on its role in DNA repair and genome integrity, not its catalytic function in methylation. No sentence in the context directly links DNMT1 to DNA methylation maintenance. \n\n**Answer:** DNMT1  \n**Note:** The context does not provide a direct supporting sentence for this answer. The connection between DNMT1 and DNA methylation maintenance relies on prior biological knowledge rather than the provided text.", "retries": 1}
{"idx": 235, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Serotonin 5-HT2A receptors' is correct and aligns with the gold standard '5-HT2A', though it includes additional descriptor words. The supporting sentence is relevant and provides logical support, but it is slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the **serotonin 5-HT2A receptor**.", "retries": 1}
{"idx": 236, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a reasonable explanation for the answer, referencing p53's role as a tumor suppressor. However, it includes some redundancy by discussing general scientific knowledge not present in the context, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "Answer: p53", "model_support": "The context does not explicitly mention the term \"guardian of the genome\" or directly refer to p53 by this nickname. However, the answer **p53** is correct based on general scientific knowledge, as p53 is widely recognized as \"the guardian of the genome\" for its role in preventing genomic instability. \n\nIn the provided context, the supporting sentence that indirectly supports this answer is:  \n**\"The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors.\"**  \n\nThis sentence establishes p53 as a central tumor suppressor in the discussion, aligning with its well-known role. While the nickname itself is not stated in the text, the context focuses on p53's tumor-suppressive functions, which are consistent with its canonical identity as \"the guardian of the genome.\"", "retries": 1}
{"idx": 237, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer. However, it is slightly less direct than the gold supporting sentence, as it does not explicitly mention the subcutaneous injection or dosages, which would make it more precise.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "They were injected subcutaneously (s.c.) with L-DOPA methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-DOPA/benserazide) alone or in combination with (-)-OSU6162 (1.0, 3.0, 6.0 or 10 mg/kg, s.c.).", "model_answer": "Answer: L-DOPA", "model_support": "Supporting sentence: \"L-DOPA/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\" \n\nThis sentence explicitly states that **benserazide is co-administered with L-DOPA** in the study, as indicated by the combined notation \"L-DOPA/benserazide.\"", "retries": 1}
{"idx": 238, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it is slightly more complex and less direct than the gold supporting sentence. The model's supporting sentence discusses the release of a phytoalexin from a preformed conjugate, which requires additional reasoning to connect it directly to medicarpin, whereas the gold supporting sentence clearly states the rapid accumulation of medicarpin in response to elicitor treatment.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Treatment of (14)C-labeled, elicited cells with l-alpha-aminooxy-beta-phenylpropionic acid... suggested that the **phytoalexin could be released from a preformed conjugate** under these conditions.\"  \nThe term \"phytoalexin\" is explicitly linked to **medicarpin** in this context, as the labeled compound released corresponds to medicarpin.", "retries": 1}
{"idx": 239, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: CaN (Calcineurin)", "model_support": "Supporting sentence: Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization. \n\n**Analysis:** This sentence explicitly states that the calcium/calmodulin-dependent protein phosphatase **CaN (calcineurin)** is responsible for dephosphorylating NFAT, which is a critical step in its activation and subsequent nuclear translocation. This directly answers the question about the phosphatase involved in NFAT activation.", "retries": 1}
{"idx": 240, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about the study's methods and findings, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "\"Mowat-Wilson\" syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: In order to address these open questions we analyzed the ZFHX1B gene in five patients... Direct sequencing demonstrated truncating ZFHX1B mutations in all four patients with the characteristic facial phenotype... We demonstrate that there is a specific clinical entity... which we propose be called the \"Mowat-Wilson syndrome.\" \n\nThe context explicitly states that **ZFHX1B mutations** are associated with the syndrome's characteristic features (facial gestalt, mental retardation, and variable MCAs), and directly links the gene to the condition through mutation analysis in affected patients.", "retries": 1}
{"idx": 241, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the association between DUX4 ectopic expression and FSHD, aligning well with the context provided.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: Our results suggest that up-regulation of both DUX4 and PITX1 in FSHD muscles may play critical roles in the molecular mechanisms of the disease. \n\n**Analysis**:  \nThe context explicitly states that the **up-regulation of DUX4** (ectopic expression) occurs in **FSHD muscles**, directly linking the disease to abnormal DUX4 activity. This sentence confirms the association between FSHD and DUX4 misexpression.", "retries": 1}
{"idx": 242, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by highlighting the active nuclear import process and the specific amino acid requirement, which logically supports the conclusion that APOBEC3B is predominantly nuclear. Although the model's supporting sentence includes additional mechanistic details, these do not detract from the clarity or correctness of the logic.\",\n  \"match\": true\n}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase).  \n\n**Analysis**: The sentence explicitly states that APOBEC3B (A3B) undergoes an **active nuclear import process**, which directly indicates its **predominant localization in the nucleus**. The mention of a \"nuclear localization determinant\" and the requirement for specific amino acids further supports that A3B is targeted to the nucleus. Additionally, the comparison to AID, a well-known nuclear enzyme, reinforces this conclusion.", "retries": 1}
{"idx": 243, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'Factor Xa' matches the gold standard 'Xa'. The supporting sentence is relevant and covers the answer by identifying betrixaban as a direct inhibitor of factor Xa. However, it contains slight redundancy by referencing the title of the context rather than directly quoting a more concise sentence from the body of the text. Overall, the logic is sound but could be more succinct.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: **\"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"**  \n\nThis sentence explicitly identifies betrixaban as a **direct inhibitor of factor Xa**, aligning with the question.", "retries": 1}
{"idx": 244, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and highlights phospholamban (PLN) as a regulatory molecule of SERCA2a, but it focuses more on the consequences of superinhibition rather than directly emphasizing PLN’s regulatory role in Ca(2+) cycling. It introduces slight redundancy by mentioning remodeling without tightly focusing on the regulatory aspect as clearly as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban (PLN), the reversible inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), is a key regulator of myocyte Ca(2+) cycling with a significant role in heart failure.", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: **SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.**  \nThis sentence explicitly identifies **phospholamban (PLN)** as the regulatory molecule modulating **SERCA2a** function, highlighting its role in inhibiting SERCA2a activity.", "retries": 1}
{"idx": 245, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the role of ibrutinib in delaying CLL development, which aligns well with the gold standard's emphasis on its effectiveness against BTK in CLL.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: Inhibition of BTK kinase activity through either targeted genetic inactivation or **ibrutinib** in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of **ibrutinib**.", "retries": 1}
{"idx": 246, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, as both refer to thyroid-related abnormalities in Williams syndrome. However, the model's supporting sentence is somewhat lengthy and includes information about the debate on thyroid assessment frequency, which is not directly necessary to support the answer. While the logic is strong, a more concise supporting sentence would improve clarity and relevance.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Biochemical thyroid abnormalities, including congenital hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: However, the frequency of biochemical thyroid assessment, particularly in the first year of life, is being debated. In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.  \n\n**Analysis**: The context explicitly states that the infant has Williams syndrome (WBS) and congenital hypothyroidism caused by thyroid hypoplasia. This directly supports the conclusion that biochemical thyroid abnormalities, including congenital hypothyroidism, are common in Williams syndrome. The debate about thyroid assessment frequency in early life further implies that such abnormalities are clinically relevant in this population.", "retries": 1}
{"idx": 247, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for dermatitis herpetiformis, but it is slightly redundant as it repeats the title without adding significant explanatory value. It could be more concise while still covering the essential information.\", \"match\": true}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.", "model_answer": "Answer: Dermatitis herpetiformis (DH)", "model_support": "Supporting sentence: [Dermatitis herpetiformis occurring in patients with celiac disease in childhood]. \n\n**Analysis:** The context explicitly identifies *dermatitis herpetiformis (DH)* as the rash associated with gluten sensitivity, particularly in the context of celiac disease (CD). The opening sentence of the study directly links DH to gluten-related conditions (celiac disease), and subsequent sections reinforce this association by discussing the pathophysiology, diagnosis, and gluten-related triggers of DH.", "retries": 1}
{"idx": 248, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of ibrutinib in CLL by referencing its ability to delay CLL development through BTK inhibition, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: Inhibition of BTK kinase activity through either targeted genetic inactivation or **ibrutinib** in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of **ibrutinib**. \n\nThe sentence explicitly names **ibrutinib** as the BTK inhibitor used in the study to demonstrate its role in delaying CLL development.", "retries": 1}
{"idx": 249, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (DNMT1). The supporting sentence provided in the gold standard is concise, directly relevant, and logically explains the role of DNMT1 in maintaining DNA methylation patterns. Although the model notes that no explicit supporting sentence exists in the context, the hypothetical example it provides aligns well with the gold supporting sentence, demonstrating strong logical reasoning.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We propose a new model that suggests that the maintenance of DNA methylation relies not only on the recognition of hemimethylated DNA by DNA methyltransferase 1 (DNMT1) but also on the localization of the DNMT3A and DNMT3B enzymes to specific chromatin regions that contain methylated DNA.", "model_answer": "Answer: DNA methyltransferase 1 (DNMT1)", "model_support": "The context provided does not explicitly mention the enzyme **DNA methyltransferase 1 (DNMT1)** or any specific enzyme involved in DNA methylation maintenance. Therefore, **no sentence in the context supports the answer**. The answer likely relies on general biochemical knowledge rather than the text given. \n\nExample of a hypothetical supporting sentence (if present in the context):  \n*\"DNA methyltransferase 1 (DNMT1) ensures the faithful copying of DNA methylation patterns during cell division.\"*  \n*(This sentence is not in the provided context.)*", "retries": 1}
{"idx": 250, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It correctly identifies Pendred syndrome's association with hypothyroidism due to dyshormonogenesis, which is related to thyroid abnormalities. However, it introduces sensorineural hearing loss, which, while characteristic of Pendred syndrome, is not the focus of the question or gold answer. The supporting sentence discusses dyshormonogenetic goitres and their growth despite treatment, which is relevant but does not directly cover the gold answer ('thyroid'). Overall, the answer and supporting sentence are somewhat relevant but do not fully align with the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene.", "model_answer": "Answer: Pendred syndrome is characterized by sensorineural hearing loss and congenital hypothyroidism due to dyshormonogenesis.", "model_support": "Supporting sentence: \"It is known that dyshormonogenetic goitres have a tendency to grow despite appropriate treatment with L-thyroxine.\"  \n**Analysis**: This sentence supports the presence of **dyshormonogenesis** (impaired thyroid hormone synthesis), which leads to **congenital hypothyroidism** (requiring L-thyroxine substitution). While the context does not explicitly mention sensorineural hearing loss, Pendred syndrome is classically associated with both dyshormonogenesis/hypothyroidism and hearing loss. The need for lifelong L-thyroxine therapy in infancy further confirms hypothyroidism due to dyshormonogenesis.", "retries": 1}
{"idx": 251, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer provided by the model (CYP17) is close to the gold standard (CYP17A1) but not an exact match. The supporting sentence is problematic because it explicitly states that the context does not provide support for the answer, which contradicts the instructions to extract relevant information from the given context. Although the model correctly identifies a closely related enzyme based on external knowledge, the lack of contextual support and the slight mismatch in the answer result in a lower score.\", \"match\": false}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Answer: CYP17 (17α-hydroxylase/C17,20-lyase)", "model_support": "The context does not explicitly mention the enzyme inhibited by Orteronel (CYP17). While the provided text discusses Orteronel's effects on androgen suppression and clinical outcomes, it does not specify the molecular target (CYP17/17α-hydroxylase/C17,20-lyase) as the mechanism of action. Therefore, **no sentence in the context supports the stated answer**. \n\nTo clarify: The correct answer (CYP17) is based on external pharmacological knowledge, but the given context lacks this detail.", "retries": 1}
{"idx": 252, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is not as directly relevant or concise as the gold supporting sentence. While it references the analysis of bortezomib, it does not explicitly state that bortezomib is indicated for multiple myeloma treatment, which is critical to directly support the answer. The gold supporting sentence more clearly and concisely links bortezomib to its indication for multiple myeloma.\",\n  \"match\": true\n}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, indicated for multiple myeloma (MM) treatment, is available in 3.5-mg vials, a quantity higher than the average dose commonly prescribed.", "model_answer": "Answer: Multiple myeloma", "model_support": "Supporting sentence: *This analysis aimed to demonstrate, through real-world data, which would be the optimal vial presentation for bortezomib in Brazil and quantify the reduction in medication waste related to this option.*  \n**Analysis**: The context explicitly states that bortezomib is used in the treatment of multiple myeloma (\"patients with MM [multiple myeloma] treated with bortezomib\" in the **Methods** section). The abbreviation \"MM\" is standard for multiple myeloma in medical literature.", "retries": 1}
{"idx": 253, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing imatinib's interaction with BCR-ABL, though it includes additional details about resistance that slightly increase verbosity without being necessary to confirm the target.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a hematopoietic stem cell cancer driven by the BCR-ABL fusion protein that arises from the translocation of chromosomes 9 and 22.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"resistance is usually caused by mutations within BCr-ABL, decreasing the affinity of imatinib binding.\"  \n\nThis sentence directly indicates that **imatinib binds to BCR-ABL**, confirming it as the drug's molecular target. The mutations in BCR-ABL reduce imatinib's ability to inhibit this tyrosine kinase, which is central to the pathogenesis of Philadelphia chromosome-positive chronic myelogenous leukemia (CML).", "retries": 1}
{"idx": 254, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model is irrelevant as it mentions no information to support the incorrect answer. The gold answer 'X-linked dystonia-parkinsonism' is clearly stated in the context within parentheses next to 'lubag,' which makes the model's response entirely off-topic.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "Answer: The synonym of the lubag disease is \"Hemachondromatosis.\"", "model_support": "The context does not mention \"lubag disease,\" \"Hemachondromatosis,\" or any related terms. Therefore, **no sentence in the provided context supports the answer**. The question and answer appear unrelated to the given text.", "retries": 1}
{"idx": 255, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical reasoning by connecting matrix degradation in coeliac disease to dermatitis herpetiformis (DH), though it introduces MMP-related details that are not strictly necessary for answering the question. This makes the supporting sentence slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "BACKGROUND: Dermatitis herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80% of DH patients have gluten sensitive enteropathy manifested by crypt hyperplasia and villous atrophy.", "model_answer": "Answer: Dermatitis herpetiformis (DH) is the typical rash associated with gluten.", "model_support": "Supporting sentence: *Matrix degradation mediated by collagenase 1 (MMP-1) and stromelysin 1 (MMP-3) has previously been implicated in the pathobiology of coeliac intestine and cutaneous DH blisters.*  \n**Analysis**: The context explicitly links \"cutaneous DH blisters\" (dermatitis herpetiformis) to coeliac disease, which is an autoimmune disorder triggered by gluten. This establishes that DH is the skin manifestation of gluten-related immune responses.", "retries": 1}
{"idx": 256, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant in pointing out that the context does not explicitly discuss subcellular localization; however, it fails to cover the gold answer as the context actually does provide information about APOBEC3B being predominantly nuclear. Thus, while the logic of the supporting sentence is reasonable, it overlooks key details in the context.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The context does not specify whether APOBEC3B protein is predominantly cytoplasmic or nuclear.", "model_support": "The context does not mention the subcellular localization (cytoplasmic vs. nuclear) of APOBEC3B protein. Supporting sentence: The text focuses on the functional inhibition of L1 retrotransposition by APOBEC3B/APOBEC3F but does not describe their cellular compartmentalization or localization.", "retries": 1}
{"idx": 257, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly verbose and lacks the specific mention of the MR CLEAN study, which is central to the gold supporting sentence. Including 'MR CLEAN' would have made the supporting sentence more precise.\",\n  \"match\": true\n}", "gold_answer": "acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 258, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but focuses on the reversal agent PRT4445 rather than directly stating that betrixaban is a factor Xa inhibitor. The logic is sound but includes slight redundancy by introducing additional context about the decoy.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis**: The context explicitly states that PRT4445 is a \"factor Xa decoy\" designed to reverse anticoagulants with \"anti-Xa activity.\" Since betrixaban is mentioned as the anticoagulant paired with PRT4445, this directly implies that betrixaban inhibits **factor Xa**.", "retries": 1}
{"idx": 259, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While the explanation provided by the model references additional context, the chosen supporting sentence aligns well with the gold supporting sentence and succinctly conveys the key information about PD-1 blockade.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "Answer: PD-1 (Programmed Cell Death Protein 1)", "model_support": "Supporting sentence: We examined the effect of PD-1 blockade on T-cell response to DC/tumor fusions ex vivo.  \n**Explanation**: The context explicitly mentions \"PD-1 blockade\" in relation to enhancing T-cell responses, directly linking the antibodies (CT-011) to targeting **PD-1**. While MK-3475 is not named in the text, CT-011 is clearly associated with PD-1 inhibition.", "retries": 1}
{"idx": 260, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard (FGFR3 is equivalent to fibroblast growth factor receptor 3). The supporting sentence is relevant and correctly identifies FGFR3 as the gene associated with skeletal dysplasias, but it includes additional details about hypochondroplasia and Down syndrome that are not directly necessary for answering the question about achondroplasia. This makes the supporting sentence slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "fibroblast growth factor receptor 3 (FGFR3)", "gold_support": "These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.", "model_answer": "Answer: FGFR3", "model_support": "Supporting sentence: Hypochondroplasia due to FGFR3 gene mutation (N540K) and mosaic form of Down syndrome in the same patient. \n\n**Analysis:** While the context discusses hypochondroplasia (a milder skeletal dysplasia than achondroplasia), the question asks about achondroplasia. Both conditions are caused by mutations in the **FGFR3** gene, though at different sites (G380R for achondroplasia vs. N540K for hypochondroplasia). The context explicitly links FGFR3 to hypochondroplasia, confirming the gene's role in skeletal dysplasias, including achondroplasia.", "retries": 1}
{"idx": 261, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'JNK (c-Jun N-terminal kinase)' matches the gold standard 'JNK'. However, the supporting sentence provided by the model is incorrect as it states there is no supporting sentence in the context, while the gold supporting sentence directly references an in vitro kinase assay from the context that supports the answer. The correct supporting sentence should have been extracted from the context, but the answer itself is accurate.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "The context does not mention which MAP kinase phosphorylates c-Jun. Therefore, there is no supporting sentence in the provided text to answer this question. The answer \"JNK (c-Jun N-terminal kinase)\" is a general biochemical fact not derived from the given context.", "retries": 1}
{"idx": 262, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a **stroke** recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 263, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the NF1 gene mutation, with slight redundancy but overall logical support. The model's supporting sentence focuses on a specific detail (4 base pair deletion) that is accurate and supports the answer, though it could be broader to align more closely with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "It is well known that patients with von Recklinghausen syndrome (NF-1) (OMIM 162200) carrying NF1 germline mutations are predisposed to endocrine tumors including pheochromocytomas and duodenal somatostatinomas.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: Mutation analysis of peripheral blood leukocytes confirmed the 4 base pair deletion in exon 4 starting at codon 167 (499 del TGTT).  \n\n**Analysis**:  \nThe context explicitly identifies the **NF1 gene** as the locus of the germline mutation in the NF-1 patient. The deletion (499 del TGTT) in exon 4 of the *NF1* gene is confirmed through molecular techniques (PCR, sequencing), and the study further investigates allelic loss and expression of this gene. The conclusion also emphasizes the role of the *NF1* gene as a tumor suppressor in sporadic insulinomas, reinforcing its association with NF-1.", "retries": 1}
{"idx": 264, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antioxidant') in meaning, though it includes additional clarification ('Peroxiredoxin 2 (PRDX2) is an...'). The supporting sentence is relevant and supports the answer indirectly by referencing 'Prx-like activity,' which aligns with antioxidant properties. However, it is slightly verbose and less direct compared to the gold supporting sentence, which explicitly mentions 'antioxidant enzyme.'\", \"match\": true}", "gold_answer": "antioxidant", "gold_support": "Here, we offer the first evidence that an antioxidant enzyme has a key role in this transition.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme.", "model_support": "Supporting sentence: The natural compound gliotoxin, which is known to exert a Prx-like activity, inhibited proliferation and migration as well as lung metastasis of Prx2-deficient melanoma cells. \n\n**Analysis**:  \nThe sentence references \"Prx-like activity\" of gliotoxin, where \"Prx\" refers to peroxiredoxin (PRDX2). The term \"Prx-like activity\" implies that peroxiredoxins, including PRDX2, share functional characteristics with known antioxidant compounds like gliotoxin. While the context does not explicitly use the word \"antioxidant,\" the association with Prx-like activity and the established role of peroxiredoxins as antioxidant enzymes in biomedical literature supports the conclusion that PRDX2 is an antioxidant enzyme.", "retries": 1}
{"idx": 265, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 266, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('S-adenosylmethionine' vs. 'S-Adenosyl methionine'), and both refer to the same biochemical compound SAM. However, the model's supporting sentence is incorrect in stating that no sentence supports the answer, as the gold supporting sentence explicitly mentions S-Adenosyl methionine as the methyl donor. While the model answer is correct, the reasoning about the lack of context support reduces the score slightly.\", \"match\": true}", "gold_answer": "S-Adenosyl methionine", "gold_support": "To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine.", "model_answer": "Answer: S-adenosylmethionine (SAM)", "model_support": "The context does not mention the methyl donor for histone methyltransferases (e.g., S-adenosylmethionine, SAM). Therefore, **no sentence in the provided context supports the answer** to the question about the methyl donor. The answer relies on general biochemical knowledge rather than the specific text given. \n\n**Note:** The question appears to test prior knowledge, but the required supporting evidence is absent from the provided context.", "retries": 1}
{"idx": 267, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While it correctly lists features like hemiplegia, microcephaly, developmental delay, and seizures, it introduces 'cerebral atrophy on the affected side,' which is not explicitly mentioned in the context. The supporting sentence is relevant but does not cover the gold answer ('cerebral hemiatrophy') as it focuses on clinical symptoms rather than the diagnostic feature from the CT scan.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Hemiplegia, microcephaly, developmental delay, and seizures with associated cerebral atrophy on the affected side.", "model_support": "Supporting sentence: A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains. \n\n**Analysis**: The context explicitly lists *seizures, spastic hemiplegia, microcephaly, and developmental delay* as features in this case. While the answer includes *cerebral atrophy on the affected side*, this is not mentioned in the provided context. The quoted sentence supports the features described in the case but does not address cerebral atrophy.", "retries": 1}
{"idx": 268, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the topic of TAp73 isoforms but does not provide information about the number of isoforms, which is the focus of the question. While it correctly describes the existence of TAp73 and DeltaNp73 as distinct isoforms, it fails to address the specific count mentioned in the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions. \n\n**Analysis**: The context explicitly states that TAp73 and DeltaNp73 are distinct isoforms generated from the p73 gene via alternative promoters, but it does not specify the exact number of TAp73 isoforms. The text uses the plural \"isoforms\" without quantifying them (e.g., \"TAp73 isoforms\" vs. \"two TAp73 isoforms\"). Therefore, the answer is that the text does not specify the number of TAp73 isoforms.", "retries": 1}
{"idx": 269, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights Bach1's regulatory role in HO-1 expression, which aligns with its function as a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "BTB and CNC homolog 1 (Bach1) is a transcriptional repressor of heme oxygenase-1 (HO-1).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: It plays an important role in the feedback regulation of HO-1 expression, which protects cells from various insults including oxidative stress and inflammatory cytokines. \n\n**Analysis**: The context explains that Bach1 regulates HO-1 expression. Since HO-1 is a protective protein, and Bach1 deficiency leads to increased HO-1 expression (as shown in the study), this implies that Bach1 normally acts as a **repressor** of HO-1. The phrase \"feedback regulation\" aligns with this, suggesting Bach1 downregulates HO-1 under normal conditions.", "retries": 1}
{"idx": 270, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by explicitly stating Bach1's role as a transcriptional repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.  \n\n**Analysis**: The title explicitly identifies Bach1 as a \"transcriptional repressor,\" which directly answers the question. The experimental findings further support this: Bach1 binds to the NA site in the absence of heme (SA treatment), repressing alpha-globin gene expression. Hemin (heme) disrupts this interaction, restoring gene expression, confirming Bach1's role as a repressor.", "retries": 1}
{"idx": 271, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the supporting sentence is not explicitly pulled from the context provided, the gold supporting sentence confirms that 'Clostridium botulinum' is indeed mentioned as the cause of botulism in the background information. Thus, the model’s recognition of the correct answer and acknowledgment of general scientific knowledge aligns well with the gold standard.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "BACKGROUND: Botulism is a serious neuroparalytic disease caused by toxins of Clostridium botulinum.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly mention **Clostridium botulinum** as the causative bacterium for botulism. While the text discusses botulinum toxin production under anaerobic conditions (a characteristic of *Clostridium* species), it does not name the specific bacterium. Therefore, **there is no supporting sentence in the provided context** for this answer. The answer relies on general scientific knowledge rather than the text provided. \n\n**Answer:**  \nClostridium botulinum  \n**Supporting sentence:** *None provided in the context.*", "retries": 1}
{"idx": 272, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and supports the answer, but it focuses on specific cases (deletions in the ZEB2 gene) rather than providing the broader and more comprehensive explanation found in the gold supporting sentence. It contains slight redundancy by mentioning 'novel partial gene deletions,' which is not necessary for the core logic.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions. \n\n(Additional context: The title also explicitly states \"Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome,\" directly linking the ZEB2 gene to the condition.)", "retries": 1}
{"idx": 273, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and provides context about Clostridium botulinum, but it is slightly redundant and less focused than the gold supporting sentence. The model's supporting sentence mentions multiplex real-time PCR, which is not directly necessary to justify the answer.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease in animals is mainly caused by toxins produced by Clostridium botulinum strains belonging to group III, although outbreaks due to toxins produced by group I and II organisms have been recognized.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: Multiplex real-time PCR for detecting and typing Clostridium botulinum group III organisms and their mosaic variants. \n\n**Analysis**: The context explicitly identifies *Clostridium botulinum* (specifically group III strains) as the causative agent of botulism, emphasizing its role in producing toxins responsible for the disease. This aligns with the widely recognized fact that *Clostridium botulinum* is the primary bacterium associated with botulism, including foodborne (e.g., sausage poisoning) and animal cases.", "retries": 1}
{"idx": 274, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that nestin-positive cells are linked to neural precursor markers, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "nestin", "gold_support": "Only a minority of stem cells expressed nestin, a marker for neural precursor cells.", "model_answer": "Answer: Nestin", "model_support": "Supporting sentence: Cultivation in serum-free medium supplemented with specific growth factors resulted in a markedly higher percentage of **nestin-positive cells**.  \n\n**Analysis**:  \nThe sentence directly identifies *nestin* as a marker expressed by BMSCs under conditions promoting neural differentiation. Nestin is a well-established intermediate filament protein used as a marker for neural precursor/stem cells, including those in the subventricular zone (SVZ). The context links nestin expression to neural differentiation protocols, aligning with its role as a non-specific marker for neuronal precursor cells in the SVZ.", "retries": 1}
{"idx": 275, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer mentions both alpha-synuclein and synphilin-1, but the gold standard specifies only alpha-synuclein as the main component. While synphilin-1 is relevant to Lewy body formation, it is not identified as the main component in the context provided. The supporting sentences are somewhat lengthy and mix relevant information with additional details about synphilin-1A and inclusion bodies, which are not necessary for directly supporting the gold answer. Logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Aggregated proteins, specifically alpha-synuclein and synphilin-1.", "model_support": "Supporting sentences:  \n1. \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"  \n2. \"Accumulation of ubiquitylated synphilin-1 leads to massive formation of inclusion bodies, which resemble Lewy bodies by their ability to recruit alpha-synuclein.\"  \n3. \"The fact that alpha-synuclein interacts with synphilin-1A, and is recruited to synphilin-1A inclusion bodies in neurons together with synphilin-1, further indicates that synphilin-1A cell model is relevant for research on Parkinson's disease.\"  \n\nThese sentences explicitly state that **alpha-synuclein** and **synphilin-1/synphilin-1A** are key components of Lewy bodies and their pathological inclusions.", "retries": 1}
{"idx": 276, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Icatibant,' does not match the gold standard 'ecallantide.' While Icatibant is another drug used to treat hereditary angioedema (HAE), it is not the correct investigational name for DX-88. The supporting sentence is relevant to the context of HAE treatment but does not provide logical support for the incorrect answer, and it fails to mention ecallantide or clarify the identity of DX-88.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "DX-88 (ecallantide), a 60-amino acid recombinant protein discovered through phage display technology, is a highly specific, potent inhibitor of human plasma kallikrein that has been used successfully in the treatment of patients experiencing acute HAE attacks.", "model_answer": "Answer: Icatibant", "model_support": "Supporting sentence: This case study demonstrates that DX-88 can produce dramatic clinical benefits in a patient with an acute abdominal HAE attack, resolving both symptoms and pathologic signs.  \n**Note**: While the context does not explicitly name DX-88 as \"Icatibant,\" this is a well-established fact in medical literature (DX-88 is the investigational code name for Icatibant, a bradykinin B2 receptor antagonist approved for HAE). The context supports the use of DX-88 in treating HAE but does not directly state its generic name.", "retries": 1}
{"idx": 277, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('semagacestat') but is present in the context as 'γ-secretase inhibitor,' which is a correct but incomplete identification. The supporting sentence is relevant but does not directly cover the gold answer ('semagacestat'). It mentions LY450139 as a γ-secretase inhibitor but omits the specific name 'semagacestat,' which reduces its effectiveness.\", \"match\": false}", "gold_answer": "semagacestat", "gold_support": "The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.", "model_answer": "Answer: γ-secretase inhibitor", "model_support": "Supporting sentence: In the present study, 9 dogs were treated with a single dose of the γ-secretase modulator E2012, the γ-secretase inhibitor LY450139, or vehicle with a dosing interval of 1 week.", "retries": 1}
{"idx": 278, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information and correctly identifies cysteine as the residue most commonly involved in CADASIL mutations. However, it includes some redundancy by mentioning exceptions and providing extra analysis about 'different from loss or gain of a cysteine,' which slightly detracts from conciseness.\", \"match\": true}", "gold_answer": "cysteine", "gold_support": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease due to mutations involving loss or gain of a cysteine residue in the NOTCH3 gene.", "model_answer": "Answer: Cysteine", "model_support": "Supporting sentence: \"Moreover genetic variants different from loss or gain of a cysteine residue are identified and presented.\"  \nThis implies that while some mutations involve cysteine residues (the typical hallmark of CADASIL), the study also found exceptions. However, the **majority** of CADASIL-associated mutations in the NOTCH3 gene are known to involve **loss or gain of a cysteine residue**, as highlighted in the conclusion. The phrase \"different from loss or gain of a cysteine residue\" confirms that cysteine mutations are the most common, making cysteine the correct answer.", "retries": 1}
{"idx": 279, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'p53', matches the gold standard. The supporting sentence provides relevant information and logically connects p53 to its role as 'the guardian of the genome,' even though it does not directly quote the gold supporting sentence. It includes a slight redundancy by referencing external scientific literature, but overall, it is accurate and supports the answer well.\",\n  \"match\": true\n}", "gold_answer": "di", "gold_support": "The p53 gene has been referred to as 'the guardian of the genome' because it controls apoptosis and cell cycle arrest.", "model_answer": "Answer: p53", "model_support": "The context does not explicitly mention the phrase \"guardian of the genome.\" However, the p53 tumor suppressor protein is widely recognized in scientific literature as \"the guardian of the genome\" due to its critical role in maintaining genomic stability. The study focuses on the **p53 gene** (specifically codon 72 polymorphism and protein expression), which is central to this designation. \n\nSupporting sentence from the context:  \n**\"The purpose of this study was to evaluate the association of p53 codon 72 genetic polymorphism and the p53 immunohistochemistry with Helicobacter pylori-associated gastroduodenal diseases, including gastric cancer.\"**  \n\nThis sentence confirms the focus on p53, which is universally acknowledged as \"the guardian of the genome.\"", "retries": 1}
{"idx": 280, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly ('Factor Xa' is equivalent to 'xa'); supporting sentence is concise, directly relevant, and provides clear logical reasoning by linking betrixaban to the class of direct factor Xa inhibitors. Minor additional context about the drug class is acceptable and does not detract from the clarity or relevance.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation... \n\nAlthough the context does not explicitly mention betrixaban, it explicitly states that **direct factor Xa inhibitors** (a class of drugs including betrixaban) inhibit **factor Xa**. This sentence establishes that all members of this drug class, including betrixaban, target factor Xa.", "retries": 1}
{"idx": 281, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It precisely quotes the phrase referring to p53 as 'the guardian of the genome,' aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'\"", "retries": 1}
{"idx": 282, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'microautophagy,' does not match the gold standard, 'chaperone-mediated autophagy (CMA),' but is present in the context. The supporting sentence discusses microautophagy but does not cover the gold answer or mention the KFERQ motif, which is central to the correct answer. While the context provided by the model is relevant to autophagy pathways, it fails to directly address the role of the KFERQ motif in chaperone-mediated autophagy.\", \"match\": false}", "gold_answer": "chaperone-mediated autophagy (CMA)", "gold_support": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes through the LAMP-2A (Lysosome-associated membrane protein type 2A) receptor.", "model_answer": "Answer: Microautophagy", "model_support": "Supporting sentence: \"These two processes and the lesser understood microautophagy, which involves direct engulfment of proteins into lysosomes, occur at basal and induced levels.\"  \n\nThe context does not explicitly mention the **KFERQ motif** or its association with autophagy pathways. However, the provided answer (**microautophagy**) is inferred from the description of microautophagy as a lysosomal engulfment process, which is distinct from macroautophagy (involving autophagosomes). While the KFERQ motif is classically linked to **chaperone-mediated autophagy (CMA)** in established literature, the context only discusses **microautophagy** and does not clarify the role of KFERQ. Thus, the answer is based solely on the context’s description of microautophagy as a lysosomal engulfment mechanism, even though it lacks direct linkage to the KFERQ motif.", "retries": 1}
{"idx": 283, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence acknowledges that the context does not explicitly state the targeted strand but correctly explains that the answer relies on general biological knowledge. Although the model provides a hypothetical supporting sentence for clarity, it identifies that no direct supporting sentence exists in the given text. The gold supporting sentence is more concise and directly references the context, making the model's explanation slightly redundant but still logical and relevant.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "It has been previously shown that disruption of RAD26 in yeast strain W303-1B results in a strain that is deficient in transcription-coupled repair (TCR), the preferential repair of the transcribed strand of an expressed gene over the non-transcribed strand and the rest of the genome.", "model_answer": "Answer: The transcribed strand.", "model_support": "The context does not explicitly mention which DNA strand is targeted by transcription-coupled repair (TCR). While TCR is generally known to repair the transcribed strand (a well-established biological concept), the provided text focuses on the role of *RAD26* and its homolog *CSB* in TCR without specifying the targeted strand. Therefore, **no direct supporting sentence exists in the given context** to confirm the answer \"the transcribed strand.\" The answer relies on prior knowledge rather than the provided text. \n\nExample of a hypothetical supporting sentence (not present in the actual context):  \n*\"Transcription-coupled repair specifically targets the transcribed DNA strand to remove lesions that block RNA polymerase.\"*  \n\nSince the context lacks such a sentence, the answer cannot be substantiated solely from the provided information.", "retries": 1}
{"idx": 284, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'SERCA (sarco(endo)plasmic reticulum calcium pump),' is correct but too general and does not specify the main isoform relevant to the sarcoplasmic reticulum in the heart, which is SERCA2 (specifically SERCA2a). The supporting sentence provides relevant information about SERCA's function, but it does not focus on the specific role of SERCA2 or its importance in the sarcoplasmic reticulum as described in the gold standard. Therefore, while the model's response is accurate, it lacks precision and fails to fully align with the gold answer.\",\n  \"match\": false\n}", "gold_answer": "SERCA2", "gold_support": "During diastole, muscle relaxation occurs as Ca2+ is again removed from cytosol, predominantly by accumulation into SR via the action of SERCA2a.", "model_answer": "Answer: SERCA (sarco(endo)plasmic reticulum calcium pump)", "model_support": "Supporting sentence: SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores. \n\n**Analysis**: This sentence explicitly defines SERCA (sarco(endo)plasmic reticulum calcium pump) as the protein responsible for pumping calcium into intracellular stores (including the sarcoplasmic reticulum), directly answering the question.", "retries": 1}
{"idx": 285, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the NF1 gene, but it focuses more on the 'two-hit' hypothesis and tumor-suppressor role rather than directly describing the gene's function as specified in the gold supporting sentence. It is slightly less concise and lacks mention of neurofibromin or its relation to GTPase-activating proteins.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "The NF1 gene codes for a protein called \"neurofibromin.\" It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: \"The evidence points to the NF1 gene being a tumor-suppressor gene. NF1 patients also have an increased incidence of certain malignant tumors that are believed to follow the 'two hit' hypothesis, with one allele constitutionally inactivated and the other somatically mutated.\"", "retries": 1}
{"idx": 286, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly states that all three complexes in Drosophila are H3K4 methyltransferases, aligning perfectly with the gold answer.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "Methylation of histone H3 lysine 4 (H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax (Trx).", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: Our study demonstrates that all three complexes in Drosophila are H3K4 methyltransferases; however, dSet1/COMPASS is the major monoubiquitination-dependent H3K4 di- and trimethylase in Drosophila.  \n\n**Analysis:**  \nThe context explicitly states that all three Drosophila COMPASS family complexes (dSet1, Trx, and Trr) function as **H3K4 methyltransferases**. Since Trx corresponds to human MLL1/2, this directly supports that MLL1 methylates **H3K4**. The sentence identifies H3K4 as the target residue for these enzymes, confirming the answer.", "retries": 1}
{"idx": 287, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'p16INK4a' is very close to the gold standard 'p16INK4,' with only a minor difference in formatting (full name vs. shorthand). However, the supporting sentence is somewhat indirect and focuses on the lack of correlation rather than clearly stating the regulatory relationship between Bmi-1 and p16INK4a. While the logic connecting the answer to the context is reasonable, the supporting sentence could be more concise and directly relevant.\", \"match\": true}", "gold_answer": "p16INK4", "gold_support": "Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.", "model_answer": "Answer: p16INK4a", "model_support": "Supporting sentence: Our data suggest that the oncogenic role of Bmi-1 in human primary breast carcinomas is not determined by its capacity to inhibit INK4a/ARF proteins or to induce telomerase activity. \n\n**Analysis:**  \nThe conclusion explicitly states that Bmi-1's oncogenic role in breast carcinomas is **not** mediated through inhibition of INK4a/ARF proteins (which includes **p16INK4a**). This implies that **p16INK4a** is a known downstream target of Bmi-1 in general (as supported by prior literature), but this study found **no correlation** between Bmi-1 and p16INK4a expression in their dataset. The answer reflects the broader biological context where Bmi-1 typically regulates p16INK4a, even though the specific study did not observe a correlation. The quoted sentence from the conclusion indirectly supports the answer by highlighting the absence of this regulatory mechanism in the studied tumors, confirming p16INK4a as the relevant cyclin-dependent kinase inhibitor associated with Bmi-1.", "retries": 1}
{"idx": 288, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer (Tarenflurbil) is incorrect and does not match the gold standard (Semagacestat). The supporting sentence provided by the model highlights the lack of supporting evidence in the context for its incorrect answer, which indicates that the model failed to extract the correct information from the context. The supporting sentence itself is irrelevant as it does not support the gold answer. Therefore, both the answer and supporting sentence fail to meet the criteria.\", \"match\": false}", "gold_answer": "Semagacestat", "gold_support": "The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.", "model_answer": "Answer: Tarenflurbil", "model_support": "The context provided does not mention \"LY450139\" or explicitly link it to Tarenflurbil. Therefore, **no sentence in the given context supports the claim that LY450139 is the investigational name of Tarenflurbil**. The answer provided (Tarenflurbil) cannot be validated based on the quoted text. \n\nIf the user intended to reference external knowledge (e.g., LY450139 is an investigational name for Tarenflurbil in some contexts), the supporting evidence is absent from the provided context.", "retries": 1}
{"idx": 289, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is slightly different but still directly references the correct synonym from the context, making it accurate and appropriate.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: \"Woman with x-linked recessive dystonia-parkinsonism: clue to the epidemiology of parkinsonism in Filipino women?\"  \n\n**Explanation**: The context explicitly uses \"X-linked dystonia-parkinsonism\" as the full name of the condition (also known as *lubag* in the Philippines). The title of the study directly references this term, establishing it as the synonym for the disease.", "retries": 1}
{"idx": 290, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about the antiparallel nature of the structure; however, it focuses on the alpha-helices within R16 rather than directly stating that the heterodimer itself is antiparallel. This introduces slight redundancy and indirectness compared to the gold supporting sentence, which explicitly mentions the heterodimer.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.", "retries": 1}
{"idx": 291, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'Factor Xa' is equivalent to the gold answer 'Xa'. The supporting sentence references a factor Xa decoy and anti-Xa activity, which logically supports the answer, but it includes additional details about PRT4445 that are not strictly necessary to answer the question.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis:** The context explicitly links betrixaban to \"anticoagulants with anti-Xa activity\" and pairs it with a **factor Xa decoy** (PRT4445). This directly implies that betrixaban inhibits **Factor Xa**, as reversal agents like PRT4445 are designed to counteract the effects of anticoagulants targeting specific clotting factors. The phrase \"anti-Xa activity\" further confirms that betrixaban acts as a **factor Xa inhibitor**.", "retries": 1}
{"idx": 292, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer '1,4-benzothiazepine' is more specific than the gold answer 'benzothiazepine,' but it is still correct and aligns with the broader category of benzothiazepine. The supporting sentence references diltiazem as a 1,5-benzothiazepine derivative, which indirectly supports the classification of JTV519 by highlighting its distinction from diltiazem. However, the supporting sentence does not explicitly state that JTV519 is a 1,4-benzothiazepine derivative, leading to slight redundancy. Overall, the answer matches the gold standard, and the reasoning is logical but could be more direct.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Analysis**:  \nThe context explicitly states that diltiazem is a **1,5-benzothiazepine derivative**. While JTV519 is not directly described in the context as a 1,4-benzothiazepine derivative, the comparison with diltiazem (a 1,5 derivative) implies that JTV519 belongs to the **1,4-benzothiazepine** class, as these are distinct subgroups within the benzothiazepine family. This inference aligns with prior knowledge from the example provided (where JTV519 is explicitly labeled as a 1,4-benzothiazepine derivative). However, the direct supporting sentence for JTV519’s classification is **not present** in this specific context. The comparison with diltiazem (1,5) indirectly highlights the structural distinction but does not explicitly state JTV519’s classification.  \n\n**Final Answer**:  \nThe drug JTV519 is a **1,4-benzothiazepine** derivative.  \n\n**Supporting Sentence**:  \n*The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.*  \n\n(Note: This sentence does not explicitly state JTV519’s classification but provides context for the chemical distinction between JTV519 and diltiazem.)", "retries": 1}
{"idx": 293, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (ZFHX1B and Zfhx1b are equivalent in this context); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "Answer: Zfhx1b", "model_support": "Supporting sentence: Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.", "retries": 1}
{"idx": 294, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, correctly identifying alpha-synuclein as the main component of Lewy bodies. However, the supporting sentence is somewhat indirect and lacks the concise specificity of the gold supporting sentence. While it provides relevant context about PD being a Lewy body disorder, it does not explicitly state that alpha-synuclein is the main component of Lewy bodies or directly link its aggregation to the pathogenesis of PD. The reasoning provided in the analysis is accurate but introduces unnecessary details that slightly reduce clarity.\",\n  \"match\": true\n}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD.", "model_answer": "Answer: Alpha-synuclein (AS)", "model_support": "Supporting sentence: Parkinson disease (PD) is the most important movement disorder and about 50% of patients develop dementia over the time. PD belongs to the group of **Lewy body disorders**.  \n**Analysis**: While the context does not explicitly name alpha-synuclein (AS) as the main component of Lewy bodies, it classifies PD as a Lewy body disorder. In biomedical literature, Lewy bodies are well-established as protein aggregates primarily composed of **alpha-synuclein**. The context further discusses AS (alpha-synuclein) and its interactions with beta-synuclein (BS), implicitly linking AS to the pathogenesis of Lewy body disorders. The critical supporting detail is the classification of PD as a Lewy body disorder, combined with the focus on AS in the study, which aligns with the known scientific consensus.", "retries": 1}
{"idx": 295, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer of 'Five' does not match the gold standard of '7', but it is present in the context as the number of N-terminal isoforms mentioned. The supporting sentence is relevant but does not cover the gold answer since it refers to 'five p73 isoform levels,' which conflates the total number of isoforms with the variables used in the analysis. The sentence does not clarify that there are actually seven TAp73 isoforms, leading to a mismatch with the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "model_answer": "Answer: Five", "model_support": "Supporting sentence: We used all 6 variables (five p73 isoform levels plus p53 status) as input into a principal component analysis with Varimax rotation (VrPCA) to filter out noise from non-disease related individual variability of p73 levels.  \n\n**Analysis**:  \nThe context explicitly states there are **five p73 isoform levels** analyzed as variables. While the question specifies \"TAp73 isoforms,\" the text does not explicitly name all five isoforms (only TAp73, ΔNp73, and ΔN'p73 are mentioned). However, the numerical answer \"five\" is directly supported by the sentence above, which lists \"five p73 isoform levels\" as part of the study's methodology. This implies the total number of p73 isoforms considered in the analysis is five, even if not all are explicitly named.", "retries": 1}
{"idx": 296, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('flumazenil'), but the supporting sentence is incorrect as it claims there is no mention of flumazenil in the context. In fact, the context explicitly mentions flumazenil as the treatment for benzodiazepine intoxication. The supporting sentence does not logically support the correct answer.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15-1788).", "model_answer": "Answer: Flumazenil", "model_support": "The context does not mention Flumazenil or any specific drug used as an antidote for benzodiazepine overdose. Therefore, there is no supporting sentence in the provided context for the given answer.", "retries": 1}
{"idx": 297, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies medicarpin as the phytoalexin in alfalfa, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in **medicarpin** biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence explicitly identifies **medicarpin** as the phytoalexin produced via the biosynthetic pathway involving IFR in alfalfa.", "retries": 1}
{"idx": 298, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'CGRP (calcitonin gene-related peptide) receptor.' Although the model notes that the context does not explicitly provide a supporting sentence, the gold supporting sentence from the background section directly supports the answer. Thus, the answer is accurate and aligns perfectly with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.", "model_answer": "Answer: CGRP (calcitonin gene-related peptide) receptor", "model_support": "The context provided does not explicitly mention the specific receptor targeted by telcagepant (CGRP receptor). While the answer is correct based on external knowledge (telcagepant is a CGRP receptor antagonist), **no sentence in the given context directly supports this conclusion**. The text focuses on tolerability and adverse events, not the drug's mechanism of action. \n\n**Answer:** CGRP (calcitonin gene-related peptide) receptor  \n**Supporting sentence:** *Not explicitly stated in the provided context.*  \n\n**Note:** The correct receptor is known from prior scientific literature, but the context here does not include the necessary information to justify the answer.", "retries": 1}
{"idx": 299, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights Dnmt1's specificity for methylation of hemimethylated CpG sites, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "The maintenance methylation of hemimethylated CpG sites by the DNA methyltransferase Dnmt1 is the molecular basis of the inheritance of DNA methylation patterns.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.  \n\n**Analysis**: The context explicitly identifies Dnmt1 as the enzyme responsible for methylation of hemimethylated CpG sites, which is the core function of DNA (cytosine-5-)-methylation maintenance. While the rest of the text discusses structural and functional details of Dnmt1 (e.g., catalytic domain, CXXC domain variants), the first sentence directly states Dnmt1's role in this process.", "retries": 1}
{"idx": 300, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence mentions the modified forms of alpha-synuclein found in Lewy bodies, which aligns well with the context and gold standard.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "Answer: α-Synuclein (AS)", "model_support": "Supporting sentence: Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS. \n\n**Analysis**: The context explicitly states that Lewy bodies are composed of α-synuclein (AS) in modified forms (phosphorylated, nitrated, monoubiquitinated), confirming AS as the main component.", "retries": 1}
{"idx": 301, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies two isoforms (TAp73 alpha and Delta Np73 alpha), which aligns with the provided context but fails to account for the broader complexity implied by the gold answer of '7'. Thus, while relevant, the supporting sentence does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: p73, the first p53 gene homologue, encodes an array of p73 proteins including p73 alpha full-length (TAp73 alpha) and amino-truncated isoforms (Delta Np73 alpha), two proteins with opposite biological functions. \n\n**Analysis:** The sentence explicitly identifies two distinct TAp73 isoforms—TAp73 alpha (full-length) and Delta Np73 alpha (amino-truncated)—as part of the p73 protein family in humans. These two isoforms are described as having opposing biological functions, confirming the answer of \"two\" TAp73 isoforms.", "retries": 1}
{"idx": 302, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information about TCR targeting the transcribed strand through the role of Cockayne syndrome gene products. However, it contains slight redundancy by introducing details about the Cockayne syndrome gene products, which are not necessary to directly support the answer. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.", "retries": 1}
{"idx": 303, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (ZEB2) does not match the gold standard (ZFHX1B), but ZEB2 is a known synonym for ZFHX1B and is mentioned in related contexts. However, the supporting sentence provided by the model is incorrect, as it states that the context does not mention the gene, while the gold supporting sentence directly identifies ZFHX1B as the responsible gene. The supporting sentence is relevant to the context but fails to cover the gold answer.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "Haploinsufficiency of a gene termed ZFHX1B (also known as SIP1) on chromosome 2 is responsible for this condition, and clinical genetic testing for MWS recently became available.", "model_answer": "Answer: ZEB2", "model_support": "The context provided does not mention the specific gene responsible for Mowat-Wilson syndrome (ZEB2). Therefore, the answer **cannot be supported** by any sentence in the given context. The text focuses on clinical features, management strategies, and epidemiology but does not discuss genetic causes.", "retries": 1}
{"idx": 304, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about CYP17A1, but it is somewhat verbose and includes additional details not directly necessary to support the answer. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: We evaluated its effects on CYP17A1 enzymatic activity, steroid production in monkey adrenal cells and human adrenal tumor cells, and serum levels of dehydroepiandrosterone (DHEA), cortisol, and testosterone after oral dosing in castrated and intact male cynomolgus monkeys.", "retries": 1}
{"idx": 305, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 306, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('iron') in essence, though it is slightly more verbose ('Iron deficiency'). The supporting sentence is relevant and covers the answer, but it introduces specific context (chronic hemoptysis in cystic fibrosis) that is not necessary to support the general relationship between iron deficiency and restless leg syndrome. This makes it somewhat redundant compared to the gold supporting sentence, which is more concise and broadly applicable.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.", "model_answer": "Answer: Iron deficiency", "model_support": "Supporting sentence: Restless leg syndrome manifested by iron deficiency from chronic hemoptysis in cystic fibrosis.", "retries": 1}
{"idx": 307, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about γ-secretase inhibitor and its development are acceptable as they provide useful context without being excessive.\", \"match\": true}", "gold_answer": "semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "Answer: Semagacestat", "model_support": "Supporting sentence: Semagacestat (LY450139) is a novel γ-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD).", "retries": 1}
{"idx": 308, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, using the full name 'SERCA (Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase)', which is synonymous with the gold answer. The supporting sentence is concise, directly relevant, and logically ties the modulation of SERCA activity to its role as the main calcium pump in the sarcoplasmic reticulum, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "Answer: SERCA (Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: Modulation of rabbit muscle sarcoplasmic reticulum **Ca(2+)-ATPase** activity by novel quercetin derivatives.  \n(SERCA is the full name for **Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase**, and the context directly refers to this enzyme as the target of modulation, confirming it as the main calcium pump of the sarcoplasmic reticulum.)", "retries": 1}
{"idx": 309, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SECIS element' is equivalent to 'SECIS'). The supporting sentence is relevant and provides context for the SECIS element, mentioning its functional role in selenocysteine insertion. However, it is slightly less specific compared to the gold supporting sentence, which directly references the stem-loop structure and examples from specific genes. This makes the model's supporting sentence somewhat less precise but still logical and relevant.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Two functional SECIS elements were identified in the 3' untranslated region of the rat selenoprotein P mRNA, with predicted stem-loops and critical nucleotides similar to those in the SECIS elements in the type I iodothyronine 5' deiodinase (5'DI) and glutathione peroxidase selenoprotein mRNAs.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons.", "retries": 1}
{"idx": 310, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK gene' vs 'XK'), though it includes a slight redundancy by specifying 'gene.' The supporting sentence is relevant and covers the answer adequately, but it could be more precise. Instead of referencing the title, quoting the direct evidence from the results—such as the mention of the XK missense mutation in exon 3—would provide clearer and more specific support.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"  \n**Analysis**: The title of the study explicitly states that the McLeod phenotype is linked to a **missense mutation in the XK gene**, directly answering the question. While the study design and results further elaborate on the analysis of XK DNA and RNA, the gene association is most clearly and concisely stated in the title.", "retries": 1}
{"idx": 311, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While myelosuppression is mentioned in the context as the dose-limiting toxicity, the question asks for the 'major adverse effect,' which is cardiotoxicity according to the gold answer and supporting sentence. The supporting sentence provided by the model discusses myelosuppression but does not cover the gold answer of cardiotoxicity. The information provided is relevant to the broader context of doxorubicin's effects but fails to address the specific major adverse effect identified in the gold standard.\", \"match\": false}", "gold_answer": "Cardiotoxicity", "gold_support": "Cardiotoxicity is a major adverse effect of the anthracycline antibiotics and can be acute or chronic; in the acute setting, electrocardiographic abnormalities may be seen, including ST-T elevations and arrhythmias, but chronic cardiotoxicity represents a serious adverse effect that may be lethal due to the development of irreversible, cumulative dose-dependent, congestive cardiomyopathy.", "model_answer": "Answer: Myelosuppression, predominantly neutropenia and leucopenia.", "model_support": "Supporting sentence: \"Myelosuppression, predominantly neutropenia and leucopenia, is the dose-limiting toxicity; in addition to this, mucositis, nausea, vomiting and alopecia are frequent, whereas hepatopathy, characterised by elevated bilirubin concentrations, occurs less frequently.\" \n\nThe context explicitly identifies myelosuppression (with emphasis on neutropenia and leucopenia) as the **dose-limiting toxicity**, which directly supports it being the major adverse effect of anthracyclines like doxorubicin.", "retries": 1}
{"idx": 312, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the drug's function, which strengthens understanding without being overly verbose.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.", "model_answer": "Answer: Ecallantide", "model_support": "Supporting sentence: Ecallantide, a novel plasma kallikrein inhibitor, inhibits production of bradykinin, the key mediator of these angioedema attacks. \n\n**Analysis:**  \nThe context directly introduces \"Ecallantide\" as the drug name. While the question references \"DX-88\" (not explicitly mentioned in the provided text), the correct answer aligns with \"Ecallantide\" as the drug discussed. The supporting sentence confirms the drug's identity and mechanism, validating the answer.", "retries": 1}
{"idx": 313, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'). However, the supporting sentence provided by the model is incorrect as it claims no direct support exists in the context, while the gold supporting sentence shows that the context does mention JNK evaluation via Western blot. The model's supporting explanation could thus be more precise but still acknowledges the general relevance of MAPK pathways. Slight misalignment leads to a score of 4.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "The expressions of Bcl-2, Bax, caspase-3, extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal protein kinases (JNK), and p38 were evaluated by Western blot.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "The context does not explicitly mention which MAP kinase phosphorylates the transcription factor c-jun. While the text refers to the involvement of the mitogen-activated protein kinase (MAPK) pathways in apoptosis, it does not specify **JNK (c-Jun N-terminal kinase)** or its role in phosphorylating **c-jun**. This answer relies on external biochemical knowledge rather than the provided context. \n\n**Supporting sentence**: The context does **not** contain a sentence that directly supports this answer.", "retries": 1}
{"idx": 314, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Na⁺-Ca²⁺ exchanger' matches the gold standard 'NCX' as they are equivalent terms in this context. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by specifying that SEA0400 is a specific inhibitor of the Na⁺-Ca²⁺ exchanger. Minor extra details in the supporting sentence do not detract from its relevance or clarity.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "Using SEA0400, a potent and selective inhibitor of the Na+-Ca2+ exchanger (NCX), we examined whether NCX is involved in nitric oxide (NO)-induced disturbance of endoplasmic reticulum (ER) Ca2+ homeostasis followed by apoptosis in cultured rat microglia.", "model_answer": "Answer: Na⁺-Ca²⁺ exchanger", "model_support": "Supporting sentence: SEA0400, a specific inhibitor of the Na⁺-Ca²⁺ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia.", "retries": 1}
{"idx": 315, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Nestin' matches the gold standard 'nestin' (case-insensitive match). However, the supporting sentence provided by the model is incorrect because it states that no sentence in the context supports the answer, which is untrue. The gold supporting sentence directly mentions nestin as a marker for precursor cells in the subventricular zone. While the answer is correct, the supporting sentence mixes irrelevant reasoning by incorrectly claiming lack of support from the context, resulting in a score of 3.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "In the subventricular zone, this effect was exerted selectively on a precursor subpopulation expressing nestin but not neuronal or glial cell-specific proteins.", "model_answer": "Answer: Nestin", "model_support": "The context does not mention any intermediate filament (IF) protein, including Nestin, as a marker for neuronal precursor cells in the subventricular zone. Therefore, **no sentence in the provided context supports the answer \"Nestin.\"** The question appears to require external knowledge or a different context, as the given text focuses on nitric oxide's effects on neurogenesis rather than specific cell markers.", "retries": 1}
{"idx": 316, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly by correctly identifying peroxiredoxin 2 (PRDX2) as an antioxidant enzyme. The supporting sentence is concise, directly relevant, and logically supports the classification of PRDX2 as an antioxidant enzyme by referencing its identification as an Srx-dependent modified enzyme within the context of an antioxidant system. Minor additional details in the reasoning do not detract from the strong logical connection.\", \"match\": true}", "gold_answer": "antioxidant", "gold_support": "The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme.", "model_support": "Supporting sentence: \"PRDX2, identified as an Srx-dependent modified enzyme, was stimulated by gonadotropins.\"  \n**Analysis**: The context explicitly identifies PRDX2 as an *Srx-dependent modified enzyme*, and the broader discussion frames both Srx and PRDX2 as components of an **antioxidant system** (e.g., \"suggest the existence of an antioxidant system to maintain H₂O₂ production and elimination\"). This directly supports the classification of PRDX2 as an antioxidant enzyme.", "retries": 1}
{"idx": 317, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, and the supporting sentence acknowledges the relationship between Microsporidia and Fungi. However, it introduces unnecessary doubt by overemphasizing the lack of explicit kingdom classification in the context, which slightly detracts from the logical support provided by the phylogenetic analysis mentioned in the text. The gold supporting sentence is more concise and directly highlights the relevant evidence.\",\n  \"match\": true\n}", "gold_answer": "Fungi", "gold_support": "Phylogenetic analysis indicates a relationship between the Microsporidia and the Fungi.", "model_answer": "Answer: Fungi", "model_support": "The context does not explicitly state the kingdom classification of Microsporidia. While the text discusses their genetic relationships with other eukaryotic organisms, it does not specify that they belong to the Fungi kingdom. Therefore, the answer \"Fungi\" is **not directly supported** by the provided context. The classification of Microsporidia as Fungi may rely on prior knowledge or external taxonomic frameworks not included in the given text. \n\n**Key observation**: The context focuses on genetic analysis (e.g., LPI values, KOG clustering) and does not mention their taxonomic kingdom.", "retries": 1}
{"idx": 318, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but includes some redundancy by combining two sentences when one concise sentence would suffice.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Huntington disease is a hereditary neurodegenerative disorder resulting in loss of motor, cognitive, and behavioral functions and is characterized by a distinctive pattern of cerebral metabolic abnormalities. The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.  \n\n**Analysis:** The context explicitly states that the study investigated pridopidine treatment in patients with Huntington disease, directly linking the drug to this disorder.", "retries": 1}
{"idx": 319, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Parallel heterodimers') does not match the gold standard ('antiparallel'). However, the supporting sentence is relevant in mentioning the correct pairing of motifs, but it fails to cover the gold answer. The context explicitly states that the spectrin heterodimer forms through antiparallel lateral association, making the model's interpretation incorrect.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "The spectrin heterodimer is formed by the antiparallel lateral association of an alpha and a beta subunit, each of which comprises largely a series of homologous triple-helical motifs.", "model_answer": "Answer: Parallel heterodimers.", "model_support": "Supporting sentence: \"correct pairing of motifs, i.e. alpha21-beta1 and alpha20-beta2.\"  \n\n**Analysis**:  \nThe context explicitly describes the pairing of alpha and beta subunit motifs (e.g., alpha21 with beta1 and alpha20 with beta2), which implies a **parallel orientation** of the subunits. In antiparallel arrangements, such sequential pairing (alpha21-beta1 and alpha20-beta2) would not occur, as the subunits would align in opposite directions. The complementary electrostatic interactions and structural stabilization described further support this parallel alignment model.", "retries": 1}
{"idx": 320, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer ('luba syndrome') is incorrect and does not match the gold standard ('X-linked dystonia-Parkinsonism'). Additionally, the supporting sentence admits there is no relevant information in the context to support the model's answer, making it irrelevant and unsupported. The gold answer and supporting sentence clearly indicate the correct synonym and its basis in the provided context.\", \"match\": false}", "gold_answer": "X-linked dystonia-Parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The synonym of the lubag disease is \"luba syndrome.\"", "model_support": "The context provided does not mention \"lubag disease\" or \"luba syndrome,\" and no sentence in the text supports the synonym relationship stated in the answer. Therefore, there is **no supporting sentence** in the context for this claim. The example answer appears to be unrelated to the given context. \n\n**Note:** \"Lubag disease\" (also called \"luba syndrome\") is a rare autosomal recessive genetic disorder, but this information is not present in the provided context.", "retries": 1}
{"idx": 321, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but includes additional details about EC50 values that slightly increase verbosity without being necessary to support the answer.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: The change of NCX current and the increase of [Ca2+]i during I/R can be blocked by SEA0400 in a dose-dependent manner with an EC50 value of 31 nM and 28 nM for the inward and outward NCX current, respectively.", "retries": 1}
{"idx": 322, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that [18F]altanserin is used for PET studies targeting the serotonin 5-HT2A receptor. The logic aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 323, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer focuses on 'thyroid' abnormalities characteristic of Pendred syndrome, while the model's answer incorrectly emphasizes normal TSH and iodine organification, which are not the key hormone abnormalities associated with the condition. The supporting sentence is relevant to the model's answer but does not cover the gold answer, as it discusses normal findings rather than the thyroid dysfunction implied by the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter.", "model_answer": "Answer: Normal serum thyrotropin (TSH) levels and normal iodine organification.", "model_support": "Supporting sentence: \"while serum thyrotropin (TSH) levels and iodine organification (examined by the perchrolate or thiocyanate discharge test) remained normal.\"", "retries": 1}
{"idx": 324, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It explicitly identifies EWS/FLI1 as the fusion protein involved in Ewing sarcoma development, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "Answer: EWS/FLI1", "model_support": "Supporting sentence: EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. \n\nThis sentence explicitly identifies **EWS/FLI1** as the fusion protein involved in Ewing sarcoma pathogenesis.", "retries": 1}
{"idx": 325, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer logically, but contains slight redundancy by including additional details about emergency physicians using it prospectively. The core logic is strong, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 326, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing medicarpin biosynthesis. Minor extra details are acceptable as they do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: Molecular cloning and expression of alfalfa (Medicago sativa L.) vestitone reductase, the penultimate enzyme in **medicarpin biosynthesis**.", "retries": 1}
{"idx": 327, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and is clinically accurate in this context. The supporting sentence is relevant and supports the answer by emphasizing the ROSIER scale's effectiveness in identifying acute stroke. However, it could be slightly more concise and directly reference the development of the scale for stroke recognition, as the gold supporting sentence does. Overall, the logic is strong, but there is minor room for improvement in brevity and alignment with the gold standard.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.  \n\n**Analysis:**  \nThe context explicitly states that the ROSIER scale was developed and validated for distinguishing **acute stroke** from stroke mimics (e.g., seizures, syncope, sepsis) in emergency room settings. The interpretation section directly links the ROSIER scale to its clinical application in identifying acute stroke patients.", "retries": 1}
{"idx": 328, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is identical to the gold supporting sentence, ensuring perfect alignment.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the \"guardian of the genome,\" is the most frequent event found in 50% of human cancers.", "retries": 1}
{"idx": 329, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Rheumatoid Arthritis is more common in women') is factually correct and aligns with general medical knowledge, but the context provided does not support this claim. The context focuses on gender differences in disease progression and treatment responses within a specific cohort, not on prevalence or incidence. The supporting sentence correctly identifies that the context does not provide evidence for the model's answer, but it fails to directly reference the key data from the gold supporting sentence (e.g., the higher number of women in the study). As such, while the answer is correct, the lack of direct alignment between the context and the model's reasoning lowers the score.\", \"match\": true}", "gold_answer": "women", "gold_support": "RESULTS: At baseline, men (n = 67) and women (n = 225) had similar disease activity and radiographic damage; men, however, had significantly worse erosion, while women had worse joint space narrowing.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "The answer provided (\"Rheumatoid Arthritis is more common in women\") is **not supported by the context**. The context focuses on a **DMARD-naive seropositive early RA cohort** and examines **gender differences in disease progression and treatment responses**, not the **prevalence or incidence** of RA in men versus women. The conclusion only states that at baseline, men and women in the study had **similar disease activity and joint damage**, and highlights differences in treatment outcomes over time, not the relative frequency of RA between genders. \n\nThe answer reflects general medical knowledge (RA is indeed more common in women), but the **context does not provide evidence** to support this specific claim.", "retries": 1}
{"idx": 330, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns well with the gold standard, as both refer to thyroid abnormalities being common in Williams syndrome. However, the supporting sentence, while relevant, is slightly more detailed than necessary and includes case-specific information (e.g., 'an infant with WBS'), which adds redundancy. The gold supporting sentence is more concise and directly addresses the core issue of thyroid abnormalities in Williams syndrome.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Biochemical thyroid abnormalities, including congenital hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.  \n\n**Analysis**: The context explicitly links Williams syndrome (WBS) with congenital hypothyroidism in the described case, highlighting that thyroid abnormalities (e.g., hypoplasia, elevated TSH, and low FT4) are associated with WBS. The concluding statement further reinforces the need for thyroid evaluation in WBS patients, implying that such hormonal abnormalities are common in this syndrome.", "retries": 1}
{"idx": 331, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect compared to the gold supporting sentence. The model's supporting sentence focuses on the functional role of Hsp70 in preventing Nox5 degradation, which implies its upregulation but does not explicitly state it as clearly as the gold sentence.\", \"match\": true}", "gold_answer": "Hsp70", "gold_support": "Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation.", "model_answer": "Answer: Hsp70", "model_support": "Supporting sentence: Silencing Hsp70 prevented Hsp90 inhibitor-mediated degradation of Nox5.  \n\n**Analysis**:  \nThe context indicates that Hsp70 activity is required for Hsp90 inhibitor-induced degradation of Nox proteins (e.g., Nox5). When Hsp70 is silenced, the degradation of Nox5 mediated by Hsp90 inhibitors is blocked. This implies that **Hsp70 is upregulated or functionally activated during Hsp90 inhibition**, as its activity is necessary for the observed effects. The opposing roles of Hsp90 and Hsp70 (as stated in the conclusion) further support that Hsp70 counteracts Hsp90 inhibition, aligning with the answer.", "retries": 1}
{"idx": 332, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('antioxidant') in essence by correctly identifying PRDX2 as an antioxidant enzyme. The supporting sentence provided by the model acknowledges that the context does not explicitly mention the classification but aligns with the gold supporting sentence when general biochemical knowledge is considered. The logic is clear and concise.\", \"match\": true}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, was the most upregulated while tribbles homolog 3 (TRB3), a pro-apoptotic protein, was the most downregulated, implying a beneficial effect of lithium on neuronal cells.", "model_answer": "Answer: Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme.", "model_support": "The context does not mention peroxiredoxin 2 (PRDX2) or its enzymatic classification. Therefore, **no supporting sentence** is present in the provided text to confirm that PRDX2 is an antioxidant enzyme. The answer relies on general biochemical knowledge rather than the specific information in the context.", "retries": 1}
{"idx": 333, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the key fact that phosphorylated I-1 is a potent PP1 inhibitor, which aligns perfectly with the context and gold standard.\", \"match\": true}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.", "model_answer": "Answer: Inhibitor 1 (I-1)", "model_support": "Supporting sentence: Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. \n\n**Analysis:**  \nThe context explicitly states that phosphorylated inhibitor 1 (I-1) is a potent PP1 inhibitor, establishing I-1 as the primary protein responsible for PP1 inhibition. While the activity depends on phosphorylation (at Ser67 or Thr35), the question asks for the **protein** (not its modified state), and the first sentence directly identifies I-1 as the inhibitor.", "retries": 1}
{"idx": 334, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides contextual information about alpha-synuclein being abnormally deposited in neurons and glial cells, which indirectly supports its role in Lewy bodies. However, it does not explicitly mention Lewy bodies or their specific composition, making it slightly less direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid. \n\n**Analysis:**  \nWhile the context does not explicitly mention \"Lewy bodies,\" it establishes that **alpha-synuclein** is the central pathological protein in alpha-synucleinopathies (e.g., Parkinson’s disease, where Lewy bodies are the hallmark). The first sentence explicitly defines alpha-synucleinopathies as disorders characterized by abnormal alpha-synuclein deposition in neurons and glial cells, which aligns with the known composition of Lewy bodies (alpha-synuclein aggregates). Thus, the sentence supports the conclusion that alpha-synuclein is the main component of Lewy bodies.", "retries": 1}
{"idx": 335, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly ('Acute stroke' is a valid synonym for 'Stroke'); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about stroke mimics are acceptable as they clarify the context.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.** \n\nThis sentence directly states the disorder (acute stroke) for which the ROSIER scale is used, emphasizing its role in distinguishing acute stroke from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 336, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('FSHD'). The supporting sentence is concise, directly relevant, and logically links the FSHD-causing D4Z4 array to DUX4 production, which aligns with the gold supporting sentence. Minor extra details in the model's supporting sentence do not detract from the clarity or accuracy of the response.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: **Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.**  \nThis sentence explicitly links the *FSHD-causing D4Z4 array* to the regulation of *DUX4 production*, establishing FSHD (Facioscapulohumeral Muscular Dystrophy) as the disease associated with ectopic DUX4 expression.", "retries": 1}
{"idx": 337, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information and establishes a clear connection between 'Lubag' and 'XDP (X-linked Dystonia-Parkinsonism)', though it includes additional details about case studies that are not necessary for supporting the synonym relationship, leading to slight verbosity.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism.", "model_answer": "Answer: XDP (X-linked Dystonia-Parkinsonism)", "model_support": "Supporting sentence: We present cinematographic material of 11 cases of Lubag carrying the XDP haplotypes who manifest with a wide spectrum of movement disorders...  \nThe term \"XDP\" is explicitly linked to \"Lubag\" in this sentence, indicating that **XDP (X-linked Dystonia-Parkinsonism)** is the synonym for Lubag disease.", "retries": 1}
{"idx": 338, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect and could be more concise. The model supporting sentence discusses the mechanism of ZnMP-induced degradation of Bach1 and its effect on HO-1 up-regulation, which implies Bach1's role as a repressor but does not state it as directly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a mammalian transcriptional repressor of HO-1.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Our results indicate that ZnMP up-regulates HO-1 gene expression by markedly increasing Bach1 protein degradation in a proteasome-dependent manner. \n\n**Analysis**: The context explains that ZnMP-induced degradation of Bach1 leads to transcriptional up-regulation of HO-1. This implies that Bach1 functions as a repressor of HO-1 gene expression, as its removal (via degradation) results in increased HO-1 levels. The conclusion explicitly links the down-regulation of Bach1 to the up-regulation of HO-1, confirming Bach1's role as a repressor.", "retries": 1}
{"idx": 339, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' vs. 'XK'). The supporting sentence is concise, directly relevant, and logically explains the connection between the XK gene mutation and McLeod syndrome. Although the model supporting sentence includes additional details about the truncated protein, this does not detract from the clarity or relevance of the explanation.\", \"match\": true}", "gold_answer": "XK", "gold_support": "A spontaneous novel XK gene mutation in a patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: This point mutation creates an in-frame stop codon (W314X), and predicts a truncated **XK** protein of 313 amino acids, compared with 444 amino acids in the normal **XK** protein. \n\nThe context explicitly links the mutation to the **XK gene**, as the truncated protein product (XK) is directly associated with the described genetic alteration (W314X stop codon). McLeod syndrome is known to result from mutations in the *XK* gene, which encodes the XK protein critical for Kell antigen expression on red blood cells.", "retries": 1}
{"idx": 340, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly establishes the synonym relationship between 'Lubag disease' and 'X-linked dystonia-parkinsonism' by referencing their interchangeable use in the context. The logic is strong and to the point.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.  \n**Analysis**: The context explicitly states that \"X-linked dystonia-parkinsonism\" and \"Lubag disease\" are used interchangeably in the title, with a slash connecting the two terms. This directly establishes them as synonyms.", "retries": 1}
{"idx": 341, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'Xa'). However, the supporting sentence provided by the model incorrectly states that the context does not mention betrixaban or its mechanism of action, which is factually inaccurate. The gold supporting sentence shows that betrixaban is indeed mentioned in the context as a factor Xa inhibitor. Despite this error in the supporting sentence, the model's answer is correct and aligns with the gold standard, though the support could have been more precise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or its mechanism of action. The only anticoagulant discussed is **dabigatran**, described as a **direct thrombin antagonist** (inhibits Factor IIa). Since the question asks about **betrixaban** (a Factor Xa inhibitor) and the context lacks any reference to this drug, **no sentence in the provided context supports the answer \"Factor Xa\"**. The answer appears to be based on external knowledge, not the given text.", "retries": 1}
{"idx": 342, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by referencing the title of the study where the synonym is explicitly stated. Minor extra details in the supporting sentence do not detract from its relevance or clarity.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-linked dystonia-parkinsonism (XDP) or \"lubag\" is an X-linked recessive disorder that afflicts Filipino men, and rarely, women.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (\"lubag\") in women. \n\nAnalysis: The title of the study explicitly states that \"lubag\" is another name for \"X-linked dystonia-parkinsonism,\" with the synonym in parentheses. This is a standard format in scientific literature to indicate alternative terminology for a condition.", "retries": 1}
{"idx": 343, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about SERCA, but it focuses more on the interaction with Seipin rather than directly emphasizing SERCA's role as the main calcium pump of the sarcoplasmic reticulum. While logical, it contains slight redundancy by introducing Seipin, which is not necessary for answering the question. The gold supporting sentence is more concise and directly addresses SERCA's function.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.", "model_answer": "Answer: SERCA (sarco/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: we show that Seipin physically interacts with the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) in both Drosophila and man. \n\nAnalysis: The sentence explicitly identifies SERCA (sarco/endoplasmic reticulum Ca²⁺-ATPase) as the calcium pump associated with the sarcoplasmic reticulum. The term \"sarco/endoplasmic reticulum\" directly links SERCA to the sarcoplasmic reticulum (a specialized form of endoplasmic reticulum in muscle cells), confirming its role as the primary calcium pump in this organelle.", "retries": 1}
{"idx": 344, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and provides clear reasoning by explaining that BACH1 acts as a transcriptional repressor that antagonizes NRF2 binding until inactivated. This aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naive to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: \"the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.\" \n\nAnalysis: The term **\"transcriptional repressor\"** explicitly classifies BACH1 as a repressor, as it inhibits NRF2 binding to enhancers under non-stress conditions. This directly answers the question.", "retries": 1}
{"idx": 345, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The phrase 'still debated' introduces unnecessary ambiguity, as the gold supporting sentence clearly states the accepted classification supported by phylogenomics.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: \"However, the specific position of microsporidia within the fungal tree of life is still debated.\"  \nThis sentence explicitly places microsporidia within the **Fungi** kingdom by referencing their phylogenetic position \"within the fungal tree of life,\" aligning with their current classification.", "retries": 1}
{"idx": 346, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer captures the essence of the gold standard by identifying the autoimmune mechanism as the likely reason for narcolepsy post-vaccination, which matches the gold answer. However, it does not mention the role of an environmental trigger or genetic susceptibility, which are key details in the gold answer. The supporting sentence is relevant and aligns well with the model's answer, but it lacks specificity regarding the environmental trigger and genetic factors, making it slightly less comprehensive than the gold supporting sentence.\", \"match\": true}", "gold_answer": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "gold_support": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "model_answer": "Answer: The reason for the narcolepsy cases developed after H1N1 influenza vaccination is likely to be autoimmune, although supportive evidence is lacking.", "model_support": "Supporting sentence: The pathological explanation of this association and narcolepsy is likely to be autoimmune, although supportive evidence is lacking. \n\n**Analysis:**  \nThis sentence from the **SUMMARY** section explicitly states the proposed pathological mechanism (autoimmune) for the observed association between H1N1 vaccination and narcolepsy, while also acknowledging the lack of definitive evidence to confirm this hypothesis. It directly answers the question by framing the autoimmune theory as the most plausible explanation despite insufficient supporting data.", "retries": 1}
{"idx": 347, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but does not explicitly state that XK is responsible for McLeod syndrome. Instead, it focuses on the identification of variants in XK, which is slightly less direct than the gold supporting sentence. The logic is sound but has minor redundancy.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.  \n\n**Analysis**: The context explicitly mentions the *XK* gene in the analysis of neuroacanthocytosis-related genes. Since McLeod syndrome (MLS) is one of the two neuroacanthocytosis syndromes discussed (alongside chorea-acanthocytosis, which is caused by *VPS13A* mutations), and the study identifies genetic variants in *XK* in patients with psychiatric disorders, this supports the well-established association between *XK* mutations and McLeod syndrome. The sentence directly names *XK* as the gene under investigation, linking it to the neuroacanthocytosis-related pathogenesis.", "retries": 1}
{"idx": 348, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Na⁺/Ca²⁺ exchanger (NCX)') is correct and matches the gold standard ('NCX'), but the supporting sentence provided does not support the specific question about SEA0400. The context clearly mentions SEA0400 as an inhibitor of NCX(REV), yet the model incorrectly states there is no mention of SEA0400, which weakens its logical consistency. If the model had referenced the correct supporting sentence from the context about SEA0400, it would have scored higher.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)", "model_support": "The context does not mention the small molecule **SEA0400** at all. The discussion focuses on **PPADS** as a novel inhibitor of the reverse mode of the Na⁺/Ca²⁺ exchanger (NCX). Therefore, there is **no supporting sentence in the provided context** to answer the question about SEA0400. The answer provided (Na⁺/Ca²⁺ exchanger) is **not supported by the given text**. \n\nIf the question intended to reference **PPADS**, the supporting sentence would be:  \n*\"We found that PPADS, a P2X receptor antagonist, acts as a NCX(REV) inhibitor in guinea pig tracheal myocytes.\"*", "retries": 1}
{"idx": 349, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking 'Lubag' to X-linked dystonia-parkinsonism.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "\"Lubag\" or X-linked dystonia-parkinsonism (XDP) is a genetic syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism (XDP)", "model_support": "Supporting sentence: First case of X-linked dystonia-parkinsonism (\"Lubag\") to demonstrate a response to bilateral pallidal stimulation.", "retries": 1}
{"idx": 350, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Active mammalian centromeres' is very close to the gold standard 'centromeres,' as CENPA is indeed preferentially localized at centromeres. However, the supporting sentence discusses CENPC rather than CENPA, mixing relevant and irrelevant content by focusing on a different protein (CENPC). The logic connecting the answer to the question is reasonable but could be more precise and directly tied to CENPA using the correct supporting sentence from the context.\", \"match\": true}", "gold_answer": "centromeres", "gold_support": "CENPA is a member of the histone H3-like proteins and is thought to replace histone H3 in centromeric nucleosomes.", "model_answer": "Answer: Active mammalian centromeres.", "model_support": "Supporting sentence: CENPC is a DNA-binding protein that is located at the inner kinetochore plate of active mammalian centromeres.  \n\n**Note**: The context explicitly describes the localization of **CENPC**, not CENPA. However, the question asks about **CENPA**, and the answer provided (\"Active mammalian centromeres\") aligns with the general knowledge that CENPA is a centromere-specific histone variant. While the context does not directly state CENPA's localization, the mention of CENPC's localization at active mammalian centromeres (a closely related centromere protein) may imply the broader relevance of centromere localization for these proteins. The user's answer is likely correct in a biological context, but the supporting sentence in the provided text refers to **CENPC**, not CENPA.", "retries": 1}
{"idx": 351, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about Evolocumab targeting proprotein convertase subtilisin/kexin type 9, but it is slightly redundant as it includes the phrase 'the available clinical evidence,' which is not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab (AMG145) is a monoclonal antibody inhibiting the proprotein convertase subtilisin/kexin type 9 that binds to the liver LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Answer: proprotein convertase subtilisin/kexin type 9 (PCSK9)", "model_support": "Supporting sentence: \"Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.\"", "retries": 1}
{"idx": 352, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains the abnormal deposition of alpha-synuclein in disorders like Lewy body dementia, which aligns well with the gold answer.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid. \n\n**Analysis:**  \nLewy bodies are a pathological hallmark of alpha-synucleinopathies (e.g., Parkinson’s disease). While the context does not explicitly mention \"Lewy bodies,\" it establishes that **alpha-synuclein** is the central protein misfolded and aggregated in all alpha-synucleinopathies, including intracellular inclusions (e.g., Lewy bodies) and extracellular amyloid deposits. The quoted sentence directly supports the conclusion that alpha-synuclein is the main component of Lewy bodies.", "retries": 1}
{"idx": 353, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Nuclear' matches the gold standard, but its supporting sentence incorrectly states that the context does not provide information about subcellular localization. In fact, the gold supporting sentence directly confirms that APOBEC3B is predominantly nuclear, making the model's reasoning inaccurate and failing to cover the gold answer properly.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "Answer: Nuclear", "model_support": "The context does not explicitly state the subcellular localization (cytoplasmic or nuclear) of the APOBEC3B protein. While the text describes its enzymatic activity, mutation-inducing effects, and mRNA expression levels in breast cancer, it does **not include a sentence** confirming whether APOBEC3B is predominantly cytoplasmic or nuclear. The answer \"Nuclear\" may rely on external biological knowledge (e.g., APOBEC family members often localizing to the nucleus), but **no direct supporting sentence is present in the provided context**. \n\n**Answer:** The context does not provide a sentence confirming the subcellular localization of APOBEC3B.", "retries": 1}
{"idx": 354, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It introduces tofacitinib as the JAK inhibitor studied for rheumatoid arthritis, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA). \n\n**Analysis**: The context explicitly identifies *tofacitinib* as the JAK inhibitor under study for rheumatoid arthritis (RA), directly answering the question. The sentence introduces the drug and its indication (RA) in the same phrase.", "retries": 1}
{"idx": 355, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The explanation about chimeric proteins is correct and supports the conclusion that APOBEC3B is nuclear, but it is slightly more detailed than necessary compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: APOBEC3G/APOBEC3B chimeric proteins mapped a primary subcellular localization determinant to a region within the first 60 residues of each protein. \n\n**Analysis**: The chimeric protein experiments directly compared APOBEC3G (cytoplasmic) and APOBEC3B. Since the primary localization determinant in APOBEC3G (cytoplasmic) was contrasted with APOBEC3B's determinant in the same region, and the resulting mislocalization of mutants (e.g., Y19D) implies APOBEC3B encodes a different localization signal, the implication is that APOBEC3B's default localization differs from APOBEC3G's cytoplasmic localization—specifically, nuclear.", "retries": 1}
{"idx": 356, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for the NF1 gene's involvement, but it is slightly verbose and could be more concise. Instead of using the title of the study, a more direct explanation focusing on the NF1 gene's role in neurofibromatosis type 1 would improve clarity.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) gene is a tumor suppressor gene, and the NF1 gene product, neurofibromin, can downregulate the N-ras gene.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.  \n\n**Analysis:**  \nThe title of the study explicitly states that the **neurofibromatosis type 1 gene (NF1)** is being analyzed alongside the N-ras gene. This directly confirms the association between the NF1 gene and type 1 neurofibromatosis. Additionally, the context repeatedly refers to the \"NF1 gene\" in discussions of mutations (e.g., \"mutations in the FLR exon of the NF1 gene\"), reinforcing its role in the disease. While the study focuses on AML, the NF1 gene is explicitly named as the gene mutated in type 1 neurofibromatosis.", "retries": 1}
{"idx": 357, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ERK and p38 pathways,' does not match the gold standard 'JNK.' However, the supporting sentence correctly identifies ERK and p38 as MAP kinases involved in the inhibition of STAT3. The failure to identify JNK as the correct MAP kinase responsible for phosphorylating c-jun makes the answer incorrect, though it is present within the broader context of MAP kinases discussed in the passage. The supporting sentence is relevant but focuses on pathways that do not directly correspond to the gold answer.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "It also reduced the expressions of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and increases the expressions of reversion-inducing cysteine-rich protein with kazal motifs (RECK), as well as tissue inhibitor of metalloproteinase (TIMP) via inhibiting STAT3 by activating the mitogen-activated protein (MAP) kinases (the c-Jun N-terminal kinase (JNK), the p38 and extracellular signal-regulated kinase (ERK)) in A549 cells treated with RY10-4.", "model_answer": "Answer: ERK and p38 pathways.", "model_support": "Supporting sentence: Taken together, the observations suggested that RY10-4 had affected Bcl-2 family members, caspases, MMPs, TIMPs expressions and ROS production via inhibiting STAT3 activities through ERK and p38 pathways in A549 cells. \n\n**Analysis**: The sentence explicitly identifies the **ERK and p38 pathways** as the signaling mechanisms through which RY10-4 inhibits STAT3 activity. While the context does not directly mention c-jun, **ERK and p38 are well-established MAP kinases known to phosphorylate c-jun** in broader biological contexts. The inclusion of these pathways in the context provides indirect but sufficient support for the answer, as the question relies on general biochemical knowledge linking these pathways to c-jun phosphorylation.", "retries": 1}
{"idx": 358, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by describing the interaction between the alpha and beta chains, which implies an antiparallel orientation. However, it is slightly more complex and less direct than the gold supporting sentence, introducing details about helices and tetramerization that are not strictly necessary to justify the 'antiparallel' answer.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: These assemble a tetramer via a mechanism that relies on the completion of a single repeat by association of the partial repeats located at the C terminus of the beta-chain (two helices) and at the N terminus of the alpha-chain (one helix). \n\n**Analysis**: The sentence explains that the beta-chain's C-terminal partial repeats (two helices) associate with the alpha-chain's N-terminal partial repeat (one helix) to form a tetramer. This arrangement implies that the alpha and beta subunits are oriented in opposite directions (beta's C-terminus aligns with alpha's N-terminus), confirming an **antiparallel** orientation for the heterodimer.", "retries": 1}
{"idx": 359, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions the Ca(2+)/calcineurin/NFAT pathway, which directly links calcineurin to NFAT activation, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: The importance of the Ca(2+)/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca(2+) entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence. \n\n**Analysis**: The sentence explicitly names the **Ca²+/calcineurin/NFAT signaling pathway**, directly linking **calcineurin** (a calcium/calmodulin-dependent protein phosphatase) to NFAT activation. This aligns with the known role of calcineurin in dephosphorylating NFAT to enable its nuclear translocation and transcriptional activity.", "retries": 1}
{"idx": 360, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('repressor'). The supporting sentence is relevant and covers the answer, but it contains some redundancy and extra information that is not directly necessary to support the answer. While the logic is strong and the feedback-inhibitory role of BACH1 is mentioned, the gold supporting sentence is more concise and directly explains BACH1's role as a repressor. The additional details about the ARE site and Nrf2 dependency are not essential for answering the question.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: In the present study, we have demonstrated that BACH1 itself is regulated by Nrf2 as it is induced by Nrf2 overexpression and by Nrf2-activating agents in an Nrf2-dependent manner. **Furthermore, a functional ARE site was identified at +1411 from the transcription start site of transcript variant 2 of BACH1.** We conclude that BACH1 is a bona fide Nrf2 target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.  \n\nThe context explicitly labels BACH1 as a \"transcriptional repressor\" in the opening sentence: *\"induction of the transcriptional repressor BACH1 by Nrf2.\"* This classification aligns with the described feedback-inhibitory role of BACH1 in modulating ARE-mediated gene regulation.", "retries": 1}
{"idx": 361, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ZEB2', is correct in the broader scientific context but does not match the gold standard 'ZFHX1B' from the provided context. The supporting sentence acknowledges that the context does not mention the gene, which is accurate but fails to directly support the gold answer with relevant information from the text. Thus, while the answer is valid outside the given context, it does not align with the specific details provided.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype.", "model_answer": "Answer: ZEB2", "model_support": "The context provided does not mention the specific gene responsible for Mowat-Wilson syndrome. Therefore, no sentence in the context supports the answer \"ZEB2.\" \n\n**Analysis**: While ZEB2 is indeed the gene associated with Mowat-Wilson syndrome in scientific literature, the given context does not include this information. The example in the instructions required a direct quote from the context to support the answer, which is not possible here.", "retries": 1}
{"idx": 362, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, correctly identifying BACH1 as a 'repressor.' The supporting sentence is concise and directly relevant, clearly stating that BACH1 is a transcriptional repressor whose inactivation is necessary for NRF2-mediated induction. This aligns well with the gold supporting sentence while avoiding unnecessary details.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. \n\n**Analysis**: The context explicitly labels BACH1 as a \"transcriptional repressor\" in the opening sentence. This designation directly answers the question, confirming BACH1's role as a repressor. The subsequent discussion about BACH1 inactivation enabling NRF2 to bind the HMOX1 promoter further supports this conclusion.", "retries": 1}
{"idx": 363, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and accurate, as it highlights the efficacy and safety of tofacitinib in comparison to other DMARDs, which indirectly supports its role as a JAK inhibitor for rheumatoid arthritis treatment. However, it does not explicitly mention that tofacitinib is a JAK inhibitor, which makes it slightly less direct than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: Tofacitinib demonstrated efficacy and safety comparable to other disease-modifying antirheumatic drugs (DMARDs). \n\n(Note: While the context does not explicitly label tofacitinib as a JAK inhibitor, it is well-established in pharmacology that tofacitinib is a JAK inhibitor. The provided context focuses on its classification as a DMARD and its use in rheumatoid arthritis, which aligns with the question's requirement.)", "retries": 1}
{"idx": 364, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Epidermal growth factor (EGF)', does not match the gold standard 'EGFRvIII'. However, the supporting sentence is relevant as it discusses EGFRvIII and its relation to Rindopepimut. The logic connecting EGF to EGFRvIII is incorrect, since Rindopepimut directly targets the mutant receptor EGFRvIII rather than being an analog of EGF itself. Thus, while contextually related, the answer fails to match the gold standard.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: Epidermal growth factor (EGF)", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against **EGFRvIII** for the potential treatment of glioblastoma multiforme.  \n**Analysis**: The acronym \"EGFRvIII\" explicitly refers to the **epidermal growth factor receptor variant III** (EGFRvIII). Since Rindopepimut is described as a vaccine \"against EGFRvIII,\" it is designed to target this receptor variant, which is a mutated form of the **epidermal growth factor receptor (EGFR)**. EGFR is activated by **epidermal growth factor (EGF)**, making Rindopepimut an analog of EGF to engage the immune system against the aberrant receptor.", "retries": 1}
{"idx": 365, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Bcr-Abl') in essence, though it includes 'tyrosine kinase,' which is accurate but not strictly necessary for full alignment. The supporting sentence is relevant and supports the answer, but it references second-generation inhibitors, which introduces slight redundancy not directly tied to the gold answer. Overall, the logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: \"following the approval of the second-generation Bcr-Abl tyrosine kinase inhibitors (TKIs).\"  \nThis sentence explicitly identifies **Bcr-Abl tyrosine kinase** as the target of imatinib (a first-generation TKI) in the context of Philadelphia chromosome-positive malignancies, aligning with established knowledge that imatinib inhibits the Bcr-Abl fusion protein driving CML.", "retries": 1}
{"idx": 366, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence clearly mentions that secukinumab blocks IL-17A, which aligns perfectly with the gold answer.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.", "model_answer": "Answer: IL-17A", "model_support": "Supporting sentence: Blockade of IL-17A by secukinumab does not appear to interfere with efficacy of influenza and meningococcal vaccinations, as assessed by the achievement of protective antibody levels. \n\nThis sentence explicitly states that secukinumab acts by blocking **IL-17A**, identifying the molecular target of the monoclonal antibody.", "retries": 1}
{"idx": 367, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by confirming the database's availability, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB. \n\nThis sentence explicitly confirms the availability of LepChorionDB as a publicly accessible database for identifying chorion proteins in Lepidopteran proteomes.", "retries": 1}
{"idx": 368, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states the gene is 'Not mentioned' when the NOTCH3 gene is clearly stated in the context. The supporting sentence incorrectly claims that no specific gene is mentioned, despite the context explicitly naming the NOTCH3 gene. Both the answer and supporting sentence are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "NOTCH3 gene", "gold_support": "OBJECTIVE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 gene.", "model_answer": "Answer: Not mentioned in the provided context.", "model_support": "Supporting sentence: The provided context does not mention any specific gene involved in CADASIL.", "retries": 1}
{"idx": 369, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model, while relevant and accurate, includes additional information about interactions with DNMT3a, DNMT3b, and G9a, which is not necessary to support the specific role of DNMT1 in DNA methylation maintenance. The gold supporting sentence is more concise and directly tied to the S phase-dependent interaction critical for DNMT1's function. Thus, the supporting sentence has slight redundancy.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: Coimmunoprecipitation experiments demonstrate that both UHRF1 and UHRF2 interact with DNMT1, DNMT3a, DNMT3b and G9a.", "retries": 1}
{"idx": 370, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('multiple'). The supporting sentence is relevant and provides accurate support by referencing 'three origins (O1, O2, O3),' which confirms multiple origins. However, it contains slight redundancy by specifying the labeling of origins (O1, O2, O3), which is not necessary to answer the question directly. The gold supporting sentence is more concise while still being clear and logical.\",\n  \"match\": true\n}", "gold_answer": "multiple", "gold_support": "However, because some archaeal genomes contain multiple origins of replication, bias in gene dosage caused by delayed replication should be minimized and hence the substitution rate of genes should associate less with chromosome position.", "model_answer": "Answer: Multiple origins of replication.", "model_support": "Supporting sentence: Ortholog families were grouped by their consensus position and designated by their proximity to one of the three origins (O1, O2, O3).  \n\n**Analysis:** The explicit mention of \"three origins (O1, O2, O3)\" in the context directly supports the conclusion that archaeal genomes (specifically *Sulfolobus islandicus* in this study) contain multiple origins of replication.", "retries": 1}
{"idx": 371, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'TH receptor beta (RTH),' does not match the gold standard 'MCT8.' However, the answer is present in the context as a related defect causing reduced sensitivity to thyroid hormone. The supporting sentence is relevant to the model's answer but does not cover the gold answer (MCT8). It focuses on the TH receptor beta gene and its association with RTH, which is unrelated to MCT8 as described in the gold supporting sentence.\", \"match\": false}", "gold_answer": "MCT8", "gold_support": "One, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8;", "model_answer": "Answer: TH receptor beta (RTH)", "model_support": "Supporting sentence: The first recognized defect, which causes resistance to TH, involves the TH receptor beta gene and has been given the acronym RTH. \n\n**Analysis:** The context explicitly states that mutations in the **TH receptor beta gene** are the first identified defect causing resistance to thyroid hormone (RTH). This directly links the **TH receptor beta** to the syndrome of thyroid hormone resistance. The acronym RTH (Resistance to Thyroid Hormone) is specifically tied to this receptor gene defect, distinguishing it from other recently identified syndromes (e.g., SECISBP2 mutations). The quoted sentence provides the clearest and most direct evidence for the answer.", "retries": 1}
{"idx": 372, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides accurate information about Factor Xa inhibitors, including betrixaban. However, it contains slight redundancy by elaborating on the general properties of Factor Xa inhibitors rather than directly focusing on betrixaban as the gold supporting sentence does. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin. These agents do not require cofactors and offer selective inhibition at a critical step of amplification in the coagulation cascade. \n\n**Analysis:** The context explicitly states that the drugs discussed (including apixaban and rivaroxaban) are \"direct factor Xa inhibitors,\" and while betrixaban is not directly named, it falls into this class of drugs. The key sentence identifies the target (Factor Xa) for this group of anticoagulants, which logically applies to all members of the class, including betrixaban.", "retries": 1}
{"idx": 373, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'AIP gene', matches the gold standard conceptually as it refers to the same gene mentioned in the gold answer ('aryl hydrocarbon receptor interacting protein'). The supporting sentence is relevant and provides useful context about the germline nature of the mutation, which aligns with its implication in familial conditions. However, the supporting sentence focuses on parathyroid adenomas rather than directly referencing pituitary adenomas, making it slightly less precise compared to the gold supporting sentence. This results in a minor deduction for not being as directly aligned with the specific disease context.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: The mutation was germline in both cases despite the nonfamilial presentation.\n\n**Analysis:**  \nThe context discusses germline mutations in the AIP gene, even though the tumors presented as nonfamilial. While the study focuses on parathyroid adenomas, the germline nature of AIP mutations implies a hereditary predisposition, which aligns with the known role of AIP mutations in familial isolated pituitary adenoma (FIPA) in broader biomedical literature. The sentence explicitly confirms the germline origin of AIP mutations, supporting its implication in hereditary conditions like FIPA, even though the context does not directly mention pituitary adenomas.", "retries": 1}
{"idx": 374, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('IL-1β'). The supporting sentence is relevant and covers the answer, but it includes additional information about glycemia and inflammation, which makes it slightly verbose. While logical, it could be more concise to directly focus on the relationship between gevokizumab and IL-1β.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: CONCLUSIONS: This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.", "retries": 1}
{"idx": 375, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides specific details about the mutation in the NF1 gene; however, it contains slightly more technical detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: Direct sequence analyses revealed a single base substitution in the splicing donor site of intron 6 (IVS6 888+1, G --> A) in one NF1 allele, resulting in an altered splice site (ss) in the mutated allele.", "retries": 1}
{"idx": 376, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' and 'xa' are equivalent in meaning). The supporting sentence provided by the model is relevant and covers the answer indirectly, but it contains some redundancy and over-explanation about the lack of mention of betrixaban in the context. While the logic is sound, it could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, the answer \"Factor Xa\" cannot be supported by any sentence in the given context. The text only discusses **dabigatran** (a direct thrombin inhibitor) and general challenges with vitamin K antagonists (VKAs), but it does not reference betrixaban or its target clotting factor. \n\n**Correct conclusion**: The context lacks information about betrixaban.", "retries": 1}
{"idx": 377, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK') in meaning, though it includes the full name 'c-Jun N-terminal kinase (JNK)' instead of just 'JNK'. The supporting sentence is relevant and introduces JNK as a member of the MAPK family, but it does not explicitly mention its role in phosphorylating c-jun. While this information can be inferred from the name 'c-Jun N-terminal kinase', the supporting sentence contains slight redundancy by discussing environmental stress without directly addressing the phosphorylation function. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "JNK phosphorylates and regulates the activity of transcription factors other than c-Jun, including ATF2, Elk-1, p53 and c-Myc and non-transcription factors, such as members of the Bcl-2 family.", "model_answer": "Answer: c-Jun N-terminal kinase (JNK) phosphorylates the transcription factor c-jun.", "model_support": "Supporting sentence: The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family and are activated by environmental stress. \n\n**Analysis**: The name \"c-Jun N-terminal kinase (JNK)\" directly indicates its role in phosphorylating the transcription factor c-jun. While the context does not explicitly state this phosphorylation event, the nomenclature (\"c-Jun N-terminal kinase\") and classification as a MAPK family member provide the necessary inference. The first sentence introduces JNKs as MAPKs, establishing their identity and functional relevance to c-jun phosphorylation.", "retries": 1}
{"idx": 378, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 379, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly identifying medulloblastoma as the focus of the context. There is no unnecessary verbosity or irrelevant information.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "Answer: Medulloblastoma", "model_support": "Supporting sentence: The CDK inhibitor p18Ink4c is a tumor suppressor in **medulloblastoma**. \n\n**Analysis**: The context explicitly states that the study focuses on **medulloblastoma (MB)**, a type of tumor, and discusses its genetic mechanisms. Since the question asks for the most common pediatric cerebellar tumor and the context centers on medulloblastoma without mentioning other tumor types in this context, the term \"medulloblastoma\" in the first sentence directly supports the answer.", "retries": 1}
{"idx": 380, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is more detailed than the gold standard but still includes the correct term 'cerebral hemiatrophy,' making it accurate yet slightly verbose. The supporting sentence correctly highlights the left hemisphere and male sex dominance, aligning with the gold supporting sentence, but it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "Left hemisphere and male sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson Syndrome).", "model_answer": "Answer: Cerebral hemiatrophy, with characteristic features including contralateral hemiparesis, seizures, and ipsilateral atrophy of the cerebral hemisphere. It is more common in males and often involves the left hemisphere.", "model_support": "Supporting sentence: We conclude that male gender and left side involvement are frequent in cerebral hemiatrophy disease.", "retries": 1}
{"idx": 381, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'S-methylmethionine (SMM)', does not match the gold standard 'S-adenosylmethionine'. However, SMM is mentioned as a methyl donor in the context, albeit for homocysteine S-methyltransferases, not histone methyltransferases. The supporting sentence provided by the model explains that SMM is a methyl donor but focuses on the wrong enzymatic system (HMT rather than histone methyltransferases), making it relevant yet incorrect for the question asked. While the supporting sentence ties back to the context, it does not support the correct answer and mixes up different methyltransferase systems.\", \"match\": false}", "gold_answer": "S-adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "Answer: S-methylmethionine (SMM)", "model_support": "The answer provided is **incorrect** because the context does **not** discuss histone methyltransferases. Instead, it focuses on **homocysteine S-methyltransferases (HMTs)** in plants, specifically the **SMM cycle**. The methyl donor for the HMT reaction described in the context is **S-methylmethionine (SMM)**, but this is unrelated to histone methyltransferases. The confusion arises from a misinterpretation of the question. \n\n### Supporting sentence from the context:  \n*\"Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).\"*  \n\nThis sentence confirms that **SMM is the methyl donor** for the HMT reaction in the SMM cycle, but there is **no mention of histone methyltransferases** in the context. The question conflates two distinct enzymatic systems.", "retries": 1}
{"idx": 382, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acetylation' is very close to the gold standard 'acetylated lysines,' as it correctly identifies the type of modification recognized by bromodomains. However, the gold answer is more specific by mentioning 'lysines.' The supporting sentence provided by the model acknowledges that the context does not explicitly mention the modification but correctly explains that the recognition of acetylated lysines is a known fact from prior knowledge. It is slightly verbose but still logically supports the answer.\", \"match\": true}", "gold_answer": "acetylated lysines", "gold_support": "Double bromodomain proteins bind to acetylated lysines in histones, bringing associated histone modification and nucleosome remodeling activity to chromatin.", "model_answer": "Answer: Acetylation", "model_support": "The context does not explicitly mention the histone modification recognized by the bromodomain (e.g., acetylation). Therefore, **no sentence in the provided context directly supports the answer \"Acetylation.\"** The text focuses on the functional roles of bromodomain proteins in diseases and gene regulation but does not specify the molecular mechanism (acetylation recognition) of bromodomain activity. \n\nIf the question were answered based on prior knowledge, the correct answer would be **acetylation**, as bromodomains are well-established readers of acetylated lysine residues on histones. However, the provided context lacks this specific information.", "retries": 1}
{"idx": 383, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer (FXI) does not match the gold standard (xa). While the supporting sentence acknowledges that the context does not explicitly mention betrixaban or its target, it incorrectly speculates about FXI without solid contextual backing. The gold answer is 'xa,' which aligns with external knowledge, but this specific information isn't directly extractable from the provided context. The supporting sentence is relevant to anticoagulants but fails to cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Answer: FXI (Factor XI)", "model_support": "The context does not explicitly mention **betrixaban** or its target clotting factor. While the text discusses inhibitors of **FXI** (Factor XI) among other targets (e.g., FVIIa/TF, FIX, FXII), it does not specify which anticoagulant corresponds to **betrixaban**. Therefore, the answer **FXI** is **not directly supported by the provided context**. \n\nIf the question relies on external knowledge, betrixaban is known in the field to inhibit **Factor Xa**, not FXI. However, the context here does not provide evidence for this. \n\n**Correct response**: The context does not specify the clotting factor inhibited by betrixaban.", "retries": 1}
{"idx": 384, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by identifying medicarpin as the major phytoalexin in alfalfa. The additional explanation about its biosynthesis is accurate and supports the answer without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"The methyl group at the 9 position of **medicarpin** is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\" \n\nThis sentence explicitly identifies **medicarpin** as a key compound in the context, which is a well-established phytoalexin in *Medicago sativa* (alfalfa). The subsequent discussion of isoflavone 7-O-methyltransferase (IOMT) and its role in medicarpin biosynthesis further confirms medicarpin as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 385, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is not directly extracted from the context provided but acknowledges that the context lacks specific details about Velcade (bortezomib). The model correctly refers to general knowledge instead. Ideally, the model should have used the exact gold supporting sentence from the context.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "INTRODUCTION: Over the past decade, the novel agents thalidomide, lenalidomide, and bortezomib have emerged as effective treatment in patients with multiple myeloma (MM).", "model_answer": "Answer: Multiple myeloma", "model_support": "The context does not mention Velcade (bortezomib) or its use. Therefore, there is no supporting sentence in the provided context to answer the question. However, based on general medical knowledge, Velcade is primarily used for multiple myeloma. \n\n**Answer:** Multiple myeloma  \n**Supporting sentence:** *Not applicable (the context does not discuss Velcade/bortezomib).*", "retries": 1}
{"idx": 386, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by referencing the evaluation of Orteronel's effects on CYP17A1 enzymatic activity, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: We quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on **CYP17A1 enzymatic activity**, steroid production in monkey adrenal cells and human adrenal tumor cells, and serum levels of dehydroepiandrosterone (DHEA), cortisol, and testosterone after oral dosing in castrated and intact male cynomolgus monkeys.  \n\n**Analysis**: The context explicitly states that Orteronel's effects were evaluated in relation to **CYP17A1 enzymatic activity**, confirming that this is the enzyme inhibited by the drug. Additionally, the text notes that Orteronel is a \"non-steroidal 17,20-lyase inhibitor,\" and 17,20-lyase is one of the two catalytic activities of the CYP17A1 enzyme (the other being 17-hydroxylase). This dual nomenclature aligns with the study's focus on CYP17A1 inhibition.", "retries": 1}
{"idx": 387, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While it provides a detailed description of Pendred syndrome (goiter, sensorineural hearing loss, normal/low T4, elevated TSH), this information is not present in the context provided and relies on external knowledge. The gold answer, 'thyroid,' is a more concise and contextually supported response. The model supporting sentence correctly notes that the context does not provide support for the model's answer, but the gold supporting sentence directly references Pendred syndrome as part of dyshormonogenesis, making it more relevant to the gold answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "Answer: Goiter and sensorineural hearing loss, with normal or low thyroxine (T4) levels and elevated thyroid-stimulating hormone (TSH).", "model_support": "The context does not mention **Pendred syndrome** or its associated hormone abnormalities (goiter, sensorineural hearing loss, normal/low T4, elevated TSH). Therefore, **no sentence in the provided context supports the answer**. The answer relies on external knowledge of Pendred syndrome, which is not addressed in the given text.", "retries": 1}
{"idx": 388, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is relevant but contains redundancy by introducing both sub-pathways of NER (ggNER and TCR) without directly emphasizing the preference of TCR for the transcribed strand. While it provides context, it lacks the precision and direct relevance of the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "TCR can preferentially remove the bulky DNA lesions located at the transcribed strand of a transcriptional active gene more rapidly than those at the untranscribed strand or overall genomic DNA.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In eukaryotic cells, there are two sub-pathways of nucleotide excision repair (NER), the global genome (gg) NER and the transcription-coupled repair (TCR).  \n\n**Analysis**:  \nThe term \"transcription-coupled repair (TCR)\" inherently refers to repair of the **transcribed strand** of DNA, as TCR is specifically activated when RNA polymerase encounters DNA damage during transcription. While the context does not explicitly state \"transcribed strand,\" the definition of TCR as a sub-pathway of NER (linked to transcription) directly supports this conclusion. The methodology (e.g., strand-specific PCR) further validates the focus on the transcribed strand, as TCR is designed to repair damage on the actively transcribed DNA strand.", "retries": 1}
{"idx": 389, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about imatinib's mechanism of action, but it is slightly indirect and does not explicitly mention the BCR-ABL fusion gene or its tyrosine kinase activity. The logic is strong but could be more concise and direct.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.  \n\n**Analysis**:  \nWhile the context does not explicitly name \"BCR-ABL tyrosine kinase,\" it is well-established in biomedical literature that imatinib targets the BCR-ABL fusion tyrosine kinase in Philadelphia chromosome-positive CML. The sentence above confirms imatinib's mechanism of action (inhibiting tyrosyl phosphorylation of a key protein in CML signaling), and the entire context revolves around monitoring BCR-ABL mRNA as a biomarker. This strongly implies that the target is the BCR-ABL tyrosine kinase.", "retries": 1}
{"idx": 390, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate reasoning by correctly identifying the mode of inheritance as autosomal dominant. However, the supporting sentence includes slight redundancy by explaining that the context does not explicitly state the mode of inheritance, which is unnecessary since the gold supporting sentence directly provides this information from the context. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "This family showed typical features of this syndrome with QT prolongation, torsades de pointes ventricular tachycardia, sudden death and an autosomal dominant inheritance pattern.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context does not explicitly state the mode of inheritance for Romano-Ward syndrome. However, based on standard medical knowledge, Romano-Ward long QT syndrome is inherited in an **autosomal dominant** pattern. The context mentions \"a family with the Romano-Ward syndrome,\" which aligns with the typical familial clustering seen in autosomal dominant conditions, but it does not directly specify the mode of inheritance. The answer relies on general knowledge rather than a direct quote from the provided text. \n\nIf strictly adhering to the requirement for a supporting sentence from the context, there is no explicit statement about inheritance. The correct answer (autosomal dominant) is inferred from established medical literature.", "retries": 1}
{"idx": 391, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model incorrectly states that there is no relevant information in the context, while the gold supporting sentence demonstrates that the context does indeed contain a relevant statement about KN-93 inhibiting CaM kinase II. The model's supporting sentence contains a factual inaccuracy regarding the presence of relevant information in the context, but the answer itself is correct.\", \"match\": true}", "gold_answer": "CaM kinase II", "gold_support": "NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide.", "model_answer": "Answer: Ca2+/calmodulin-dependent protein kinase II (CaM kinase II)", "model_support": "The context provided does not mention the small molecule KN-93 or its inhibitory effects on any kinase. Therefore, there is **no supporting sentence** in the given context to answer the question about which kinase is inhibited by KN-93. The answer likely relies on external knowledge (e.g., KN-93 is a well-known inhibitor of Ca²⁺/calmodulin-dependent protein kinase II in general), but the specific context cited here does not include this information.", "retries": 1}
{"idx": 392, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard (CYP17A1), but includes additional details (17α-hydroxylase/C17,20-lyase) that are correct but not explicitly required. The supporting sentence provides relevant and logical reasoning by linking the suppression of androgen synthesis to CYP17A1, though it is somewhat verbose and relies on external inference rather than directly quoting the context. Overall, the logic is strong, but slight redundancy exists.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Answer: CYP17A1 (17α-hydroxylase/C17,20-lyase)", "model_support": "The context does not explicitly mention the enzyme inhibited by Orteronel. However, based on the description of its mechanism (suppressing androgen levels and inhibiting androgen synthesis), the answer **CYP17A1 (17α-hydroxylase/C17,20-lyase)** is inferred from external knowledge, as this enzyme is a well-established target for hormonal therapies in prostate cancer. The supporting implication in the context is:  \n**\"Orteronel treatment suppresses androgen levels and causes shrinkage of androgen-dependent organs, such as the prostate gland\"** and **\"more complete suppression of androgen synthesis than conventional androgen deprivation therapies.\"**  \nThese effects are consistent with CYP17A1 inhibition, a key enzyme in androgen biosynthesis.", "retries": 1}
{"idx": 393, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Kell (KEL) gene', does not match the gold standard 'XK'. However, it is a plausible inference based on general knowledge of McLeod syndrome, which involves abnormalities in the Kell blood group system. The supporting sentence mentions the McLeod phenotype but does not directly link it to the XK gene mutation described in the context, making it relevant yet incomplete. The logic is reasonable but does not fully align with the gold standard.\", \"match\": false}", "gold_answer": "XK", "gold_support": "McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene.", "model_answer": "Answer: Kell (KEL) gene", "model_support": "Supporting sentence: Investigation results included an elevated creatine kinase, caudate atrophy and hypoperfusion, acanthocytes in the peripheral blood and the McLeod phenotype. \n\n**Analysis:** While the context does not explicitly mention the Kell (KEL) gene, the diagnosis of **McLeod phenotype** (a hallmark of McLeod syndrome) is directly tied to mutations in the *KEL* gene in established medical knowledge. The presence of the McLeod phenotype in the patient's investigation results supports the association with the KEL gene mutation, even though the gene itself is not named in the text.", "retries": 1}
{"idx": 394, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 395, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Cortisol deficiency', does not match the gold standard answer, 'growth hormone'. However, the answer is present in the context as cortisol deficiency is mentioned in relation to hypoglycemia. The supporting sentence is relevant but does not cover the gold answer, which pertains to growth hormone deficiency.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "We describe an 18-month-old boy with Costello syndrome (CS) with proven partial growth hormone (GH) deficiency and hypoglycemic episodes.", "model_answer": "Answer: Cortisol deficiency", "model_support": "Supporting sentence: The hypoglycemia is deemed to be due to cortisol deficiency.", "retries": 1}
{"idx": 396, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('small-cell lung cancer' vs. 'Small cell lung cancer (SCLC)'). The supporting sentence is concise, directly relevant, and provides clear reasoning by referencing H146 SCLC cells as the specific model system for studying Lambert-Eaton syndrome antibodies. This aligns perfectly with the gold supporting sentence in logic and relevance.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Human small-cell lung cancer (SCLC) cells are believed to express the antigens responsible for the production of pathological antibodies in the Lambert-Eaton syndrome (LES), a Ca2+ channel disorder in which quantal transmitter release from the motor nerve terminal is impaired.", "model_answer": "Answer: Small cell lung cancer (SCLC)", "model_support": "Supporting sentence: *Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.* 1. Whole-cell patch-clamp techniques were used to study the voltage-dependent Ca2+ channels expressed by **H146 SCLC cells** and the effects of LES antibodies on these channels...  \n\nThe context explicitly references **H146 SCLC (small cell lung cancer) cells** as the model system for studying Lambert-Eaton syndrome (LES) antibodies. This directly supports the conclusion that small cell lung cancer (SCLC) is the most strongly associated with Lambert-Eaton syndrome.", "retries": 1}
{"idx": 397, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes additional details (hemiatrophy of one side of the body, seizures, and contralateral cerebral atrophy) that are not incorrect but go beyond the concise term 'cerebral hemiatrophy.' The supporting sentence provides relevant information about the clinical presentation, which supports parts of the answer, but it is somewhat lengthy and does not directly emphasize 'cerebral hemiatrophy' as the core feature. Logic is reasonable but could be more focused.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "MRI brain revealed characteristic features diagnostic of congenital type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Hemiatrophy of one side of the body, seizures, and contralateral cerebral atrophy.", "model_support": "Supporting sentence: A 15-year-old female presented with seizures, right-sided hemiparesis, hemiatrophy of the right side of the body and mental retardation.  \n\n**Analysis**: The context explicitly describes the patient's clinical features—seizures, hemiatrophy of one side of the body, and hemiparesis—which align with the answer. While contralateral cerebral atrophy is not directly mentioned in the text, the syndrome’s classical definition includes this radiological finding (as implied by the title \"Classical imaging findings\"). However, the **quoted sentence** supports the listed features (hemiatrophy, seizures) and provides the basis for the answer.", "retries": 1}
{"idx": 398, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa' in meaning, though it is slightly more verbose. The supporting sentence provides relevant information about betrixaban's relationship with factor Xa, but it includes extra details about a potential reversal agent (PRT4445), making it somewhat redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 399, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and contains important information about the localization determinant being mapped to a region within the first 60 residues of each protein. However, it is slightly indirect and does not explicitly state that APOBEC3B is nuclear, which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: APOBEC3G/APOBEC3B chimeric proteins mapped a primary subcellular localization determinant to a region within the first 60 residues of each protein. \n\n**Analysis**: The context contrasts APOBEC3G (cytoplasmic) with APOBEC3B through chimeric protein experiments. Since APOBEC3G is explicitly described as cytoplasmic and the chimeric studies reveal distinct localization determinants in APOBEC3B, this implies APOBEC3B has a different default localization (nuclear). The sentence highlights that the subcellular localization determinant in APOBEC3B (mapped to its first 60 residues) differs from APOBEC3G, supporting the conclusion that APOBEC3B is not cytoplasmic like APOBEC3G.", "retries": 1}
{"idx": 400, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model’s supporting sentence introduces the topic of ZEB2 gene analysis but does not directly mention haploinsufficiency or the specific mutations as clearly as the gold supporting sentence. However, it still logically supports the answer.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: \"Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort...\" \n\nThe context explicitly states that the ZEB2 gene is the focus of molecular diagnostic analysis for Mowat-Wilson syndrome, with mutations (nonsense, frameshift, splice site) and deletions in this gene being the underlying genetic cause.", "retries": 1}
{"idx": 401, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' vs. '5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by stating that [18F]altanserin PET reliably quantifies 5-HT2AR availability, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: CONCLUSION: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.", "retries": 1}
{"idx": 402, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the development of a stroke recognition instrument, which aligns with the ROSIER scale's purpose. Minor extra details in the explanation are acceptable as they do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: We used logistic regression analysis and clinical reasoning to develop a **stroke recognition instrument** for application in this setting. \n\nThe context explicitly describes the development and validation of a **stroke recognition instrument** (implied to be the ROSIER scale) for identifying acute stroke in emergency room patients. While the acronym \"ROSIER\" is not explicitly stated, the described seven-item tool with clinical criteria (e.g., neurological signs, history of symptoms) aligns with the purpose of the ROSIER scale for stroke assessment.", "retries": 1}
{"idx": 403, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Na⁺/Ca²⁺ exchanger (NCX)' is correct and matches the gold standard 'NCX'. However, the supporting sentence provided by the model does not mention SEA0400 or its role as an inhibitor of NCX, which is critical to answering the question. Instead, the supporting sentence discusses general effects of NCX inhibition without tying it back to SEA0400, making it insufficient and somewhat misleading in this context.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400 (1 μM), a pharmacological inhibitor of NCX, significantly shortened the MAP duration (P < .01) and reduced dispersion (P < .05).", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)", "model_support": "The context does not mention the small molecule **SEA0400** or its role as an inhibitor of the **Na⁺/Ca²⁺ exchanger (NCX)**. The provided text discusses the general effects of **NCX inhibition** in heart failure but does not specify any drug (e.g., SEA0400) as the inhibitor used in the study. The experiments referenced use **sotalol** and **veratridine**, but these are not NCX inhibitors. \n\n**Answer**: The context does not provide information about SEA0400 or its target.  \n**Supporting sentence**: *Acute inhibition of the Na⁺/Ca²⁺ exchanger reduces proarrhythmia in an experimental model of chronic heart failure.*  \n\n(Note: The user’s answer incorrectly attributes the NCX inhibition to SEA0400, which is not mentioned in the provided context.)", "retries": 1}
{"idx": 404, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer, but contains slight redundancy by discussing the model's implications on AdoMet regulation rather than directly focusing on its role as a methyl donor. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "S-adenosylmethionine", "gold_support": "Angiosperms synthesize S-methylmethionine (SMM) from methionine (Met) and S-adenosylmethionine (AdoMet) in a unique reaction catalyzed by Met S-methyltransferase (MMT).", "model_answer": "Answer: S-adenosylmethionine (AdoMet)", "model_support": "Supporting sentence: \"This model indicates that the SMM cycle consumes half the AdoMet produced, and suggests that the cycle serves to stop accumulation of AdoMet...\" \n\n**Analysis**: The context discusses the role of the SMM cycle in regulating **AdoMet (S-adenosylmethionine)**, a well-established methyl donor for histone methyltransferases. While the text does not explicitly name \"histone methyltransferases,\" it directly identifies AdoMet as the substrate being regulated by the SMM cycle. Since AdoMet is the universal methyl donor for all methyltransferases (including histone methyltransferases), this sentence supports the answer.", "retries": 1}
{"idx": 405, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence is concise, directly relevant, and provides clear logical reasoning by mentioning the specific mutation in the XK gene. Minor extra details like the specific nucleotide transition are acceptable as they support the context without excessive verbosity.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: We describe a family with a novel point mutation in the **XK gene** consisting of a C to T base transition at nucleotide position 977, introducing a stop codon.", "retries": 1}
{"idx": 406, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Answer: Factor Xa (FXa)", "model_support": "Supporting sentence: New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa. \n\n**Analysis**: While the context does not explicitly name betrixaban, it establishes that FXa is the target of a class of oral anticoagulants. Betrixaban is a well-known direct FXa inhibitor in clinical use, and the context provides the foundational information linking FXa inhibition to this drug class. The sentence above directly supports the conclusion that FXa is the inhibited clotting factor.", "retries": 1}
{"idx": 407, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing the SET domain in the context of Set1A, which is a histone methyltransferase. However, the supporting sentence includes additional details (the 123-amino acid fragment) that are not necessary to directly support the answer, introducing slight redundancy.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Data base analysis indicates that human Set1A protein shares 39% identity with an uncharacterized SET domain protein, KIAA1076, hereafter denoted Set1B.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: A 123-amino acid fragment upstream of the Set1A SET domain is necessary for interaction with CFP1, Ash2, Rbbp5, and Wdr5. \n\n**Analysis**: The context explicitly mentions the \"SET domain\" as a critical structural feature of Set1A (a histone methyltransferase). While the question broadly asks about histone methyltransferases, the SET domain is a well-established hallmark of this enzyme family, and the quoted sentence directly references this domain in the context of a histone methyltransferase complex.", "retries": 1}
{"idx": 408, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (H3K4). However, the supporting sentence provided by the model does not directly mention H3K4 methylation, which is explicitly stated in the gold supporting sentence. Instead, the model's supporting sentence focuses on MLL1's regulatory role without referencing the specific histone residue, making it less precise than the gold supporting sentence. While the answer is correct, the support could be improved by directly referencing the relevant evidence from the context.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "It has also been shown that MDR1 activation is accompanied by increased methylation on lysine 4 of histone H3 (H3K4).", "model_answer": "Answer: Histone H3 lysine 4 (H3K4)", "model_support": "The context does not explicitly state which histone residue is methylated by MLL1. While the study identifies MLL1 as a histone methyltransferase involved in MDR1 regulation, the specific residue (e.g., H3K4) is not mentioned in the provided text. The answer \"Histone H3 lysine 4 (H3K4)\" relies on external knowledge about MLL1's known function, not a direct statement in the context. \n\n**Supporting sentence from the context**:  \n\"The regulation of MDR1 by MLL1 has functional consequences in that downregulation of MLL1 led to increased retention of the Pgp-specific substrate DIOC(2)(3), as well as increased cellular sensitivity to several Pgp substrates.\"  \n\nThis sentence confirms MLL1's role in MDR1 regulation but does not specify the methylated histone residue.", "retries": 1}
{"idx": 409, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence mentions Akt inhibitor blocking mTOR phosphorylation, which is a correct but less direct piece of evidence compared to the gold supporting sentence that explicitly ties rapamycin to mTOR inhibition. Overall, the logic is sound, but the supporting sentence could be more concise and directly aligned with the gold standard.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "L-Leucine also increased the levels of phosphorylated molecular target of rapamycin (mTOR) and two of its targets, ribosomal protein S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1); furthermore, rapamycin (an mTOR inhibitor) blocked all of the mitogenic effects of L-leucine.", "model_answer": "Answer: mTOR", "model_support": "Supporting sentence: Akt inhibitor blocked L-leucine-induced mTOR phosphorylation.  \n**Analysis**: The context explicitly mentions mTOR phosphorylation as a downstream target in the L-leucine signaling cascade. Since Rapamycin is a well-known inhibitor of mTOR (as established in biomedical literature), the reference to mTOR in this context directly supports the answer.", "retries": 1}
{"idx": 410, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Mild thyroid dysfunction' does not match the gold standard 'thyroid,' as it focuses on a specific manifestation rather than the general concept of thyroid abnormalities. The supporting sentence is relevant but does not cover the gold answer, which should refer to the characteristic features of Pendred syndrome, including goiter and iodine organification defect.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect.", "model_answer": "Answer: Mild thyroid dysfunction.", "model_support": "Supporting sentence: The mild thyroid dysfunction in these patients suggests that PS should be considered in all patients with congenital or early-onset hearing impairment.", "retries": 1}
{"idx": 411, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('NF1 gene' is equivalent to 'NF1'). The supporting sentence is relevant and provides information about neurofibromin being mutated in NF1, which logically connects to the answer. However, it includes slightly extraneous details about mitochondria, making it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: Because of their co-localization with the tumor suppressor protein neurofibromin, which is mutated in NF1, mitochondria were particular attractive candidates for investigation.  \n\nThe sentence explicitly states that the **NF1 gene** (which encodes the neurofibromin protein) is the one mutated in neurofibromatosis type 1.", "retries": 1}
{"idx": 412, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is close to the gold standard but specifies 'congenital hypothyroidism' rather than simply 'thyroid,' which slightly narrows the scope. The supporting sentence is relevant and supports the answer well, though it includes additional details (e.g., 'due to an important thyroid hypoplasia') that are accurate but not strictly necessary. Overall, the logic is sound, but there is minor redundancy.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Congenital hypothyroidism is a common hormone abnormality in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 413, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and supports the answer by mentioning the connection between betrixaban and factor Xa activity. However, it introduces additional information about a reversal agent (PRT4445), which is not directly necessary to answer the question, making the sentence slightly verbose.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 414, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence introduces Selenoprotein P as a protein of 'considerable intrigue' due to its unusual composition, which aligns with the gold answer. However, it does not explicitly mention the critical detail about the multiple selenocysteine residues that directly support the answer, making it slightly less precise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Whereas most selenoproteins contain a single selenocysteine residue, the human, bovine and rodent selenoprotein P genes encode proteins containing 10-12 selenocysteines.", "model_answer": "Answer: Selenoprotein P", "model_support": "Supporting sentence: Selenoprotein P is a protein of considerable intrigue, due to its unusual composition and requirements for its biosynthesis. \n\n**Analysis**:  \nThe context highlights that Selenoprotein P is notable for its \"unusual composition,\" which is directly attributed to its high number of selenocysteine (Se-Cys) residues. While the specific count (17 Se-Cys codons) is mentioned in the zebrafish protein, the background explicitly states that Selenoprotein P genes have only been reported in mammals (including humans) prior to this study. This establishes that the human (and mammalian) Selenoprotein P inherently contains multiple Se-Cys residues, making it the correct answer.", "retries": 1}
{"idx": 415, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with clear reasoning. Minor extra details about RyR2s and SR Ca²⁺ leak are acceptable as they do not detract from the core logic.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.  \n\n**Note**: While the provided context (second text) refers to K201 (JTV519) as a \"multi-channel blocker,\" the specific classification as a **1,4-benzothiazepine derivative** is explicitly stated in the first context cited in the example. The second context does not explicitly mention the 1,4-benzothiazepine group, but the equivalence between K201 and JTV519 allows the answer to be derived from the first context.", "retries": 1}
{"idx": 416, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more detailed than necessary. While it correctly identifies key features of Dyke-Davidoff-Masson syndrome, such as hemispheric atrophy, seizures, and cognitive impairments (especially in visuospatial functions), the gold answer is simply 'cerebral hemiatrophy,' which is more concise. The supporting sentence provided by the model is logically relevant but mixes multiple details from different sentences rather than focusing on one clear, concise statement like the gold supporting sentence. This makes the logic reasonable but less direct than ideal.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The purpose of this study was to retrospectively evaluate the cognitive and electroclinical characteristics of right cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome [DDMS]).", "model_answer": "Answer: A clinically and neuroradiologically confirmed diagnosis characterized by hemispheric atrophy, seizures, and cognitive impairments, particularly in visuospatial functions.", "model_support": "Supporting sentences:  \n1. \"Cognitive assessments with a particular emphasis on visuospatial functions... were analyzed for five patients with a **clinically and neuroradiologically confirmed diagnosis of right-sided DDMS**.\"  \n2. \"Electroclinically, the main seizure types were **simple partial motor, complex partial, and secondarily generalized seizures**.\"  \n3. \"Neuropsychological assessments demonstrated **consistent impairments in tasks that have a spatial component (spatial processing and orientation discrimination)**.\"  \n4. \"Interictal EEG delineated lower amplitudes and slow background activity in the **affected hemisphere**.\"  \n\nThese sentences collectively confirm the features of DDMS: **hemispheric atrophy** (implied by EEG findings in the affected hemisphere), **seizures** (specific seizure types), and **visuospatial cognitive impairments**.", "retries": 1}
{"idx": 417, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly verbose compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DNA methyltransferase 1 (Dnmt1) mutation affects Snrpn imprinting in the mouse male germ line.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: This defect does not appear in mouse models with mutations in Dnmt3a and Mthfr genes and, therefore, it is specific for the Dnmt1 gene and is suggestive of a role of DNMT1 in imprint resetting or maintenance in the male germ line.", "retries": 1}
{"idx": 418, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is very close to the gold standard 'benzothiazepine', with only a minor difference in specificity. The supporting sentence provided by the model discusses the lack of explicit information in the context, but correctly references external knowledge that aligns with the gold supporting sentence. However, it introduces slight redundancy by elaborating on the absence of the detail in the given text rather than directly quoting the relevant sentence from the context. Overall, the logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly mention the chemical classification of JTV519 as a **1,4-benzothiazepine derivative**. While the drug's mechanisms and therapeutic effects are discussed, its chemical structure is not described in the given text. The answer likely relies on external knowledge or a different context (e.g., the example provided earlier). In this specific context, there is **no supporting sentence** directly stating JTV519's chemical group. \n\nIf the user intended to reference the example context (which includes the sentence: *\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker...\"*), that sentence would support the answer. However, within the current context, the information is absent.", "retries": 1}
{"idx": 419, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('1,4-benzothiazepine' is a more specific but correct variant of 'benzothiazepine'). However, the supporting sentence provided by the model is incorrect because it states that the context does not mention JTV519 as a derivative of 1,4-benzothiazepine, while the context explicitly does so in the very first sentence. Despite this error, the model's answer itself is accurate, and therefore the score reflects a minor issue with the explanation rather than the answer.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The provided context does not explicitly mention that JTV519 is a derivative of **1,4-benzothiazepine**. While the example in the user's query references a prior context where this information is explicitly stated, the current context focuses on JTV519's functional effects (e.g., cardioprotection, calcium regulation) and does not describe its chemical classification. \n\n**Answer:** The supporting sentence is not present in the given context. The chemical group (1,4-benzothiazepine) is referenced in a prior context (not this one).", "retries": 1}
{"idx": 420, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies that the context lacks specific numerical data, yet it fails to extract the relevant information from the context where the number '15' is clearly stated. Thus, while the supporting sentence is relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "15", "gold_support": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains 15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4.", "model_answer": "Answer: The context does not specify the exact number of tissue kallikrein genes in the human genome.", "model_support": "Supporting sentence: The context does not provide a specific number for the quantity of tissue kallikrein genes in the human genome. The text discusses the kallikrein gene family broadly but does not include numerical data on the total count of genes.", "retries": 1}
{"idx": 421, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer includes Dnmt1, Dnmt3a, and Dnmt3b, but the gold standard specifies only Dnmt1 as responsible for maintenance methylation. The supporting sentence mentions the contribution of Dnmt3a and Dnmt3b in maintenance methylation, which does not align with the gold standard that assigns this role exclusively to Dnmt1. While the model's answer is present in the context, it goes beyond the gold answer by including enzymes not responsible for 'maintenance methylation,' thus reducing accuracy.\", \"match\": false}", "gold_answer": "Dnmt1", "gold_support": "It is generally accepted that DNA methyltransferases carry out specific and non-overlapping functions, Dnmt3a and Dnmt3b being responsible for the establishment of methylation around the time of implantation and Dnmt1 ensuring that methylation is faithfully copied to daughter cells via what has come to be known as \"maintenance methylation.\"", "model_answer": "Answer: Dnmt1, Dnmt3a, and Dnmt3b", "model_support": "Supporting sentence: \"A new model is emerging that takes into account a contribution of the de novo enzymes Dnmt3a and Dnmt3b in the maintenance of the DNA methylation.\" \n\n**Analysis**:  \n1. The context explicitly states that **Dnmt1** was traditionally thought to maintain DNA methylation but is now challenged as insufficient alone.  \n2. The **new model** introduces **Dnmt3a and Dnmt3b** (de novo enzymes) as contributors to maintenance methylation.  \n3. The hypothesis later proposed confirms the role of **Dnmt3b** (not Dnmt1) in maintaining methylation of specific genes, but the broader model includes all three enzymes (Dnmt1, Dnmt3a, Dnmt3b).", "retries": 1}
{"idx": 422, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA),' which, although relevant in the broader context of stroke-related disorders, does not exactly match the gold answer 'stroke.' The supporting sentence provides a reasonable link between the ROSIER scale and its use in diagnosing stroke, but it is somewhat indirect and mixes contextual information rather than focusing specifically on the ROSIER scale’s application for stroke. Logic is sound but could be more precise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: \"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"  \nThis sentence establishes the purpose of the study, which directly relates to the use of the ROSIER scale for identifying stroke and transient ischaemic attack (TIA), as stated in the context.", "retries": 1}
{"idx": 423, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a **stroke recognition tool** on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 424, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and contains accurate information regarding alpha-synuclein's role in Lewy bodies. However, it introduces slight redundancy by discussing the 'new era in the study of Parkinson's disease,' which is not directly necessary to support the answer. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Distinctive histopathology was revealed with alpha-synuclein immunostaining, including pleomorphic Lewy bodies, synuclein-positive glial inclusions and widespread, severe neuritic dystrophy.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: The identification of the alpha-synuclein gene on chromosome 4q as a locus for familial Lewy-body parkinsonism and of alpha-synuclein as a component of Lewy bodies has heralded a new era in the study of Parkinson's disease. \n\nThis sentence explicitly states that **alpha-synuclein** is a **component of Lewy bodies**, directly indicating that the antibodies used for immunostaining are raised against **alpha-synuclein**.", "retries": 1}
{"idx": 425, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.  \n\n**Analysis**: The title of the study explicitly states that pridopidine (ACR16) was tested in patients with **Huntington disease**, directly answering the question. This sentence is the most concise and unambiguous support for the conclusion.", "retries": 1}
{"idx": 426, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors. \n\n**Analysis**: The context categorizes newer anticoagulants into **factor Xa inhibitors** and **thrombin (IIa) inhibitors**. While betrixaban is not explicitly named in the text, it is a well-known factor Xa inhibitor in clinical use. The sentence establishes that factor Xa inhibitors are a distinct class of anticoagulants, supporting the answer that betrixaban inhibits **Factor Xa**.", "retries": 1}
{"idx": 427, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that gevokizumab targets IL-1β by modulating its signaling, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\" \n\nThis sentence directly states that Gevokizumab targets **Interleukin-1β (IL-1β)** by modulating its signaling pathway.", "retries": 1}
{"idx": 428, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients (e.g. age < 50 years, post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch.", "model_answer": "Answer: Autologous epidural blood patch", "model_support": "Supporting sentence: Complications of autologous epidural blood patch are rare.  \n\n**Analysis:**  \nWhile the context does not explicitly state \"definitive treatment,\" the mention of **autologous epidural blood patch** in relation to complications and the prior discussion of optimal blood volume (12–20 ml) strongly imply its role as the standard therapeutic intervention for low-pressure headache caused by PDPHA. The reference to complications being rare underscores its safety and efficacy, supporting its use as the definitive treatment.", "retries": 1}
{"idx": 429, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Bcr-Abl tyrosine kinase,' is very close to the gold standard 'Bcr-Abl' but includes additional specification ('tyrosine kinase') that, while accurate, is not required for a direct match. The supporting sentence is relevant and covers the answer logically by emphasizing the necessity and sufficiency of Bcr-Abl tyrosine kinase in CML transformation. However, it does not directly reference Imatinib's inhibition of Bcr-Abl as the gold supporting sentence does, making it slightly less precise.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib mesylate is a new drug that can inhibit the tyrosine kinase activity of Bcr-Abl, the receptors for platelet-derived growth factor receptor(PDGF) and stem cell factor, or c-kit.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: The expression of Bcr-Abl tyrosine kinase has been shown to be necessary and sufficient for the transformed phenotype of CML cells.", "retries": 1}
{"idx": 430, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, identifying 'AIP (aryl hydrocarbon receptor-interacting protein) gene' as the correct gene implicated in familial isolated pituitary adenoma. However, the supporting sentence states there is no supporting context available, which is incorrect since the gold supporting sentence provides relevant information from the context about aryl hydrocarbon receptor interacting protein gene mutations being linked to these tumors. The omission of this logical support slightly lowers the score.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "Answer: AIP (aryl hydrocarbon receptor-interacting protein) gene", "model_support": "The provided context does not mention the **AIP (aryl hydrocarbon receptor-interacting protein) gene** or its role in familial isolated pituitary adenoma. Therefore, there is **no supporting sentence** in the given context for the answer. \n\nThe context discusses the lack of reliable molecular markers and the limited success in implicating classical proto-oncogenes or tumor suppressor mutations in sporadic pituitary tumors, but it does not reference the **AIP gene** specifically. The answer (AIP gene) is not supported by the provided text.", "retries": 1}
{"idx": 431, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy by mentioning treatment success, which is not necessary for directly supporting the answer. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "Growth hormone", "gold_support": "Growth hormone deficiency in Costello syndrome.", "model_answer": "Answer: Growth hormone (GH) deficiency", "model_support": "Supporting sentence: To our knowledge, these are the only patients with Costello syndrome who have been successfully treated for GH deficiency.", "retries": 1}
{"idx": 432, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context explicitly mentions 'three genera of the Flaviviridae family' (Pestivirus, Flavivirus, and Hepacivirus), making the correct answer 'three'. The supporting sentence provided by the model incorrectly states that the context does not mention the Flaviviridae family or its classification, which is factually wrong as the gold supporting sentence clearly identifies the three genera. The model's supporting sentence fails to logically support any part of the gold answer and introduces incorrect reasoning.\", \"match\": false}", "gold_answer": "three", "gold_support": "Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV).", "model_answer": "Answer: Five", "model_support": "The answer provided (five genera in the Flaviviridae family) is **not supported by the context**. The context discusses antiviral activity of compounds against specific viruses (e.g., BVDV, HCV, YFV, RSV) but does **not mention the Flaviviridae family or its taxonomic classification**. Therefore, no sentence in the context can be cited to justify the answer. The correct approach would be to state that the context does not provide information on the number of genera in the Flaviviridae family.", "retries": 1}
{"idx": 433, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the deletion of ZEB2 in the context of Mowat-Wilson syndrome, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "Individuals with Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: High resolution microarray analysis revealed 0.9 Mb deletion of 2q22.3 involving two genes: ZEB2 and GTDC1. \n\n**Analysis**: The sentence explicitly identifies **ZEB2** as one of the genes within the deleted region (2q22.3) associated with Mowat-Wilson syndrome (MWS). While GTDC1 is also mentioned, **ZEB2 is the well-established causative gene for MWS**, as confirmed by clinical genetics literature. The context directly links the deletion of ZEB2 to the syndrome.", "retries": 1}
{"idx": 434, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly, using the correct acronym 'SERCA.' However, the supporting sentence is relevant but does not directly explain that SERCA is the main calcium pump of the sarcoplasmic reticulum. Instead, it discusses the modulation of SERCA activity for therapeutic purposes, which is slightly indirect. The gold supporting sentence more clearly and concisely ties SERCA to its role as the calcium pump crucial for calcium homeostasis.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "Answer: SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvment.  \n\n(Note: \"involvment\" is likely a typo for \"involvement,\" but the term \"SERCA\" is clearly used as the acronym for sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase throughout the context.)", "retries": 1}
{"idx": 435, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but does not directly mention BRG1, leading to slight redundancy. The logic is correct as the context supports the inference of BRG1 being the interacting subunit, but the supporting sentence could be more specific by directly referencing BRG1.\",\n  \"match\": true\n}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: FANCA was demonstrated to associate with the endogenous SWI/SNF complex. \n\nThe context explicitly states that FANCA interacts with the **endogenous SWI/SNF complex**, and earlier identifies **BRG1** as a subunit of this complex. While the sentence does not directly name BRG1 as the interacting subunit, the question asks for the specific subunit of the SWI/SNF complex that interacts with FANCA. Since BRG1 is the only subunit explicitly mentioned in the context, and the interaction with the SWI/SNF complex is described, **BRG1** is inferred as the subunit involved. The direct evidence is the association of FANCA with the SWI/SNF complex, and the identification of BRG1 as its subunit.", "retries": 1}
{"idx": 436, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces IM resistance, which is not necessary to directly support the answer, while the gold supporting sentence is more concise and focused on the mechanism of imatinib binding to BCR-ABL.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Imatinib mesylate (IM) binds to the BCR-ABL protein, inhibiting its kinase activity and effectively controlling diseases driven by this kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: IM resistance has been associated with kinase mutations or increased BCR-ABL expression.  \n**Analysis**: The context directly identifies BCR-ABL as the tyrosine kinase targeted by imatinib (IM), as resistance mechanisms are described in relation to BCR-ABL (e.g., mutations or expression changes). This confirms BCR-ABL as the Philadelphia chromosome-positive CML kinase inhibited by imatinib.", "retries": 1}
{"idx": 437, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard (5 vs. 7). However, the supporting sentence is relevant and refers to the context of TAp73 isoforms, though it incorrectly specifies only 5 isoforms instead of 7. The logic in the supporting sentence is reasonable but does not cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 5", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "retries": 1}
{"idx": 438, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer, 'Acute stroke,' is effectively synonymous with the gold standard 'stroke' in this context, fulfilling the requirement for a match. The supporting sentence is concise and directly relevant, logically explaining that the ROSIER scale differentiates acute stroke from mimics, aligning well with the gold supporting sentence's implication. Minor extra detail in the supporting sentence does not detract from its clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.*", "retries": 1}
{"idx": 439, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('interleukin-5'). However, the supporting sentence incorrectly states that the context does not mention Mepolizumab or its target, when in fact the gold supporting sentence demonstrates that this information is present in the text. Despite this error, the model correctly identifies the target molecule based on external knowledge, warranting a score of 4.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "There has been a variable effect with the leukotriene receptor antagonist montelukast and promising early results with mepolizumab, a monoclonal antibody against interleukin-5.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "The context does not mention Mepolizumab or its target molecule (Interleukin-5, IL-5). Therefore, **no sentence in the provided context supports the answer**. The question requires external knowledge beyond the given text.", "retries": 1}
{"idx": 440, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes additional details ('partial iodide organification defect leading to thyroid hormone biosynthesis abnormalities') which are correct but more specific than the concise 'thyroid' expected in the gold answer. The supporting sentence is somewhat detailed but logically explains the connection between SLC26A4 mutations and the partial iodide organification defect, which aligns with the context of thyroid hormone abnormalities. However, it could be more concise to better match the gold supporting sentence.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural deafness, goiter and a partial defect in iodide organification.", "model_answer": "Answer: Partial iodide organification defect leading to thyroid hormone biosynthesis abnormalities.", "model_support": "Supporting sentence: Loss-of-function mutations in the SLC26A4 gene are associated with a partial iodide organification defect, presumably because of a reduced iodide efflux into the follicular lumen. \n\n**Analysis**: This sentence directly links the genetic cause of Pendred syndrome (SLC26A4 mutations) to the **partial iodide organification defect**, which disrupts thyroid hormone biosynthesis. The context explicitly connects this defect to impaired iodide handling in the thyroid gland, a key step in thyroid hormone production. No other hormone abnormalities are mentioned in the provided text.", "retries": 1}
{"idx": 441, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' corresponds to 'xa'). The supporting sentence explains that the context discusses factor Xa inhibitors but notes that betrixaban is not explicitly mentioned in the provided text. However, it acknowledges external knowledge could justify the answer. While the supporting sentence introduces some redundancy by discussing unrelated details (e.g., thrombin inhibitors), it still logically supports the answer overall.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly mention **betrixaban** or its mechanism of action. While the text discusses **factor Xa inhibitors** (e.g., fondaparinux, idraparinux, idrabiotaparinux) and **direct thrombin inhibitors** (e.g., dabigatran, bivalirudin), **betrixaban is not listed** as an example of either. Therefore, the assertion that betrixaban inhibits **Factor Xa** cannot be directly supported by the provided context. \n\nIf the question assumes external knowledge, the answer would rely on prior understanding that betrixaban is a factor Xa inhibitor. However, **within the given context**, there is **no supporting sentence** for this claim.", "retries": 1}
{"idx": 442, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it lists various symptoms instead of identifying 'cerebral hemiatrophy' as the characteristic feature. However, the information provided in the answer is present in the context. The supporting sentence is relevant but focuses on the symptoms rather than directly supporting the gold answer. It does not succinctly cover the key feature of cerebral hemiatrophy.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The so-called Dyke-Davidoff-Masson syndrome (DDMS) is a rare disorder of cerebral hemiatrophy.", "model_answer": "Answer: Facial asymmetry, contralateral atrophy (including the trunk and extremities), hemiparesis, speech difficulties, mental retardation, and epilepsy.", "model_support": "Supporting sentence: The clinical presentation may consist of facial asymmetry, contralateral atrophy (including the trunk, and the extremities) and hemiparesis, speech difficulties, mental retardation, and epilepsy.", "retries": 1}
{"idx": 443, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying BCR-ABL as the target of Imatinib. The supporting sentence is relevant and provides context about the BCR-ABL positive cell lines, confirming the drug's mechanism. However, it is slightly verbose and less direct compared to the gold supporting sentence, which succinctly explains the molecular aberration caused by the fusion gene.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND: Chronic myelogenous leukemia (CML) is characterized by a molecular aberration, a fusion BCR-ABL gene encoding for aberrant tyrosine kinase activity, which is crucial in the pathogenesis of CML.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The single agents and their combinations were studied for in vitro effect on proliferation of BCR-ABL positive cell lines KBM5 and KBM7 by 3(4,5-dimethylthiazol-2yl)-2,5 diphenyl-tetrazolium bromide assay and on primary patient-derived BCR-ABL cells by clonogenic assays. \n\n**Analysis:** The context explicitly identifies \"BCR-ABL positive cell lines\" as the target of STI571 (Imatinib/Gleevec) in the study. The BCR-ABL fusion protein, a constitutively active tyrosine kinase resulting from the Philadelphia chromosome translocation, is the well-established molecular target of Imatinib in Philadelphia chromosome-positive CML. This sentence directly links the drug's mechanism to BCR-ABL, confirming its role as the target.", "retries": 1}
{"idx": 444, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'AIP gene' is correct and matches the gold standard conceptually, as 'Aryl hydrocarbon receptor interacting protein' is the full name of the AIP gene. The supporting sentence is relevant and covers the answer with clear reasoning, mentioning 'AIP-mutated FIPA patients,' which links the mutation to the condition. However, it includes additional details about phenotypic diversity that are not strictly necessary for supporting the answer, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors. \n\nThe sentence explicitly mentions \"AIP-mutated FIPA patients,\" directly linking mutations in the **AIP gene** to the condition. Additionally, the context later refers to \"AIP-negative FIPA families,\" further confirming that the AIP gene is a key player in this disorder.", "retries": 1}
{"idx": 445, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Four genera') does not match the gold standard ('three'). However, the supporting sentence correctly identifies that the context does not support the model's answer and explains that the claim is based on external knowledge. The supporting sentence is relevant but does not cover the gold answer.\", \"match\": false}", "gold_answer": "three", "gold_support": "The family Flaviviridae contains three genera of positive-strand RNA viruses, namely, Flavivirus, Hepacivirus (e.g., hepatitis C virus [HCV]), and Pestivirus.", "model_answer": "Answer: Four genera.", "model_support": "The context does not explicitly mention the number of genera in the Flaviviridae family. The provided text focuses on pestiviruses and HCV (both members of the Flaviviridae family) but does not state how many genera comprise the family. The answer \"Four genera\" is a general virology fact (Flaviviridae includes Flavivirus, Hepacivirus, Pestivirus, and Pegivirus), but **no sentence in the given context supports this specific claim**.", "retries": 1}
{"idx": 446, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard 'p53'. However, 'PTEN' is mentioned in the context as a tumor suppressor with a newly proposed role as a guardian of the genome. The supporting sentence is relevant to the model's answer but does not cover the gold answer, as it focuses on PTEN instead of p53.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 447, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Iron deficiency' is very close to the gold standard 'Iron,' as both refer to the same underlying cause of restless leg syndrome. However, the supporting sentence focuses on iron deficiency causing anemia, which is not directly relevant to the pathophysiology of restless leg syndrome. While the logic connecting iron deficiency to health issues is reasonable, the supporting sentence mixes relevant (iron deficiency) and less relevant (anemia) content, making it somewhat indirect for the specific context of restless leg syndrome.\", \"match\": true}", "gold_answer": "Iron", "gold_support": "Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.", "model_answer": "Answer: Iron deficiency", "model_support": "Supporting sentence: Iron deficiency has been long been known to cause anaemia, iron excess to cause haemochromatosis.  \n\n**Analysis:**  \nThe context explicitly states that iron deficiency causes anemia. While the connection between iron deficiency and restless legs syndrome (RLS) is not directly mentioned in the body text, the **title** (\"Iron, brain and restless legs syndrome\") implies this association. However, since the user’s answer is \"Iron deficiency\" and the context only directly links iron deficiency to anemia, the most explicit supporting sentence is the one about anemia. The title may suggest the broader relevance to RLS, but without explicit mention in the body text, the direct evidence is limited to the anemia-related statement.", "retries": 1}
{"idx": 448, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about p53 and its regulatory network, but it is slightly indirect and does not explicitly mention 'guardian of the genome.' The sentence could be more concise and directly tied to the specific role outlined in the gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53, encoded by the TP53 gene, is recognized as the guardian of the human genome because it regulates many downstream genes to exercise its function in cell cycle and cell death.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Recent studies have revealed that several microRNAs (miRNAs) are important components of the p53 tumor suppressor network...  \n**Analysis**: While the context does not explicitly state \"guardian of the genome,\" the term **p53** is directly identified as the tumor suppressor under discussion. The phrase \"tumor suppressor network\" and the focus on p53's regulatory mechanisms align with its well-established role as the \"guardian of the genome\" in scientific literature. The answer is supported by the context's repeated emphasis on p53 as the central tumor suppressor gene.", "retries": 1}
{"idx": 449, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but includes slightly more detail ('specifically subclinical hypothyroidism') which is accurate based on the context. The supporting sentence is relevant and supports the answer well, though it does not cover the full scope of the gold supporting sentence, which mentions both morphology and subclinical hypothyroidism. Slight redundancy exists in focusing only on subclinical hypothyroidism in younger patients, while the gold supporting sentence provides a broader statement.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Answer: Thyroid hormone abnormalities, specifically subclinical hypothyroidism.", "model_support": "Supporting sentence: The prevalence of patients with subclinical hypothyroidism was significantly higher in the younger patients.", "retries": 1}
{"idx": 450, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions 'congenital hypothyroidism and sensorineural hearing loss,' which is correct for Pendred syndrome based on general medical knowledge. However, the gold standard specifies 'thyroid' as the key abnormality, which is more precise in this context. The supporting sentence is relevant but does not directly cover the gold answer ('thyroid') and lacks clear reasoning from the provided context. Additionally, the context does mention PDS (Pendred syndrome) indirectly, so the model's claim that it is absent is inaccurate.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "Answer: Congenital hypothyroidism and sensorineural hearing loss.", "model_support": "The context does not explicitly mention **Pendred syndrome** or its characteristic features (congenital hypothyroidism and sensorineural hearing loss). While the text discusses genetic causes of congenital hypothyroidism and associated syndromes, it does not specifically reference Pendred syndrome. The answer provided is accurate in general medical knowledge but **lacks direct support from the quoted context**. \n\n**Supporting sentence (if any):** None. The context does not mention Pendred syndrome.", "retries": 1}
{"idx": 451, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains some redundancy by mentioning the analysis of GDNF and the silent mutation (A45A), which are not necessary to directly support the role of the ret gene in MEN2 and Hirschsprung disease. The logic is sound, but the additional details make it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ret", "gold_support": "Germline mutations of the ret protooncogene are the underlying cause of the MEN2 syndromes and a proportion of cases of HSCR.", "model_answer": "Answer: ret gene", "model_support": "Supporting sentence: Molecular analysis of the *ret* and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.  \n\nThe context explicitly states that the *ret* gene and GDNF were analyzed in the context of MEN2 and HSCR. While no GDNF mutations were found, the focus on *ret* as a target for molecular analysis directly supports its role in these conditions. Additionally, the mention of a silent mutation in *ret* (A45A) further implicates this gene in the phenotype.", "retries": 1}
{"idx": 452, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context, as the context implies multiple isoforms without specifying the number. The supporting sentence is relevant but overly general, failing to cover the gold answer (7). It mentions the existence of TAp73 isoforms but does not provide any information about their count.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The context does not specify the exact number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions. \n\n**Analysis**: The context describes the existence of TAp73 and DeltaNp73 isoforms but does not specify the exact number of distinct TAp73 isoforms identified in humans. While it mentions \"TAp73 isoforms\" (plural), the text does not quantify how many unique variants exist.", "retries": 1}
{"idx": 453, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides detailed context about collagen being used for species identification and its application to ancient bone samples, which aligns with the question. However, it includes additional information about peptide markers and processed food, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "Species identification by analysis of bone collagen using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: Analysis of the collagen from 32 different mammal species identified a total of 92 peptide markers that could be used for species identification, for example, in processed food and animal feed. A set of ancient (>100 ka@10 degrees C) bone samples was also analysed to show that the proposed method has applications to archaeological bone identification. \n\n**Key analysis:** The context explicitly states that collagen peptides are analyzed for species identification and that the method applies to archaeological bone identification. The direct mention of \"collagen\" as the protein analyzed across species and its application to ancient bone samples confirms its role in both dating (implied through archaeological context) and species identification.", "retries": 1}
{"idx": 454, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but it is slightly more specific than the gold supporting sentence, focusing on point mutations rather than the broader correlation with the phenotype.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites.", "retries": 1}
{"idx": 455, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and accurate, contains additional information about BRCA-deficient breast cancer that is not directly necessary to support the answer. It introduces slight redundancy without detracting from the logical connection between the answer and the context.\", \"match\": true}", "gold_answer": "PARP", "gold_support": "We used two PARP inhibitors in clinical development, olaparib and rucaparib, as well as genetic downmodulation of PARP-1 for in vitro studies.", "model_answer": "Answer: Poly (ADP-ribose) polymerase (PARP)", "model_support": "Supporting sentence: Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising results in Breast Cancer (BRCA) deficient breast cancer, but not in molecularly unselected patient populations. \n\n**Analysis:** The context explicitly states that olaparib is a PARP inhibitor (e.g., \"PARP inhibition, alone or combined with... olaparib\"). Since PARP (Poly (ADP-ribose) polymerase) is the enzyme targeted by PARP inhibitors, this directly identifies the target of olaparib.", "retries": 1}
{"idx": 456, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is equivalent to '5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin is used to evaluate 5-HT2A receptors in the rat brain. Although some additional details are provided, they do not detract from the clarity or correctness of the response.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: **\"Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain...\"**  \n\nThis sentence explicitly states that [18F]altanserin is used to evaluate **5-HT2A receptors** in the rat brain. Additional confirmation is found in the **\"RESULT\"** and **\"CONCLUSION\"** sections, which validate the use of [18F]altanserin for quantifying 5-HT2A receptor (5-HT2AR) availability in vivo.", "retries": 1}
{"idx": 457, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by identifying BACH1 as a 'transcriptional repressor,' which aligns with the gold answer. However, it contains slight redundancy by including details about Nrf2 regulation, which are not necessary to directly support the role of BACH1 as a repressor.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"the transcriptional repressor BACH1 itself is regulated by Nrf2 as it is induced by Nrf2 overexpression...\" \n\nThe term \"transcriptional repressor\" explicitly identifies BACH1's role as a repressor.", "retries": 1}
{"idx": 458, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer correctly identifies two hormone abnormalities (hypercalcemia and early puberty) that are common in Williams syndrome, which aligns with the gold standard. However, it misses 'hypothyroidism,' another key endocrine abnormality explicitly mentioned in the gold supporting sentence. The supporting sentences selected by the model are relevant and explain treatment approaches for hypercalcemia and early puberty, but they do not directly reference hypothyroidism, leading to slight incompleteness. Despite this, the logic is strong, and the information provided is concise and accurate.\",\n  \"match\": false\n}", "gold_answer": "yroidis", "gold_support": "Williams syndrome (WS) is characterized by cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvar aortic stenosis, hypertension), distinctive facies, connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty).", "model_answer": "Answer: Hypercalcemia and early puberty.", "model_support": "Supporting sentences:  \n1. \"Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate.\"  \n2. \"Early puberty may be treated with a gonadotropin-releasing hormone agonist.\"  \n\nThese sentences explicitly identify **hypercalcemia** (a calcium homeostasis disorder) and **early puberty** (a hormonal developmental abnormality) as hormone-related manifestations in Williams syndrome.", "retries": 1}
{"idx": 459, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Collagen' matches the gold standard exactly. The supporting sentence refers to enzymatic crosslinks in collagen, which indirectly supports the role of collagen in archaeological applications by highlighting its analysis. However, it does not directly mention collagen's use in archaeology for dating or species identification, making it slightly less precise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "The developed strategy permitted unprecedented biochemical analyses of bone-matrix proteins, including collagen modifications, using nearly nanoscale amounts of exceptionally homogenous bone tissue.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: \"the levels of two enzymatic crosslinks (pyridinoline and deoxypiridinoline) were higher in osteonal than interstitial tissue...\" \n\n**Analysis**: The context discusses collagen crosslinks (pyridinoline and deoxypiridinoline) as part of the collagen matrix in bone. While the text does not explicitly state collagen's role in archaeology, collagen is a well-established protein in archaeological research for dating (via radiocarbon analysis) and species identification due to its preservation in ancient bone. The mention of collagen crosslinks and the application of the methodology to archaeology supports the inference that collagen is the relevant protein.", "retries": 1}
{"idx": 460, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Tumor suppressor p53 functions as a 'guardian of the genome' to prevent cells from transformation.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Tumor suppressor p53 functions as a \"guardian of the genome\" to prevent cells from transformation.", "retries": 1}
{"idx": 461, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (SPINK5) does not match the gold standard (LEKTI), but SPINK5 is mentioned in the context as the gene responsible for Netherton syndrome. The supporting sentence is relevant but does not directly cover the gold answer (LEKTI). It discusses the identification of the causative gene and protein without explicitly linking it to LEKTI, which reduces its effectiveness.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome and its multifaceted defective protein LEKTI.", "model_answer": "Answer: SPINK5 (Serine Protease Inhibitor, Kazal-type 5)", "model_support": "The context provided does not explicitly name the protein (SPINK5) responsible for Netherton syndrome. However, the following sentence supports the general statement that the causative gene and protein have been identified, which is foundational for understanding the disease mechanism:\n\n**Supporting sentence:**  \n\"Following the identification of the NS causative gene and protein, specific diagnostic tools have been developed...\"  \n\nWhile the context does not directly mention **SPINK5**, this sentence confirms that the gene/protein responsible for Netherton syndrome has been identified, enabling targeted research and diagnostics. The specific protein (SPINK5) is part of established scientific knowledge about Netherton syndrome but is not included in the provided text.", "retries": 1}
{"idx": 462, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Epidermal growth factor (EGF)') does not match the gold standard ('EGFRvIII'). However, the supporting sentence is relevant as it mentions EGFRvIII, which is connected to the context. The issue lies in the fact that the model incorrectly interprets the analog relationship and provides EGF instead of EGFRvIII, which is the correct target described in the gold supporting sentence.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: Epidermal growth factor (EGF)", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against **EGFRvIII** for the potential treatment of glioblastoma multiforme.  \n\n**Analysis**:  \nThe context specifies that Rindopepimut targets **EGFRvIII** (epidermal growth factor receptor variant III), a mutated form of the **epidermal growth factor receptor (EGFR)**. Since EGFR is the receptor for **epidermal growth factor (EGF)**, Rindopepimut functions as an analog of EGF, designed to elicit immune responses against the EGFRvIII-expressing tumor cells. The direct reference to \"EGFRvIII\" in the context establishes the link to the **epidermal growth factor (EGF)** family.", "retries": 1}
{"idx": 463, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but lacks explicit mention of betrixaban. The logic is clear and directly supports the classification of betrixaban as a factor Xa inhibitor, though it does not provide the specific detail that betrixaban is listed among examples in the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n**Analysis**: While the context does not explicitly name betrixaban, it categorizes newer anticoagulants into **factor Xa inhibitors** and **thrombin (factor IIa) inhibitors**. Since betrixaban is a known factor Xa inhibitor (implied by the question), the classification in the sentence directly supports the answer.", "retries": 1}
{"idx": 464, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains the mechanism of direct factor Xa inhibitors, which includes betrixaban, making it logically sound.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation... \n\n**Analysis**: While the context does not explicitly mention betrixaban, it establishes that all drugs in the \"direct factor Xa inhibitors\" class (which includes betrixaban) inhibit **Factor Xa**. The quoted sentence explicitly defines the mechanism of this drug class, supporting the answer.", "retries": 1}
{"idx": 465, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Epidermal growth factor (EGF)', does not match the gold standard 'EGFRvIII'. However, EGF is mentioned in the context as the ligand for EGFR. The supporting sentence explains that Rindopepimut targets EGFRvIII, but it incorrectly infers that Rindopepimut functions as an analog of EGF rather than directly targeting EGFRvIII itself. While relevant, the supporting sentence does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: Epidermal growth factor (EGF)", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against **EGFRvIII** for the potential treatment of glioblastoma multiforme.  \n**Analysis**: The drug Rindopepimut is described as a vaccine targeting **EGFRvIII** (epidermal growth factor receptor variant III), which is a mutated form of the **EGFR** (epidermal growth factor receptor) protein. Since EGFR is the receptor for **epidermal growth factor (EGF)**, Rindopepimut functions as an analog or mimetic of EGF to engage the EGFR pathway, making EGF the relevant growth factor.", "retries": 1}
{"idx": 466, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Thrombin') does not match the gold standard ('xa'), but it is present in the context as a valid target for other anticoagulants. The supporting sentence mentions direct thrombin inhibitors and their clinical relevance, which is relevant to the context but does not cover the gold answer (Factor Xa). Therefore, while the information provided is somewhat related, it fails to directly address the correct clotting factor inhibited by betrixaban.\", \"match\": false}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Answer: Thrombin", "model_support": "Supporting sentence: Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.  \n**Analysis**: The context categorizes betrixaban (a direct thrombin inhibitor) under \"direct thrombin inhibitors,\" which are explicitly stated to target **thrombin**. While the sentence does not mention betrixaban by name, it establishes the pharmacological class of direct thrombin inhibitors, confirming their mechanism of action.", "retries": 1}
{"idx": 467, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "One-year safety and tolerability profile of pridopidine in patients with Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: This study provides Class IV evidence that pridopidine (< 90 mg/day) is generally safe and well-tolerated in patients with **Huntington disease** for up to 1 year.", "retries": 1}
{"idx": 468, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces additional details about Tsix and its relationship with Xist, which, while accurate, are not necessary to directly support the role of Xist in X-chromosome inactivation. The logic is sound but slightly more verbose than required.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "During XCI, one X is randomly silenced by Xist.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"X chromosome choice is determined by asymmetric expression of Tsix whose antisense action represses Xist.\"  \nThis sentence explicitly states that **Xist** is the transcript repressed by Tsix, directly linking Xist to the regulation of X-chromosome inactivation (XCI). Xist is the long non-coding RNA known to coat the inactive X chromosome and drive its silencing, making it the key transcript responsible for XCI.", "retries": 1}
{"idx": 469, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence acknowledges that the gene responsible for Mowat-Wilson syndrome is not mentioned, yet it references irrelevant information about CREBBP and EP300, which are unrelated to Mowat-Wilson syndrome. While the reasoning is partially correct in identifying the lack of direct mention, the supporting sentence introduces unrelated content instead of focusing on the relevant part of the context where ZEB2 is discussed.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "A similar issue of differential diagnosis was raised by a large 4.3 Mb 2q22.3q23.1 deletion encompassing ZEB2, the gene responsible for the Mowat-Wilson syndrome, whose signs may overlap with RSTS.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is not mentioned in the provided context.", "model_support": "The context does not mention the gene responsible for Mowat-Wilson syndrome.  \nSupporting sentence: *The known genetic causes are point mutations or deletions of the CREBBP (50-60%) and EP300 (5%) genes.*  \nThis sentence specifies the genetic causes of Rubinstein-Taybi syndrome but does not address Mowat-Wilson syndrome or its associated gene (ZEB2). No other sentences in the context reference Mowat-Wilson syndrome.", "retries": 1}
{"idx": 470, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele.  \nThe context explicitly states that the mutation involves the **NF1 gene** (neurofibromatosis type 1 gene), which is directly linked to type 1 neurofibromatosis.", "retries": 1}
{"idx": 471, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' exactly, as '1,4-benzothiazepine' is a more specific but correct variant of the term. The supporting sentence is concise and directly relevant, logically covering the connection between JTV519 (K201) and its classification as a benzothiazepine derivative. Minor extra details in the explanation do not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: \"Increasing the electron donor characteristics of K201 by synthesizing its dioxole congener...\" (Note: While the context does not explicitly name JTV519, it is referenced as **K201**, which in the example provided earlier is identified as a **1,4-benzothiazepine derivative**. This connection is critical for answering the question.)", "retries": 1}
{"idx": 472, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Thrombin (Factor IIa)') does not match the gold standard ('Xa'), but it is present in the context as a different class of anticoagulants. The supporting sentence refers to dabigatran, which is unrelated to betrixaban, making it relevant but failing to cover the gold answer. The logic connecting betrixaban to factor Xa is missing.\", \"match\": false}", "gold_answer": "Xa", "gold_support": "Direct factor Xa inhibitors include rivaroxiban, which has shown promising results for VTE prophylaxis and is being studied for VTE treatment, as well as apixaban and betrixaban, which are at earlier stages of clinical validation.", "model_answer": "Answer: Thrombin (Factor IIa)", "model_support": "Supporting sentence: Dabigatran is a direct thrombin inhibitor that has undergone clinical trials for VTE prophylaxis and treatment.\n\n**Analysis**: While the context does not explicitly name betrixaban, it categorizes **direct thrombin inhibitors** (like dabigatran) as a class of drugs targeting **thrombin (Factor IIa)**. Betrixaban belongs to this class, and the sentence establishes that direct thrombin inhibitors inhibit thrombin. Thus, the mechanism of action (inhibiting thrombin) is inferred for all agents in this class, including betrixaban.", "retries": 1}
{"idx": 473, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (subclinical hypothyroidism and altered TSH bioactivity) that are not explicitly required by the simpler gold answer ('thyroid'). The supporting sentence is somewhat lengthy, mixing specific experimental details (e.g., TSH response to TRH, B/I ratio) with relevant content. While the logic connecting the abnormalities to Williams syndrome is reasonable, the sentence could be more concise to directly support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "Answer: Thyroid function abnormalities, including subclinical hypothyroidism and altered TSH bioactivity.", "model_support": "Supporting sentence: \"TSH response to thyrotropin-releasing hormone (TRH) injection [...] was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2]. These abnormalities are similar to those seen in patients with hypothalamic hypothyroidism.\" \n\nThese sentences directly describe the observed thyroid hormone abnormalities (subclinical hypothyroidism and altered TSH bioactivity) in the context of Williams syndrome (WS).", "retries": 1}
{"idx": 474, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the discussion of p73 isoforms, but it does not cover the gold answer (7) and instead supports the incorrect answer (two). The reasoning focuses on TA and ΔN as examples without addressing the full range of TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: p73 is expressed as TA and ΔN isoforms, both of which are implicated in tumor suppression and/or promotion. \n\n**Analysis**: The context explicitly states that p73 exists in two isoforms (TA and ΔN). Since TAp73 refers to the TA isoform, the answer \"two\" is directly supported by this sentence.", "retries": 1}
{"idx": 475, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "In chronic myeloid leukemia (CML), BCR-ABL-mediated oncogenic signaling can be successfully targeted with the BCRABL- inhibitors imatinib, nilotinib, and dasatinib leading to complete cytogenetic (Philadelphia chromosome not detectable upon cytogenetic testing of bone marrow) and even complete molecular (BCR-ABL not detectable by PCR in peripheral blood) responses.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Effects of BCR-ABL inhibitors on anti-tumor immunity.  \n\n**Analysis**: The context explicitly refers to \"BCR-ABL inhibitors,\" which directly identifies the target of these drugs (including imatinib) as the **BCR-ABL tyrosine kinase**. This fusion protein, formed by the Philadelphia chromosome translocation, is the hallmark of CML and the primary molecular target of imatinib (Gleevec). The sentence establishes the therapeutic focus of the discussion, confirming that imatinib inhibits BCR-ABL.", "retries": 1}
{"idx": 476, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.", "model_answer": "Answer: Phosphatase inhibitor-1 (I-1)", "model_support": "Supporting sentence: Non-phosphorylated I-1 is inactive, whereas I-1 phosphorylated by protein kinase A (PKA) at Thr35 is a potent PP1 inhibitor. \n\n**Analysis**: This sentence explicitly states that phosphorylated I-1 acts as a potent inhibitor of PP1, directly answering the question. The context clarifies that while non-phosphorylated I-1 is inactive, its phosphorylated form (at Thr35) specifically inhibits PP1, establishing I-1 as the primary inhibitor of PP1.", "retries": 1}
{"idx": 477, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer with logical reasoning, but it contains slight redundancy by mentioning AP-1 activation, which is not strictly necessary to directly support the answer about JNK phosphorylating c-Jun.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "In parallel with these immunosuppressive phenomena, DHA attenuated post-stroke oxidative stress, c-Jun N-terminal kinase (JNK) phosphorylation, c-Jun phosphorylation and activating protein-1 (AP-1) activation but further elevated ischemia-induced NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: DHA treatment also had an immunosuppressive effect in lipopolysaccharide/interferon-γ-stimulated glial cultures by attenuating JNK phosphorylation, c-Jun phosphorylation and AP-1 activation...", "retries": 1}
{"idx": 478, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX'), though it includes slightly more detail by specifying 'Na+/Ca2+ exchanger (NCX)'. The supporting sentence is relevant and provides accurate context, but it contains some redundancy by elaborating on retinal cell death, which is not directly necessary to justify the answer. Overall, the logic is strong, but a more concise supporting sentence would improve the response.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.", "retries": 1}
{"idx": 479, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and closely matches the gold standard, as it identifies alpha-synuclein as the main component of Lewy bodies. However, the inclusion of 'aggregated proteins' in the answer makes it slightly less precise compared to the gold answer. The supporting sentence mentions the interaction between synphilin-1 and alpha-synuclein and its presence in Lewy bodies, which is relevant but contains additional information about synphilin-1 that is not directly necessary for supporting the answer. This results in slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Aggregated proteins, specifically alpha-synuclein.", "model_support": "Supporting sentence: Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies. \n\nAnother supporting sentence: Accumulation of ubiquitylated synphilin-1 leads to massive formation of inclusion bodies, which resemble Lewy bodies by their ability to recruit alpha-synuclein.", "retries": 1}
{"idx": 480, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the database's function, which aligns well with the gold standard.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "Answer: mpMoRFsDB", "model_support": "Supporting sentence: mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins. \n\nThe database name \"mpMoRFsDB\" is explicitly stated in the context as the resource containing molecular recognition features (MoRFs) in membrane proteins.", "retries": 1}
{"idx": 481, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly captures the regulatory role of PLN over SERCA2a as described in the context.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: Dephosphorylated PLN inhibits SERCA2a. \n\nExplanation: The context explicitly states that phospholamban (PLN) directly regulates SERCA2a by inhibiting its activity when dephosphorylated. This establishes PLN as the primary molecular regulator of SERCA2a function in cardiac muscle.", "retries": 1}
{"idx": 482, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly links alpha-synuclein aggregation to Lewy body formation, making it logically sound and aligned with the gold standard.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation, so that antiaggregation strategies would be very useful to prevent alpha-synuclein fibril formation.\n\nThe sentence explicitly links **alpha-synuclein aggregation** to **Lewy body formation**, establishing alpha-synuclein as the primary component of Lewy bodies. The pronoun \"its\" refers to alpha-synuclein, which was introduced in the context as the central pathological protein in DLB.", "retries": 1}
{"idx": 483, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('xa'). The supporting sentence provided by the model is concise, directly relevant, and logically explains that betrixaban is a direct factor Xa inhibitor. The reasoning aligns perfectly with the gold supporting sentence, which explicitly states that betrixaban is one of the inhibitors of factor Xa. There is no redundancy or unnecessary content.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Betrixaban is a direct factor Xa inhibitor.", "model_support": "The context does not explicitly mention the specific clotting factor inhibited by betrixaban. While the text lists betrixaban as one of the new oral anticoagulants, it does not provide details about its mechanism of action (e.g., whether it inhibits factor Xa or thrombin). Therefore, the answer **cannot be directly supported by the provided context**. \n\n**Answer:** The context does not specify which clotting factor is inhibited by betrixaban.", "retries": 1}
{"idx": 484, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about disorder-based protein-protein interactions are acceptable as they do not detract from the core relevance.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "Answer: mpMoRFsDB", "model_support": "Supporting sentence: mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins. \n\nAnalysis: The context explicitly states \"mpMoRFsDB\" as the database name in the sentence \"mpMoRFsDB provides valuable information...\" and further confirms its availability at the specified URL. This directly answers the question about the database of molecular recognition features in membrane proteins.", "retries": 1}
{"idx": 485, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it includes additional information about the 24-25 nm periodic structural repeat, which is not necessary to justify the 10 nm diameter. This makes it slightly redundant compared to the gold supporting sentence, which directly mentions the formation of 10 nm filaments.\",\n  \"match\": true\n}", "gold_answer": "10 nm", "gold_support": "Scanning tunneling microscope (STM) and transmission electron microscope (TEM) micrographs showed that acidic keratins and basic keratins can assemble into dimers and further into 10 nm filamentsin vitro.", "model_answer": "Answer: 10 nm", "model_support": "Supporting sentence: One of the explicit features of plant keratin intermediate filaments is a 24-25 nm periodic structural repeat along the axis of both the 10 nm filaments and protofilaments.", "retries": 1}
{"idx": 486, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly links the gene to Mowat-Wilson syndrome. However, it includes additional details about biliary anomalies, which, while related, are not necessary to support the answer. This makes the sentence slightly verbose but still logically sound.\", \"match\": true}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "Answer: zfhx1b", "model_support": "Supporting sentence: \"We identified a patient with Mowat-Wilson syndrome who also developed cholestasis and histopathologic features consistent with biliary atresia, suggesting that mutations involving zfhz1b may lead to biliary developmental anomalies or injury to the biliary tract.\"  \n\n(Note: The context contains a typographical error in the gene name \"zfhz1b\" instead of the correct \"zfhx1b,\" but the sentence directly links the gene to Mowat-Wilson syndrome.)", "retries": 1}
{"idx": 487, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Developmental gene regulation,' is very close to the gold standard 'development' and captures the essence of the process. However, it is slightly more verbose than necessary. The supporting sentence provides relevant information about bivalent domains and their role in regulating developmental genes, which aligns with the context and gold answer. While the logic is strong, the sentence is somewhat lengthy and includes additional details not strictly required to support the answer.\",\n  \"match\": true\n}", "gold_answer": "development", "gold_support": "The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs).", "model_answer": "Answer: Developmental gene regulation", "model_support": "Supporting sentence: We identified a specific modification pattern, termed \"bivalent domains,\" consisting of large regions of H3 lysine 27 methylation harboring smaller regions of H3 lysine 4 methylation. Bivalent domains tend to coincide with TF genes expressed at low levels. We propose that bivalent domains silence developmental genes in ES cells while keeping them poised for activation. \n\nAnalysis: The context explicitly links conserved noncoding elements (HCNE-rich loci) to **bivalent domains**, which are described as chromatin structures regulating **developmental genes** in embryonic stem cells. The analysis of 56 HCNE-rich loci reveals their role in maintaining developmental genes in a \"poised\" state, directly pointing to **developmental gene regulation** as the primary process governed by these elements.", "retries": 1}
{"idx": 488, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is less detailed compared to the gold supporting sentence. While the model's supporting sentence is correct and relevant, it lacks the explicit mention of 'Na⁺/Ca²⁺ exchange inhibitor' which would make it more precise and aligned with the gold standard.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400. \n\nExplanation: The context explicitly states that SEA0400 inhibits the effects of SNP, which are mediated through the **Na⁺/Ca²⁺ exchanger (NCX)**. Earlier in the text, it is mentioned that SNP causes Ca²⁺ influx via the reverse of NCX. By blocking these effects (Ca²⁺ influx, ROS production, etc.), SEA0400 directly targets the NCX pathway.", "retries": 1}
{"idx": 489, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('1,4-benzothiazepine'), but the supporting sentence is incorrect. The model incorrectly claims that the context does not explicitly state JTV519 is a derivative of 1,4-benzothiazepine, whereas the gold supporting sentence clearly identifies this fact in the background information. The supporting sentence provided by the model introduces confusion by focusing on unrelated details about the mechanism of action rather than the chemical classification.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "BACKGROUND: A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. The information in this context focuses on its mechanism of action (e.g., PKC activation) but does not mention its chemical classification. The answer \"1,4-benzothiazepine\" is likely derived from a different context (as shown in the example), but **this specific context does not contain a supporting sentence** for the answer. \n\n**Note**: There may be an inconsistency between the question and the provided context. If the question assumes prior knowledge from the example, the answer would still rely on external information not present in the current context.", "retries": 1}
{"idx": 490, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is effectively equivalent to '5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that [18F]altanserin PET quantifies 5-HT2AR availability. Minor extra details do not detract from the strong logical connection.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: **[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.**  \n(From the **CONCLUSION** section of the context.)", "retries": 1}
{"idx": 491, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('AF'). The supporting sentence is relevant and supports the answer by mentioning atrial fibrillation, but it focuses on the experimental aspect of reducing AF duration rather than explicitly stating that AF is the most prevalent arrhythmia. While logical, the supporting sentence could be more directly aligned with the gold supporting sentence for full conciseness and relevance.\", \"match\": true}", "gold_answer": "AF", "gold_support": "Atrial fibrillation (AF) is associated with increased morbidity and is in addition the most prevalent cardiac arrhythmia.", "model_answer": "Answer: Atrial fibrillation (AF)", "model_support": "Supporting sentence: The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels. \n\n**Analysis**: While the context does not explicitly state \"atrial fibrillation (AF) is the most prevalent arrhythmia,\" the entire study focuses on AF as the primary arrhythmia being investigated. The first sentence directly references AF, establishing its relevance in the context of antiarrhythmic drug research, which aligns with the general biomedical consensus that AF is the most common clinically significant arrhythmia.", "retries": 1}
{"idx": 492, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by highlighting that TCR is directed at the transcribed strand. Minor extra details about Cockayne syndrome are acceptable as they do not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of **transcribed strands**. \n\nThis sentence explicitly states that TCR targets the **transcribed strand** of DNA for repair.", "retries": 1}
{"idx": 493, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence, while relevant, is less direct and contains additional information about the disease being autosomal dominant and linked to chromosome 4q35, which is not directly related to the key evidence needed to support the answer. The gold supporting sentence is more concise and directly ties DUX4 expression to FSHD in a clear experimental context.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: FSHD is an autosomal dominant disease linked to chromosome 4q35, but the causative gene remains controversial.", "retries": 1}
{"idx": 494, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively highlights that gevokizumab negatively modulates IL-1β signaling, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism. \n\n**Analysis**: This sentence directly states that Gevokizumab targets IL-1β signaling, confirming that the drug's mechanism involves interacting with **Interleukin-1β (IL-1β)** as the primary molecular target. Subsequent details about receptor interactions (e.g., IL-1RI) describe downstream effects but do not change the fact that IL-1β is the central molecule being modulated.", "retries": 1}
{"idx": 495, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical reasoning by explaining the role of stalled RNA polymerase in TCR, which indirectly supports why the transcribed strand is targeted. However, it does not directly state that TCR removes lesions from the transcribed strand, making it slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Among these is a process called transcription-coupled repair (TCR) that catalyzes the removal of DNA lesions from the transcribed strand of expressed genes, often resulting in a preferential bias of damage clearance from this strand relative to its non-transcribed counterpart.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: It is also believed that the signal for TCR is the stalled RNA polymerase that results when DNA damage prevents its translocation during transcription elongation.  \n\n**Analysis**: Transcription-coupled repair (TCR) is activated when DNA damage blocks the progression of RNA polymerase during transcription elongation. Since RNA polymerase moves along the **transcribed strand** (the template strand being read for RNA synthesis), the stalled polymerase directly indicates damage on this strand. This establishes that TCR specifically targets the transcribed strand.", "retries": 1}
{"idx": 496, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and introduces extra details about PRT4445, which are not necessary to directly support the answer. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis:** The context explicitly states that PRT4445 (a factor Xa decoy) is being evaluated alongside betrixaban. This implies that betrixaban exerts its anticoagulant effect by targeting **Factor Xa**, as PRT4445 is described as a reversal agent for anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 497, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('factor Xa' vs. 'xa'). However, the supporting sentence provided by the model is incorrect in stating that there is no supporting sentence in the context, as the gold supporting sentence directly provides the necessary information from the context. Despite this error, the model answer itself is correct and aligns with the gold answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context does not explicitly state which clotting factor is inhibited by betrixaban. While the passage lists betrixaban among other new oral anticoagulants (dabigatran, rivaroxaban, apixaban, endoxaban), it does not specify their mechanisms of action or target clotting factors. The answer \"factor Xa\" is accurate based on external knowledge (as betrixaban is a direct factor Xa inhibitor), but **no sentence in the provided context directly supports this claim**. \n\n**Answer:** There is no supporting sentence in the context provided.", "retries": 1}
{"idx": 498, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is logically connected to the answer, but it includes slightly more detail than necessary and could be more concise.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: These findings may relate to the fact, that dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.", "retries": 1}
{"idx": 499, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by linking DUX4 production to FSHD through the D4Z4 array.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.  \n\n**Analysis:** The context explicitly states that the D4Z4 array is \"FSHD-causing\" and directly links its regulation to DUX4 production. This sentence establishes the association between ectopic DUX4 expression (a hallmark of FSHD pathogenesis) and the disease Facioscapulohumeral Muscular Dystrophy (FSHD).", "retries": 1}
{"idx": 500, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing phospholamban's regulatory role on SERCA2a, but it does not directly mention its key regulatory function in Ca cycling or contractility as explicitly as the gold supporting sentence. It is slightly less specific but still logically connected.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban has been suggested to be a key regulator of cardiac sarcoplasmic reticulum (SR) Ca cycling and contractility and a potential therapeutic target in restoring the depressed Ca cycling in failing hearts.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: the findings suggest that important species-dependent differences in phospholamban regulation of SERCA2a occur.", "retries": 1}
{"idx": 501, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The supporting sentence explicitly mentions TBC1D7 as part of the TSC1-TSC2 complex, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "Answer: TBC1D7", "model_support": "Supporting sentence: We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.", "retries": 1}
{"idx": 502, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence accurately highlights the deposition of alpha-synuclein as the central feature of Lewy bodies, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: It is currently unknown, however, whether any of the APP isoforms is instrumental in **alpha-synuclein deposition** in dementia with Lewy bodies (DLB).  \n\n**Analysis**: The context explicitly states that the study investigates the role of APP isoforms in **alpha-synuclein deposition** in DLB. While the rest of the text focuses on APP isoform expression, the question asks for the main component of Lewy bodies, which is **alpha-synuclein**, a well-established hallmark of DLB pathology. The quoted sentence directly references this protein as a key pathological feature.", "retries": 1}
{"idx": 503, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the medulloblastoma model from the context.\", \"match\": true}", "gold_answer": "medulloblastoma", "gold_support": "Mouse models have increased our understanding of the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor that often forms in the cerebellum.", "model_answer": "Answer: Medulloblastoma", "model_support": "Supporting sentence: In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse **medulloblastoma** model.  \n**Analysis**: The context explicitly states that the study focuses on a \"mouse medulloblastoma model,\" directly identifying medulloblastoma as the tumor type under investigation. Since the question asks for the most common pediatric cerebellar tumor and medulloblastoma is a well-established primary pediatric cerebellar tumor, this sentence provides the necessary support for the answer.", "retries": 1}
{"idx": 504, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa' in meaning, though it is slightly more verbose. The supporting sentence is relevant and provides information about betrixaban's mechanism as an anti-Xa agent, but it mentions a factor Xa decoy (PRT4445) which is not directly necessary to support the answer, introducing slight redundancy. Overall, the logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 505, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly captures the purpose of the ROSIER scale as stated in the context.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"  \n\n**Analysis:**  \nThe context explicitly states that the ROSIER scale was developed and validated to distinguish **acute stroke** from stroke mimics (e.g., seizures, syncope, sepsis) in emergency room settings. The interpretation section directly ties the ROSIER scale's purpose to acute stroke diagnosis.", "retries": 1}
{"idx": 506, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence identifies flumazenil as a benzodiazepine antagonist, aligning perfectly with its role in treating benzodiazepine overdose.\", \"match\": true}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is the first benzodiazepine antagonist which can be used in humans and is a well established for treatment of benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: For the first time a causal treatment of hepatic encephalopathy may be possible by the **benzodiazepine antagonist flumazenil**.  \n\n**Analysis:**  \nThe context explicitly identifies flumazenil as a **benzodiazepine antagonist**, which directly supports its role as an antidote for benzodiazepine overdose. While the text focuses on hepatic encephalopathy, the pharmacological classification of flumazenil as a benzodiazepine antagonist aligns with its established use as an antidote in overdose scenarios.", "retries": 1}
{"idx": 507, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces additional context ('Evaluation of...in Chinese patients in Hong Kong') that is not strictly necessary to answer the question. While this does not detract significantly from the relevance, a more concise explanation would improve the clarity.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.  \n**Analysis**: The title explicitly states that the ROSIER scale is designed for the recognition of **stroke** in emergency room settings, directly answering the question. Additionally, the study's focus on \"suspected stroke patients\" in the methods further confirms its application for stroke diagnosis.", "retries": 1}
{"idx": 508, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but incorrectly states that the context does not mention betrixaban. The gold supporting sentence clearly shows that betrixaban is mentioned as a Factor Xa inhibitor. Despite this error, the model answer is correct and logically supported by the context provided.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Most are small synthetic molecules that target factor IIa (e.g., dabigatran etexilate, AZD-0837) or factor Xa (e.g., rivaroxaban, apixaban, betrixaban, DU176b, idrabiotaparinux).", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or its mechanism of action (inhibition of Factor Xa). Therefore, there is no supporting sentence in the provided context for the answer \"Factor Xa.\" The question and answer appear to be unrelated to the given context, which discusses general properties of new anticoagulants but does not specify drugs like betrixaban.", "retries": 1}
{"idx": 509, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'glucocerebrosidase gene (GBA)' is an acceptable elaboration of 'glucocerebrosidase.' The supporting sentence provides relevant information and covers the answer logically, though it includes slight redundancy by explaining general knowledge about Gaucher disease rather than directly referencing the context provided. This makes the reasoning slightly less concise but still correct and relevant.\",\n  \"match\": true\n}", "gold_answer": "glucocerebrosidase", "gold_support": "A 26-year-old Bedouin with moderate thrombocytopenia and enlarged spleen and liver was diagnosed as having type I Gaucher disease based on the presence of Gaucher cells in the bone marrow biopsy and enzymatic determination of glucocerebrosidase activity.", "model_answer": "Answer: The gene mutated in Gaucher disease is the glucocerebrosidase gene (GBA).", "model_support": "The gene mutated in Gaucher disease is the **glucocerebrosidase gene (GBA)**. \n\n**Supporting sentence**: The context does not explicitly name the gene in the provided text. However, Gaucher disease is a well-established autosomal recessive disorder caused by mutations in the **GBA** gene, which encodes the enzyme glucocerebrosidase. While the context describes a specific mutation (259T) and its effects, it does not directly state the gene name. The answer relies on general biomedical knowledge, as the context implicitly refers to the GBA gene through the discussion of Gaucher disease pathogenesis. \n\n**Note**: The context lacks an explicit sentence naming the GBA gene, but the answer is correct based on established medical knowledge.", "retries": 1}
{"idx": 510, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'Lumbar spine (fifth lumbar vertebra),' is very close to the gold answer, 'Lumbosacral,' but it does not fully capture the transitional nature of the vertebra as implied by 'lumbosacral.' The supporting sentence is somewhat specific and relevant, but it focuses on the radiographic detail rather than directly addressing the lumbosacral region as a whole. It could be more concise and general to better align with the gold standard.\", \"match\": false}", "gold_answer": "Lumbosacral", "gold_support": "Lumbosacral transitional vertebra causing Bertolotti's syndrome: a case report and review of the literature.", "model_answer": "Answer: Lumbar spine (fifth lumbar vertebra)", "model_support": "Supporting sentence: Radiographic investigation revealed an anomalous enlargement of the left transverse process of the fifth lumbar vertebra forming a pseudarthrosis with the infrajacent ala of the sacrum.", "retries": 1}
{"idx": 511, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('antiparallel'). The supporting sentence is relevant and supports the answer by referencing antiparallel dimer formation, but it introduces additional details about α-actinin that are not necessary to answer the question. This makes the supporting sentence slightly redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Spectrins comprise α- and β-subunits made up predominantly of a series of homologous repeating units of about 106 amino acids; the α- and β-chains form antiparallel dimers by lateral association, and tetramers through head-to-head contacts between the dimers.", "model_answer": "Answer: Antiparallel heterodimers.", "model_support": "Supporting sentence: an analysis of the sequences of the strongly interacting repeats, βIR1, βIIR1, αIR21 and αIIR20 and repeats in α-actinin, which also interact very strongly in forming an antiparallel dimer. \n\nThis sentence explicitly states that α-actinin forms an **antiparallel dimer**, and the context implies that the same antiparallel orientation applies to erythroid and non-erythroid spectrin subunits (αIβI and αIIβII) based on their structural and functional similarities.", "retries": 1}
{"idx": 512, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the broader context of p73 isoforms. The supporting sentence mentions TAp73 and DeltaNp73 isoforms but does not explicitly state the number of TAp73 isoforms. While the reasoning provided in the analysis correctly identifies that multiple TAp73 isoforms exist, the answer 'Two' is incorrect as it conflates the two main families (TAp73 and ΔNp73) with the specific count of TAp73 isoforms, which is seven according to the gold standard. The supporting sentence is relevant but fails to cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms. \n\n**Analysis**: The sentence explicitly distinguishes between **TAp73** and **DeltaNp73 isoforms**, indicating that TAp73 is a distinct group of isoforms separate from DeltaNp73. While the context does not explicitly state the number of TAp73 isoforms, the phrasing \"all TAp73\" implies the existence of multiple TAp73 isoforms. In biomedical literature, p73 is known to have **two main isoforms**: TAp73 (with a transactivation domain) and ΔNp73 (lacking the N-terminal domain). The answer \"Two\" aligns with this established knowledge and is indirectly supported by the context’s focus on distinguishing between these two isoform families.", "retries": 1}
{"idx": 513, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs 'xa'). However, the supporting sentence provided by the model is incorrect as it claims there is no supporting sentence in the context, while the gold supporting sentence clearly mentions betrixaban as an orally active direct factor Xa inhibitor. The model should have identified this information from the context. Despite this, the answer itself is correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly mention betrixaban or its mechanism of action (inhibition of Factor Xa). Therefore, there is **no supporting sentence** in the provided context to directly answer the question. The answer \"Factor Xa\" would require external knowledge, as the context only discusses dabigatran and rivaroxaban as examples of new anticoagulants but does not include betrixaban.", "retries": 1}
{"idx": 514, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and aligns with the gold supporting sentence in identifying calsequestrin as the main calcium-binding protein in the sarcoplasmic reticulum. It provides clear and logical reasoning by referencing the conclusion of the study, which confirms the role of calsequestrin.\",\n  \"match\": true\n}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum (SR) of muscle cells during relaxation.", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: *Thus, we conclude that this protein corresponds to the calsequestrin isoform in frog ventricular muscle.*  \n\n**Analysis**: The context explicitly identifies calsequestrin as the protein studied, emphasizing its role in calcium storage within the sarcoplasmic reticulum (SR). The biochemical and structural characterization (e.g., molecular weight, pH-dependent behavior, amino acid sequence) confirms it as the primary calcium-binding protein in the SR. The conclusion directly states that this protein is the calsequestrin isoform, aligning with its well-established role as the main calcium-binding protein in SR.", "retries": 1}
{"idx": 515, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about RANKL's role and how it is inhibited by OPG, but does not directly mention Denosumab's action or its pharmacologic similarity to OPG as in the gold supporting sentence. The logic is sound, but there is a slight lack of direct coverage of Denosumab's mechanism.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Denosumab (AMG 162), a fully human monoclonal antibody to RANKL, shares the pharmacologic attributes of OPG but has a significantly longer half-life that allows less frequent administration.", "model_answer": "Answer: RANKL (receptor activator of nuclear factor-kappaB ligand)", "model_support": "Supporting sentence: RANKL stimulates osteoclast formation, function and survival, and each of these effects is inhibited by OPG.  \n**Analysis**: Denosumab (Prolia) is a monoclonal antibody that targets RANKL, binding directly to it to inhibit its activity. The context explicitly identifies RANKL as a key mediator of osteoclast activity and notes that OPG inhibits RANKL's effects. Since Denosumab functions similarly to OPG by blocking RANKL, the ligand it binds to is **RANKL**.", "retries": 1}
{"idx": 516, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'AIP gene' is correct and matches the gold standard conceptually, though it is less specific than the gold answer ('aryl hydrocarbon receptor interacting protein'). The supporting sentence provides relevant information about AIP mutations causing a distinct phenotype, but it does not directly reference the discovery or the statistical prevalence mentioned in the gold supporting sentence. It is logical but lacks some key details that would make it fully aligned with the gold standard.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: AIP mutations cause a low penetrance autosomal dominant disease with often a distinct phenotype characterized by young-onset, aggressive, large GH, mixed GH and PRL or PRL-secreting adenomas.", "retries": 1}
{"idx": 517, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'EGFR gene' is equivalent to 'epidermal growth factor receptor (EGFR) gene.' The supporting sentence is relevant and covers the EGFR gene but does not explicitly mention the drugs erlotinib and gefitinib, which are key to fully supporting the gold answer. It contains slight redundancy by discussing disadvantages of methods for detecting EGFR mutations rather than focusing on the association with drug response. Despite this, the logic connecting EGFR mutations to drug response is still present in the broader context.\", \"match\": true}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the responses to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with non-small-cell lung cancer (NSCLC).", "model_answer": "Answer: EGFR gene", "model_support": "Supporting sentence: Although various methods for detecting EGFR gene mutations have been developed, they have several disadvantages.  \n\n**Analysis:** The context repeatedly refers to the *epidermal growth factor receptor gene (EGFR)* as the target for mutation detection. While the text does not explicitly mention erlotinib or gefitinib, it is well-established in clinical oncology that EGFR mutations (e.g., L858R, exon 19 deletions) are biomarkers for response to EGFR tyrosine kinase inhibitors like erlotinib and gefitinib. The quoted sentence directly identifies the EGFR gene as the focus of the study, which underpins the broader implication that EGFR mutations determine drug response.", "retries": 1}
{"idx": 518, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it could be more direct. The chosen supporting sentence refers to the effects of Bach1 ablation rather than explicitly stating that Bach1 is a repressor of the HO-1 gene, which would have been more concise and precise.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice. \n\n**Analysis**: The context explicitly refers to Bach1 as a **\"transcription repressor\"** in its opening sentence, directly establishing its role as a repressor. This classification is further supported by the observation that genetic ablation of Bach1 (removing its repressive function) leads to increased HO-1 expression, consistent with its role in suppressing HO-1 transcription.", "retries": 1}
{"idx": 519, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it discusses the trend of increasing diameter with temperature without providing the specific numerical value (10 nm) mentioned in the gold supporting sentence.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.", "model_answer": "Answer: The average diameter of intermediate filaments is not explicitly provided in the context.", "model_support": "Supporting sentence: As the temperature increased, both the average diameter and average length of particles in the supernatant increased. \n\nThe context explicitly states that the average diameter (and length) of particles in the supernatant increased with temperature but does **not provide a numerical value** for the average diameter itself. Thus, the answer is correct as the context does not include a specific measurement for the average diameter of intermediate filaments.", "retries": 1}
{"idx": 520, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('af' being an abbreviation for 'atrial fibrillation'), but the supporting sentence does not adequately cover the gold answer. The model incorrectly claims there is no supporting sentence in the context, whereas the context explicitly states that AF is the most common cardiac arrhythmia affecting a specific percentage of the population. This information directly supports the answer. The model's supporting sentence reflects a misunderstanding of the context.\", \"match\": true}", "gold_answer": "af", "gold_support": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population.", "model_answer": "Answer: Atrial fibrillation", "model_support": "The context does not explicitly state that atrial fibrillation (AF) is the most prevalent form of arrhythmia worldwide. While the text discusses AF in athletes, it focuses on incidence patterns in this specific population and does not provide global prevalence data. The question’s answer (\"Atrial fibrillation\") is factually correct in general medical knowledge, but **no sentence in the provided context supports this claim**. The context is limited to discussing AF in athletes, not global arrhythmia prevalence.", "retries": 1}
{"idx": 521, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model incorrectly states that the context does not explicitly mention the chemical classification of JTV519, when in fact it does ('the 1,4-benzothiazepine derivative JTV519'). Despite this error, the correct answer is given, and the reasoning reflects an understanding of what should have been identified in the text, albeit with slight redundancy.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. The necessary supporting sentence from the example (e.g., \"JTV519 (K201), a 1,4-benzothiazepine derivative...\") is absent in the current context. While the drug's mechanism and therapeutic effects are described, its chemical classification is not mentioned here. Therefore, the answer cannot be determined solely from the given context. \n\n**Note:** The answer \"1,4-benzothiazepine\" is accurate based on external knowledge (as shown in the example), but the supporting sentence is missing in the provided context.", "retries": 1}
{"idx": 522, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('tofacitinib'), but the supporting sentence is incorrect and does not cover the gold answer. The provided supporting sentence discusses general activity around JAK inhibitors without mentioning tofacitinib or its approval for rheumatoid arthritis. Although the answer is correct, the supporting sentence fails to justify it using the context provided.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "After two decades of research and development activity focussed on orally active kinase inhibitors, the first such drug (the JAK inhibitor Xeljanz, tofacitinib) was approved by the FDA in November 2012 for the treatment of rheumatoid arthritis (RA).", "model_answer": "Answer: Tofacitinib", "model_support": "The context provided does not explicitly mention **tofacitinib** or any specific JAK inhibitor approved for rheumatoid arthritis. While the passage discusses the development of JAK inhibitors and fostamatinib (a Syk inhibitor) in clinical trials, **no direct statement supports tofacitinib as the approved JAK inhibitor** for rheumatoid arthritis within the given text. \n\n**Supporting sentence**: *There is an intense activity in many companies both on expanding the utility of JAK inhibitors in other auto-immune indications...*  \nThis sentence highlights the general focus on JAK inhibitors but does not name tofacitinib or confirm its approval. The answer \"tofacitinib\" may rely on external knowledge not present in the provided context.", "retries": 1}
{"idx": 523, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 524, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'), but the supporting sentence contains some redundancy. While it correctly identifies Factor Xa as the target of betrixaban, it unnecessarily includes details about clinical trials (e.g., EXPLORE-Xa) that are less directly relevant to the mechanism of action. The reasoning is logical but could be more concise by focusing on betrixaban's role as a direct Factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "The clotting factor inhibited by betrixaban is **Factor Xa**.  \n\n**Supporting sentence**:  \n\"Betrixaban was tested in Phase II studies in orthopedic thromboprophylaxis (EXPERT) and atrial fibrillation (EXPLORE-Xa), and is being evaluated in a Phase III trial of extended thromboprophylaxis in medical patients (APEX).\"  \n\nThe inclusion of \"EXPLORE-Xa\" in the study name directly references Factor Xa as the target of betrixaban, aligning with its mechanism as a direct Factor Xa inhibitor.", "retries": 1}
{"idx": 525, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The context explicitly mentions two isoforms (TA and ΔN), but the gold answer states there are seven. The supporting sentence is relevant to the model's answer but does not cover or logically support the gold answer, as it only highlights two isoforms instead of the full count.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two (TA and ΔN)", "model_support": "Supporting sentence: The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and ΔN isoforms.  \n\n**Analysis**: The context explicitly states that the p73 gene is expressed as **TA** and **ΔN** isoforms, confirming the existence of two distinct isoforms in humans. This directly supports the answer.", "retries": 1}
{"idx": 526, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 527, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by including details about the regions examined and the use of ubiquitin, which are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: We examined substantia nigra, paralimbic regions (entorhinal cortex, cingulate gyrus, insula and hippocampus), and neocortex (frontal and occipital association cortices) with double alpha-synuclein and ubiquitin immunostaining in 25 cases meeting neuropathological criteria for DLB. \n\n**Analysis:** The sentence explicitly states that alpha-synuclein immunostaining was used alongside ubiquitin immunostaining to examine Lewy bodies. This confirms the antibody was raised against alpha-synuclein.", "retries": 1}
{"idx": 528, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the topic of sudden cardiac death in athletes, yet it fails to cover the specific gold answer (hypertrophic cardiomyopathy) and instead discusses general findings without specifying the cause.\", \"match\": false}", "gold_answer": "hypertrophic cardiomyopathy", "gold_support": "The most common cause of death was hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).", "model_answer": "Answer: The context does not specify the most common cause of sudden cardiac death in young athletes.", "model_support": "Supporting sentence: The incidence of athlete SCD, the types of sports involved, and the cardiac causes of death in our study were comparable with those of previous reports. \n\n**Analysis**: The context explicitly states that the study's findings (including cardiac causes of death) align with previous reports but does **not specify** the most common cause of sudden cardiac death in young athletes. While prior research often identifies conditions like hypertrophic cardiomyopathy as the leading cause, this context refrains from naming specific causes, only referencing general comparability to prior studies.", "retries": 1}
{"idx": 529, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a clear explanation of the role of calcineurin in the Ca²+/calcineurin/NFAT pathway, aligning with the gold supporting sentence. However, it contains additional information about SCID syndrome that, while related, is not directly necessary to explain the role of calcineurin in NFAT activation, making it slightly more verbose than needed.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: The importance of the Ca²+/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca²+ entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes... \n\nThis sentence explicitly identifies **calcineurin** as the calcium/calmodulin-dependent protein phosphatase integrated into the Ca²+/calcineurin/NFAT signaling pathway that regulates NFAT activation in lymphocytes.", "retries": 1}
{"idx": 530, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is effectively equivalent to '5-HT2A'). The supporting sentence is concise and directly relevant, clearly stating that [18F]altanserin is a ligand for the 5-HT2A receptor. The reasoning is strong and logical without unnecessary verbosity.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent. \n\n**Analysis**: The first sentence explicitly identifies [18F]altanserin as a **5-HT2A receptor PET ligand**, directly answering the question about the target receptors. The rest of the context focuses on metabolite characterization and pharmacokinetics, not receptor specificity beyond 5-HT2A.", "retries": 1}
{"idx": 531, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly identifies Bach1 as a transcriptional repressor with logical reasoning supported by the context. Minor additional details in the explanation do not detract from the clarity and correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.\"  \n\nThis sentence explicitly identifies Bach1 as a **transcriptional repressor**, which is further supported by the context showing that its binding to the NA site in the HS-40 enhancer suppresses alpha-globin gene expression. Heme disrupts this repression by promoting Bach1 nuclear export, thereby relieving inhibition and allowing gene activation.", "retries": 1}
{"idx": 532, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and lacks explicit mention of Lewy bodies. It provides a broader context about alpha-synuclein deposition without directly referencing Lewy bodies as the gold supporting sentence does.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\n**Analysis**: While the context does not explicitly mention \"Lewy bodies,\" it establishes that alpha-synucleinopathies are defined by the abnormal deposition of alpha-synuclein in neurons and glial cells. Since Lewy bodies (a pathological hallmark of Parkinson's disease and related synucleinopathies) are composed primarily of aggregated alpha-synuclein, the sentence above provides the foundational evidence linking alpha-synuclein to the core component of Lewy bodies.", "retries": 1}
{"idx": 533, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant, does not directly state that beta-Trcp is the E3 ubiquitin ligase responsible for IFNAR1 ubiquitination and degradation. Instead, it discusses stabilization by Tyk2, which indirectly supports the role of beta-Trcp but lacks the direct clarity and conciseness of the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: β-Trcp (beta-Trcp)", "model_support": "Supporting sentence: Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination. \n\n**Analysis:**  \nThe context implies that β-Trcp is typically involved in IFNAR1 ubiquitination/degradation, as the stabilization by Tyk2 occurs independently of β-Trcp binding. This suggests that under normal conditions (without Tyk2 stabilization), β-Trcp serves as the E3 ubiquitin ligase mediating IFNAR1 ubiquitination and degradation.", "retries": 1}
{"idx": 534, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signalling.", "retries": 1}
{"idx": 535, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the regulatory domain's role in stabilizing p53, which indirectly supports its function as a tumor suppressor and 'guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n**Analysis**: The context explicitly discusses p53, a well-established tumor suppressor protein famously referred to as \"the guardian of the genome\" in biomedical literature due to its critical role in maintaining genomic stability. While the term \"guardian of the genome\" is not directly used in the provided text, the entire context revolves around p53's structural and functional mechanisms, which are central to its role as a tumor suppressor. The first sentence establishes p53 as the subject, directly supporting the answer.", "retries": 1}
{"idx": 536, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the supporting sentence is relevant and correctly states that hormone analysis was normal, it fails to address the key point in the gold answer regarding thyroid abnormalities (specifically, thyroid goiter). The model's answer dismisses hormone abnormalities entirely, which overlooks the presence of thyroid-related findings mentioned in the context.\", \"match\": false}", "gold_answer": "Thyroid", "gold_support": "Thyroid goiter was found in 46.5% of cases.", "model_answer": "Answer: There are no characteristic hormone abnormalities in Pendred syndrome; hormone analysis is normal.", "model_support": "Supporting sentence: Hormone analysis was normal and perchlorate test negative in all cases. \n\nThis sentence explicitly states that hormone analysis results were normal in all patients with Pendred syndrome in the study, directly supporting the conclusion that there are no characteristic hormone abnormalities associated with the condition.", "retries": 1}
{"idx": 537, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about L-dopa and its combination with a peripheral decarboxylase inhibitor (PDI), but it is somewhat verbose and includes unnecessary details like the effects on plasma levels of various compounds. The logic is sound, but the extra content slightly detracts from conciseness.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "In a cross-sectional study blood was obtained, 2 h after dosing, from 104 patients with idiopathic parkinsonism, divided into four groups: no L-dopa treatment (group 1), L-dopa alone (group 2), L-dopa + benserazide (Madopar) (group 3) and L-dopa + carbidopa (Sinemet) (group 4).", "model_answer": "Answer: Levodopa (L-dopa)", "model_support": "Supporting sentence: The effect of levodopa (L-dopa), alone or in combination with a peripheral decarboxylase inhibitor (PDI), on plasma levels of aromatic-L-amino acid decarboxylase (ALAAD, = dopa decarboxylase), L-dopa, 3-O-methyl-dopa (3-OMD)...  \n\n**Analysis**: The context explicitly states that L-dopa is studied both alone and in combination with a **peripheral decarboxylase inhibitor (PDI)**. Benserazide is a well-known PDI (as per external knowledge in pharmacology), and the text directly links PDIs to L-dopa therapy. While the term \"benserazide\" is not mentioned, the reference to PDI co-administered with L-dopa supports the answer.", "retries": 1}
{"idx": 538, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect. The supporting sentence focuses on the heterozygous state of the daughters rather than directly stating that mutations in the XK gene cause McLeod syndrome. While logical and related, it does not cover the gold answer as concisely or directly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: The patient's daughters had two populations of red cells, consistent with them being heterozygous for an XK0 allele.  \n\n**Analysis**: The context explicitly states that the patient's daughters are heterozygous for an **XK0 allele**, and the grandson (who will develop McLeod syndrome) also carries this allele. This directly links the **XK gene** mutation to McLeod syndrome. The XK gene encodes the Kx antigen, and mutations (e.g., XK0) cause the McLeod phenotype, including erythrocyte acanthocytosis and Kell antigen deficiency. The X-linked inheritance pattern and molecular evidence (XK0 allele) confirm the genetic basis.", "retries": 1}
{"idx": 539, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "serine 129", "gold_support": "Alpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies.", "model_answer": "Answer: Ser129", "model_support": "Supporting sentence: The G protein-coupled receptor kinase 2 (Gprk2) phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity.", "retries": 1}
{"idx": 540, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence provides relevant information about factor Xa inhibitors but is slightly verbose and less direct compared to the gold supporting sentence. It does not explicitly mention betrixaban's action on factor Xa, which makes it less concise than ideal, though the logic is still sound.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...", "retries": 1}
{"idx": 541, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively conveys p53's role in preserving genomic integrity, which aligns with its designation as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: When p53 function is impaired, its ability to preserve genomic integrity is compromised.  \n**Analysis**: The context directly links p53 to its role in preserving genomic integrity, which is the basis for its designation as \"the guardian of the genome.\" While the exact phrase \"guardian of the genome\" is not used in the text, the description of p53's function in maintaining genomic stability (e.g., preventing mutations and chromosomal abnormalities) aligns with this well-established characterization. The quoted sentence explicitly states p53's role in genomic integrity, supporting the answer.", "retries": 1}
{"idx": 542, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence is also incorrect, as the context explicitly mentions that APOBEC3B appeared predominantly nuclear. Both the answer and supporting sentence fail to acknowledge this information, making them irrelevant and logically unsupported.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The context does not specify whether APOBEC3B protein is predominantly cytoplasmic or nuclear.", "model_support": "Supporting sentence: The context does not contain any information about the cellular localization (cytoplasmic vs. nuclear) of APOBEC3B protein.", "retries": 1}
{"idx": 543, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but includes slight redundancy by elaborating on the number of selenocysteines and other details not necessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression.", "model_answer": "Answer: Selenoprotein P", "model_support": "Supporting sentence: The coding nucleotide sequence of its cDNA insert displayed high homology to rat and human selenoprotein P cDNA but contained 12 rather than 10 TGAs (12 rather than 10 selenocysteines in deduced amino acids)...", "retries": 1}
{"idx": 544, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and includes extra details about PRT4445, which is not necessary to answer the question. The logic connecting betrixaban to factor Xa inhibition is sound but could be more concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis:** The context explicitly identifies PRT4445 as a \"factor Xa decoy\" used in conjunction with betrixaban. Since reversal agents (like PRT4445) are designed to counteract the mechanism of specific anticoagulants, this directly implies that **betrixaban inhibits factor Xa**. The phrase \"universal reversal agent for all anticoagulants with anti-Xa activity\" further confirms that betrixaban belongs to the class of factor Xa inhibitors.", "retries": 1}
{"idx": 545, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the inability of BCR-ABL kinase inhibitors to fully eradicate leukemia stem cells, which logically supports the role of BCR-ABL as the target of Imatinib.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "CML is induced by the BCR-ABL oncogene, whose gene product is a BCR-ABL tyrosine kinase.", "model_answer": "Answer: BCR-ABL kinase", "model_support": "Supporting sentence: \"However, the inability of BCR-ABL kinase inhibitors to completely kill leukemia stem cells (LSCs) indicates that these kinase inhibitors are unlikely to cure CML.\"\n\n**Analysis**: The context explicitly states that BCR-ABL kinase inhibitors (e.g., Imatinib) are used in CML treatment, directly linking BCR-ABL as the target of these drugs. This aligns with the known mechanism of Imatinib in targeting the BCR-ABL fusion protein caused by the Philadelphia chromosome translocation in CML.", "retries": 1}
{"idx": 546, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence, though noting the lack of explicit mention of betrixaban in the context, correctly identifies the relevant part of the context that lists betrixaban among factor Xa inhibitors. It provides clear and logical reasoning by contrasting it with dabigatran, ensuring accuracy. The evaluation aligns perfectly with the gold answer and supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is no supporting sentence in the context to confirm that betrixaban inhibits **Factor Xa**. The answer cannot be validated based on the given text. \n\nIf the question were about **dabigatran**, the context states:  \n*\"Currently, data from a phase III clinical trial are available for dabigatran only, which show the direct thrombin antagonist to be at least noninferior in efficacy to VKA...\"*  \nThis would indicate dabigatran inhibits **thrombin (Factor IIa)**, not Factor Xa.  \n\nThe answer \"Factor Xa\" is **inaccurate** for the context provided.", "retries": 1}
{"idx": 547, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('women'), and while the supporting sentence is relevant, it focuses on characteristics of women with RA rather than directly stating prevalence. The provided sentence is somewhat indirect compared to the gold supporting sentence, which explicitly mentions the ratio of women to men. However, the logic connecting the model's supporting sentence to the answer is reasonable, though not as concise or direct as the gold standard.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "Supporting sentence: Colombian women with RA are more at risk of having an early age at onset and developing polyautoimmunity and abdominal obesity, and they perform more household duties than their male counterparts.  \n\n**Analysis:**  \nWhile the context does not explicitly state that RA is *more common* in women, it highlights that **women with RA** face higher risks for specific factors (e.g., early onset, polyautoimmunity). This implies a focus on gender-based differences in RA manifestations rather than prevalence. However, the question assumes a conclusion about prevalence (\"more common\"), which is not directly stated in the context. The provided answer aligns with general knowledge (RA is more prevalent in women globally), but the context does not explicitly confirm this in Latin American populations. The closest supporting sentence reflects the study's focus on women's increased vulnerability after diagnosis, not incidence rates.", "retries": 1}
{"idx": 548, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly links PBT2 to Alzheimer's disease using information from the context.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "Answer: Alzheimer's disease", "model_support": "Supporting sentence: Drug development based on the metals hypothesis of Alzheimer's disease.  \nThe context explicitly states that the discussion of PBT2 and related compounds is part of \"drug development based on the metals hypothesis of Alzheimer's disease,\" directly linking PBT2 to Alzheimer's disease as the target disorder.", "retries": 1}
{"idx": 549, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (FXI) does not match the gold standard (xa), but FXI is mentioned in the context as a target of investigational anticoagulants. The supporting sentence is relevant to the context and mentions FXI as a target, but it does not correctly support the gold answer (xa). This mismatch and the lack of direct alignment with betrixaban's actual target lead to a lower score.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Answer: FXI (Factor XI)", "model_support": "Supporting sentence: Currently tested ASOs and aptamers are inhibitors of FXI, FXII, thrombin, FIXa, and platelet GPIV.  \n\n**Analysis**:  \nThe context explicitly lists FXI as a clotting factor targeted by investigational anticoagulants (specifically ASOs and aptamers). While **betrixaban** is not directly named in the text, the question likely assumes that the answer aligns with the context’s discussion of FXI inhibition. However, based on external knowledge, **betrixaban is a FXa inhibitor**, not FXI. The provided context does not mention betrixaban, so the answer **FXI** appears to be an error or misalignment with the context. The correct supporting sentence from the context is the one listing FXI as a target, even though the drug name is not explicitly tied to it here.", "retries": 1}
{"idx": 550, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('memory loss') but is present in the context. The supporting sentence is relevant to the study's findings but does not cover the specific symptom of memory loss mentioned in the gold answer. It discusses consistency with other studies without addressing the explicit detail about memory problems.\", \"match\": false}", "gold_answer": "memory loss", "gold_support": "The strongest associations were for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8), night sweats (OR 9.9, 95% CI 6.5-15.2), general fatigue (OR 9.6, 95% CI 8.3-11.1) and sexual dysfunction (OR 4.6, 95%CI 3.2-6.6).", "model_answer": "The context provided does not mention any specific memory problems reported in \"Gulf War syndrome.\"", "model_support": "Supporting sentence: Nevertheless, the results are consistent with those of other studies of post-Gulf war illness and thus strengthen overall findings in this area of research.  \n**Analysis**: The context does not explicitly mention memory problems in Gulf War syndrome (GWS). The study focuses on general self-reported ill health and symptom reporting but does not specify individual symptoms like memory issues. The conclusion notes consistency with other studies but does not elaborate on specific symptoms.", "retries": 1}
{"idx": 551, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by identifying Factor Xa as the critical enzyme targeted by this class of inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "EXPERT OPINION: A large body of Phase II and Phase III data is now available for FXa inhibitors such as rivaroxaban, apixaban, edoxaban and betrixaban.", "model_answer": "Answer: Factor Xa (FXa)", "model_support": "Supporting sentence: Factor Xa (FXa) is a critical enzyme in the coagulation cascade responsible for thrombin generation, the final enzyme that leads to fibrin clot formation.  \n\n**Analysis**: The context explicitly identifies FXa as the target enzyme inhibited by drugs like rivaroxaban, apixaban, and edoxaban. While betrixaban is not named in the text, it is a known FXa inhibitor in clinical use. The introductory sentence establishes FXa as the key target for this class of anticoagulants, supporting the conclusion that betrixaban inhibits FXa.", "retries": 1}
{"idx": 552, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and provides accurate information about CMA components, but it does not explicitly mention the KFERQ motif, which is central to the question. Thus, while logical and correct, it lacks the directness of the gold supporting sentence.\", \"match\": true}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.", "model_answer": "Answer: Chaperone-mediated autophagy (CMA)", "model_support": "Supporting sentence: Lysosome-associated membrane protein type 2A (LAMP2A) and the heat-shock cognate protein 70 (Hsc70) constitute specific CMA components.  \n\n**Analysis**: While the context does not explicitly mention the \"KFERQ motif,\" the question assumes prior knowledge that **chaperone-mediated autophagy (CMA)** is the pathway specifically triggered by the KFERQ motif on cytosolic proteins. The context supports this by identifying **LAMP2A** and **Hsc70** as key components of CMA, which is inherently tied to the KFERQ motif mechanism in CMA. The sentence directly defines these components as part of the CMA pathway, aligning with the question's premise.", "retries": 1}
{"idx": 553, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence, although a title, accurately reflects the information in the gold supporting sentence by identifying betrixaban as one of the direct inhibitors of factor Xa.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban]. \n\n**Analysis**:  \nThe title explicitly states that betrixaban is one of the \"direct inhibitors of factor Xa,\" directly answering the question. This classification is further reinforced in the body of the text, which discusses these four drugs as a class of direct factor Xa inhibitors.", "retries": 1}
{"idx": 554, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'parallel heterodimers' while the gold standard clearly indicates 'antiparallel.' The supporting sentence discusses lateral association and dimer nucleation but does not provide any evidence to support the model's claim of parallel heterodimers. Instead, it misses the explicit information from the context that spectrin forms antiparallel heterodimers. The reasoning provided in the analysis is flawed because it incorrectly interprets 'lateral association' as indicative of parallel orientation without basis. This results in an irrelevant and incorrect answer and supporting sentence.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Answer: Parallel heterodimers.", "model_support": "Supporting sentence: Lateral association of the flexible rodlike monomers involves a multiple-step process that is initiated by a high affinity association near the actin-binding end of the molecule (dimer nucleation site). \n\n**Analysis**: The sentence describes the lateral association of spectrin monomers and identifies the dimer nucleation site near the actin-binding end. While the context does not explicitly state \"parallel\" or \"antiparallel,\" the term \"lateral association\" and the structural arrangement implied by the dimer nucleation site at the actin-binding end align with the formation of **parallel heterodimers** in this study. The absence of evidence for antiparallel orientation in the text supports the conclusion provided.", "retries": 1}
{"idx": 555, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It succinctly explains that the ROSIER scale is used as a stroke recognition tool, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: Emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 556, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is very close to the gold standard, as 'congenital hypothyroidism' directly relates to thyroid abnormalities. However, the gold answer is more concise ('thyroid'). The supporting sentence is relevant and covers the answer but includes slight additional details (e.g., mentioning the infant case), making it slightly verbose compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Congenital hypothyroidism is a common hormone abnormality in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 557, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, identifying LEKTI as the causative protein. The supporting sentence is relevant and provides logical support by linking LEKTI deficiency to the disease mechanism. However, it introduces slight redundancy by elaborating on the pituitary gland and GH processing, which is not directly necessary to explain the cause of Netherton syndrome.\",\n  \"match\": true\n}", "gold_answer": "LEKTI", "gold_support": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.", "model_answer": "Answer: LEKTI (Lysosomal and Endosomal Trafficking Inhibitor)", "model_support": "Supporting sentence: It is proposed that a lack of inhibition of proteases due to a deficiency of **LEKTI** in the pituitary gland leads to the overprocessing of human GH in NS. \n\n**Analysis**: The sentence explicitly links **LEKTI deficiency** to the pathogenesis of Netherton syndrome (NS), explaining how its absence disrupts protease inhibition and contributes to the disease mechanism. This directly identifies LEKTI (Lysosomal and Endosomal Trafficking Inhibitor) as the causative protein in NS.", "retries": 1}
{"idx": 558, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant to the context of the study, does not directly state that alpha-synuclein is the main component of Lewy bodies, which is critical for fully supporting the answer. The gold supporting sentence explicitly makes this connection, whereas the model's supporting sentence only implies it indirectly through the focus on DLB and Lewy bodies. Slight redundancy or missing explicitness lowers the score.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.  \n**Analysis**: While the context does not explicitly name alpha-synuclein as the main component of Lewy bodies, the entire study focuses on alpha-synuclein isoforms (112 and 140) in DLB, a condition defined by Lewy bodies. The differential expression of alpha-synuclein isoforms and their relevance to DLB pathogenesis strongly imply that alpha-synuclein is the primary component of Lewy bodies. This aligns with established scientific knowledge, as alpha-synuclein aggregation is a hallmark of Lewy bodies in DLB.", "retries": 1}
{"idx": 559, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Often referred to as the Guardian of the Genome, the list of known functions of p53 include regulatory roles in cell cycle arrest, apoptosis, angiogenesis, DNA repair and cell senescence.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The major tumour suppressor protein, p53, is one of the most well-studied proteins in cell biology. \n\n**Analysis:** While the context does not explicitly use the term \"guardian of the genome,\" it refers to p53 as \"the major tumour suppressor protein,\" which is widely recognized in scientific literature as the basis for its nickname \"the guardian of the genome.\" The first sentence establishes p53's role as a critical tumor suppressor, aligning with the established terminology.", "retries": 1}
{"idx": 560, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The context provided suggests that there are multiple TAp73 isoforms, with the gold answer specifying '7'. However, the model's answer 'Two' refers to the total number of p73 isoforms mentioned (TAp73 and DeltaNp73), which is incorrect for the specific question about TAp73 isoforms. The supporting sentence mentions both TAp73 and DeltaNp73 but does not provide evidence to support the specific count of TAp73 isoforms. Thus, while somewhat relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: The p73 gene is able to encode transcriptionally active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms. \n\n**Analysis**: The context explicitly states that the p73 gene encodes **TAp73** and **DeltaNp73** as distinct transcript isoforms. While the question specifically asks about TAp73 isoforms, the phrasing of the sentence (\"as well as a dominant-negatively acting DeltaNp73 transcript isoforms\") implies that **TAp73 and DeltaNp73 are two separate isoforms** of the p73 gene. The answer \"two\" may refer to the total p73 isoforms (TAp73 and DeltaNp73), though the question focuses on TAp73. The supporting sentence is critical for this conclusion.", "retries": 1}
{"idx": 561, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is technically correct within the context provided, as the specific E3 ubiquitin ligase (beta-TrCP) is not explicitly stated in the question or surrounding text. However, the supporting sentence fails to capture the key detail from the context that 'beta-TrCP' was identified as the relevant E3 ubiquitin ligase for IkB degradation. The supporting sentence acknowledges the absence of mention but overlooks the critical clue provided in the context about beta-TrCP.\",\n  \"match\": false\n}", "gold_answer": "beta-TrCP", "gold_support": "Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involved in IkappaB-alpha degradation.", "model_answer": "The E3 ubiquitin ligase that ubiquitinates IkB leading to its proteasomal degradation is not mentioned in the provided context.", "model_support": "The context does not mention the E3 ubiquitin ligase responsible for ubiquitinating IkB.  \n**Supporting sentence**: The context discusses the regulatory role of clusterin (CLU) and its domain (DeltaCLU) in the NF-kappaB pathway, including interactions with phospho-IkappaB-alpha, but does not reference any E3 ubiquitin ligase involved in IkB ubiquitination or degradation.", "retries": 1}
{"idx": 562, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying the 'SET domain' as the characteristic domain of histone methyltransferases. The supporting sentence provided by the model is incorrect in stating that the context does not mention the SET domain; however, the gold supporting sentence confirms that the SET domain is indeed mentioned in the context as the catalytic motif of histone methyltransferases. Despite this error in the model's supporting explanation, the answer itself is correct and aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity.", "model_answer": "Answer: Histone methyltransferases have a characteristic SET domain.", "model_support": "The context does not explicitly mention the **SET domain** as the characteristic domain of histone methyltransferases. While it is a well-established fact in general biology that histone methyltransferases (e.g., SUV39H1) contain a SET domain, the provided text does **not include any sentence** directly stating or implying this. \n\n**Conclusion**: The answer (\"SET domain\") is **not supported by the given context**.", "retries": 1}
{"idx": 563, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively highlights Bach1's repressive role by referencing its absence leading to resistance to HO-1 reduction.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "This study was undertaken to clarify the effects of HO-1 and its repressor Bach1 in osteoclastogenesis.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: Bach1(-/-) mouse bone marrow-derived macrophages were partially resistant to the RANKL-dependent HO-1 reduction and showed impaired osteoclastogenesis.  \n\n**Analysis**:  \nThe context indicates that **Bach1-deficient (Bach1(-/-)) cells exhibit reduced osteoclastogenesis** and are \"partially resistant to the RANKL-dependent HO-1 reduction.\" This implies that **Bach1 normally promotes the downregulation of HO-1** (a protective anti-inflammatory pathway), thereby allowing osteoclastogenesis to proceed. Since Bach1's absence leads to higher HO-1 levels and impaired osteoclast formation, Bach1 functions as a **repressor** of HO-1, indirectly facilitating osteoclastogenesis.", "retries": 1}
{"idx": 564, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in noting that the context does not explicitly state which clotting factor betrixaban inhibits. However, the supporting sentence fails to extract relevant implicit information from the context, which groups betrixaban with other drugs like rivaroxaban and apixaban, implying they share a similar mechanism (factor Xa inhibition). Thus, while the supporting sentence is relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "The provided context does not specify which clotting factor is inhibited by betrixaban.", "model_support": "The context does not mention betrixaban or its mechanism of action.  \n**Supporting sentence:** The provided context does not specify which clotting factor is inhibited by betrixaban.", "retries": 1}
{"idx": 565, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a slightly different but equally valid explanation from the gold supporting sentence, focusing on the functional role of Nestin in stem cell criteria rather than just its coexpression.\",\n  \"match\": true\n}", "gold_answer": "Nestin", "gold_support": "A small subset of Prominin-1(+) cells coexpressed the nonspecific precursor cell marker Nestin as well as GFAP and Sox2.", "model_answer": "Answer: Nestin", "model_support": "Supporting sentence: \"Upon fluorescence-activated cell sorting, only Prominin-1/Nestin double-positive cells fulfilled the defining stem cell criteria of proliferation, self-renewal, and multipotentiality as assessed by a neurosphere assay.\" \n\n**Analysis**: Nestin is an intermediate filament (IF) protein commonly used as a marker for neuronal precursor cells, including in the subventricular zone. The context explicitly links Nestin with Prominin-1 in identifying neural stem cells, confirming its role as a non-specific marker for these precursor cells.", "retries": 1}
{"idx": 566, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Iron deficiency' matches the gold standard 'iron' in essence, though it is slightly more verbose. The supporting sentence provided by the model is relevant and supports the connection between iron depletion and RLS severity, but it includes additional details that are not necessary for directly supporting the answer. The gold supporting sentence is more concise and directly mentions both iron depletion and RLS together, making it slightly superior in terms of brevity and clarity.\", \"match\": true}", "gold_answer": "iron", "gold_support": "High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.", "model_answer": "Answer: Iron deficiency", "model_support": "Supporting sentence: RLS severity scores were significantly lower in the IV iron group. \n\nThe context implies that iron depletion contributes to RLS symptoms, as the study investigates whether addressing iron depletion (via IV iron) reduces RLS severity. The results show that IV iron treatment (which more effectively replenishes iron stores) leads to lower RLS severity, supporting the link between iron deficiency and RLS.", "retries": 1}
{"idx": 567, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing Knudson's two-hit hypothesis, which is associated with autosomal dominant inheritance.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Li-Fraumeni syndrome (LFS) is a highly penetrant, autosomal dominant, human familial cancer predisposition.", "model_answer": "Answer: Autosomal dominant", "model_support": "Supporting sentence: This report of LOH indicates that Knudson's two-hit hypothesis, a hallmark of human autosomal dominant cancer syndromes, can be modeled in zebrafish.", "retries": 1}
{"idx": 568, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Thrombin') does not match the gold standard ('xa'), but it is present in the context as part of the broader category of anticoagulants. The supporting sentence mentions thrombin inhibitors and Factor X inhibitors as clinically advanced but does not specifically address betrixaban or clearly link it to Factor Xa, making the support relevant but incomplete.\", \"match\": false}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Answer: Thrombin", "model_support": "Supporting sentence: Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced. \n\n**Analysis:**  \nThe context categorizes betrixaban (a direct thrombin inhibitor) as part of the group of anticoagulants that inhibit **thrombin**, even though it is not explicitly named. The sentence directly supports the answer by identifying thrombin as the target of this class of drugs.", "retries": 1}
{"idx": 569, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"  \n\nThis sentence explicitly states that the ROSIER scale is used for **stroke** recognition in the prehospital setting.", "retries": 1}
{"idx": 570, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Expression of the X inactive-specific transcript (Xist) is thought to be essential for the initiation of X chromosome inactivation and dosage compensation during female embryo development.", "model_answer": "Answer: Xist transcript", "model_support": "Supporting sentence: These results suggest that Xist expression precedes the onset of late replication in the bovine embryo, in a pattern compatible with a possible role of bovine Xist in the initiation of X chromosome inactivation.", "retries": 1}
{"idx": 571, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy. The model's supporting sentence introduces evolutionary studies, which is not directly necessary for explaining XIST's role in X chromosome inactivation, whereas the gold supporting sentence is more concise and directly tied to the function of XIST.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "The human XIST gene, a candidate for a role in X chromosome inactivation, has recently been cloned and sequenced, yielding a 17 kb cDNA with no apparent significant, conserved open reading frame.", "model_answer": "Answer: XIST", "model_support": "Supporting sentence: In the absence of a conserved open reading frame, we have turned to evolutionary studies as a first step toward elucidating a function for XIST in the process of X inactivation.", "retries": 1}
{"idx": 572, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the reasoning by highlighting the inverse relationship between Bach1 and HO-1 expression levels, which aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied. \n\n**Analysis:**  \nThe observation that HO-1 expression is elevated in Bach1-deficient mice (Bach1(-/-)) compared to wild-type mice (Bach1(+/+)) directly indicates that Bach1 functions as a repressor of HO-1. In the absence of Bach1, HO-1 expression is upregulated, suggesting Bach1 normally suppresses HO-1 transcription. This inverse relationship between Bach1 and HO-1 levels confirms its role as a repressor.", "retries": 1}
{"idx": 573, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a direct explanation of SAM as the methyl donor cofactor in the context of histone methyltransferases.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor, we have carried out structure-guided design, synthesis, and characterization of orthogonal vSET methyltransferase mutant/SAM analogue pairs using a 'bump-and-hole' strategy.", "model_answer": "Answer: S-adenosyl-l-methionine (SAM)", "model_support": "Supporting sentence: To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor...  \n\nThis sentence explicitly identifies **S-adenosyl-l-methionine (SAM)** as the methyl donor cofactor used for the viral histone methyltransferase (vSET), confirming its role as the methyl donor for histone methyltransferases.", "retries": 1}
{"idx": 574, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, explicitly mentioning H3K4 as the residue methylated by MLL1. Minor additional context in the supporting sentence does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: Thus, we identified a molecular mechanism by which the recruitment of a **H3K4 histone methyltransferase** complex on the promoter of a NF-kappaB-dependent gene induces its expression... \n\nThe sentence explicitly states that the histone methyltransferase complex involved is specific to **H3K4**, directly answering the question about the residue methylated by MLL1 (which is part of this complex).", "retries": 1}
{"idx": 575, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer correctly identifies 'Factor Xa' as the clotting factor inhibited by betrixaban, matching the gold standard. The supporting sentence from the gold context explicitly lists betrixaban among the orally active direct factor Xa inhibitors, providing clear and concise support for the answer. Although the model's supporting sentence mentions that the context does not directly reference betrixaban, this does not detract from the correctness of the answer or the logical connection to the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is no sentence in the context that supports the answer \"Factor Xa\" for the question about betrixaban. The answer appears to rely on external knowledge not included in the given text. \n\n**Key observation**: The context discusses **dabigatran** (a direct thrombin inhibitor) and **rivaroxaban** (a Factor Xa inhibitor) as examples of new anticoagulants but does not reference betrixaban.", "retries": 1}
{"idx": 576, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about TCR being linked to transcriptional activity, which indirectly supports that TCR targets the transcribed strand. However, it is slightly verbose and less direct compared to the gold supporting sentence, which explicitly states that TCR is targeted to the transcribed strand.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: Our findings support the general view that the genomic domains within which transcription is active are more accessible than the bulk of the genome to the recognition and repair of lesions through the global pathway and that TCR is superimposed upon that pathway of NER. \n\n**Analysis**:  \nThe context explicitly states that TCR (transcription-coupled repair) operates within \"genomic domains where transcription is active,\" which are inherently associated with the **transcribed strand** of genes. This aligns with the established understanding that TCR specifically targets the transcribed DNA strand during RNA polymerase II (RNAPII) transcription. The quoted sentence confirms that TCR is functionally linked to transcriptional activity, reinforcing that it acts on the transcribed strand.", "retries": 1}
{"idx": 577, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer ('Autosomal recessive') does not match the gold standard for Wilson's disease, which is also 'autosomal recessive' but the context provided does not discuss Wilson's disease at all. The supporting sentence refers to Hallervorden-Spatz disease, which is irrelevant to Wilson's disease. Therefore, both the answer and supporting sentence are incorrect and do not logically support the gold answer.\", \"match\": false}", "gold_answer": "autosomal recessive", "gold_support": "Inheritance seems most likely to be autosomal recessive.", "model_answer": "Answer: Autosomal recessive", "model_support": "Supporting sentence: When familial, it is inherited recessively and has been linked to chromosome 20.  \n\n**Analysis**: The context explicitly states that Hallervorden-Spatz disease (HSD) is inherited recessively when familial. However, the question asks about **Wilson's disease**, which is **not discussed in the context** in terms of its mode of inheritance. The provided answer (\"autosomal recessive\") is incorrect for Wilson's disease (which is typically autosomal dominant), and the supporting sentence refers to HSD, not Wilson's disease. The context does **not** provide any information about the inheritance of Wilson's disease.", "retries": 1}
{"idx": 578, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence does not explicitly mention 'guardian of the genome,' it logically supports the focus on p53 as the correct answer.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Analysis**: While the context does not explicitly use the term \"guardian of the genome,\" it directly references **p53** as the subject of the study. The nickname \"guardian of the genome\" is a well-established term in biomedical literature for p53, and the sentence above confirms the focus on p53, supporting the answer.", "retries": 1}
{"idx": 579, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'EGFR' matches the gold standard 'epidermal growth factor receptor (EGFR) gene' in meaning, though it is less detailed. The supporting sentence is relevant and provides logical support by referencing the correlation between EGFR mutations and sensitivity to gefitinib and erlotinib. However, it is slightly verbose and includes additional details (e.g., statistics) that are not strictly necessary to justify the answer. Overall, the logic is strong, but the extra content reduces conciseness.\", \"match\": true}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor.", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: \"We found from sequencing the EGFR TK domain that 7 of 10 gefitinib-sensitive tumors had similar types of alterations; no mutations were found in eight gefitinib-refractory tumors (P = 0.004). Five of seven tumors sensitive to erlotinib [...] had analogous somatic mutations, as opposed to none of 10 erlotinib-refractory tumors (P = 0.003).\"\n\n**Analysis**: The text explicitly states that mutations in the **EGFR** tyrosine kinase (TK) domain correlate with sensitivity to both **gefitinib** and **erlotinib**. Gefitinib-sensitive tumors had EGFR mutations (7/10), while refractory tumors lacked them (0/8). Similarly, erlotinib-sensitive tumors showed EGFR mutations (5/7), whereas refractory tumors did not (0/10). This directly links **EGFR mutations** to response to both drugs.", "retries": 1}
{"idx": 580, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence refers to the inheritance of Long QT syndrome (LQTS) in general, which includes both autosomal dominant and recessive patterns, rather than directly stating that Jervell and Lange-Nielsen syndrome (JLNS) is autosomal recessive. While the model's supporting sentence is relevant and provides some context for ion channel mutations, it does not explicitly confirm the recessive nature of JLNS as clearly as the gold supporting sentence. Thus, there is slight redundancy and less precision compared to the ideal support.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait.", "model_answer": "Answer: Autosomal recessive", "model_support": "Supporting sentence: \"Long QT syndrome (LQTS) is a separate disorder of either autosomal dominant or recessive inheritance caused by mutations in four different ion channel genes; KCNQ1 is the one most frequently involved.\"  \n\n**Analysis**: While the context does not explicitly state the inheritance mode of Jervell and Lange-Nielsen syndrome (JLNS), it clarifies that **frameshift/stop mutations cause JLNS**, which are typically loss-of-function mutations requiring biallelic (recessive) disruption. The sentence about LQTS’s inheritance (autosomal dominant or recessive) is mentioned separately, but the key implication for JLNS lies in the distinction between mutation types. The context states:  \n*\"In general, frameshift/stop mutations cause JLNS, and missense/splice site mutations cause LQTS...\"*  \nThis directly supports the conclusion that JLNS follows an **autosomal recessive** pattern, as frameshift/stop mutations are loss-of-function and require biallelic inactivation.", "retries": 1}
{"idx": 581, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is missing because the model claims no explicit sentence supports the answer. In fact, the context does include a relevant sentence that directly mentions Clostridium botulinum as the cause of botulism. Despite this oversight, the answer is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease is caused by exposure to toxins produced by Clostridium botulinum and other botulinum toxin-producing clostridia.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly name the bacterium responsible for botulism (e.g., *Clostridium botulinum*). While the question's answer is factually correct based on general knowledge, **no sentence in the provided context directly supports this answer**. The context discusses botulism's clinical management and implications but does not mention the causative organism. \n\n**Answer:** Clostridium botulinum  \n**Supporting sentence:** None (the context does not explicitly state the bacterium).", "retries": 1}
{"idx": 582, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('PP1'). The supporting sentence is relevant and covers the answer by indicating that Hsp20 targets the PP1-PLN axis, but it is slightly less specific compared to the gold supporting sentence. It does not explicitly mention the reduction in PP1 activity or its regulation of PLN signaling, which are key details in the gold supporting sentence. Thus, the supporting sentence has minor redundancy and lacks some precision.\", \"match\": true}", "gold_answer": "PP1", "gold_support": "Interestingly, the activity of type 1 protein phosphatase (PP1), a known regulator of PLN signaling, was significantly reduced by Hsp20 overexpression, suggesting that the Hsp20 stimulatory effects are partially mediated through the PP1-PLN axis.", "model_answer": "Answer: Protein phosphatase-1 (PP1)", "model_support": "Supporting sentence: CONCLUSIONS: Hsp20 is a novel regulator of sarcoplasmic reticulum Ca cycling by targeting the PP1-PLN axis.", "retries": 1}
{"idx": 583, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and contains accurate information, but it includes additional details about the conditions being treated, which makes it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 584, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes 'transient ischaemic attack (TIA)' which, although related, is not explicitly the focus of the ROSIER scale in the context provided. The supporting sentence is somewhat lengthy and mixes relevant information with less pertinent details about the study's objective rather than directly focusing on the use of the ROSIER scale for stroke diagnosis as mentioned in the gold supporting sentence. Logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: **OBJECTIVE: To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.** \n\nThe study explicitly focuses on evaluating diagnostic tools (like the ROSIER scale) for identifying **stroke and transient ischaemic attack (TIA)**, as stated in its objective. The results and conclusions further confirm that both ROSIER and FAST are used to assess patients with suspected acute stroke/TIA.", "retries": 1}
{"idx": 585, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard (l-DOPA), but the supporting sentence does not align with the gold supporting sentence. The context explicitly mentions that benserazide is co-administered with l-DOPA in experiment 1 ('l-DOPA (12 mg/kg+15 mg/kg benserazide, ip)'). The model incorrectly focuses on buspirone as the co-administered drug, which is inaccurate for this question. While the answer is correct, the supporting sentence fails to cover the gold answer and instead introduces irrelevant information about buspirone.\", \"match\": true}", "gold_answer": "l-DOPA", "gold_support": "In experiment 1, l-DOPA-primed rats were pre-treated with Vehicle (0.9% NaCl), various doses of the partial 5-HT(1A) agonist, buspirone (0.25, 1.0 or 2.5 mg/kg, ip) or buspirone (2.5 mg/kg, ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip).", "model_answer": "Answer: l-DOPA", "model_support": "The context does not mention **benserazide** at all. It discusses **buspirone** as the drug co-administered with **l-DOPA** in experiments. The correct supporting sentence from the context is:  \n**\"In experiment 2, l-DOPA-naïve rats received co-administration of l-DOPA+buspirone (1.0 or 2.5 mg/kg, ip) for 2 weeks.\"**  \n\nHowever, the question incorrectly references **benserazide** (a drug not mentioned in the context) instead of **buspirone**. Based on the provided context, the answer **l-DOPA** is **incorrect**, as the context does not support the co-administration of l-DOPA with benserazide. The actual co-administered drug in the study is **buspirone**.", "retries": 1}
{"idx": 586, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('BCR-ABL'), though it includes 'tyrosine kinase,' which is technically correct but not part of the gold answer. The supporting sentence provides relevant context about the translocation causing CML; however, it does not explicitly mention the BCR-ABL fusion gene or its role in pathogenesis, making it slightly less direct than the gold supporting sentence. Overall, the logic is sound but contains minor redundancy.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myelogenous leukemia (CML) is a clonal hematopoietic disorder caused by the reciprocal translocation between chromosome 9 and 22. \n\n**Analysis**: The reciprocal translocation between chromosomes 9 and 22 in CML creates the **BCR-ABL fusion gene**, which encodes the constitutively active **BCR-ABL tyrosine kinase**. Imatinib (Gleevec) is a tyrosine kinase inhibitor specifically targeting this aberrant kinase, which drives the pathogenesis of Philadelphia chromosome-positive CML. While the context does not explicitly name BCR-ABL, the described genetic mechanism (chromosome 9/22 translocation) directly supports the inference that BCR-ABL is the target of imatinib.", "retries": 1}
{"idx": 587, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect because it states that no sentence in the context supports the answer, whereas the gold supporting sentence directly provides clear and relevant evidence from the context. Despite this, the model's answer itself is accurate.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, a dipeptidyl boronic acid and potent inhibitor of the 26S proteasome, is remarkably effective against multiple myeloma (MM) but not against solid tumors.", "model_answer": "Velcade (bortezomib) is mainly used for multiple myeloma.", "model_support": "The context does not explicitly mention Velcade (bortezomib) or its use for multiple myeloma. While the text discusses proteasome inhibitors and challenges in their application for solid tumors, it does not provide a direct statement about Velcade or its clinical use. Therefore, **no sentence in the provided context supports the answer**. \n\nHowever, based on external knowledge (not derived from the context), Velcade is indeed used for multiple myeloma. The example in the initial prompt required a direct quote from the context, which is absent here.", "retries": 1}
{"idx": 588, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about factor Xa inhibitors but does not explicitly mention betrixaban. The supporting sentence is slightly less precise than the gold supporting sentence, which directly lists betrixaban as an example of a factor Xa inhibitor. However, it still provides logical support for the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Analysis:**  \nThe context categorizes newer anticoagulants into **factor Xa inhibitors** and **thrombin (factor IIa) inhibitors**. While betrixaban is not explicitly named in the provided text, the question links it to **Factor Xa inhibition**, which is a class of drugs discussed in the context. The supporting sentence confirms that factor Xa inhibitors are a distinct group of anticoagulants, aligning with the answer.", "retries": 1}
{"idx": 589, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'One' does not match the gold standard of '7'. However, the supporting sentence is relevant as it mentions the existence of TAp73 isoforms, though it does not specify the number. The model fails to capture the correct count from the context, which leads to a lower score.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively. \n\n**Analysis**: The sentence explicitly states that the P1 promoter regulates \"TAp73 isoforms\" (plural) and the P2 promoter regulates \"ΔNp73 isoforms\" (also plural). However, the question asks for the number of **TAp73** isoforms. While the sentence uses the plural form (\"isoforms\"), the context implies that **TAp73** refers to a single isoform (as it is contrasted with ΔNp73, another distinct isoform). The answer \"one\" aligns with the standard biological understanding that TAp73 represents a single isoform generated by the P1 promoter, while ΔNp73 is another isoform from the P2 promoter. The sentence supports this by separating the two isoforms as distinct products of their respective promoters.", "retries": 1}
{"idx": 590, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and does not explicitly state that JNK phosphorylates c-jun. The logic is sound, as the context makes it clear that JNK is the kinase in question, but the supporting sentence could be more direct.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "OBJECTIVE: To investigate the effects of antidepressant citalopram on the gene expressions of tumor necrosis factor-alpha (TNF-α) and interleukin 1 beta (IL-1β), and to discuss the impacts of citalopram on p38 and c-jun N-terminal kinase (JNK) of mitogen-activated protein kinase (MAPK) family in microglial cells.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: The effects of citalopram on the phosphorylation of p38MAPK and JNK were observed after pretreatment for 30 min. \n\n**Analysis**: The context explicitly references **JNK** (c-Jun N-terminal kinase) as part of the MAPK pathway. While the text does not directly state \"JNK phosphorylates c-jun,\" the acronym **JNK** inherently refers to the kinase that phosphorylates **c-jun** (as its full name implies). The study’s focus on JNK phosphorylation aligns with established biological knowledge that JNK is the primary MAP kinase responsible for phosphorylating the transcription factor c-jun.", "retries": 1}
{"idx": 591, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'), and the supporting sentence is relevant and accurate in identifying betrixaban as a factor Xa inhibitor by association with other drugs in the same class. However, the supporting sentence focuses on rivaroxaban and apixaban rather than directly referencing betrixaban, which introduces slight redundancy and indirectness. A more concise supporting sentence referencing betrixaban explicitly would have warranted a perfect score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Another factor Xa inhibitor, edoxaban, is under evaluation in an ongoing phase III clinical trial and others such as AZD0837, betrixaban and darexaban are still in safety and tolerability phase II studies.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"factor Xa inhibitors rivaroxaban and apixaban have proven, in large, multicenter, randomized, phase III, clinical studies, to be at least as efficient as warfarin in stroke prevention in patients with AF.\"  \n\n**Analysis**: While the context does not explicitly name *betrixaban*, it categorizes *rivaroxaban* and *apixaban* as **factor Xa inhibitors**, implying that other drugs in this class (including betrixaban) inhibit the same clotting factor. The question relies on recognizing that betrixaban is a known factor Xa inhibitor in clinical use, even if not directly mentioned in the provided text.", "retries": 1}
{"idx": 592, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe),' is correct and aligns with the gold standard 'SAM' since SAMe is the full name of SAM. However, the supporting sentence is somewhat verbose and focuses more on the experimental findings rather than directly stating SAMe's role as the methyl donor for histone methyltransferases. While it provides relevant context, it could be more concise and specific to the gold supporting sentence. The logic connecting SAMe to its role as a methyl donor is strong but slightly indirect.\",\n  \"match\": true\n}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"S-adenosylmethionine (SAMe) and its metabolite methylthioadenosine (MTA) blocked lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNFalpha) expression in RAW (murine macrophage cell line) and Kupffer cells at the transcriptional level...\" \n\nWhile the context does not explicitly name SAMe as the methyl donor for histone methyltransferases, the study's focus on SAMe's modulation of histone methylation (e.g., \"the mechanism... is mainly mediated by MTA and SAH at the level of histone methylation\") and the well-established role of SAMe as the universal methyl donor in biological systems (a foundational biochemical fact) directly support this conclusion. The context implicitly confirms SAMe's role as the methyl donor by linking it to histone methylation regulation.", "retries": 1}
{"idx": 593, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions gevokizumab's modulation of IL-1β signaling, which aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\" \n\n**Analysis**:  \nThe sentence explicitly states that **gevokizumab targets IL-1β signaling**, directly implicating **Interleukin-1β (IL-1β)** as the molecule modulated by the drug. Further evidence is provided in the context where it is described that gevokizumab affects **IL-1β binding to its receptor (IL-1RI)** and reduces its activity, reinforcing that IL-1β is the primary molecular target.", "retries": 1}
{"idx": 594, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "In archaeological studies, the isotopic enrichment values of carbon and nitrogen in bone collagen give a degree of information on dietary composition.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: The isotopic enrichments of individual amino acids from bone collagen and dietary protein have the potential to provide more precise information about the components of diet.", "retries": 1}
{"idx": 595, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly states that dephosphorylated PLN inhibits SERCA2a, which aligns perfectly with the gold supporting sentence and provides a strong rationale for PLN being the regulatory molecule.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: Dephosphorylated PLN inhibits SERCA2a. \n\n**Analysis:**  \nThe sentence explicitly states that phospholamban (PLN) directly inhibits the activity of SERCA2a when in its dephosphorylated state. This establishes PLN as the primary regulatory molecule for SERCA2a function in cardiac muscle. Further context reinforces this by explaining how phosphorylation of PLN (at Ser16 or Thr17) relieves this inhibition, confirming PLN's central role in modulating SERCA2a activity.", "retries": 1}
{"idx": 596, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly explains that Mepolizumab is an anti-IL-5 monoclonal antibody, which logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.", "retries": 1}
{"idx": 597, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence refers to 'continuous-infusion flumazenil in the management of chlordiazepoxide toxicity,' which is specific but slightly narrow compared to the broader context of benzodiazepine overdose provided in the gold supporting sentence.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.  \n\n**Analysis**: The context explicitly states that flumazenil is used as a treatment (antidote) for chlordiazepoxide toxicity, a type of benzodiazepine overdose. The first sentence directly links flumazenil to this role, establishing it as the antidote.", "retries": 1}
{"idx": 598, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('S-adenosylmethionine' vs. 'adenosylmethionine'), with only a minor difference in phrasing that does not affect correctness. The supporting sentence provided by the model is relevant and covers the gold answer, referencing S-adenosylmethionine as the methyl donor. However, it introduces unnecessary details about methionine and cytochrome c-557, which are not directly related to histone methyltransferases. This makes the explanation slightly verbose but still logically supports the correct answer.\", \"match\": true}", "gold_answer": "adenosylmethionine", "gold_support": "The purified cytochrome can act as a methyl acceptor for a methyltransferase activity in the cell extract that uses S-adenosylmethionine as methyl donor.", "model_answer": "Answer: S-adenosylmethionine (AdoMet)", "model_support": "The context does not explicitly mention the methyl donor for histone methyltransferases. Instead, it discusses the methylation of cytochrome c-557 by the **methyl group of methionine**. However, the user's answer refers to **S-adenosylmethionine (AdoMet)**, which is the standard methyl donor for most histone methyltransferases in general biochemical knowledge. Since the context does not address histone methyltransferases or AdoMet, the answer provided is **not supported by the given text**. The correct methyl donor for the cytochrome c methyltransferase described in the context is **methionine**, as stated in the first sentence:  \n*\"The mitochondrial cytochrome c-557 of Crithidia oncopelti contains two lysine residues and an N-terminal proline residue that are methylated in vivo by the methyl group of methionine.\"*  \n\n**Note:** The user’s answer (AdoMet) is accurate for histone methyltransferases in general but is not supported by the specific context provided here.", "retries": 1}
{"idx": 599, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly ties the SET domain to histone methyltransferase activity by referencing how mutations disrupt this function, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: Analysis of mutant PRC2 complexes in vitro, and H3-K27 methylation in vivo, shows that each SET domain mutation disrupts PRC2 histone methyltransferase.  \n\n**Analysis**: The sentence explicitly connects the **SET domain** to the histone methyltransferase activity of PRC2, demonstrating that mutations in this domain directly impair the enzyme's function. This establishes the SET domain as the critical structural and functional unit for histone methyltransferase activity in this context.", "retries": 1}
{"idx": 600, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that orteronel's inhibitory activity was evaluated in relation to CYP17A1 enzymatic activity, aligning well with the gold supporting sentence. Minor additional details do not detract from the clarity or correctness of the reasoning.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on **CYP17A1 enzymatic activity**, steroid production in monkey adrenal cells and human adrenal tumor cells, and serum levels of dehydroepiandrosterone (DHEA), cortisol, and testosterone after oral dosing in castrated and intact male cynomolgus monkeys.\" \n\n**Analysis**: The context explicitly states that orteronel's inhibitory activity is evaluated in relation to **CYP17A1 enzymatic activity**, confirming that this enzyme is the target of the drug. Additionally, the text notes that orteronel inhibits 17,20-lyase and 17-hydroxylase activities, which are catalytic functions of CYP17A1.", "retries": 1}
{"idx": 601, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Medicarpin' matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that medicarpin is the product of the biosynthesis pathway involving isoflavone reductase (IFR), aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in **medicarpin biosynthesis**, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence explicitly identifies **medicarpin** as the phytoalexin synthesized by the pathway involving IFR, confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 602, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides the necessary information to support the answer by specifying the availability of LepChorionDB. Although it does not include all the details from the gold supporting sentence, it still logically supports the answer without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 603, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Bcr-Abl tyrosine kinase' is very close to the gold standard 'BCR-ABL', with only a minor difference in formatting and inclusion of 'tyrosine kinase', which does not detract from the correctness. The supporting sentence mentions 'Bcr-Abl tyrosine kinase inhibitors' and connects it to overcoming drug resistance, which supports the answer but is slightly less direct than the gold supporting sentence, as it doesn't explicitly mention the Philadelphia chromosome or the chimeric gene. Overall, the logic is sound, but the supporting sentence could be more concise and specific.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: \"Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance...\" \n\nThis sentence explicitly identifies **Bcr-Abl tyrosine kinase** as the target of imatinib (Gleevec) in the context of Philadelphia chromosome-positive chronic myelogenous leukemia (CML).", "retries": 1}
{"idx": 604, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The transcription factor Bach1 heterodimerizes with small Maf proteins to repress MARE-dependent gene expression.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: The transcription factor Bach1 heterodimerizes with small Maf proteins to repress Maf recognition element (MARE)-dependent gene expression. \n\n**Analysis**: This sentence explicitly states that Bach1 functions as a **repressor** by forming heterodimers with small Maf proteins to inhibit MARE-dependent gene expression. Further evidence in the context (e.g., increased MARE binding activity of Bach1 under succinylacetone treatment and reduced binding with hemin) aligns with its role as a repressor of the beta-globin gene via the LCR MARE.", "retries": 1}
{"idx": 605, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and lacks direct mention of Lewy bodies. It provides a broader context about alpha-synuclein deposition without explicitly linking it to Lewy bodies as the gold supporting sentence does.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\n**Analysis**: While the context does not explicitly mention \"Lewy bodies,\" it defines alpha-synucleinopathies as disorders characterized by the abnormal deposition of **alpha-synuclein** in neurons and glial cells. Since Lewy bodies are a pathological hallmark of alpha-synucleinopathies (e.g., Parkinson’s disease), the sentence directly supports the conclusion that alpha-synuclein is their main component.", "retries": 1}
{"idx": 606, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that [18F]altanserin PET quantifies 5-HT2AR availability. Minor differences in wording (e.g., '5-HT2AR' vs. '5-HT2A') are acceptable as they refer to the same receptor.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.\"  \n(From the **CONCLUSION** section of the context.)", "retries": 1}
{"idx": 607, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Transvaginal ultrasound,' is more specific than the gold answer, 'ultrasound,' but it is still correct and aligns with the context. The supporting sentence is relevant and provides logical support for the answer, though it includes slight redundancy by emphasizing sensitivity and screening, which is not directly necessary for the answer. Overall, the logic is clear and accurate.\",\n  \"match\": true\n}", "gold_answer": "ultrasound", "gold_support": "OBJECTIVE: To determine whether transvaginal ultrasound measurement of bladder wall thickness can be used as a screening test for detrusor instability in women with urinary symptoms.", "model_answer": "Answer: Transvaginal ultrasound", "model_support": "Supporting sentence: The measurement of a mean bladder wall thickness greater than 5 mm with transvaginal ultrasound is a sensitive screening method for diagnosing detrusor instability in symptomatic women without outflow obstruction.", "retries": 1}
{"idx": 608, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about antiparallel spectrin dimers, but it contains slight redundancy by mentioning specific repeats (HEalpha1,2 and HEalpha2,3) that are not directly related to the gold supporting sentence. Despite this, the logic connecting the answer to the supporting sentence is strong.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Two of the less stably folded fragments, human erythroid alpha-spectrin repeats 13 and 14 (HEalpha13,14) and human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel spectrin dimers.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: More stably folded fragments, human erythroid alpha-spectrin repeats 1 and 2 (HEalpha1,2) and human erythroid alpha-spectrin repeats 2 and 3 (HEalpha2,3), lie nearly opposite each other on antiparallel spectrin dimers of a tetramer.", "retries": 1}
{"idx": 609, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'ZEB2' is correct in the context but does not match the gold standard 'SIP-1', which is an alternative name for the same gene. The supporting sentence provided by the model is relevant but overly verbose, including unnecessary details about the clinical features and experimental findings, while failing to directly mention that ZEB2 is also known as SIP-1. This makes the logic less concise and fails to fully support the gold answer.\", \"match\": false}", "gold_answer": "SIP-1", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: Mowat-Wilson syndrome is a genetic condition characterized by a recognizable facial phenotype... and variable multiple congenital anomalies. The anomalies may include Hirschsprung disease, heart defects, structural eye anomalies including microphthalmia, agenesis of the corpus callosum, and urogenital anomalies. Microcephaly, seizure disorder and constipation are common. Approximately 80% of patients have a nonsense or frameshift mutation detectable by sequencing, with the rest having gross deletions necessitating a dosage sensitive assay. Here we report on the results of comprehensive molecular testing for 27 patients testing positive for MWS. **Twenty-one patients had a nonsense, frameshift, or splice site mutation identified by sequencing; 14 of which localized to exon 8 and 17 of which are novel. Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.** \n\n(Note: The critical phrase is \"Six patients had deletions in the ZEB2 gene,\" explicitly naming ZEB2 as the gene associated with Mowat-Wilson syndrome.)", "retries": 1}
{"idx": 610, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about collagen extraction, but it is slightly verbose and includes procedural details that are not essential to directly support the answer. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "Collagen is the most suitable fraction and is the material normally used in radiocarbon dating.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: The most widespread method for collagen extraction is based on the Longin procedure, which consists in HCl demineralization to dissolve the inorganic phase of the samples, followed by dissolution of collagen in a weak acid solution. \n\n**Analysis**: The context explicitly states that collagen is the target protein extracted from bones for radiocarbon (14C) dating. The Longin procedure, described as the standard method, focuses on isolating collagen, confirming its role in archaeological dating and analysis.", "retries": 1}
{"idx": 611, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Thyroid hormone abnormalities' is very close to the gold standard 'thyroid', though it is slightly more verbose. The supporting sentence is relevant and mentions the measurement of thyroid hormone levels, which supports the answer, but it includes additional details about USG and scyntography that are not necessary to justify the answer. Therefore, there is slight redundancy in the supporting sentence.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted. \n\n**Analysis:** The context explicitly mentions the assessment of thyroid hormone levels in patients with Pendred syndrome, which is directly linked to the characteristic endocrine abnormalities associated with the condition. Pendred syndrome (PS) is caused by mutations in the *SLC26A4* gene, which encodes a protein involved in iodide transport and organification in the thyroid gland. The described measurement of thyroid hormones and iodine organification confirms that thyroid dysfunction is a key feature of PS.", "retries": 1}
{"idx": 612, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' is close but not an exact match to the gold answer, 'benzothiazepine.' The supporting sentence provided by the model incorrectly states that the context does not mention the chemical classification, while the gold supporting sentence explicitly identifies JTV-519 as a '1,4-benzothiazepine derivative.' Although the model's supporting sentence acknowledges the focus on JTV-519’s activity, it fails to utilize the information in the context that directly supports the gold answer. Thus, the answer is present in the context but not fully accurate, and the supporting sentence does not correctly reflect the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly mention the chemical classification of JTV-519 (e.g., \"1,4-benzothiazepine derivative\"). The information in this specific context focuses on JTV-519's role in reversing cisplatin resistance and its effects on intracellular platinum accumulation, but it does not describe its chemical structure or parent compound group. Therefore, the answer **cannot be determined from the given context**. \n\n**Note**: The example answer provided in the user's message (answering \"1,4-benzothiazepine\") is likely based on a different context (e.g., the earlier example about myocardial function), which is not present here.", "retries": 1}
{"idx": 613, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein has long been recognized as the central factor protecting humans from cancer. It has been famously dubbed \"the guardian of the genome\" due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "retries": 1}
{"idx": 614, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a correct explanation of FSHD being caused by issues with DUX4 expression, which aligns with the context. However, it is slightly more verbose than necessary compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 615, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('alpha-synuclein'). The supporting sentence is relevant and provides context by mentioning alpha-synuclein in relation to Lewy bodies, but it is slightly verbose and includes information about DLB being characterized by Lewy bodies, which is not directly needed to support the answer. The logic is sound, though more concise phrasing would improve it.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: \"Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies. Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.\"  \n\n**Analysis**: While the context does not explicitly state \"alpha-synuclein\" as the main component of Lewy bodies in the body of the text, the **title** and the **first sentence** together establish the association between alpha-synuclein (the focus of the study) and Lewy bodies (a hallmark of DLB). The entire study investigates alpha-synuclein isoforms in DLB, implying its central role in Lewy body formation. This aligns with established scientific knowledge that alpha-synuclein is the primary component of Lewy bodies, as demonstrated in the context’s focus.", "retries": 1}
{"idx": 616, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by clearly indicating that benserazide is co-administered with L-Dopa.\", \"match\": true}", "gold_answer": "L-Dopa", "gold_support": "They were injected subcutaneously (s.c.) with L-Dopa methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-Dopa/benserazide) alone or in combination with JL-18 (at the doses of 0.1, 0.3, or 0.9 mg/kg, s.c.).", "model_answer": "Answer: L-Dopa", "model_support": "Supporting sentence: \"L-Dopa/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\"  \n\nThe use of \"L-Dopa/benserazide\" in this context explicitly indicates that benserazide is co-administered with L-Dopa.", "retries": 1}
{"idx": 617, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains the role of RNA polymerase stalling in recruiting repair proteins to the transcribed strand, aligning perfectly with the context and gold standard.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage. The stalled RNA polymerase complex may then mediate recruitment of repair proteins to damage in the transcribed strand.  \n\n**Analysis**:  \nThe context explicitly states that transcription-coupled repair (TCR) addresses damage on the **transcribed strand** of active genes, as the RNA polymerase complex becomes stalled at DNA lesions on this strand. This stalling recruits repair proteins (e.g., CSB/Rad26) specifically to the transcribed strand, defining TCR's mechanism and target.", "retries": 1}
{"idx": 618, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant because it acknowledges that the context does not explicitly confirm the autosomal dominant inheritance but still attempts to infer from a vague part of the text. While logically correct, this introduces unnecessary verbosity. A more concise and direct supporting sentence could have been used.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Dystrophic myotonia is a sufficiently rare disease inherited mainly by the autosomal dominant type.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant pattern.", "model_support": "The provided context does not explicitly state the mode of inheritance for myotonic dystrophy. While the study investigates the \"inheritance\" of the condition, it does not specify whether it follows an autosomal dominant pattern. The correct answer (autosomal dominant) is based on general medical knowledge, but **no direct supporting sentence is present in the context**. \n\nIf forced to infer from the context, the closest relevant sentence is:  \n*\"A clinical, genetic, and electromyographic study was carried out to elucidate the problem of this condition inheritance...\"*  \nHowever, this does not confirm the autosomal dominant pattern.", "retries": 1}
{"idx": 619, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, specifying 'hypothyroidism,' which is a thyroid-related abnormality and is correct based on the context. However, it does not exactly match the broader term 'thyroid' from the gold answer. The supporting sentence captures relevant information about hypothyroidism but includes additional details that, while accurate, are more verbose than necessary. It mixes specific findings (e.g., subclinical and overt hypothyroidism cases) with broader relevance to thyroid abnormalities. The logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Answer: Hypothyroidism (including subclinical and overt forms) is common in Williams syndrome.", "model_support": "Supporting sentence: Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%). \n\nAdditional supporting context: In all WS patients with diagnosis of subclinical or overt hypothyroidism, thyroid hypoplasia was detected. No cases of subclinical or overt hypothyroidism were found in WS with normal thyroid volume. \n\nConclusion reinforcement: CONCLUSIONS: Patients with WS should be monitored for thyroid function and a thyroid ultrasound screening should be considered, especially in those patients with changes in thyroid function.", "retries": 1}
{"idx": 620, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and does not explicitly mention the ZFHX1B gene causing Mowat-Wilson syndrome. It discusses phenotypic resemblance between mutant mice and humans but lacks a direct logical link to the gene's role in the syndrome. The supporting sentence could be more concise and specific.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "Answer: Zfhx1b", "model_support": "Supporting sentence: These mutant mice display craniofacial and gastrointestinal malformations that show resemblance to those found in human patients with Mowat-Wilson syndrome. \n\n**Analysis:**  \nThe context explicitly links the conditional mutation in the *Zfhx1b* gene in neural crest precursor cells to the development of malformations resembling Mowat-Wilson syndrome in mice. The sentence directly associates the *Zfhx1b* gene with the syndrome by stating that the observed defects in the mutant mice mirror those in human patients. This establishes *Zfhx1b* as the responsible gene.", "retries": 1}
{"idx": 621, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'CaN (Calcineurin)' is essentially correct and matches the gold standard 'phosphatase 2B' since calcineurin is another name for phosphatase 2B. The supporting sentence is relevant and provides accurate information about the dephosphorylation of NFAT by CaN, which is critical for its function. However, it does not explicitly mention the full name 'protein phosphatase 2B,' which would have made it more precise. The supporting sentence is slightly less detailed than the gold supporting sentence, leading to a score of 4 instead of 5.\", \"match\": true}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: CaN (Calcineurin)", "model_support": "Supporting sentence: Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.", "retries": 1}
{"idx": 622, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for medicarpin being the major phytoalexin, but it contains slight redundancy by elaborating on the release from a preformed conjugate, which is not directly necessary to confirm medicarpin as the major phytoalexin.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Treatment of (14)C-labeled, elicited cells with l-alpha-aminooxy-beta-phenylpropionic acid... resulted in the initial appearance of labeled medicarpin of very low specific activity, suggesting that the **phytoalexin** could be released from a preformed conjugate under these conditions.\"  \n\nThe term \"phytoalexin\" is explicitly used to describe **medicarpin** in this context, confirming its role as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 623, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as 'cerebral hemiatrophy' is implied within 'contralateral cerebral atrophy.' However, it introduces additional details not explicitly mentioned in the context (e.g., compensatory hypertrophy), making it somewhat broader than necessary. The supporting sentence reflects clinical features but does not directly address the diagnostic structural abnormality ('cerebral hemiatrophy') highlighted in the gold supporting sentence. It mixes relevant clinical symptoms with the lack of explicit mention of imaging findings, reducing its precision.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Characteristic features of Dyke-Davidoff-Masson syndrome include hemiparesis, seizures, contralateral cerebral atrophy, and compensatory hypertrophy of the ipsilateral parieto-occipital region.", "model_support": "Supporting sentence: A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains. \n\n**Analysis:**  \nThe context explicitly describes the clinical features observed in the patient, including **spastic hemiplegia** (a form of hemiparesis), **recurrent generalized seizures**, **microcephaly**, and **developmental delay**. These align with the characteristic features of Dyke-Davidoff-Masson syndrome listed in the answer. However, the structural findings (contralateral cerebral atrophy and ipsilateral parieto-occipital hypertrophy) mentioned in the answer are **not directly stated** in the provided context. The supporting sentence reflects the **clinical presentation** described in the case, which corresponds to the **clinical features** of the syndrome (hemiparesis, seizures, microcephaly, and developmental delay). The structural brain abnormalities (atrophy/hypertrophy) are standard diagnostic criteria for DDM but are not included in the given context.", "retries": 1}
{"idx": 624, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'The transcribed strand of active genes' is very close to the gold answer 'the transcribed strand,' with only slight verbosity by including 'of active genes.' The supporting sentence is relevant and mentions TCR's role in active genes, which indirectly covers the concept of the transcribed strand. However, it does not explicitly mention the 'transcribed strand' as the gold supporting sentence does, leading to a minor gap in precision despite strong logical support.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Answer: The transcribed strand of active genes.", "model_support": "Supporting sentence: CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes. \n\n**Analysis:**  \nThe sentence explicitly states that transcription-coupled repair (TCR) is specifically involved in repairing **active genes**, which aligns with the known biological mechanism that TCR targets the **transcribed strand** of actively transcribed genes. While the term \"transcribed strand\" is not explicitly mentioned in the context, the reference to \"active genes\" directly supports the inference that TCR acts on the transcribed strand (since transcription requires the transcribed strand to be read). The distinction between TCR (for active genes) and bulk NER (for inactive DNA) further confirms this specificity.", "retries": 1}
{"idx": 625, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('autosomal dominant'). However, the supporting sentence provided by the model does not directly reference the context or include a relevant sentence from it. While the model correctly identifies that the inheritance pattern is autosomal dominant, it fails to utilize the specific background information provided in the context. The gold supporting sentence directly references the 'autosomal dominant' inheritance within the context, making it more accurate and concise.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "BACKGROUND: Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant pattern.", "model_support": "The context provided does not explicitly mention the inheritance pattern of myotonic dystrophy (DM2). While the answer \"autosomal dominant\" is factually correct in general medical knowledge, the specific text excerpt does not include a sentence stating or implying this. Therefore, **there is no supporting sentence in the given context** to directly confirm the inheritance pattern. \n\nExample of a hypothetical supporting sentence (not present in the context):  \n*\"Myotonic dystrophy is inherited in an autosomal dominant manner, with variable expressivity and anticipation.\"*  \n\nSince the context focuses on clinical findings and not genetic inheritance, the answer cannot be validated from the provided text.", "retries": 1}
{"idx": 626, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It provides a detailed description of hypothyroidism and related abnormalities, which are relevant but go beyond the concise focus of the gold answer. The supporting sentence is relevant but overly detailed and does not directly cover the gold answer, which focuses more simply on thyroid abnormalities.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "Answer: Hypothyroidism, characterized by an exaggerated and prolonged TSH response to TRH, low TSH bioactivity, and subclinical thyroid dysfunction.", "model_support": "Supporting sentence: TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2]. These abnormalities are similar to those seen in patients with hypothalamic hypothyroidism.", "retries": 1}
{"idx": 627, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the preclinical and clinical translation of tofacitinib, which strengthens its relevance without being overly verbose.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).", "retries": 1}
{"idx": 628, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in identifying the clotting factor inhibited by betrixaban. However, the supporting sentence states that the answer is not supported by the context, which is incorrect because the context explicitly mentions that betrixaban is a direct inhibitor of factor Xa. Despite this misstep in reasoning, the correct information is present in the context and cited correctly in the gold supporting sentence. The model’s supporting explanation introduces unnecessary confusion but does not entirely derail from logical relevance.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Betrixaban is a direct factor Xa inhibitor.", "model_support": "The answer is **not supported by the context**. The provided text does not explicitly state which clotting factor is inhibited by **betrixaban**. While the context lists betrixaban as one of the new oral anticoagulants, it does not describe its pharmacological mechanism or target clotting factor. The detailed mechanisms discussed in the context apply only to **dabigatran** (direct thrombin inhibitor) and **rivaroxaban** (factor Xa inhibitor), but **no specific information about betrixaban is included**. \n\n**Correct analysis**: The context does not provide evidence to support the claim that betrixaban is a direct factor Xa inhibitor. The answer relies on external knowledge, not the given text.", "retries": 1}
{"idx": 629, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 630, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly states that SUV39H1 utilizes both the chromodomain and the SET domain for catalysis, which logically supports the role of the SET domain as the characteristic catalytic domain of histone methyltransferases.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Deletion of the chromodomain or point mutation of the conserved amino acids, W64A or W67A, of SUV39H1 impaired enzyme activity despite the presence of an intact catalytic SET domain.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: Thus, SUV39H1 utilizes both the chromodomain and the SET domain for catalysis.  \n\n**Analysis:**  \nThe context explicitly states that SUV39H1 employs both the chromodomain and the **SET domain** for catalytic activity. While the chromodomain is involved in substrate recognition (binding methylated histones), the **SET domain** is the catalytic core responsible for methyltransferase activity in histone methyltransferases. This aligns with the broader classification of histone methyltransferases, where the **SET domain** is the defining catalytic domain. The quoted sentence directly supports the answer by identifying the **SET domain** as a critical component of SUV39H1's enzymatic function.", "retries": 1}
{"idx": 631, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('growth hormone') but is present in the context as 'None'. The supporting sentence is relevant to the context of Costello syndrome and discusses features associated with it, such as tumors and mutations. However, it fails to cover the gold answer (growth hormone deficiency) adequately. Instead, it focuses on the absence of hormone-related information, which leads to a failure in identifying the correct answer.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients.", "model_answer": "Answer: None.", "model_support": "The context does not mention any hormone deficiency being implicated in Costello syndrome. The discussion focuses on genetic mutations (HRAS, BRAF, MEK1), clinical differences in cardiac abnormalities, tumor occurrences, and phenotypic distinctions between Costello and CFC syndromes. There is no reference to hormonal imbalances or deficiencies in the provided text. \n\n**Supporting sentence**: *Although malignant tumors have been viewed as characteristic for Costello syndrome due to HRAS mutations, however, we report here on a MEK1 mutation in a patient with a malignant tumor, a hepatoblastoma.*  \nThis sentence highlights the association of Costello syndrome with HRAS mutations and tumors but does not link it to hormone deficiency, reinforcing that the answer is \"None.\"", "retries": 1}
{"idx": 632, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: It has been famously dubbed \"the guardian of the genome\" due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "retries": 1}
{"idx": 633, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard (5 vs. 7). However, the supporting sentence is relevant as it mentions the measurement of 5 N-terminal isoforms, which partially aligns with the context but fails to cover the gold answer of 7 isoforms. The supporting sentence does not provide information about the additional isoforms, leading to an incomplete explanation.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Five", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "retries": 1}
{"idx": 634, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes a comparison with Mahalanobis distance, which adds slight redundancy. The logic is clear and the support is strong, but it could be more concise by focusing solely on delta-distance as the common measure.\", \"match\": true}", "gold_answer": "delta-distance", "gold_support": "The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.", "model_answer": "Answer: delta-distance", "model_support": "Supporting sentence: We demonstrate that the Mahalanobis distance is better than the **delta-distance** at measuring genomic signature differences between plasmids and chromosomes of potential hosts.", "retries": 1}
{"idx": 635, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer logically, but it is slightly less detailed compared to the gold supporting sentence. The model's supporting sentence implies the prevention of SNP effects by SEA0400, which aligns with NCX inhibition, but it lacks explicit mention of 'Na+/Ca2+ exchanger' or the prevention of 'cytotoxicity,' making it less comprehensive than the gold standard.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400. \n\n**Analysis**: The context establishes that SNP-induced effects (Ca²⁺ influx, ROS production, and cytotoxicity) are mediated via the Na⁺/Ca²⁺ exchanger (NCX) pathway. The specific statement that \"these effects of SNP were prevented by SEA0400\" directly links SEA0400 to inhibition of NCX activity, as the observed outcomes (Ca²⁺ influx, etc.) are explicitly tied to NCX function in the study. This confirms SEA0400 as an NCX inhibitor.", "retries": 1}
{"idx": 636, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support, but it contains slight redundancy by mentioning that the context does not explicitly name the bacterium, which is unnecessary given the clarity of the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "Botulism is a disease characterized by neuromuscular paralysis and is produced from botulinum neurotoxins (BoNTs) found within the Gram positive bacterium Clostridium botulinum.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly mention the bacterium responsible for botulism (Clostridium botulinum). However, the question refers to \"botulinum neurotoxin intoxication,\" which is directly associated with **Clostridium botulinum** as the causative agent. While the provided text does not include a direct statement naming the bacterium, the answer is inferred from general biomedical knowledge. \n\n**Supporting sentence**: The first line of the context discusses \"botulinum neurotoxin intoxication,\" which is produced by *Clostridium botulinum*, though the bacterium itself is not explicitly named in the text.", "retries": 1}
{"idx": 637, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence explicitly identifies medicarpin as a key compound and aligns well with the gold supporting sentence in relevance and clarity.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of **medicarpin** is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.  \n\nThis sentence explicitly identifies **medicarpin** as a key compound in the context, establishing it as the central subject of the study on isoflavone metabolism in alfalfa. The entire context focuses on enzymes and pathways related to medicarpin biosynthesis, confirming its status as the major phytoalexin in *Medicago sativa L.*", "retries": 1}
{"idx": 638, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'beta-Trcp', is a correct and acceptable abbreviation of the full gold answer, 'SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)', making it a match. The supporting sentence provided by the model is relevant and explains the recruitment of beta-Trcp for IFNAR1 ubiquitination and degradation, aligning with the gold supporting sentence. However, it does not explicitly mention the full name 'SCFbeta-Trcp' as in the gold standard, and there is slight redundancy in its phrasing when discussing serine residues. Despite this, the logic and relevance are strong.\", \"match\": true}", "gold_answer": "SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: beta-Trcp", "model_support": "Supporting sentence: \"the integrity of two Ser residues at positions 535 and 539 within the specific destruction motif present in the cytoplasmic tail of IFNAR1 is essential for the ability of IFNAR1 to recruit beta-Trcp as well as to undergo efficient ubiquitination and degradation.\" \n\nThis sentence explicitly identifies **beta-Trcp** as the E3 ubiquitin ligase required for IFNAR1 ubiquitination and degradation, highlighting its recruitment by IFNAR1 through phosphorylation of specific serine residues (Ser535/539).", "retries": 1}
{"idx": 639, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the connection between ZFHX1B and Mowat-Wilson syndrome by highlighting its role in the clinical manifestations of the disease. While it does not explicitly mention mutations or specific defects, it is still highly relevant and aligns well with the context.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "ZFHX1B mutations cause a complex developmental phenotype characterized by severe mental retardation (MR) and multiple congenital defects.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the \"Mowat-Wilson\" syndrome.", "retries": 1}
{"idx": 640, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'BCR-ABL tyrosine kinase' is very close to the gold standard 'BCR-ABL,' with only a slight addition of descriptive detail that does not detract from correctness. The supporting sentence mentions reactivation of the BCR-ABL signal transduction but focuses on resistance in advanced phases rather than directly explaining Imatinib's target. It contains relevant information but is somewhat indirect and less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is characterised by the occurrence of the Philadelphia (Ph) chromosome (9/22 translocation) and the formation of a fusion protein--the BCR-ABL transcript with constitutive activation of the BCR-ABL tyrosine kinase and consequent changes in the intracellular signal transduction, which is responsible for the deregulated myeloid cell proliferation.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The results in the advanced phase are far less favourable, which is explained by the development of resistance owing to reactivation of the BCR-ABL signal transduction. \n\n**Analysis**: The context explicitly links resistance to STI571 (Imatinib/Gleevec) in advanced chronic myeloid leukemia (CML) to reactivation of the **BCR-ABL** signal transduction pathway. This implies that **BCR-ABL tyrosine kinase** is the molecular target of the drug, as its inhibition is central to the drug's mechanism of action in Philadelphia chromosome-positive CML.", "retries": 1}
{"idx": 641, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is essentially correct and aligns with the gold standard 'stroke,' as 'acute stroke' specifies the type of stroke contextually addressed by the ROSIER scale. The supporting sentence is concise, directly relevant, and logically explains the purpose of the ROSIER scale in differentiating acute stroke from mimics, which strongly supports the answer. Minor additional detail ('acute') does not detract from the correctness or relevance.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence explicitly states the purpose of the ROSIER scale, linking it to the identification of **acute stroke** in emergency room settings.", "retries": 1}
{"idx": 642, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly explains that SGLT2 inhibition is a treatment mechanism for T2DM, aligning logically with the gold answer.\", \"match\": true}", "gold_answer": "sodium glucose co-transporter 2", "gold_support": "The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies.", "model_answer": "Answer: Sodium glucose co-transporter 2 (SGLT2)", "model_support": "Supporting sentence: Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM). \n\n**Analysis:** The context explicitly states that sodium-glucose co-transporter 2 (SGLT2) inhibition is the mechanism being studied in the CANVAS trial, which evaluates canagliflozin. This sentence directly identifies SGLT2 as the target transporter inhibited by canagliflozin.", "retries": 1}
{"idx": 643, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The correct answer is 'Fungi,' but the model incorrectly identifies Microsporidia as belonging to Sporozoa within the kingdom Protozoa. The supporting sentence is relevant in mentioning Microsporidia, but it refers to them being placed in Sporozoa, which is incorrect according to the context and gold answer. The supporting sentence also does not cover the gold answer or reasoning that Microsporidia are now classified under Fungi due to protein sequence evidence.\",\n  \"match\": false\n}", "gold_answer": "Fungi", "gold_support": "The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.", "model_answer": "Answer: Sporozoa (within the kingdom Protozoa)", "model_support": "Supporting sentence: Haplosporidia and the (formerly microsporidian) metchnikovellids are now both placed within the phylum Sporozoa.", "retries": 1}
{"idx": 644, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('BCR-ABL tyrosine kinase' is a valid and equivalent response to 'BCR-ABL'). The supporting sentence is concise, directly relevant, and provides clear reasoning by linking imatinib's mechanism of action to its specific activity against BCR-ABL tyrosine kinase, as supported by general biomedical knowledge. Although the context does not explicitly state this, the explanation logically bridges the gap without introducing unnecessary verbosity or irrelevant details.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND/AIM: Imatinib mesylate, a tyrosine kinase inhibitor with specific activity against the breakpoint cluster region--Abelson murine leukemia (BCR-ABL) tyrosine kinase has been developed for treatment of chronic myelogenous leukemia (CML).", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The context does not explicitly mention the BCR-ABL tyrosine kinase as the target of imatinib (Gleevec). However, the answer is inferred from general knowledge of CML pathophysiology and imatinib's mechanism, as the Philadelphia chromosome (Ph1) in CML is characterized by the BCR-ABL fusion gene, and imatinib is a well-established BCR-ABL tyrosine kinase inhibitor. The provided context focuses on clinical outcomes (hematologic/cytogenetic responses) rather than molecular mechanisms. \n\n**Answer**: BCR-ABL tyrosine kinase  \n**Note**: While the context does not explicitly state the target, the answer is consistent with established biomedical knowledge about imatinib's role in inhibiting BCR-ABL in Ph1-positive CML.", "retries": 1}
{"idx": 645, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group that is activated by dual phosphorylation at Tyr and Thr. \n\n**Analysis**: The context lists c-Jun as a transcription factor regulated by MAP kinase phosphorylation. However, the final sentence explicitly identifies **Jnk** (c-Jun N-terminal kinase) as a MAP kinase-related kinase activated by dual phosphorylation. While the context does not directly state that JNK phosphorylates c-Jun, the name \"c-Jun N-terminal kinase\" (JNK) and its classification as a MAP kinase family member, combined with the established biochemical knowledge (widely recognized in literature), strongly imply that JNK is the specific kinase responsible for phosphorylating c-Jun. The sentence about Jnk's activation mechanism supports its role in the MAP kinase pathway and aligns with the known function of JNK in phosphorylating c-Jun.", "retries": 1}
{"idx": 646, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' matches the gold standard 'stroke' in essence, as 'acute stroke' is a specific and accurate description. The supporting sentence is concise, directly relevant, and logically explains that the ROSIER scale differentiates acute stroke from mimics, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.**  \n\nThis sentence directly states that the ROSIER scale is used to distinguish **acute stroke** from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 647, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for p53 being a tumor suppressor, but it includes information about TA-p73 and p63, which adds slight redundancy. The logic connecting p53 to its role as 'the guardian of the genome' could be more direct, as the gold supporting sentence better highlights this specific role.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors. \n\n**Analysis:** While the context does not explicitly use the term \"guardian of the genome,\" it directly references *p53* as a tumor suppressor in the opening sentence. The phrase \"guardian of the genome\" is a well-established nickname for p53 in scientific literature, and the context aligns with this by framing p53 as a central tumor suppressor alongside its homologues. The answer is supported by the explicit mention of p53 in the context.", "retries": 1}
{"idx": 648, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant and verbose, as it explains that the context does not explicitly provide the information, which is unnecessary since the gold supporting sentence directly provides the required evidence from the text. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.", "model_answer": "Answer: PCSK9 (proprotein convertase subtilisin/kexin type 9)", "model_support": "The context provided does not explicitly mention the enzyme targeted by Evolocumab. While the text describes its lipid-lowering effects and mechanism of action (e.g., reducing LDL-C, apolipoprotein B100, and lipoprotein(a)), it does not specify **PCSK9 (proprotein convertase subtilisin/kexin type 9)** as the target. Therefore, the information required to answer the question is **not present in the given context**. \n\nHowever, based on external pharmacological knowledge, Evolocumab is a monoclonal antibody that inhibits PCSK9. This inference relies on prior knowledge beyond the provided text, which does not include the term \"PCSK9\" or related mechanisms. \n\n**Answer:**  \nThe context does not explicitly state the enzyme targeted by Evolocumab. However, based on established pharmacological knowledge, Evolocumab targets **PCSK9 (proprotein convertase subtilisin/kexin type 9)**.  \n\n**Supporting sentence (from external knowledge, not the context):**  \n*Not applicable; the context does not mention PCSK9.*", "retries": 1}
{"idx": 649, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' differing only in specificity. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for stroke differentiation, though it contains slight redundancy by specifying 'acute stroke' instead of the broader term 'stroke.' Overall, the logic is strong, but the answer could be more concise to match the gold standard exactly.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n(From the *Interpretation* section of the context.)", "retries": 1}
{"idx": 650, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'p38 MAPK,' does not match the gold standard, 'c-Jun NH2-terminal kinase (JNK).' However, the answer is present in the context, as p38 MAPK is discussed in relation to the inhibition of AP-1/c-jun. The supporting sentence mentions AP-1 but does not directly address JNK or its role in phosphorylating c-jun, making it relevant yet insufficient to support the gold answer.\", \"match\": false}", "gold_answer": "c-Jun NH2-terminal kinase", "gold_support": "E2 also attenuated the LPS activation of p38 mitogen-activated protein kinase (MAPK) but not that of extracellular-regulated protein kinase 1/2 (ERK1/2) and c-Jun NH2-terminal kinase (JNK).", "model_answer": "Answer: p38 MAPK", "model_support": "Supporting sentence: Moreover, E2 and E2-BSA inhibited LPS-induced activation of nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1). This inhibitory effect of E2 was only partially antagonized by ICI 182780.  \n\n**Analysis**: The context explicitly links p38 MAPK to the inhibition of AP-1 (a transcription factor complex including c-jun) activation by estrogen. While the sentence does not directly name \"p38 MAPK\" as the kinase phosphorylating c-jun, the prior experimental evidence in the context (e.g., p38 inhibition with SB 203580 reduces LPS-induced NO production, and E2 inhibits p38 activation) establishes that p38 MAPK mediates the effects on AP-1/c-jun. Thus, the broader context supports the conclusion that **p38 MAPK** is the kinase responsible for phosphorylating c-jun in this pathway.", "retries": 1}
{"idx": 651, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is a precise match to the gold standard 'stroke,' as 'acute stroke' is a specific and accurate descriptor within the context of the ROSIER scale. The supporting sentence is concise, directly relevant, and logically explains the purpose of the ROSIER scale in differentiating acute stroke from mimics in the ER.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.* \n\nThis sentence directly states that the ROSIER scale is used for **acute stroke**, as it was designed to distinguish acute stroke from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 652, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it includes the title of the context rather than directly quoting a sentence from the body of the text. The chosen supporting sentence could be more specific and concise by referencing the sentence that explicitly lists betrixaban as one of the factor Xa inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban. \n\n**Analysis:** The title explicitly identifies betrixaban as a direct inhibitor of factor Xa. Additionally, the context clarifies that all four drugs (rivaroxaban, apixaban, edoxaban, and betrixaban) are direct factor Xa inhibitors, with the title serving as the most direct evidence.", "retries": 1}
{"idx": 653, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).", "retries": 1}
{"idx": 654, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly links the McLeod phenotype to a XK missense mutation, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.  \n\nThis sentence explicitly states that the McLeod phenotype is linked to a **XK gene missense mutation**, directly answering the question about the genetic basis of McLeod syndrome.", "retries": 1}
{"idx": 655, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer provided by the model matches the gold standard ('interleukin-17A'), but the supporting sentence is incorrect. The model claims that the context does not explicitly state the molecule targeted by Secukinumab, which is factually wrong because the BACKGROUND section clearly mentions that Secukinumab is an 'anti-interleukin-17A monoclonal antibody.' Therefore, while the answer itself is correct, the reasoning in the supporting sentence does not align with the context and fails to directly reference the relevant sentence from the text.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.", "model_answer": "Answer: Interleukin-17A (IL-17A)", "model_support": "The context does not explicitly state the molecule targeted by Secukinumab. While the provided text discusses the **efficacy, safety, and usability** of Secukinumab in treating psoriasis, it does not mention its mechanism of action or the specific target (e.g., IL-17A). Therefore, **no sentence in the context supports the answer** to this question. \n\nHowever, based on external knowledge (not derived from the context), Secukinumab is a monoclonal antibody targeting **interleukin-17A (IL-17A)**, a cytokine involved in psoriasis pathogenesis. This information is not included in the provided context.", "retries": 1}
{"idx": 656, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly by identifying 'EAE (Experimental Autoimmune Encephalomyelitis)' as the most widely used model for MS. The supporting sentence is concise, directly relevant, and provides logical reasoning that supports the answer, citing the 'EAE+Cyclosporine' model as a strong representation of MS-related sensory abnormalities. Minor extra details are present but do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "Experimental Autoimmune Encephalomyelitis (EAE)", "gold_support": "The aim of our study was to characterize the sensory abnormalities and in particular the clinical signs linked to persistent pain in two models of Experimental Autoimmune Encephalomyelitis (EAE) in the rat.", "model_answer": "Answer: EAE (Experimental Autoimmune Encephalomyelitis)", "model_support": "Supporting sentence: Our results suggest that the model \"EAE+Cyclosporine\" in the rat is a good model of chronic sensory abnormalities observed in MS patients both from a behavioural and pharmacological point of view. \n\n(Note: While the context does not explicitly state that EAE is the \"most widely used\" model overall, it references the \"EAE+Cyclosporine\" model as a validated MS model, and EAE (Experimental Autoimmune Encephalomyelitis) is a well-established and widely recognized animal model for MS in scientific literature.)", "retries": 1}
{"idx": 657, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while acknowledging that the context does not explicitly state the full form of 'mTOR,' correctly references external knowledge to provide the accurate expansion. It also notes the lack of explicit support in the given text, aligning with the instructions. The gold supporting sentence is more concise but the model’s reasoning still maintains high clarity and relevance.\",\n  \"match\": true\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.", "model_answer": "Answer: Mammalian target of rapamycin", "model_support": "Supporting sentence: The context does not explicitly state the full form of \"mTOR.\" However, based on general biomedical knowledge, \"mTOR\" stands for **Mammalian target of rapamycin**. The provided context uses \"mTOR\" in phrases like \"mTOR signal-related molecule expression\" and \"inhibition of mTOR complex 2 (mTORC2)\" but does not include a sentence that directly expands the acronym. \n\nIf strictly adhering to the requirement for a supporting sentence from the context, **there is no explicit sentence** in the given text that defines \"mTOR.\" The answer relies on external knowledge rather than the provided context.", "retries": 1}
{"idx": 658, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking dermatitis herpetiformis to gluten sensitivity. Although the model supporting sentence is brief, it effectively conveys the necessary information without unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: Tolerance to oats in dermatitis herpetiformis.  \n\nThis sentence establishes the context that dermatitis herpetiformis (DH) is a condition related to gluten sensitivity, as the study investigates oat tolerance in patients with DH (a gluten-related disorder). The entire study's premise hinges on DH being a gluten-associated condition, confirming its typical association with gluten.", "retries": 1}
{"idx": 659, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.", "retries": 1}
{"idx": 660, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer logically but contains slight redundancy in mentioning mTORC2 instead of focusing solely on mTOR.\", \"match\": true}", "gold_answer": "mammalian target of rapamycin", "gold_support": "The role of the distinct mammalian target of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation and survival in PAH and their therapeutic relevance are unknown.", "model_answer": "Answer: mammalian target of rapamycin", "model_support": "Supporting sentence: Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.  \n\nThe acronym **mTOR** is explicitly defined as \"mammalian target of rapamycin\" in the expanded form of **mTORC2** (\"mammalian target of rapamycin complex 2\") in the first sentence of the context.", "retries": 1}
{"idx": 661, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides clear evidence by mentioning the use of pridopidine in patients with Huntington disease. However, it includes additional details about the imaging technique that are not necessary to directly support the answer, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: \"[(18)F]Fluorodeoxyglucose positron emission tomographic imaging was used to measure the regional cerebral metabolic rate of glucose at baseline and after 14 days of open-label pridopidine treatment in 8 patients with Huntington disease.\"  \n\nThis sentence explicitly states that pridopidine was tested in patients diagnosed with Huntington disease, confirming the disorder targeted in the study.", "retries": 1}
{"idx": 662, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the active nuclear import process of APOBEC3B and ties it to its nuclear localization, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: \"Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID.\"  \n\nThis sentence explicitly describes the **active nuclear import mechanism** of APOBEC3B, indicating that the protein must be transported into the nucleus. The focus on nuclear localization and the comparison to AID (a well-known nuclear enzyme) directly support the conclusion that APOBEC3B is predominantly nuclear.", "retries": 1}
{"idx": 663, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about the construction of the database and its web address, which makes it slightly more verbose than necessary. However, the logic remains strong, and the extra information does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work. LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 664, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer 'Nestin' matches the gold standard 'nestin' exactly. Although the model notes that there is no supporting sentence in the provided context, this is accurate because the model correctly identifies that the context does not explicitly mention nestin as an intermediate filament protein despite external knowledge indicating its role. The gold supporting sentence provides the necessary evidence from a broader context.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats.", "model_answer": "Answer: Nestin", "model_support": "The context provided does not mention \"Nestin\" or any intermediate filament (IF) protein as a marker for neuronal precursor cells in the subventricular zone. Therefore, **there is no supporting sentence in the given context** to justify the answer \"Nestin.\" The answer likely relies on external knowledge rather than the provided text.", "retries": 1}
{"idx": 665, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence acknowledges that the context does not explicitly mention betrixaban but correctly infers the answer from external knowledge. However, it introduces slight redundancy by explaining the lack of context instead of directly referencing the relevant information from the context (e.g., the list of direct factor Xa inhibitors).\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given context to answer the question about which clotting factor betrixaban inhibits. The answer \"Factor Xa\" is likely inferred from external knowledge (as betrixaban is a known Factor Xa inhibitor), but the context does not include this information.", "retries": 1}
{"idx": 666, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'XK gene' matches the gold standard 'XK' exactly, as both refer to the same gene. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by mentioning the specific XK gene point mutation associated with McLeod syndrome. Minor extra details like the mutation (C977T) are acceptable because they do not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Here, we present an immunohistochemical study in skeletal muscle of normal controls and a McLeod patient with a **XK gene point mutation** (C977T) using affinity-purified antibodies against XK and Kell proteins.", "retries": 1}
{"idx": 667, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why the transcribed strand is targeted by transcription-coupled repair (TCR). It effectively highlights the specificity of TCR for the transcribed strand by contrasting it with the non-transcribed strand, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "Answer: Transcribed strand", "model_support": "Supporting sentence: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\" \n\nThis sentence explicitly states that **transcription-coupled repair (TCR)** targets the **transcribed strand** of an active gene, as NER remains functional in this strand even when Elc1 (a GGR component) is deleted. The absence of NER in the non-transcribed strand highlights the specificity of TCR for the transcribed strand.", "retries": 1}
{"idx": 668, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides the necessary information about the availability of LepChorionDB, which logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 669, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by pointing out the synonym relationship using the slash between 'X-linked dystonia-parkinsonism' and 'Lubag disease.'\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.  \nThe use of a slash (/) directly equates \"X-linked dystonia-parkinsonism\" with \"Lubag disease,\" indicating they are synonyms.", "retries": 1}
{"idx": 670, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions gevokizumab's modulation of IL-1β signaling, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism. \n\n**Analysis:**  \nThe sentence explicitly states that gevokizumab modulates **IL-1β signaling**, directly identifying **IL-1β** as the targeted molecule. Additional context confirms that the drug affects IL-1β's interaction with its receptor by altering its electrostatic properties, reinforcing that IL-1β is the primary molecular target.", "retries": 1}
{"idx": 671, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It explains the creation and purpose of LepChorionDB, aligning well with the gold supporting sentence while maintaining brevity and relevance.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work. \n\n**Analysis:** The sentence explicitly introduces LepChorionDB as the database created for identifying and classifying Lepidopteran chorion proteins, using specific tools (pHMMs) for classification. It also establishes its purpose for functional and evolutionary studies, confirming its availability for proteome analysis.", "retries": 1}
{"idx": 672, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Serotonin 5-HT2A receptors' is correct and matches the gold standard '5-HT2A', though it includes additional descriptive wording. The supporting sentence is relevant and supports the answer by mentioning [18F]altanserin as a radiotracer for PET studies of the serotonin 5-HT2A receptor; however, it is slightly verbose and less direct compared to the gold supporting sentence, which succinctly ties the binding results to the specific receptor.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors", "model_support": "Supporting sentence: To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 673, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('autosomal dominant') while providing additional correct details about the mutation's behavior. However, it includes extra information (sex and size dependency, intergenerational expansion) not required by the gold answer, making it more verbose. The supporting sentences, though relevant, are longer than necessary and mix specific findings (sex and size dependency, expansion) that aren't essential to the concise gold answer. Overall, the logic is strong but could be simplified.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Myotonic dystrophy type 1 is a neuromuscular, degenerative and progressive disease, with an autosomal dominant pattern of inheritance, variable expressivity and incomplete penetrance.", "model_answer": "Answer: Myotonic dystrophy type 1 (DM1) is inherited in an autosomal dominant pattern, with the mutation showing sex and size-dependent transmission. The CTG triplet expansion in the DMPK gene tends to increase in size between generations, correlating with increased severity and earlier age of onset.", "model_support": "Supporting sentences:  \n1. \"Transmission of the DM1 mutation is sex and size dependent among the Costa Rican patients.\"  \n2. \"There is an important increment in the size of the mutation between generations...\"  \n\nThese sentences directly support the answer by confirming that DM1 inheritance involves **sex and size-dependent transmission** and **intergenerational expansion of the CTG triplet**, which correlate with disease severity and earlier onset. The autosomal dominant pattern is implied by the mutation's presence in the DMPK gene (chromosome 19q13.3) and its transmission across generations.", "retries": 1}
{"idx": 674, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model acknowledges that the context does not explicitly state 'HEXA' but correctly identifies that the HEXA gene is the one being discussed through inference from the context. The gold supporting sentence directly mentions HEXA, confirming the accuracy of the model's answer. Despite the lack of explicit mention in the context, the model demonstrates strong logical reasoning.\",\n  \"match\": true\n}", "gold_answer": "HEXA", "gold_support": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.", "model_answer": "Answer: The HEXA gene.", "model_support": "The context does not explicitly mention the gene most commonly mutated in Tay-Sachs disease (HEXA). While the mutations **G749T** and **C1351G** are discussed, the gene name **HEXA** (which encodes the alpha subunit of hexosaminidase A, the enzyme defective in Tay-Sachs disease) is not identified in the provided text. The answer relies on general knowledge of Tay-Sachs genetics rather than direct evidence from the context. \n\n**No supporting sentence for \"HEXA\" is present in the given context.**", "retries": 1}
{"idx": 675, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, as it mentions heme regulating Bach1's nuclear export, which indirectly supports its role as a repressor. However, it does not explicitly state that Bach1 is a transcriptional repressor of specific genes like the gold supporting sentence does, resulting in slight vagueness.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1 and beta-globin genes, both of which are known to be transcriptionally induced by heme.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. \n\n**Analysis**: The context explains that heme induces the nuclear export of Bach1, which regulates gene expression. This implies that Bach1's presence in the nucleus (when heme synthesis is inhibited) likely represses gene expression, while its exclusion (under heme treatment) allows gene activation. The regulatory mechanism described aligns with Bach1 functioning as a repressor under normal conditions, as its removal (by heme) enables gene expression.", "retries": 1}
{"idx": 676, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is a slightly expanded but correct version of '5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that the reduction in binding reflects the loss of 5-HT2A receptors, which aligns well with the gold supporting sentence. Minor extra detail in the answer is acceptable as it doesn't detract from clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 677, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant but slightly verbose and does not directly state the conclusion as clearly as the gold supporting sentence. It introduces the debate without firmly resolving it in favor of the Fungi classification, though the implication is present.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: However, the specific position of microsporidia within the fungal tree of life is still debated.  \n\n**Analysis**: The context explicitly states that the phylogenetic position of microsporidia is debated *within the fungal tree of life*, which directly implies their classification under the **Fungi** kingdom. While the exact placement within Fungi is unresolved, the framing of the debate itself confirms their current taxonomic grouping in the fungal kingdom.", "retries": 1}
{"idx": 678, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Thyroid hormone abnormalities,' closely matches the gold standard 'thyroid' but is slightly more specific than necessary. The supporting sentence provides relevant information about measuring thyroid hormone levels and conducting related tests in Pendred syndrome patients, which logically connects to the answer. However, it includes additional details like USG and scyntography that are not directly needed to support the answer, introducing slight redundancy. Overall, the logic is strong, but the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted. \n\n**Analysis:** The context explicitly states that thyroid hormone levels were measured in patients with Pendred syndrome (PS) as part of the diagnostic evaluation. This directly supports the conclusion that thyroid hormone abnormalities are characteristic of PS. While the specific nature of the abnormalities (e.g., elevated/lowered levels) is not detailed in the results, the measurement of thyroid hormones in the context of PS confirms their relevance to the syndrome.", "retries": 1}
{"idx": 679, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral **factor Xa inhibitor**, for prevention of thromboembolic events after total knee replacement (EXPERT).", "retries": 1}
{"idx": 680, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and supports the answer by referencing a factor Xa decoy used with betrixaban, but it includes additional details about PRT4445 that are not necessary to directly support the answer. This makes the supporting sentence slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban...\"  \n\nThis sentence indicates that betrixaban targets **Factor Xa**, as it is paired with a \"factor Xa decoy\" (PRT4445) as a potential reversal agent. The context further categorizes betrixaban among \"novel anticoagulants\" alongside other factor Xa inhibitors, confirming its mechanism of action.", "retries": 1}
{"idx": 681, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' vs. '5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains the relationship between [18F]altanserin and the evaluation of 5-HT2A receptors, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 682, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 683, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence provides relevant information about the XK0 allele and its connection to McLeod syndrome, which aligns with the context. However, it introduces slight redundancy by discussing the patient's daughters and heterozygosity, which is not necessary for directly supporting the answer. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: The patient's daughters had two populations of red cells, consistent with them being heterozygous for an XK0 allele.  \n**Analysis**: The sentence explicitly links the **XK0 allele** to the genetic basis of McLeod syndrome (MLS). The term \"XK0\" refers to a mutation in the **XK gene**, which is responsible for encoding the Kx antigen. The X-linked inheritance pattern and the presence of reduced Kell antigen expression further confirm the involvement of the **XK gene** in this disorder.", "retries": 1}
{"idx": 684, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Kx gene (XK gene)' does not match the gold standard 'XK' exactly but is related. The supporting sentence acknowledges that the context does not explicitly mention the Kx gene or XK gene, making it relevant but insufficient to cover the gold answer. The answer relies on external knowledge rather than information provided in the context.\", \"match\": false}", "gold_answer": "XK", "gold_support": "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.", "model_answer": "Answer: Kx gene (XK gene)", "model_support": "The answer \"Kx gene (XK gene)\" is **not explicitly supported** by the provided context. The context discusses the genetic mapping of McLeod syndrome to the Xp21 region and identifies a critical region but does not mention the **Kx gene (XK gene)** or its mutation as the cause of the syndrome. The context focuses on chromosomal localization and markers (e.g., 3BH/R 0.3, CpG islands) rather than specifying the gene responsible. \n\n**Supporting sentence (if applicable):** None of the sentences in the context directly name the Kx gene (XK gene) as the causative gene for McLeod syndrome. The answer likely relies on external knowledge (e.g., the XK gene encodes the Kx antigen, which is absent in McLeod syndrome), but the provided text does not include this information.", "retries": 1}
{"idx": 685, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('alpha-synuclein'). The supporting sentence is relevant and provides logical reasoning, referencing the independence of tau pathology and linking Lewy bodies to α-synuclein. However, it is slightly verbose and indirect compared to the concise gold supporting sentence, which directly mentions the immunohistochemistry for alpha-synuclein.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).", "model_answer": "Answer: α-Synuclein", "model_support": "The context does not explicitly mention the specific antibody used for immunostaining Lewy bodies (LBs). However, based on standard knowledge in neurodegenerative diseases, Lewy bodies are classically associated with **α-synuclein** pathology (e.g., Parkinson’s disease and Lewy body dementia). The study compares PSP/LBD with \"pure LB disease (LBD),\" which is inherently linked to α-synuclein accumulation. While the context does not directly state the antibody used, the conclusion that LBs in PSP are \"independent of tau pathology\" implies that the antibody targets a protein distinct from tau (e.g., α-synuclein). \n\n**Supporting sentence**:  \n*\"The findings suggest that LBs in PSP are similar in distribution to those in LBD and independent of tau pathology.\"*  \n\nThis implies that LBs in PSP/LBD share characteristics with LBD, which is defined by α-synuclein pathology, thereby indirectly supporting the use of α-synuclein-specific antibodies.", "retries": 1}
{"idx": 686, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('FSHD'), but the supporting sentence is somewhat lengthy and includes content that does not directly support the answer (e.g., 'However, no one knows what triggers muscle defect...'). While the explanation provided in the context mentions FSHD and DUX4-fl expression, the chosen supporting sentence could be more concise and focused on the direct relationship between FSHD and ectopic DUX4 expression. The logic is reasonable but could be improved with a tighter focus.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "Answer: Facio-scapulo-humeral dystrophy (FSHD)", "model_support": "Supporting sentence: *However, no one knows what triggers muscle defect and when alteration arises. To gain further insights into the molecular mechanisms of the disease, we evaluated at the molecular level, the perturbation linked to the FSHD genotype...*  \n\nThe context explicitly associates the FSHD genotype (facio-scapulo-humeral dystrophy) with dysregulation of the **DUX4** gene (via detection of the DUX4-fl pathogenic transcript in FSHD biopsies) and its role in the disease mechanism. The sentence *\"Importantly, in FSHD fetuses, we mainly detected the non-spliced DUX4-fl isoform\"* directly links **ectopic DUX4 expression** to **FSHD**.", "retries": 1}
{"idx": 687, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Thyroid hormone concentrations' matches the gold standard 'thyroid' in essence, as both refer to thyroid-related changes. The supporting sentence is relevant and explains that MCT8 mutations affect a thyroid hormone transporter, which logically connects to altered thyroid hormone levels. However, it does not explicitly mention 'altered TH levels' or specify high T3 levels, which makes it slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels.", "model_answer": "Answer: Thyroid hormone concentrations", "model_support": "Supporting sentence: Mutations in the MCT8 gene coding for the monocarboxylate thyroid hormone transporter 8 have been associated with AHDS.  \n\n**Analysis**:  \nThe context explicitly states that the MCT8 gene encodes a **thyroid hormone transporter**, and mutations in this gene are causally linked to Allan-Herndon-Dudley syndrome (AHDS). While the study highlights that some patients may have **normal serum T3 levels**, the core pathophysiology of AHDS involves impaired transport of thyroid hormones due to MCT8 dysfunction. This directly supports the conclusion that **thyroid hormone concentrations** are altered in AHDS, even if serum levels appear normal in some cases.", "retries": 1}
{"idx": 688, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the use of EAE animals in MS research, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE) is an animal model for studying multiple sclerosis (MS).", "model_answer": "Answer: Experimental Autoimmune Encephalomyelitis (EAE)", "model_support": "Supporting sentence: \"Thus, treating EAE animals with calpain inhibitors may block these events and ameliorate disability.\"  \n\nThe context explicitly refers to **Experimental Autoimmune Encephalomyelitis (EAE)** as the animal model used for studying multiple sclerosis (MS). The phrase \"EAE animals\" directly links EAE to MS research, confirming it as the widely used model.", "retries": 1}
{"idx": 689, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold answer 'stroke' in this context and matches the intended meaning. The supporting sentence is concise, directly relevant, and logically supports the answer by summarizing the purpose of the ROSIER scale as differentiating acute stroke from mimics. Minor additional detail ('in the ER') does not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 690, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains p53's role in preserving genomic integrity, which aligns with the concept of it being the 'guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: When p53 function is impaired, its ability to preserve genomic integrity is compromised. \n\n**Analysis:** The term \"guardian of the genome\" is a widely recognized designation for p53 in scientific literature, referring to its critical role in maintaining genomic stability. While the exact phrase \"guardian of the genome\" is not explicitly stated in the context, the first sentence directly describes p53's function in preserving genomic integrity, which underpins its nickname. This sentence supports the inference that p53 is the tumor suppressor referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 691, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer. The context hints at two main isoform categories (TA and ΔN), which justifies the model's answer of 'two,' but it fails to capture the further subdivision into seven specific TAp73 isoforms as indicated by the gold answer. The supporting sentence discusses TA and ΔN isoforms but misses the additional detail about multiple TAp73 subtypes.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: p73, a p53 family tumor suppressor, is expressed as TA and ΔN isoforms.  \n**Analysis**: The context explicitly states that p73 exists in two main isoform types: **TA** (transactivation domain-containing) and **ΔN** (N-terminally truncated). While the text does not specify further subtypes of TAp73 (e.g., α, β, γ), the direct mention of \"TA and ΔN isoforms\" implies two distinct categories. The answer \"two\" aligns with this dichotomy, as the question specifically refers to TAp73 isoforms (the TA group), which are distinct from ΔN isoforms. The quoted sentence directly supports the conclusion.", "retries": 1}
{"idx": 692, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is less specific than the gold supporting sentence. The model supporting sentence mentions 'abnormal calcium signaling' and links it to calsequestrin mutation, but it does not explicitly state that calsequestrin is a high-capacity calcium-binding protein in the sarcoplasmic reticulum, which is critical for logical precision.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin (CASQ2)", "model_support": "Supporting sentence: Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.  \n**Analysis**: The context explicitly names *calsequestrin* (CASQ2) as the protein whose mutation is studied, directly linking it to calcium signaling in the sarcoplasmic reticulum (SR). This establishes CASQ2 as the primary calcium-binding protein of the SR discussed in the text.", "retries": 1}
{"idx": 693, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically covers the answer by explicitly stating that [18F]altanserin is used to determine 5-HT2A receptor availability. Minor extra details are acceptable as they do not detract from the clarity and relevance of the sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Suitability of [18F]altanserin and PET to determine **5-HT2A receptor** availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.  \n\nThis sentence explicitly states that [18F]altanserin is used to evaluate **5-HT2A receptor** availability in the rat brain.", "retries": 1}
{"idx": 694, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The context explicitly lists betrixaban as a direct inhibitor of factor Xa, which aligns perfectly with the gold answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].  \n\nThe context explicitly lists betrixaban among the \"direct inhibitors of factor Xa\" in the title, confirming its mechanism of action.", "retries": 1}
{"idx": 695, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about the interaction between alpha-spectrin and beta-spectrin subunits, indirectly supporting the antiparallel nature of their arrangement. However, it is slightly more complex and less direct compared to the gold supporting sentence, which explicitly mentions 'antiparallel heterodimer.' The additional detail in the model's supporting sentence introduces slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: These assemble a tetramer via a mechanism that relies on the completion of a single repeat by association of the partial repeats located at the C terminus of the beta-chain (two helices) and at the N terminus of the alpha-chain (one helix). \n\n**Analysis**: The sentence explains that the beta-chain's C-terminal partial repeats (two helices) associate with the alpha-chain's N-terminal partial repeat (one helix) to form a tetramer. This orientation (C-terminus of beta-chain interacting with N-terminus of alpha-chain) directly indicates an **antiparallel** arrangement between the alpha-spectrin and beta-spectrin subunits.", "retries": 1}
{"idx": 696, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'S-adenosylmethionine (SAMe)' is correct and matches the gold standard 'SAM' as SAMe is the full name of SAM. However, the supporting sentence, while relevant, contains slight redundancy by discussing the conversion to MTA, which is not directly necessary to establish SAMe as the methyl donor. The gold supporting sentence is more concise and directly states SAMe's role as a methyl donor without additional details. Overall, the logic is sound but could be more focused.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: SAMe can convert to MTA spontaneously, so the effect of exogenous SAMe may be mediated by MTA.  \n\n**Analysis**: The sentence implies that SAMe is the precursor (methyl donor) that generates MTA, which is involved in modulating histone methylation. While the context does not explicitly name SAMe as the methyl donor for histone methyltransferases, the statement that SAMe converts to MTA (a key player in the observed effects on histone methylation) indirectly supports SAMe's role as the methyl donor. This aligns with the conclusion that SAMe's effects are mediated through its metabolites in the context of histone methylation.", "retries": 1}
{"idx": 697, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer by mentioning TCR and its focus on transcribed strands. However, it introduces additional details about Cockayne syndrome gene products and stalled RNA polymerase, which are not necessary to directly support the answer, making it slightly verbose.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.", "retries": 1}
{"idx": 698, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('JNK'). The supporting sentence is relevant and supports the answer by mentioning specific JNK isoforms (JNK1β, JNK2α) and their interaction with M3/6. However, it contains slight redundancy by elaborating on specific enzymatic activities (e.g., 'higher enzymatic activity towards JNK2α2') that are not necessary to directly support the answer. The gold supporting sentence is more concise while still covering the key point about DUSP8's role in dephosphorylating JNK.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: M3/6 exhibited stronger binding towards JNK1β and JNK2α isoforms and this was reflected in higher enzymatic activity towards JNK2α2 when compared to JNK1α1 in vitro. \n\n**Analysis**: The context explicitly states that M3/6 (DUSP8) interacts with multiple JNK isoforms (JNK1β, JNK2α, JNK1α, JNK3) and demonstrates isoform-specific enzymatic activity. This interaction directly implicates JNK (c-Jun N-terminal kinase) as the target of DUSP8 regulation, as DUSP8 functions as a phosphatase modulating JNK phosphorylation and signaling.", "retries": 1}
{"idx": 699, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (BCR-ABL), though it is slightly more verbose by including 'tyrosine kinase,' which is implied in the gold answer. The supporting sentence is relevant but contains redundancy by stating that the context does not explicitly mention the target, which is unnecessary since the gold supporting sentence directly references BCR-ABL kinase inhibition as key to CML treatment. Overall, the logic is sound, but slight verbosity reduces the score.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The discovery of targeted tyrosine kinase inhibition of BCR-ABL kinase dramatically changed the treatment of CML.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "The context does not explicitly mention the specific tyrosine kinase targeted by Imatinib (Gleevec). However, based on standard biomedical knowledge, the **BCR-ABL tyrosine kinase** is the established target of Imatinib in Philadelphia chromosome-positive chronic myeloid leukemia (CML). While the provided text discusses the use of TKIs for CML and references the Philadelphia chromosome, it does not directly state the target of Imatinib within the context itself. \n\n**Answer:** BCR-ABL tyrosine kinase  \n**Supporting sentence:** The context does not explicitly state this; the answer is inferred from standard knowledge of CML pathophysiology and Imatinib's mechanism.", "retries": 1}
{"idx": 700, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard ('flumazenil'), but the supporting sentence is incorrect. The model incorrectly states that the context does not explicitly mention flumazenil, while the gold supporting sentence directly references flumazenil treatment in the context. The supporting sentence fails to cover the gold answer despite relevant information being present in the context.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "A 54-y-old man ingested 2 g of bulk laboratory diazepam and was treated with activated charcoal, enhanced diuresis and flumazenil infusion.", "model_answer": "Answer: Flumazenil", "model_support": "The context does not explicitly mention flumazenil or any specific antidote for benzodiazepine overdose. While flumazenil is the standard antidote for benzodiazepine toxicity, the provided text focuses on the prolonged half-lives of diazepam and nordiazepam in overdose cases and advises against re-administering benzodiazepines after awakening in suicide attempts. There is no direct statement in the context supporting the use of flumazenil. \n\n**Answer:** The context does not provide a supporting sentence for the use of flumazenil as an antidote.", "retries": 1}
{"idx": 701, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('calsequestrin') but includes additional detail (CASQ2), which is not incorrect but slightly more specific than required. The supporting sentence provided by the model is relevant and supports the answer logically, but it is more detailed and less direct compared to the gold supporting sentence, introducing concepts like 'arrhythmogenic mutation' and mechanisms that are not essential to answering the question. This makes it somewhat redundant, though it still covers the key idea of CASQ2's role in calcium binding within the SR.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin (CASQ2)", "model_support": "Supporting sentence: Our data suggest that the arrhythmogenic CASQ2(D307H) mutation impairs SR Ca²⁺ storing and release functions and destabilizes the Ca²⁺-induced Ca²⁺ release mechanism by reducing the effective Ca²⁺ buffering inside the SR and/or by altering the responsiveness of the Ca²⁺ release channel complex to luminal Ca²⁺. \n\n**Analysis:** The context focuses on calsequestrin (CASQ2) as the central protein mutated in the study, directly linking it to sarcoplasmic reticulum (SR) calcium storage, release, and buffering. While the term \"main calcium binding protein\" is not explicitly stated, the study's entire premise hinges on CASQ2's critical role in SR calcium regulation, as evidenced by the functional consequences of its mutation (impaired SR Ca²⁺ storage/release, disrupted calcium signaling). This establishes CASQ2 as the primary SR calcium-binding protein under investigation.", "retries": 1}
{"idx": 702, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that EWS/FLI1 regulates a key protein in Ewing sarcoma. Minor additional context about increased cell survival and chemoresistance is acceptable as it does not detract from the logic.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "Answer: EWS/FLI1", "model_support": "Supporting sentence: EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.", "retries": 1}
{"idx": 703, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Syk kinase,' is essentially correct and matches the gold standard, 'spleen tyrosine kinase,' as Syk is an accepted abbreviation. However, the supporting sentence is slightly redundant, quoting the title of the study which includes additional information not directly relevant to the specific enzyme inhibited by fostamatinib. While the logic is clear and the support is adequate, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "spleen tyrosine kinase", "gold_support": "OBJECTIVE: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies.", "model_answer": "Answer: Syk kinase", "model_support": "Supporting sentence: An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents. \n\n**Analysis:** The title explicitly identifies the drug (R788/fostamatinib) as a **Syk kinase inhibitor**, establishing the enzyme (Syk kinase) as the target of the drug's action.", "retries": 1}
{"idx": 704, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context as the NCI-H520 cell-line is mentioned. However, the supporting sentence fails to cover the gold answer and instead emphasizes the lack of information, which is incorrect since the context does provide relevant details about the cell-line being derived from squamous cell carcinoma.\", \"match\": false}", "gold_answer": "squamous cell carcinoma", "gold_support": "Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population.", "model_answer": "The context does not provide information about the origin of the NCI-H520 cell-line.", "model_support": "The context does not mention the NCI-H520 cell-line or its tissue origin. Supporting sentence: None of the sentences in the provided context refer to the NCI-H520 cell-line or its derivation.", "retries": 1}
{"idx": 705, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Calsequestrin (CASQ2)' matches the gold standard 'CASQ' closely, as CASQ is an accepted abbreviation for calsequestrin. The supporting sentence provided by the model is relevant and covers the role of CASQ2 in calcium handling within the sarcoplasmic reticulum, but it contains some redundancy and verbosity. While the logic connecting CASQ2 to its function is strong, the sentence could be more concise. The gold supporting sentence is more direct in identifying CASQ2 as a high-capacity calcium-binding protein in the SR.\", \"match\": true}", "gold_answer": "CASQ", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin (CASQ2)", "model_support": "Supporting sentence: Our data suggest that the arrhythmogenic CASQ2(D307H) mutation impairs SR Ca²⁺ storing and release functions and destabilizes the Ca²⁺-induced Ca²⁺ release mechanism by reducing the effective Ca²⁺ buffering inside the SR and/or by altering the responsiveness of the Ca²⁺ release channel complex to luminal Ca²⁺. \n\nThis sentence directly links **CASQ2 (calsequestrin)** to critical roles in **SR Ca²⁺ storage and release**, confirming its identity as the primary calcium-binding protein in the sarcoplasmic reticulum. The study explicitly attributes the mutation's effects to disruptions in these CASQ2-dependent functions.", "retries": 1}
{"idx": 706, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the drug's purpose, which is acceptable as it does not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH). \n\nThe sentence explicitly states that **Riociguat** is the generic name of the drug **Adempas** in parentheses.", "retries": 1}
{"idx": 707, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains p53's role in response to genomic stress, aligning perfectly with its identity as 'the guardian of the genome'.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "model_answer": "Answer: p53", "model_support": "Supporting sentence: In response to genomic stresses, p53 causes cell cycle arrest to allow time for genomic damage to be repaired before cell division or induces apoptosis to eliminate irreparably damaged cells. \n\nThis sentence highlights p53's role in responding to genomic damage by enforcing cell cycle arrest or apoptosis, which aligns with its established identity as \"the guardian of the genome.\" While the exact phrase \"guardian of the genome\" is not explicitly used in the context, the described function directly supports the inference that p53 is the tumor suppressor referred to by this title.", "retries": 1}
{"idx": 708, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('cerebral hemiatrophy') but includes related features of the syndrome, which are present in the broader context of Dyke-Davidoff-Masson syndrome. However, the supporting sentence from the context only mentions seizures, spastic hemiplegia, microcephaly, and developmental delay, which do not fully cover the gold answer or the additional features mentioned in the model's answer (e.g., contralateral skull hyperostosis and ipsilateral cerebral atrophy). The supporting sentence is relevant but incomplete and fails to address the key feature of cerebral hemiatrophy.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "Answer: Characteristic features of Dyke-Davidoff-Masson syndrome include hemiparesis, seizures, contralateral skull hyperostosis, and ipsilateral cerebral atrophy.", "model_support": "The context does not explicitly mention the characteristic features of Dyke-Davidoff-Masson syndrome (contralateral skull hyperostosis and ipsilateral cerebral atrophy). The provided answer includes features not described in the context. However, the **supporting sentence** from the context is:  \n\"A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains.\"  \n\nThis sentence supports the presence of **seizures, hemiparesis (spastic hemiplegia), microcephaly, and developmental delay**, which are part of the syndrome but do not include the classic features of **contralateral skull hyperostosis** or **ipsilateral cerebral atrophy** mentioned in the answer. The answer appears to combine general knowledge with the context.", "retries": 1}
{"idx": 709, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing TCR as a distinct process superimposed on global NER, but it contains slight redundancy and does not explicitly highlight the 'transcribed strand' as clearly as the gold supporting sentence. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: Our findings support the general view that the genomic domains within which transcription is active are more accessible than the bulk of the genome to the recognition and repair of lesions through the global pathway and that **TCR is superimposed upon that pathway of NER**.  \n\nExplanation: While the context does not explicitly state \"transcribed strand\" in the quoted text, the sentence implies that **transcription-coupled repair (TCR)** operates as a specialized mechanism *in addition to* global NER. TCR is classically defined as targeting the **transcribed DNA strand** during active transcription (a well-established biological principle). The context aligns with this established understanding by distinguishing TCR as a distinct process acting on transcribed regions, even though it does not directly name the transcribed strand.", "retries": 1}
{"idx": 710, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by linking alpha-synuclein to Lewy bodies in DLB. Minor extra details do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: \"It is currently unknown, however, whether any of the APP isoforms is instrumental in **alpha-synuclein deposition** in dementia with Lewy bodies (DLB).\"  \n\nThis sentence explicitly links **alpha-synuclein** to the pathological hallmark of Lewy bodies in DLB, confirming its role as the main component.", "retries": 1}
{"idx": 711, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p16Ink4", "gold_support": "In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation.", "model_answer": "Answer: p16Ink4a", "model_support": "Supporting sentence: This conserved requirement for Bmi-1 to promote self-renewal and to repress p16Ink4a expression suggests that a common mechanism regulates the self-renewal and postnatal persistence of diverse types of stem cell.", "retries": 1}
{"idx": 712, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard conceptually, as 'Light-harvesting complex II (LHCII)' refers to the same entity as the gold answer. However, the supporting sentence provided by the model incorrectly claims that the context does not explicitly state LHCII's abundance, whereas the gold supporting sentence directly provides this information from the text. The model's supporting sentence introduces unnecessary confusion by questioning the context's clarity when the context indeed provides clear support. Despite this, the logic is still mostly sound.\", \"match\": true}", "gold_answer": "Light-harvesting pigment-protein complex of Photosystem II", "gold_support": "Light-harvesting pigment-protein complex of Photosystem II (LHCII) is the largest photosynthetic antenna complex of plants and the most abundant membrane protein in the biosphere.", "model_answer": "Answer: Light-harvesting complex II (LHCII)", "model_support": "The context does not explicitly state that Light-harvesting complex II (LHCII) is the most abundant membrane protein on Earth. While LHCII is a central focus of the study, the text does not include a sentence confirming its abundance. The answer relies on general knowledge rather than direct support from the provided context. \n\n**Answer:**  \nThe context does not provide a sentence supporting the claim that LHCII is the most abundant membrane protein.", "retries": 1}
{"idx": 713, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies TBC1D7 as part of the TSC1-TSC2 complex and explains its functional role in mTORC1 regulation, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "Answer: TBC1D7", "model_support": "Supporting sentence: We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity. \n\n**Analysis**:  \nThe sentence explicitly identifies **TBC1D7** as the third subunit of the TSC1-TSC2 complex, forming the TSC1-TSC2-TBC1D7 (TSC-TBC) complex. This complex is described as the functional unit responsible for Rheb-GAP activity and mTORC1 regulation, directly answering the question about the upstream subunit of mTORC1.", "retries": 1}
{"idx": 714, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in essence, as both refer to the same clotting factor. The supporting sentence is concise, directly relevant, and logically explains that betrixaban is a direct inhibitor of factor Xa, aligning well with the gold supporting sentence. Minor differences in phrasing do not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban]. \n\nThe title explicitly identifies betrixaban as a **direct inhibitor of factor Xa**, establishing its mechanism of action.", "retries": 1}
{"idx": 715, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively highlights the study's focus on Huntington disease in relation to pridopidine treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 716, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information that links medicarpin to its biosynthesis in alfalfa, but it focuses more on the enzyme (IOMT) rather than directly restating the major phytoalexin as the gold supporting sentence does. This introduces slight redundancy without adding critical clarity.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The isoflavone-O-methyltransferase (IOMT), which is induced along with other enzymes involved in **medicarpin biosynthesis**, methylates the A-ring 7-hydroxyl group of daidzein in vitro, a reaction that probably does not occur in vivo.  \n\nThis sentence explicitly associates the enzyme (IOMT) with **medicarpin biosynthesis**, establishing medicarpin as the primary phytoalexin in alfalfa.", "retries": 1}
{"idx": 717, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it mentions the title of the context rather than directly focusing on the specific detail about betrixaban inhibiting Factor Xa. The logic is sound, but it could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].", "retries": 1}
{"idx": 718, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but references a reversal agent (PRT4445) which is not necessary to answer the question. The mention of 'factor Xa decoy' adds slight redundancy, though the logic connecting betrixaban to Factor Xa inhibition is strong.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis**: The context explicitly links betrixaban to \"anti-Xa activity\" through the development of a factor Xa decoy reversal agent (PRT4445). This directly indicates that betrixaban inhibits **Factor Xa**, as reversal agents are specific to the target of the anticoagulant (in this case, Factor Xa).", "retries": 1}
{"idx": 719, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the conclusion that MALAT-1 is upregulated in cancer by describing the effect of its silencing on cancer cell migration. However, it is slightly less direct than the gold supporting sentence, which explicitly states that MALAT-1 is upregulated. The model's supporting sentence requires additional logical inference to connect the observation of impaired migration upon silencing with the upregulation of MALAT-1.\", \"match\": true}", "gold_answer": "upregulated", "gold_support": "Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.", "model_answer": "Answer: Upregulated", "model_support": "Supporting sentence: SiRNA-mediated MALAT-1 silencing impaired in vitro bladder cancer cell migration.  \n**Analysis**: The study demonstrates that reducing MALAT-1 levels (via siRNA) impairs cancer cell migration, indicating that MALAT-1 is **upregulated** in bladder cancer cells under normal conditions (i.e., not silenced). If MALAT-1 were downregulated in cancer, silencing it further would have no effect or even enhance migration, which is not observed here. The functional consequences of silencing (reduced migration and EMT markers) directly imply its overexpression in the cancer context.", "retries": 1}
{"idx": 720, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('DNMT1'). The supporting sentence provided by the model is relevant and identifies DNMT1 as the enzyme involved in DNA methylation, aligning with the gold answer. However, it includes extra details about homologous recombination and gene silencing, which are not directly necessary to support the answer, making it slightly verbose compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a co-repressor that supports the maintenance and de novo action of DNMT1.", "model_answer": "Answer: DNA methyltransferase 1 (DNMT1)", "model_support": "Supporting sentence: \"Correction of double strand DNA breaks proceeds in an error-free pathway of homologous recombination (HR), which can result in gene silencing of half of the DNA molecules caused by action by DNA methyltransferase 1 (DNMT1).\" \n\nThis sentence explicitly identifies **DNA methyltransferase 1 (DNMT1)** as the enzyme responsible for DNA (cytosine-5-)-methylation, which is central to the question.", "retries": 1}
{"idx": 721, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the model's supporting sentence incorrectly states that there is no supporting sentence in the context, while the gold supporting sentence is present and directly relevant. The correct supporting sentence from the context could have been used, which would have resulted in a perfect score.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The oncogenic potential of iPSCs is further underscored by the findings that the critical tumor suppressor p53, known as the guardian of the genome, suppresses induced pluripotency.", "model_answer": "Answer: p53", "model_support": "The context does not mention any specific tumor suppressor protein or refer to \"the guardian of the genome.\" Therefore, **no sentence in the provided context supports the answer** \"p53.\" The answer relies on general scientific knowledge rather than the given text.", "retries": 1}
{"idx": 722, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly specify the E3 ubiquitin ligase. However, the gold answer (beta-TrCP) is indeed present in the context, and the supporting sentence provided by the model fails to cover this information. The model's supporting sentence reflects an incorrect assumption that the context lacks relevant details when, in fact, it contains a direct reference to beta-TrCP2. This results in a score of 2 due to the failure to extract the correct answer despite its presence in the context.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.", "model_answer": "The context does not specify which E3 ubiquitin ligase mediates the ubiquitination and degradation of IFNAR1.", "model_support": "Supporting sentence: The context does not specify which E3 ubiquitin ligase mediates the ubiquitination and degradation of IFNAR1.  \n\n**Analysis**:  \nThe context explicitly states that catalytic activation of Tyk2 is required for ligand-induced IFNAR1 ubiquitination and lysosomal proteolysis but does not identify the specific E3 ubiquitin ligase responsible for these processes. While it highlights Tyk2’s role in signaling pathways leading to IFNAR1 degradation, it does not name or imply a specific E3 ligase (e.g., no mention of enzymes like NEDD4, Cbl, or others). Therefore, the answer is supported by the absence of explicit information about the E3 ligase in the text.", "retries": 1}
{"idx": 723, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but contains slight redundancy by discussing enhanced T-cell responses without directly emphasizing that CT-011 is an anti-PD-1 antibody. While logical, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "Answer: PD-1 (Programmed Cell Death Protein 1)", "model_support": "Supporting sentence: \"we demonstrate that PD-1 expression is increased in T cells of patients with active myeloma, and that CT-011 enhances activated T-cell responses after DC/tumor fusion stimulation.\" \n\nThe context explicitly states that PD-1 (Programmed Cell Death Protein 1) is the target, as the study focuses on PD-1 blockade (via CT-011) to counteract tumor-mediated immune suppression. CT-011 is directly linked to modulating PD-1 activity in this context.", "retries": 1}
{"idx": 724, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and logical, is more general and does not directly state that TCR targets the transcribed strand as explicitly as the gold supporting sentence. It provides a broader context about transcription and repair but lacks the concise specificity of the gold standard.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: The transcribed DNA strand.", "model_support": "Supporting sentence: Our findings support the general view that the genomic domains within which transcription is active are more accessible than the bulk of the genome to the recognition and repair of lesions through the global pathway and that TCR is superimposed upon that pathway of NER.  \n\n**Analysis**: The context explains that transcription-coupled repair (TCR) is a mechanism \"superimposed upon\" the global NER pathway, which is already active in transcriptionally accessible regions. While the context does not explicitly name the \"transcribed DNA strand,\" the implication is that TCR specifically targets the transcribed strand, as it operates in conjunction with transcriptional activity. This aligns with established knowledge that TCR prioritizes the transcribed strand (the template strand for RNA synthesis), which is repaired to prevent stalling of RNA polymerase. The supporting sentence highlights the relationship between transcription and repair, reinforcing the standard understanding of TCR’s role.", "retries": 1}
{"idx": 725, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('RET proto-oncogene' is a correct but slightly more detailed version of 'RET'). The supporting sentence is relevant and provides logical support by referencing a germline mutation in RET responsible for MEN 2. However, it contains slight redundancy by mentioning specific details (e.g., codon 620) that are not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "RET", "gold_support": "The susceptibility gene for MEN 2 is the RET proto-oncogene.", "model_answer": "Answer: RET proto-oncogene", "model_support": "Supporting sentence: In this series, there was one proven case of germline mutation in RET codon 620, which previously has been shown to be responsible for MEN 2, thus indicating heritable disease.", "retries": 1}
{"idx": 726, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard exactly as it includes specific names of genera (Flavivirus, Hepacivirus, and Pegivirus) which are not mentioned in the context. The supporting sentence provided by the model incorrectly states that the answer is not supported by the context, whereas the context indeed mentions 'two of the three genera of the Flaviviridae family.' While the model answer is factually correct based on external knowledge, it does not align with the context or gold answer. Thus, the answer is relevant but incorrect according to the context.\", \"match\": false}", "gold_answer": "three", "gold_support": "Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e.", "model_answer": "Answer: Three (Flavivirus, Hepacivirus, and Pegivirus).", "model_support": "The answer provided (three genera: Flavivirus, Hepacivirus, and Pegivirus) is **not supported by the context**. The context does not mention the classification of the Flaviviridae family or its genera. It only references specific viruses (e.g., Yellow Fever Virus as a Flavivirus and HCV as a target for inhibition) but does not explicitly state the number or names of genera in the Flaviviridae family. The answer relies on external knowledge rather than the provided text.", "retries": 1}
{"idx": 727, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, though it is slightly more detailed than necessary. The additional detail about P-type ion translocating ATPases is accurate but not essential to directly support the specific question.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "Answer: SERCA (Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.", "retries": 1}
{"idx": 728, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer ('Factor Xa') matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why betrixaban inhibits Factor Xa by referencing its classification as a direct factor Xa inhibitor. Although the model's supporting sentence includes additional context about the broader class of anticoagulants, this does not detract from the clarity or accuracy of the reasoning.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, **direct thrombin and factor Xa inhibitors** have drastically changed the landscape in the management of these disease states.  \n**Analysis**: The context explicitly categorizes betrixaban as a novel oral anticoagulant within the broader context of \"factor Xa inhibitors\" (one of the two new classes mentioned). This classification directly supports the conclusion that betrixaban inhibits Factor Xa. Additionally, the mention of a \"factor Xa decoy, PRT4445\" being evaluated alongside betrixaban further reinforces its mechanism of action as a Factor Xa inhibitor.", "retries": 1}
{"idx": 729, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking DUX4 to FSHD, but it contains slight redundancy by mentioning 'global dysregulation of gene expression,' which is not necessary to directly support the answer. The gold supporting sentence is more concise and directly ties FSHD to the specific genetic cause.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: DUX4 and its target genes contribute to the global dysregulation of gene expression observed in FSHD.", "retries": 1}
{"idx": 730, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer, but is slightly verbose and less direct compared to the gold supporting sentence. The model's supporting sentence focuses on expert suggestions for peer administration rather than directly describing naloxone's action in reversing opioid overdose effects.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Naloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: Experts have suggested that, as part of a comprehensive overdose prevention strategy, naloxone should be provided to heroin users for peer administration after an overdose.", "retries": 1}
{"idx": 731, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Epidermal growth factor (EGF)', does not match the gold standard 'EGFRvIII'. However, the context discusses EGFRvIII extensively, and the supporting sentence is relevant to the topic but does not cover the gold answer. The explanation incorrectly identifies Rindopepimut as an analog of EGF rather than correctly identifying it as targeting EGFRvIII. The supporting sentence is somewhat related but focuses on the general concept of EGFRvIII-positive glioblastoma without directly supporting the incorrect answer.\",\n  \"match\": false\n}", "gold_answer": "EGFRvIII", "gold_support": "The epidermal growth factor receptor variant III (EGFRvIII) is a naturally occurring mutant of EGFR and is expressed on approximately 20% to 30% of GBMs.", "model_answer": "Answer: Epidermal growth factor (EGF)", "model_support": "Supporting sentence: Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of **EGFRvIII-positive** glioblastoma.  \nExplanation: The drug Rindopepimut is specifically designed to target the **epidermal growth factor receptor variant III (EGFRvIII)**, which is a mutated form of the epidermal growth factor receptor (EGFR). Since EGFR is activated by epidermal growth factor (EGF), Rindopepimut functions as an EGF analog to engage the EGFRvIII receptor. The context explicitly links the drug to EGFRvIII, which is derived from the epidermal growth factor receptor family.", "retries": 1}
{"idx": 732, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence introduces the meta-analysis evaluating endovascular therapies for acute ischemic stroke, which logically encompasses the MR CLEAN study.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.  \n\n**Analysis**: The context explicitly states that the meta-analysis focuses on endovascular therapies for **acute ischemic stroke (AIS)**. Since the MR CLEAN study is one of the trials included in this meta-analysis (implied by the reference to \"prospective RCTs comparing endovascular therapies with medical management for AIS\"), the disease investigated in MR CLEAN aligns with the meta-analysis' scope of **acute ischemic stroke**.", "retries": 1}
{"idx": 733, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard in essence but includes 'gene,' which makes it slightly more specific than necessary. The supporting sentence is relevant and supports the answer, though it focuses on a detail (haplotype analysis) that isn't directly required to explain the gene mutated in Gaucher disease. This introduces slight redundancy but still maintains logical relevance.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase.", "model_answer": "Answer: glucocerebrosidase gene", "model_support": "Supporting sentence: A common origin for the Spanish D409H alleles was ruled out by haplotype analysis using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.", "retries": 1}
{"idx": 734, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the mechanism of gevokizumab's action on IL-1β, which aligns well with the gold standard context.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.", "retries": 1}
{"idx": 735, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically. However, it includes slight redundancy by mentioning the broader impact on cardiomyocyte contractility and remodeling, which is not necessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: *Importantly, regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.*  \n\nThis sentence explicitly identifies the **PLN/SERCA interactome** (Phospholamban/SERCA2A) as the central regulatory system for sarcoplasmic reticulum (SR) calcium cycling in cardiac muscle, directly linking **Phospholamban (PLN)** as the primary regulatory molecule for **SERCA2A** function.", "retries": 1}
{"idx": 736, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence, though taken from the title, correctly identifies the full form of mTOR as 'Mammalian Target of Rapamycin' in a relevant context.\", \"match\": true}", "gold_answer": "mammalian Target of Rapamycin", "gold_support": "One class of agents that are highly effective in the prevention of in-stent restenosis is the mammalian Target of Rapamycin (mTOR) inhibitors.", "model_answer": "Answer: Mammalian Target of Rapamycin", "model_support": "Supporting sentence: Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.  \n\n**Analysis:** The full name of \"mTOR\" (Mammalian Target of Rapamycin) is explicitly stated in the title of the context. This serves as the direct definition for the acronym used throughout the text.", "retries": 1}
{"idx": 737, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is accurate in stating that the context does not directly support the answer, and it correctly identifies that the answer is a general biological fact. Although the model does not quote the gold supporting sentence, its explanation aligns with the reasoning that the specific detail about intermediate filament diameter (9-10 nm) can only be found in the ultrastructural description of rhabdoid cells. This shows clear understanding.\", \"match\": true}", "gold_answer": "10 nm", "gold_support": "Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.", "model_answer": "The average diameter of intermediate filaments is 10 nanometers.", "model_support": "There is no sentence in the context that directly supports the answer about the average diameter of intermediate filaments. The context focuses on a clinical case of sinonasal teratocarcinosarcoma with rhabdoid features, describing histopathological findings (e.g., rhabdoid cells positive for vimentin, nestin, etc.) and the tumor's aggressive behavior. It does not mention intermediate filaments or their structural dimensions. The provided answer (10 nm) is a general biological fact unrelated to the context.", "retries": 1}
{"idx": 738, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and lacks explicit mention of the improvement seen with GPi stimulation, which is critical to directly support the answer.\", \"match\": true}", "gold_answer": "globus pallidus internus", "gold_support": "After bilateral stimulation of the GPi, the patient showed a clear and stable improvement of the painful dystonic syndrome within hours.", "model_answer": "Answer: Globus pallidus internus (GPi)", "model_support": "Supporting sentence: A bilateral stereotactic electrode placement targeting the ventral intermediate thalamic nucleus (VIM) and the globus pallidus internus (GPi) was performed. \n\n**Analysis**: The context explicitly states that the globus pallidus internus (GPi) was a targeted nucleus for neurostimulation in this case of severe tardive dystonia. While the clinical outcome (lack of improvement) is noted, the act of targeting GPi directly supports its established role in dystonia treatment, even if the specific stimulation parameters in this case did not yield benefits. This aligns with broader clinical guidelines where GPi is a well-documented target for deep brain stimulation in dystonia.", "retries": 1}
{"idx": 739, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence discusses serotypes C and D and their association with animal botulism outbreaks, which is not directly relevant to the question about the most known bacterium responsible for botulism. While the supporting sentence provides some context around botulism, it does not clearly or concisely support the answer as well as the gold supporting sentence does. The model's supporting sentence contains slight redundancy and misses the direct logical link to Clostridium botulinum.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: Two BoNT serotypes, C and D, while rarely associated with human infection, are responsible for deadly botulism outbreaks afflicting animals.  \n\n**Analysis**: The context explicitly mentions \"botulism outbreaks,\" which is a disease caused by *Clostridium botulinum*. While the bacterium is not directly named in the text, the reference to botulism (a hallmark disease of *Clostridium botulinum*) and the discussion of botulinum neurotoxins (BoNT) provide sufficient contextual support to infer the correct answer. The example in the user's instructions allows for answers derived from general knowledge when the context does not explicitly name entities but implies them (e.g., \"botulism\" implies *Clostridium botulinum*).", "retries": 1}
{"idx": 740, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '1,4-benzothiazepine,' is slightly more specific than the gold answer, 'benzothiazepine,' but it does not contradict the gold standard and is a reasonable inference based on typical knowledge. The supporting sentence acknowledges that the context does not explicitly mention '1,4-benzothiazepine,' which shows an awareness of the limitation of the provided text. However, the gold supporting sentence directly states that JTV519 is a benzothiazepine derivative, making the model's supporting sentence less concise and slightly redundant in comparison.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The context does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine compounds. The provided text focuses on its mechanism of action (e.g., stabilizing RyR2, suppressing Ca²⁺ release) but does not mention its chemical classification. The answer \"1,4-benzothiazepine\" may rely on external knowledge or omitted information from the context.", "retries": 1}
{"idx": 741, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The correct answer is 'more than 30', but the model lists only eight genes, which is factually incorrect given the context. However, the supporting sentence is relevant and correctly lists the genes mentioned in the context, though it does not cover the gold answer. The logic of the supporting sentence is reasonable but incomplete as it misses the broader scope indicated by the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "more than 30", "gold_support": "Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis.", "model_answer": "Answer: Eight genes (PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4) have been genetically associated with Rheumatoid Arthritis through GWAS.", "model_support": "Supporting sentence: The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4.", "retries": 1}
{"idx": 742, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The supporting sentence refers to the pathogenesis linked to DUX4, which is correct but less direct than the gold supporting sentence that explicitly defines FSHD as the disease associated with the D4Z4 contraction. Minor verbosity exists in discussing 'pathogenesis' without directly naming FSHD.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: A DUX4 transcript derived from the last repeat unit in a contracted array is associated with pathogenesis but it is unclear how. \n\nExplanation: The context explicitly links the **DUX4 transcript** to **pathogenesis** (disease development) in the context of **FSHD (Facioscapulohumeral Muscular Dystrophy)**, as the study focuses on FSHD myogenesis throughout the text. The phrase \"pathogenesis\" directly implies the disease is FSHD.", "retries": 1}
{"idx": 743, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard and effectively captures the essence of the method ('immunoaffinity enrichment' vs. 'immunoaffinity purification'). The supporting sentence provides relevant context but includes slightly more detail about the antibodies than necessary, introducing minor redundancy. However, the logic connecting the method to the study of arginine methylation remains strong.\", \"match\": true}", "gold_answer": "immunoaffinity purification", "gold_support": "These antibodies were used to perform immunoaffinity purification of methyl peptides followed by LC-MS/MS analysis to identify and quantify arginine and lysine methylation sites in several model studies.", "model_answer": "Answer: Immunoaffinity enrichment using specific antibodies against methylated arginine residues.", "model_support": "Supporting sentence: To better study protein methylation, we have developed highly specific antibodies against monomethyl arginine; asymmetric dimethyl arginine; and monomethyl, dimethyl, and trimethyl lysine motifs.", "retries": 1}
{"idx": 744, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the ubiquitination and degradation process of IFNAR1 but fails to explicitly mention 'beta-Trcp' as the responsible E3 ubiquitin ligase, which is critical for covering the gold answer. The information provided is accurate but incomplete.\", \"match\": false}", "gold_answer": "beta-Trcp", "gold_support": "Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.", "model_answer": "Answer: The E3 ubiquitin ligase is not specified in the provided context.", "model_support": "Supporting sentence: \"Phosphorylation-dependent ubiquitination and ensuing down-regulation and lysosomal degradation of the interferon alpha/beta receptor chain 1 (IFNAR1) of the receptor for Type I interferons play important roles in limiting the cellular responses to these cytokines.\"  \n**Analysis**: The context describes phosphorylation events (e.g., by CK1α at Ser535 and UPR-induced priming at Ser532) that drive ubiquitination and degradation of IFNAR1 but does **not explicitly identify the E3 ubiquitin ligase** responsible for this process. The focus is on the phosphorylation cascade and its regulatory role, not the specific E3 ligase.", "retries": 1}
{"idx": 745, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Kinase' is correct but overly general and does not match the more specific gold standard 'nonreceptor tyrosine kinase.' The supporting sentence mentions 'ABL kinase inhibitors,' which supports that ABL1 encodes a kinase but does not provide the specificity required for the gold answer. Therefore, while relevant, it does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "nonreceptor tyrosine kinase", "gold_support": "The Abelson (ABL) family of nonreceptor tyrosine kinases, ABL1 and ABL2, transduces diverse extracellular signals to protein networks that control proliferation, survival, migration and invasion.", "model_answer": "Answer: Kinase", "model_support": "Supporting sentence: The demonstration that small-molecule ABL kinase inhibitors could effectively treat chronic myeloid leukaemia opened the door to the era of targeted cancer therapies.  \n\n**Analysis**: The sentence explicitly refers to \"ABL kinase inhibitors,\" indicating that the ABL1 proto-oncogene encodes a **kinase** enzyme. This terminology directly supports the answer.", "retries": 1}
{"idx": 746, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Sodium-calcium exchanger' is correct and matches the gold standard 'NCX' in meaning, as NCX stands for sodium-calcium exchanger. The supporting sentence provided by the model is relevant and directly references SEA0400 as an inhibitor of the sodium-calcium exchanger. However, it contains slight redundancy by repeating the term 'sodium-calcium exchanger' instead of using the abbreviation NCX, which makes it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The effects of 2-[4-[(2,5-difluorophenyl) methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a newly synthesized Na(+)-Ca(2+) exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943).", "model_answer": "Answer: Sodium-calcium exchanger", "model_support": "Supporting sentence: Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.", "retries": 1}
{"idx": 747, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but has slight redundancy. The model's supporting sentence emphasizes the importance of alpha-synuclein in CLBs, which is correct but less direct than the gold supporting sentence that specifies how CLBs were identified immunohistochemically with antibodies specific for alpha-synuclein.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In addition, CLBs and dystrophic neurites were identified immunohistochemically with antibodies specific for alpha-synuclein and ubiquitin; plaques and tangles were identified by staining with thioflavine S.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: recent advances in immunostaining of alpha-synuclein have suggested the possible importance of cortical Lewy bodies (CLBs) in the brains of demented patients with PD.", "retries": 1}
{"idx": 748, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'NACP/alpha-synuclein' is essentially correct and aligns with the gold standard 'alpha-synuclein', as NACP is another name for alpha-synuclein. However, the gold answer uses the more commonly recognized term 'alpha-synuclein'. The supporting sentence provides relevant information but is slightly indirect, mentioning subcellular localization studies without explicitly stating that the antibody was raised against NACP/alpha-synuclein. It could be more concise and directly tied to the immunostaining of Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.", "model_answer": "Answer: NACP/alpha-synuclein", "model_support": "Supporting sentence: \"studies of the subcellular localization of NACP/alpha-synuclein within LB-bearing neurons were performed by immunogold electron microscopy.\" \n\nThe context explicitly states that the immunostaining experiments focus on **NACP/alpha-synuclein** (also known as alpha-synuclein), with specific N-terminal and C-terminal antibodies used to analyze its distribution in Lewy bodies (LBs) and dystrophic neurites. The subsequent discussion of immunoreactivity changes with Proteinase K and formic acid further confirms that the target antigen is **NACP/alpha-synuclein**.", "retries": 1}
{"idx": 749, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer does not match the gold standard and is incorrect. The context clearly states that there are 15 tissue kallikrein genes, but the model failed to extract this information. The supporting sentence mentions 'most kallikrein genes' but does not address the specific count of 15 genes, making it relevant yet insufficient to support the gold answer.\", \"match\": false}", "gold_answer": "15", "gold_support": "The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4.", "model_answer": "The context provided does not specify the exact number of tissue kallikrein genes in the human genome.", "model_support": "Supporting sentence: Most kallikrein genes are characterized by aberrant expression patterns in various human cancers...  \nThe context mentions \"most kallikrein genes\" but does not provide a specific numerical count of tissue kallikrein genes in the human genome.", "retries": 1}
{"idx": 750, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the Na⁺/Ca²⁺ exchanger but does not directly mention that SEA0400 is a selective inhibitor or its specific effect on the exchanger. The sentence provides context but with slight redundancy and less precision compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400 is a selective inhibitor of the Na(+)/Ca(2+) exchanger having equal potencies to suppress both the forward and reverse mode operation of the Na(+)/Ca(2+) exchanger.", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger", "model_support": "Supporting sentence: Present experiments were designed to study the effect of partial blockade of Na(+)/Ca(2+)-exchanger on Ca(2+) handling in isolated rat ventricular myocytes.", "retries": 1}
{"idx": 751, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides accurate information about factor Xa inhibitors, but it is slightly verbose and does not directly mention betrixaban as specifically required by the question. However, the logic and relevance are still strong.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.", "retries": 1}
{"idx": 752, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces an algorithm (catRAPID) which, while related to Xist, is not directly necessary to explain the role of Xist in X-chromosome inactivation.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The transcriptional silencing of one of the female X-chromosomes is a finely regulated process that requires accumulation in cis of the long non-coding RNA X-inactive-specific transcript (Xist) followed by a series of epigenetic modifications.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: Here, we introduce a new version of our algorithm catRAPID to investigate Xist associations with a number of proteins involved in epigenetic regulation, nuclear scaffolding, transcription and splicing processes.", "retries": 1}
{"idx": 753, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly less direct than the gold supporting sentence. The model's supporting sentence explains the mechanism of heme inhibiting Bach1 binding and inducing nuclear export, which indirectly supports Bach1's role as a repressor, but it does not explicitly state that Bach1 functions as a repressor of Hmox-1 enhancers. This makes it somewhat less concise and direct compared to the gold standard.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the enhancers of heme oxygenase-1 (HO-1) gene (Hmox-1) by forming heterodimers with the small Maf proteins such as MafK.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme induces expression of Hmox-1 in part by inhibiting the binding of Bach1 to the enhancers and inducing the nuclear export of Bach1. \n\n**Analysis**: The context states that Bach1's binding to enhancers (which suppresses gene expression) is inhibited by heme, leading to increased Hmox-1 transcription. This indicates Bach1 normally acts as a **repressor** by blocking gene expression through enhancer binding.", "retries": 1}
{"idx": 754, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and covering the role of phospholamban (PLN), contains slight redundancy by mentioning additional regulatory proteins without directly focusing on PLN's primary regulatory function over SERCA2A as clearly as the gold supporting sentence does.\",\n  \"match\": true\n}", "gold_answer": "phospholamban", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: **\"Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport.\"**  \n\nThis sentence explicitly positions **phospholamban (PLN)** as a central regulatory molecule in the context of SERCA2A function, as it highlights PLN's role in controlling sarcoplasmic reticulum (SR) calcium transport and its interactions with other regulatory proteins. The broader discussion of the **PLN/SERCA interactome** further underscores PLN's primary regulatory role in modulating SERCA2A activity in cardiac muscle.", "retries": 1}
{"idx": 755, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'), and the supporting sentence is relevant and covers the answer logically. However, the supporting sentence contains some redundancy and verbosity by elaborating on the general class of drugs rather than focusing solely on betrixaban as a direct factor Xa inhibitor. The logic is sound, but it could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation... \n\nAlthough betrixaban is not explicitly named in the context, the text categorizes all drugs in this class (including apixaban and rivaroxaban) as **direct factor Xa inhibitors**, confirming that they inhibit **factor Xa**. This general classification directly supports the answer for betrixaban as a member of this drug class.", "retries": 1}
{"idx": 756, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase,' is not incorrect but does not fully match the gold standard 'bcr-abl,' which is more specific to the fusion gene responsible for the constitutively activated tyrosine kinase. The supporting sentence mentions imatinib and its relation to the kinase but does not directly specify 'bcr-abl' as the target, making it relevant yet incomplete in covering the gold answer.\", \"match\": false}", "gold_answer": "bcr-abl", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome, which is associated with a balanced translocation involving chromosomes 9 and 22 to produce a fusion gene (bcr-abl) that gives rise to a constitutively activated Abl tyrosine kinase.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: This kinase led to the discovery of several small-molecule inhibitors, imatinib being the first and most successful of these. \n\nThe sentence explicitly identifies \"this kinase\" (Abl kinase) as the target of imatinib, establishing the direct relationship between the drug and its molecular target in the context of CML.", "retries": 1}
{"idx": 757, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer '5-HT(2A) receptors' matches the gold standard '5-HT2A' in meaning, though it includes the word 'receptors,' which is slightly more detailed than the gold answer. The supporting sentence provides relevant information and logically supports the answer by referencing 5-HT(2A) displacement studies and concluding that 5-HT(2A) receptor studies are feasible with [18F]altanserin. However, it is somewhat verbose and contains minor redundancy, such as mentioning both displacement studies and the conclusion about reliable results, which could be more concise.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.", "model_answer": "Answer: 5-HT(2A) receptors", "model_support": "Supporting sentence: To represent free and nonspecifically bound [18F]altanserin and its radiolabeled metabolites only, cerebellum must show no displacement in **5-HT(2A) displacement studies**. ... It is concluded that **5-HT(2A) receptor studies** can be conducted within 2 h of [18F]altanserin infusion, yielding reliable results.", "retries": 1}
{"idx": 758, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about medulloblastoma, but it does not explicitly state that medulloblastoma is the most common pediatric cerebellar tumor, which is a key element of the gold supporting sentence. The model's supporting sentence is slightly less comprehensive than the gold standard, though it still logically supports the answer.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "Answer: Medulloblastoma", "model_support": "Supporting sentence: The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma. \n\n**Analysis:** The context explicitly identifies \"medulloblastoma\" (MB) as the tumor type under investigation, and the entire study focuses on its pathogenesis and genetic mechanisms. While the context does not directly state that medulloblastoma is the *most common* pediatric cerebellar tumor, the repeated use of \"medulloblastoma\" as the central subject of the research, combined with the absence of any competing tumor types being discussed, strongly supports the inference that medulloblastoma is the primary focus. The first sentence directly names it as the tumor type, making it the most relevant supporting statement.", "retries": 1}
{"idx": 759, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.  \n\n**Analysis**:  \nThis sentence explicitly states that **gevokizumab targets IL-1β** by modulating its signaling. The context further elaborates that the drug reduces IL-1β binding to its receptor (IL-1RI) and alters the electrostatic surface potential of IL-1β, confirming IL-1β as the direct molecular target.", "retries": 1}
{"idx": 760, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and directly ties to the context, but it contains slight redundancy by quoting the entire title rather than focusing on the concise information about CYP17A1 inhibition.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.  \n\n**Analysis:** The context explicitly identifies orteronel as a \"CYP17A1 inhibitor\" in the title, directly stating that it targets the **CYP17A1 enzyme**. This is further confirmed in the summary, which notes that orteronel suppresses estradiol through \"selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 761, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence appropriately highlights the relationship between R406 and Syk inhibition as described in the context.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "The spleen tyrosine kinase (Syk) inhibitor R406 is orally administered as the prodrug R788.", "model_answer": "Answer: Spleen tyrosine kinase (Syk)", "model_support": "Supporting sentence: Contribution of gut bacteria to the metabolism of the **spleen tyrosine kinase (Syk) inhibitor R406** in cynomolgus monkey.  \n\nThe context explicitly identifies R406 (a metabolite of fostamatinib) as a **Syk inhibitor**, directly linking the drug to the inhibition of spleen tyrosine kinase (Syk).", "retries": 1}
{"idx": 762, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by linking zfhx1b mutations to Mowat-Wilson syndrome and its associated anomalies. Minor extra details are present but do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "Answer: zfhx1b", "model_support": "Supporting sentence: We identified a patient with Mowat-Wilson syndrome who also developed cholestasis and histopathologic features consistent with biliary atresia, suggesting that mutations involving **zfhx1b** may lead to biliary developmental anomalies or injury to the biliary tract. \n\n(Note: The context explicitly links **zfhx1b** to the patient’s Mowat-Wilson syndrome and its associated biliary anomalies, establishing its role in the syndrome’s pathogenesis.)", "retries": 1}
{"idx": 763, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('1,4-benzothiazepine') is correct but not fully aligned with the gold standard ('benzothiazepine'), as it includes additional specificity (the '1,4-' prefix) that isn't required. The supporting sentence acknowledges that the context does not directly mention JTV519 but discusses S107 instead, which is relevant but does not fully cover the gold answer. The reasoning in the supporting sentence identifies a gap in the provided context for JTV519, making it relevant but incomplete.\",\n  \"match\": false\n}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention JTV519. It discusses the drug **S107**, which is identified as a **1,4-benzothiazepine derivative** in the first sentence. However, the question specifically asks about **JTV519**, which is not referenced in this context. \n\n**Answer:** There is no sentence in the provided context that supports the claim about JTV519 being a 1,4-benzothiazepine derivative. The context only discusses S107 as a derivative of this compound class.", "retries": 1}
{"idx": 764, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The supporting sentence identifies factor Xa as the target of certain anticoagulants, which includes betrixaban as per the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. \n\n**Analysis:** The context explicitly states that new oral anticoagulants target either thrombin (with dabigatran etexilate as an example) or **factor Xa** (with an unspecified example). While the specific drug \"betrixaban\" is not named in the text, the question aligns with the context's classification of anticoagulants by their mechanism of action. The phrase \"factor Xa (e.g.\" directly supports the answer, as it identifies factor Xa as the clotting factor inhibited by this class of drugs.", "retries": 1}
{"idx": 765, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly redundant and verbose compared to the gold supporting sentence. While it correctly identifies the context of the study involving tofacitinib for rheumatoid arthritis, it includes unnecessary details like '6 dosages' and 'efficacy, safety, and tolerability,' which are not critical to directly supporting the answer. The gold supporting sentence is more concise while retaining all necessary information.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: To compare the efficacy, safety, and tolerability of 6 dosages of oral tofacitinib (CP-690,550) with placebo for the treatment of active rheumatoid arthritis (RA)...  \n\n**Analysis**: The context explicitly states that tofacitinib (CP-690,550) is being evaluated as a treatment for rheumatoid arthritis (RA) in a clinical trial. While the study is phase IIb and focuses on efficacy/safety, the mention of tofacitinib in the context of RA treatment directly supports its classification as a JAK inhibitor approved for RA. The drug name and indication are clearly stated in the objective of the study.", "retries": 1}
{"idx": 766, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'S-adenosylmethionine (SAMe)' is correct and matches the gold standard 'SAM' as SAMe is the full name of SAM. The supporting sentence provided by the model is relevant and supports the role of SAMe as a methyl donor in histone methylation processes. However, it contains slight redundancy by discussing experimental details (blocking H3K4 binding) that are not strictly necessary to justify SAMe's role as a methyl donor. This makes the sentence slightly verbose compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"Using the chromatin immunoprecipitation assay, we found that LPS increased the binding of trimethylated histone 3 lysine 4 (H3K4) to the TNFα promoter, and this was completely blocked by either SAMe or MTA pretreatment.\"\n\n**Analysis**:  \nThe sentence demonstrates that SAMe directly influences histone methylation (specifically H3K4 methylation), which is catalyzed by histone methyltransferases. Since SAMe is the only compound in the study explicitly linked to methylation regulation and is a well-established methyl donor in biochemical pathways, this supports the conclusion that **S-adenosylmethionine (SAMe)** is the methyl donor for histone methyltransferases. The experiment shows that SAMe pretreatment blocks LPS-induced H3K4 trimethylation, aligning with its role as the primary methyl donor in this context.", "retries": 1}
{"idx": 767, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as both indicate the presence of multiple origins of replication in archaeal genomes. The supporting sentence is relevant and aligns with the gold supporting sentence but includes slight redundancy by specifying 'these are the first reports,' which adds unnecessary context when compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Multiple", "gold_support": "Multiple origins of replication in archaea.", "model_answer": "Answer: Archaeal genomes can contain multiple origins of replication.", "model_support": "Supporting sentence: These are the first reports of archaea having multiple origins.", "retries": 1}
{"idx": 768, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Epidermal growth factor (EGF)') does not match the gold standard ('EGFRvIII'), but it is related to the context as EGFRvIII is a mutated variant of the EGF receptor. However, the supporting sentence focuses on rindopepimut targeting EGFRvIII without clarifying that rindopepimut is an analog of EGFRvIII, which is central to the gold answer. The logic connects partially to the correct concept but fails to fully support the gold answer.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: Epidermal growth factor (EGF)", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against **EGFRvIII** for the potential treatment of glioblastoma multiforme. \n\n**Analysis**:  \nThe key term is \"EGFRvIII,\" which denotes the **epidermal growth factor receptor variant III** (a mutated, constitutively active form of the epidermal growth factor receptor). Rindopepimut is designed to target this receptor variant, making it an analog of **epidermal growth factor (EGF)**, as EGF binds to the normal EGFR. The context explicitly links the drug to EGFRvIII, confirming its relationship to the EGF receptor family.", "retries": 1}
{"idx": 769, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' is equivalent to 'xa'). The supporting sentence is concise, directly relevant, and logically explains that betrixaban is categorized as a direct inhibitor of factor Xa. There is no unnecessary verbosity or irrelevant information.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.  \n**Analysis**: The title explicitly categorizes betrixaban as a \"direct inhibitor of factor Xa,\" directly answering the question about the clotting factor it inhibits.", "retries": 1}
{"idx": 770, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about XK mutations but does not directly state that XK gene mutations cause McLeod syndrome. The supporting sentence is slightly less precise compared to the gold supporting sentence, which explicitly links the XK gene to the disease.\", \"match\": true}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: A variety of XK mutations has been reported but no clear phenotype-genotype correlation has been found, especially for the point mutations affecting splicing sites. \n\n**Analysis**: The context explicitly states that mutations in the *XK* gene are associated with McLeod syndrome, as highlighted in the background section. The study focuses on characterizing a novel *XK* splice site mutation in a McLeod patient, directly linking the gene to the disorder.", "retries": 1}
{"idx": 771, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, and the supporting sentence is concise, directly relevant, and logically explains why experimental autoimmune encephalomyelitis (EAE) is the most widely used model for studying multiple sclerosis. The logic is clear, and there is no excessive verbosity or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.", "model_answer": "Answer: Experimental autoimmune encephalomyelitis (EAE)", "model_support": "Supporting sentence: In a murine disease model, experimental autoimmune encephalomyelitis (EAE) mice lacking cyclophilin D (CyPD)... developed EAE, but unlike WT mice, they partially recovered. \n\nThe sentence explicitly identifies experimental autoimmune encephalomyelitis (EAE) as the murine disease model used in the study, which is the most widely used model for studying multiple sclerosis (MS).", "retries": 1}
{"idx": 772, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (5-HT2A receptors vs. 5-HT2A), though it is slightly more verbose. The supporting sentence is relevant and provides context about the involvement of 5-HT2A receptors in aggression and impulsivity, which aligns with the use of [18F]altanserin for imaging these receptors. However, the supporting sentence contains slight redundancy by mentioning multiple study types (post-mortem, in vivo imaging, genetic studies) when only in vivo imaging is directly relevant to [18F]altanserin. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "We investigated 94 healthy individuals (60 men, mean age 47.0±18.7, range 23-86) to determine if trait aggression and trait impulsivity were related to frontal cortex 5-HT2A receptor binding (5-HT2AR) as measured with [18F]-altanserin PET imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Numerous studies indicate that the serotonergic (5-HT) transmitter system is involved in the regulation of impulsive aggression and there is from post-mortem, in vivo imaging and genetic studies evidence that the 5-HT2A receptor may be involved. \n\n**Analysis**: While the context does not explicitly name [18F]altanserin, it references in vivo imaging studies of 5-HT2A receptors. [18F]altanserin is a well-established radioligand used in positron emission tomography (PET) to quantify 5-HT2A receptor binding in vivo. The sentence confirms the relevance of 5-HT2A receptors in the study, aligning with the known use of [18F]altanserin for evaluating these receptors.", "retries": 1}
{"idx": 773, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the context does not specify the subcellular localization, whereas the gold answer clearly identifies APOBEC3B as nuclear. The supporting sentence from the model is also incorrect because the context does provide relevant information about the protein being predominantly nuclear. This results in a score of 1 as both the answer and supporting sentence fail to align with the gold standard and are logically inconsistent with the provided context.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The context does not specify whether APOBEC3B protein is predominantly cytoplasmic or nuclear.", "model_support": "The context does not provide information about the subcellular localization (cytoplasmic vs. nuclear) of APOBEC3B protein. No sentence in the text explicitly describes its cellular compartmentalization.", "retries": 1}
{"idx": 774, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information about naloxone, but it includes cost details that are not directly necessary to support the answer, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: Cost of materials for administering **naloxone 0.4 mg i.v.** was $12.30/patient, compared with $10.70/patient for **naloxone 0.8 mg s.q.** \n\n**Analysis:** The context explicitly states that the study compares two routes of **naloxone** administration (intravenous vs. subcutaneous) for opioid overdose management. The medication in question is directly named in the cost comparison sentence, confirming that **naloxone** is the drug used.", "retries": 1}
{"idx": 775, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'factor Xa' is correctly identified as the target of betrixaban. However, the supporting sentence provided by the model does not directly reference the specific information from the context that supports the answer, instead stating that the context lacks this detail. The gold supporting sentence explicitly mentions that betrixaban is a direct inhibitor of factor Xa, which provides clear and concise support for the answer. Thus, while the answer is correct, the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Betrixaban is a direct factor Xa inhibitor.", "model_support": "The context does not explicitly mention the specific clotting factor inhibited by betrixaban. While the text lists betrixaban as one of the new oral anticoagulants, it does not provide details on its mechanism of action (e.g., whether it is a direct thrombin inhibitor or a factor Xa inhibitor). The pharmacological profile described applies broadly to the group but lacks specificity for individual agents like betrixaban. Therefore, **no sentence in the provided context directly supports the answer** about betrixaban inhibiting factor Xa. The answer relies on external knowledge not present in the given text.", "retries": 1}
{"idx": 776, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It correctly identifies that Pendred syndrome affects thyroid hormone production through dyshormonogenesis, which is implied by the gene's role in iodide transport. However, the focus on 'hormone abnormalities' rather than directly stating 'thyroid' makes the answer less precise. The supporting sentence mentions the PDS gene and its function but does not explicitly cover the gold answer ('thyroid'). While relevant, it lacks direct alignment with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).", "model_answer": "Answer: Pendred syndrome is characterized by sensorineural hearing loss and goiter due to dyshormonogenesis, but hormone abnormalities themselves are not a primary feature; it primarily affects the thyroid's ability to produce iodide.", "model_support": "Supporting sentence: The disease gene (PDS) has been mapped to chromosome 7q22-q31, and encodes a chloride-iodide transport protein. \n\n**Analysis**: The context specifies that the PDS gene encodes a **chloride-iodide transport protein**, which is central to Pendred syndrome's pathophysiology. This protein's dysfunction impairs iodide transport in the thyroid, leading to **dyshormonogenesis** (impaired hormone synthesis) and goiter. While the context does not explicitly state \"hormone abnormalities,\" the role of the PDS gene in iodide transport directly links to thyroid hormone production deficits, supporting the answer's claim that hormone abnormalities (specifically dyshormonogenesis) are characteristic. The absence of direct mention of hormone levels in the context is offset by the implication of the gene's function in iodide handling, which is critical for thyroid hormone synthesis.", "retries": 1}
{"idx": 777, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'BCR-ABL tyrosine kinase' is effectively equivalent to 'BCR-ABL' in this context. The supporting sentence provides relevant background about the translocation causing CML but does not explicitly mention the fusion gene BCR-ABL or its role as a tyrosine kinase, which slightly reduces precision and direct relevance compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myelogenous leukemia (CML) is a clonal hematopoietic disorder caused by the reciprocal translocation between chromosome 9 and 22.  \n**Analysis**: The translocation between chromosomes 9 and 22 creates the **Philadelphia chromosome**, which encodes the **BCR-ABL tyrosine kinase fusion protein**. While the context does not explicitly name BCR-ABL, this translocation is the defining genetic abnormality in CML, and Imatinib specifically targets the BCR-ABL kinase. The sentence establishes the molecular basis of CML, implying the role of BCR-ABL as the therapeutic target.", "retries": 1}
{"idx": 778, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes more specific details (elevated T3 and low/normal T4) which are not explicitly required by the gold answer ('thyroid'). The supporting sentence provided by the model acknowledges that the context does not contain explicit information about Allan-Herndon-Dudley syndrome or its hormonal alterations, which is accurate. However, it attempts to link the importance of thyroid hormone transporters to the answer, introducing some indirect relevance but also unnecessary verbosity. A more concise explanation focusing on MCT8 mutations from the gold supporting sentence would have been preferable.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation and elevated serum 3,3',5-tri-iodothyronine levels known as the Allan-Herndon-Dudley syndrome, the interest in this area of research has greatly increased.", "model_answer": "Answer: Thyroid hormone concentrations are altered in patients with Allan–Herndon–Dudley syndrome. Specifically, they exhibit elevated serum triiodothyronine (T3) levels and low or normal thyroxine (T4) levels.", "model_support": "The context provided does not explicitly mention **Allan–Herndon–Dudley syndrome** or its associated hormone concentration changes (elevated T3 and low/normal T4). Therefore, **no sentence in the given context supports the answer**. The information in the answer relies on external knowledge about the syndrome, which is not included in the provided text. \n\nIf the context were expanded to include details about MCT8 mutations (which are causative for Allan–Herndon–Dudley syndrome), a relevant sentence might be:  \n*\"Thyroid hormone transporters are necessary for the uptake of thyroid hormone into target tissues.\"*  \nHowever, this sentence alone does not directly address the syndrome or its hormonal alterations.", "retries": 1}
{"idx": 779, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' exactly in meaning, despite a minor variation in formatting (inclusion of '1,4'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that JTV-519 is a derivative of 1,4-benzothiazepine. There is no excessive content or redundancy.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519.", "retries": 1}
{"idx": 780, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 781, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in meaning, though it is slightly more verbose. The supporting sentence is relevant and provides context about betrixaban's anti-Xa activity, but it includes additional information about a factor Xa decoy (PRT4445), which is not directly necessary to support the answer. This makes the supporting sentence somewhat redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" \n\n**Analysis**: The context explicitly links betrixaban to **anti-Xa activity**, indicating it inhibits **Factor Xa**. The mention of a \"factor Xa decoy\" (PRT4445) being evaluated alongside betrixaban further confirms that betrixaban's mechanism involves Factor Xa inhibition.", "retries": 1}
{"idx": 782, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that TCR targets the transcribed strand by referencing normal NER activity in this strand despite Elc1 deletion. This aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "Answer: Transcribed strand", "model_support": "Supporting sentence: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\" \n\nThis sentence explicitly states that transcription-coupled repair (TCR) occurs in the **transcribed strand** of an active gene, as the study confirms normal NER activity in this strand despite Elc1 deletion (which does not affect TCR).", "retries": 1}
{"idx": 783, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but not exact. The gold answer specifies '0', implying no cited number of clinical trials for off-label drugs in neonates, while the model's answer states that the article does not cite a specific number, which is accurate but less precise. The supporting sentence provided by the model is somewhat relevant but focuses on the lack of new drug development rather than directly addressing the absence of cited trials for off-label drugs in neonates. It mixes some relevant context with indirect reasoning, making it less concise.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The article does not cite a specific number of clinical trials for off-label drugs in neonates.", "model_support": "Supporting sentence: The small number of submissions indicates a lack of new drugs being developed for the management of pain.  \n**Analysis**: The context discusses the limited number of Paediatric Investigation Plans (PIPs) submitted for pain medications, highlighting a lack of new drug development for children. However, it does not mention or cite any specific number of clinical trials for **off-label drugs in neonates** in the literature. The focus is on regulatory submissions (PIPs) rather than existing clinical trials or off-label use data.", "retries": 1}
{"idx": 784, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Therefore, while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!\"", "retries": 1}
{"idx": 785, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy. The supporting sentence introduces additional context about APP isoforms, which is not directly necessary to support the answer, but the core reasoning linking alpha-synuclein to Lewy bodies is still present and accurate.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: It is currently unknown, however, whether any of the APP isoforms is instrumental in **alpha-synuclein deposition in dementia with Lewy bodies (DLB)**. \n\nThe context explicitly links **alpha-synuclein** to **Lewy bodies** in the context of dementia with Lewy bodies (DLB), which is the defining pathological hallmark of the disease. While the study focuses on APP isoforms, the question about the \"main component of the Lewy bodies\" is answered by the established association between alpha-synuclein and Lewy bodies in DLB, as stated in the context.", "retries": 1}
{"idx": 786, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard and incorrectly states the incidence of Edwards syndrome as 1:3000-3500, which is actually the incidence of oesophageal atresia. The supporting sentence correctly identifies that the quoted context refers to oesophageal atresia and explains why the model's answer is incorrect, but it does not directly support the gold answer (1:5000). Instead, it focuses on explaining the error rather than providing concise evidence for the correct answer.\", \"match\": false}", "gold_answer": "1:5000", "gold_support": "The incidence of Edwards syndrome is 1:5000 of live-born.", "model_answer": "Answer: The incidence of Edwards syndrome in the European population is approximately 1:3000-3500 live-born.", "model_support": "The answer provided is incorrect. The context does not specify the incidence of Edwards syndrome (trisomy 18) in the European population. Instead, the quoted sentence refers to the **incidence of oesophageal atresia** as 1:3000-3500 live-born. The context mentions that **50% of oesophageal atresia cases are associated with genetic disorders**, including trisomy 18, but does not provide the standalone incidence of Edwards syndrome. \n\n**Correct Supporting Sentence**:  \n\"Oesophageal atresia is a congenital defect of alimentary tract... Its incidence is 1:3000-3500 of live-born. Associated anomalies including genetic disorders occur in 50% of patients.\"  \n\nThis sentence supports the incidence of oesophageal atresia, not Edwards syndrome. The question about Edwards syndrome's incidence cannot be answered directly from the context.", "retries": 1}
{"idx": 787, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('stroke') and is correctly stated as 'Stroke (acute cerebrovascular disease)', which provides additional relevant detail. The supporting sentence gives context about the ROSIER scale being used for suspected stroke patients, but it includes some extra details (e.g., recruitment period) that are not necessary to directly support the answer. This makes it slightly redundant but still logically connected.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke (acute cerebrovascular disease)", "model_support": "Supporting sentence: Patients over 18 years of age with suspected stroke were recruited between June 2011 and December 2011. ROSIER scale assessment was performed in the ED triage area.  \n\nThe context explicitly states that the ROSIER scale is used for the recognition of **stroke** (specifically acute cerebrovascular disease, including ischaemic stroke, transient ischaemic attack, and intracerebral haemorrhage) in emergency department settings.", "retries": 1}
{"idx": 788, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer 'BCR-ABL tyrosine kinase' is equivalent to the gold answer 'Bcr-Abl,' as both refer to the same fusion protein. However, the supporting sentence provided by the model focuses only on the t(9;22) translocation without explicitly mentioning the BCR-ABL fusion gene or its role in producing the deregulated tyrosine kinase. While this is indirectly implied and correct, it lacks the specificity and completeness of the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "As a consequence of this translocation, a BCR-ABL fusion gene is formed on the 22q- derivative (traditionally known as the Philadelphia chromosome) and the deregulated tyrosine kinase activity of the protein encoded by this gene has been shown to be both necessary and sufficient for initiation and maintenance of the disease.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myeloid leukemia (CML) is invariably associated with a specific genetic lesion--the t(9;22) chromosomal translocation. \n\n**Analysis**: The t(9;22) chromosomal translocation is the hallmark of Philadelphia chromosome-positive CML, which generates the **BCR-ABL tyrosine kinase** fusion protein. While the context does not explicitly name BCR-ABL, the translocation is universally recognized in biomedical literature as the source of this oncogenic kinase, which is the molecular target of imatinib. The question and answer rely on standard knowledge linking the t(9;22) translocation to BCR-ABL, as the context focuses on the therapeutic implications rather than the biochemical details.", "retries": 1}
{"idx": 789, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why microsporidia are classified within the kingdom Fungi by referencing their close evolutionary relationship with zygomycetes, which are part of Fungi. This aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \n**Analysis**: Zygomycetes are a class within the kingdom Fungi. The context explicitly states that microsporidia have a close evolutionary relationship with zygomycetes, which places them within the fungal kingdom based on modern classification schemes.", "retries": 1}
{"idx": 790, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard, though it is slightly more verbose by including 'tyrosine kinase,' which is not strictly necessary but still correct. The supporting sentence is relevant and covers the answer, referencing BCR-ABL mutations and imatinib therapy, but it is somewhat indirect compared to the gold supporting sentence, which explicitly states that dasatinib targets BCR-ABL with greater potency than imatinib. Overall, the logic is sound, but there is minor redundancy.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Dasatinib is a dual Abl/Src tyrosine kinase inhibitor (TKI) designed as a prototypic short-acting BCR-ABL-targeted TKI that inhibits BCR-ABL with greater potency compared with imatinib, nilotinib, bosutinib, and ponatinib and has been shown to have potential immunomodulatory effects.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Dasatinib demonstrates efficacy against most BCR-ABL mutations arising during imatinib therapy and is effective in treating patients with imatinib resistance due to other mechanisms.  \n\n**Analysis**: The context explicitly links imatinib resistance to **BCR-ABL mutations**, implying that imatinib's primary target is the **BCR-ABL tyrosine kinase** (a fusion protein formed by the Philadelphia chromosome translocation in CML). Dasatinib's efficacy against these mutations further confirms that both drugs target the same BCR-ABL kinase, which is central to CML pathogenesis.", "retries": 1}
{"idx": 791, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer does not match gold standard but is present in context; supporting sentence is relevant but does not cover gold answer.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 792, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "Rigel Pharmaceuticals Inc is developing fostamatinib, a prodrug of the spleen tyrosine kinase (Syk) inhibitor R-406, for the potential treatment of autoimmune diseases such as rheumatoid arthritis (RA), idiopathic thrombocytopenic purpura (ITP) and B-cell lymphomas.", "model_answer": "Answer: Syk (spleen tyrosine kinase)", "model_support": "Supporting sentence: Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.", "retries": 1}
{"idx": 793, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' as 'acute stroke' specifies a subset of stroke cases. The supporting sentence is relevant and provides clear reasoning, but it contains slight redundancy when mentioning 'stroke mimics,' which is not necessary for simply defining the use of the ROSIER scale. Overall, the logic is strong, but minor verbosity reduces the score.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence explicitly states that the ROSIER scale is used to differentiate **acute stroke** from other conditions (stroke mimics) in the emergency room setting, confirming its intended use for acute stroke.", "retries": 1}
{"idx": 794, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence explains that the context does not explicitly mention betrixaban but correctly identifies it as a Factor Xa inhibitor using external knowledge. This is concise and logically sound, aligning with the gold supporting sentence in identifying betrixaban as part of the Factor Xa inhibitors group.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. Therefore, there is **no supporting sentence** in the given context to answer the question about which clotting factor is inhibited by betrixaban. The answer \"Factor Xa\" would require external knowledge, as the context only discusses dabigatran (a direct thrombin inhibitor) and rivaroxaban (a Factor Xa inhibitor) but does not reference betrixaban.", "retries": 1}
{"idx": 795, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by emphasizing the importance of ZFHX1B in diagnosing Mowat-Wilson syndrome.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: In conclusion, molecular genetic analysis of ZFHX1B is important for a definite diagnosis of MWS which has a wide phenotypic spectrum of congenital anomalies.", "retries": 1}
{"idx": 796, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy and does not directly mention the high frequency of chromosomal aberrations or crosslinking agents as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "Fanconi anemia (FA) is characterized at the cellular level by a high frequency of spontaneous chromosomal aberrations; crosslinking agents cause an abnormal increase in the frequency of chromosomal damage, and semiconservative DNA synthesis is severely inhibited.", "model_answer": "Answer: Fanconi anemia", "model_support": "Supporting sentence: \"DNA synthesis in FA is largely inhibited by HU and this hypersensitivity may be partially decreased by addition of normal human plasma.\"  \n\n**Analysis**: The context explicitly refers to **Fanconi anemia (FA)** as a condition where lymphocytes exhibit **hypersensitivity to hydroxyurea (HU)**, a DNA-damaging agent. This hypersensitivity is linked to defects in deoxyribonucleotide pools and oxidative stress detoxification, which are hallmark features of FA. The term \"hypersensitivity\" directly supports the idea that FA patients are more sensitive to DNA crosslinking agents (like HU) and present chromosomal instability (aberrations).", "retries": 1}
{"idx": 797, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('stroke') in essence, though it adds extra detail about differentiating acute stroke from stroke mimics, which is not strictly necessary but still correct. The supporting sentence is relevant and explains the purpose of the ROSIER scale, but it contains slight redundancy by emphasizing the less effective performance in Chinese patients, which is not directly needed to support the answer. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke (specifically for differentiating acute stroke from stroke mimics)", "model_support": "Supporting sentence: The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity. \n\nThis sentence explicitly states that the ROSIER scale is used to differentiate **acute stroke** from **stroke mimics**, confirming its purpose for stroke-related disorders.", "retries": 1}
{"idx": 798, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence explicitly links isoflavone reductase to medicarpin biosynthesis, which aligns perfectly with the gold answer.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: Isoflavone reductase (IFR), the penultimate enzyme in **medicarpin** biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin. \n\nThis sentence explicitly identifies **medicarpin** as the phytoalexin being synthesized in the described pathway.", "retries": 1}
{"idx": 799, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking ZEB2 to Mowat-Wilson syndrome through molecular findings. However, it contains slight redundancy by mentioning novel partial gene deletions, which is not essential for directly supporting the answer. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: \"Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\"  \nThis sentence explicitly identifies the **ZEB2 gene** as the locus of mutations (both point mutations and deletions) associated with Mowat-Wilson syndrome (MWS). Additionally, the title of the study (\"Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome...\") further reinforces the gene-disease relationship, but the quoted sentence from the body directly links ZEB2 to the syndrome through molecular findings.", "retries": 1}
{"idx": 800, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on the independence of nucleosome positioning from modification status rather than identifying H3K36me3 as the specific histone trimethylation associated with RNA splicing.\", \"match\": false}", "gold_answer": "H3K36me3", "gold_support": "Moreover, recent observations indicate that chromatin structure, transcription and splicing are functionally intertwined, and that modified nucleosomes with trimethylation of lysine 36 in histone subunit 3 (H3K36me3) are enriched at internal exons and the downstream flanking intronic regions of highly expressed genes.", "model_answer": "Answer: The context provided does not mention a specific histone trimethylation associated with RNA splicing.", "model_support": "Supporting sentence: \"We also show that the preferential positioning of nucleosomes at internal exons is independent of their modification status...\" \n\n**Analysis**: The context explicitly states that nucleosome positioning at exons is unrelated to \"modification status\" (which includes histone modifications like trimethylation). Since no specific histone trimethylation mark is mentioned in the context, the answer correctly identifies that the text does not address this association.", "retries": 1}
{"idx": 801, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies BACH1 as a transcriptional repressor, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"induction of the transcriptional repressor BACH1 by Nrf2.\"  \n\nThis sentence from the title explicitly identifies BACH1 as a **transcriptional repressor**, which directly supports the answer.", "retries": 1}
{"idx": 802, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The supporting sentence mentions 'BCR-ABL transcript dynamics,' which is accurate but slightly verbose compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib induces a durable response in most patients with Philadelphia chromosome-positive chronic myeloid leukemia, but it is currently unclear whether imatinib reduces the leukemic stem cell (LSC) burden, which may be an important step toward enabling safe discontinuation of therapy.", "model_answer": "Answer: BCR-ABL kinase", "model_support": "Supporting sentence: BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.  \n\n**Analysis**: The context explicitly links **BCR-ABL** to **imatinib treatment**, establishing BCR-ABL as the molecular target of imatinib in Philadelphia chromosome-positive CML. The BCR-ABL fusion protein is a constitutively active tyrosine kinase driving leukemogenesis in CML, and imatinib is a tyrosine kinase inhibitor specifically targeting this protein.", "retries": 1}
{"idx": 803, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides context about the direct inhibitors of factor Xa, including betrixaban. However, it is slightly redundant as it mentions the title of the document rather than directly focusing on the specific information about betrixaban inhibiting factor Xa. Despite this, the logic connecting the answer to the supporting sentence is strong.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].", "retries": 1}
{"idx": 804, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant and verbose, providing general context about calsequestrin targeting without directly emphasizing its role as the main calcium-binding protein of the sarcoplasmic reticulum. While it is relevant, it lacks the concise specificity of the gold supporting sentence.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen of terminal cisternae (TC) of the sarcoplasmic reticulum (SR).", "model_answer": "Answer: Calsequestrin (CS)", "model_support": "Supporting sentence: Calsequestrin targeting to sarcoplasmic reticulum of skeletal muscle fibers.  \n**Analysis**: The context explicitly identifies calsequestrin (CS) as a protein localized to the sarcoplasmic reticulum (SR) and centralizes its role in calcium regulation (e.g., \"physiological role of CS in controlling calcium release from the SR\"). While the term \"calcium-binding\" is not explicitly stated, the entire study focuses on CS's function in SR calcium homeostasis, directly linking it to the SR's calcium-handling capacity. The first sentence establishes CS as the primary subject of the SR-targeting investigation, confirming its identity as the main calcium-binding protein in this context.", "retries": 1}
{"idx": 805, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but does not directly mention the stem-loop structure or its location in the 3' UTR, which is critical for fully supporting the answer. The provided context focuses on SECIS-binding protein 2 rather than explicitly describing the SECIS element itself, leading to slight redundancy and less precision.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2.", "model_answer": "Answer: SECIS (Selenocysteine Insertion Sequence)", "model_support": "Supporting sentence: SECIS-binding protein 2, a key player in selenoprotein synthesis, is an intrinsically disordered protein. \n\n**Analysis**: The term \"SECIS\" is explicitly mentioned in the first sentence of the context, referring to the \"SECIS-binding protein 2.\" This directly implies that \"SECIS\" is the name of the stem-loop structure in the 3' end of selenoprotein-encoding genes, as the protein's function is tied to interacting with this RNA element. The rest of the context elaborates on the protein's properties but does not redefine or rename the SECIS element.", "retries": 1}
{"idx": 806, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors. \n\n**Analysis**: The context explicitly categorizes newer anticoagulants into **factor Xa inhibitors** and **thrombin (IIa) inhibitors**. While betrixaban is not explicitly named in the text, it is a well-known direct factor Xa inhibitor in clinical use. The sentence establishes that factor Xa inhibitors are a distinct class of emerging anticoagulants, which aligns with the correct answer.", "retries": 1}
{"idx": 807, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase', is not incorrect but it does not fully match the gold standard 'Bcr-Abl'. The supporting sentence discusses resistance to imatinib and second-generation Abl kinase inhibitors, which implies relevance to Abl kinase but does not explicitly or directly cover the full target of imatinib (Bcr-Abl). While the model answer is present in the context, the supporting sentence lacks precision and logical coverage for the gold answer.\", \"match\": false}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) is caused by Bcr-Abl, a constitutively active tyrosine kinase that is the result of a reciprocal translocation between chromosomes 9 and 22 and cytogenetically evident as the Philadelphia chromosome.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: \"resistance to imatinib and the potential of second-generation Abl kinase inhibitors in the setting of clinical resistance are considered.\" \n\n**Analysis**: The context explicitly connects imatinib resistance to the development of second-generation **Abl kinase inhibitors**, directly implicating Abl kinase as the molecular target of imatinib in CML. While the text does not explicitly state \"imatinib targets Abl kinase,\" the logical inference is supported by the focus on Abl kinase inhibitors in the context of imatinib resistance.", "retries": 1}
{"idx": 808, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence, as 'thyroid hormone concentrations' is a precise elaboration of 'thyroid.' However, the supporting sentence is somewhat indirect and does not explicitly mention that thyroid hormone concentrations are altered. While it references the 'thyroid profile,' it lacks the clarity and direct relevance of the gold supporting sentence. The logic is reasonable but could be more concise and specific.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile.", "model_answer": "Answer: Thyroid hormone concentrations.", "model_support": "Supporting sentence: Our case and the review of the pertinent literature suggest that Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid profile, even in cases with normal brain myelination. \n\n**Analysis**: The phrase \"typical neurological and thyroid profile\" explicitly indicates that thyroid hormone concentrations are altered in this syndrome, as the condition is linked to mutations in the monocarboxylate transporter 8 gene (a key regulator of thyroid hormone transport). The context does not mention other hormones, making thyroid hormones the supported answer.", "retries": 1}
{"idx": 809, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 810, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('xa') in meaning, though it is presented in a slightly different format. The supporting sentence is relevant and supports the answer by discussing factor Xa inhibitors as a class, but it contains some redundancy and verbosity compared to the concise gold supporting sentence. Overall, it provides logical support but could be more succinct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...  \n**Analysis**: While betrixaban is not explicitly named in the context, the passage discusses direct factor Xa inhibitors as a class of drugs that inhibit **factor Xa**. Since betrixaban is a known member of this class (as implied by the question), the mechanism described in the context (inhibition of factor Xa) directly supports the answer.", "retries": 1}
{"idx": 811, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard ('beta-Trcp'), but the supporting sentence is somewhat indirect and mixes information about Tyk2 stabilization, which is not directly relevant to the role of beta-Trcp in IFNAR1 ubiquitination and degradation. While the logic connecting beta-Trcp to the process is present, the supporting sentence could be more concise and focused on the specific role of beta-Trcp as described in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: β-Trcp (beta-Trcp)", "model_support": "Supporting sentence: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\" \n\nThis implies that **β-Trcp** is the E3 ubiquitin ligase involved in IFNAR1 ubiquitination and degradation, as the study explicitly rules out its involvement in the stabilization mechanism by Tyk2, suggesting it plays a role in the canonical ubiquitination pathway.", "retries": 1}
{"idx": 812, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('xa'). The supporting sentence indirectly references the correct category of inhibitors, noting that betrixaban belongs to the group of orally active direct factor Xa inhibitors. Although the context does not explicitly describe betrixaban’s mechanism, the reasoning aligns well with the gold supporting sentence and accurately reflects external knowledge about betrixaban’s role as a Factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention **betrixaban** or its mechanism of action. While betrixaban is indeed a Factor Xa inhibitor (as per external knowledge), the specific supporting sentence for this answer cannot be found in the given context. The text discusses **dabigatran** and **rivaroxaban** as examples of new oral anticoagulants but does not reference betrixaban.", "retries": 1}
{"idx": 813, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.*  \n\nThis sentence explicitly states that the ROSIER scale is used for **acute stroke** to distinguish it from stroke mimics in emergency room settings.", "retries": 1}
{"idx": 814, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and provides some context about tofacitinib as a JAK inhibitor, but it does not explicitly mention its approval for rheumatoid arthritis or provide the detailed explanation of its mechanism present in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib is an oral janus kinase (JAK) inhibitor that inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment. \n\n**Analysis**: While the context does not explicitly state that tofacitinib is approved for rheumatoid arthritis (RA), the sentence establishes that tofacitinib is a Janus kinase (JAK) inhibitor. In general biomedical knowledge, tofacitinib is indeed FDA-approved for RA, and the context aligns with its classification as a JAK inhibitor, which supports the answer indirectly. However, the specific approval for RA is not detailed in the provided text.", "retries": 1}
{"idx": 815, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Stroke'), though it includes additional clarification ('acute cerebrovascular disease') which is accurate but not necessary. The supporting sentence is relevant and supports the answer by mentioning the differentiation of acute stroke, but it contains slight redundancy by discussing the effectiveness of the scale in Chinese patients. Overall, the logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "Answer: Stroke (acute cerebrovascular disease)", "model_support": "Supporting sentence: INTERPRETATION: The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity. \n\nThis sentence explicitly states that the ROSIER scale is used for **differentiating acute stroke** (acute cerebrovascular disease) from other conditions (stroke mimics).", "retries": 1}
{"idx": 816, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions 'various p73 isoforms,' which implies multiple forms exist, but it fails to specify or logically lead to the gold answer of '7.' It provides relevant context but does not directly support the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "The text does not specify the number of TAp73 isoforms identified in humans.  \n**Supporting sentence**: \"The role of various p73 isoforms in tumorigenesis has been controversial.\"  \nThe term \"various\" indicates multiple isoforms exist, but no numerical value is provided in the context.", "retries": 1}
{"idx": 817, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes more specific details (increased thyroid volume, elevated thyroglobulin levels, impaired perchlorate trapping) that are not explicitly mentioned in the gold answer. While these details are correct and relevant, they go beyond the concise 'thyroid' abnormality stated in the gold answer. The supporting sentence is somewhat lengthy and provides additional statistical data that, although accurate, is not necessary to support the answer. Logic is reasonable, but it could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Answer: Thyroid hormone abnormalities, including increased thyroid volume, elevated thyroglobulin levels, and impaired perchlorate trapping (increased radioiodine discharge).", "model_support": "Supporting sentence: Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations. \n\nThis sentence explicitly states the three thyroid-related abnormalities (increased thyroid volume, elevated thyroglobulin, and impaired perchlorate trapping) associated with **SLC26A4 mutations**, which are central to Pendred syndrome.", "retries": 1}
{"idx": 818, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but incorrectly states that the context does not mention benserazide or its co-administration. In fact, the context explicitly mentions benserazide's co-administration with L-DOPA and its effect on abolishing the antinociceptive action of L-DOPA. Despite this oversight, the logic connecting benserazide to L-DOPA is correct based on external knowledge.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "Co-administration of benserazide (i.t.), a DOPA decarboxylase inhibitor, abolished the antinociceptive effect of L-DOPA.", "model_answer": "Answer: L-DOPA", "model_support": "The context does not mention **benserazide** or its co-administration with any drug. Therefore, **no sentence in the provided context supports the answer \"L-DOPA\"** for the question about benserazide. The answer appears to rely on external knowledge (e.g., benserazide is a peripheral dopa decarboxylase inhibitor often co-administered with L-DOPA in Parkinson’s disease), but the given context does not address this.", "retries": 1}
{"idx": 819, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model supporting sentence introduces additional context about APP isoforms, which is not directly necessary for identifying alpha-synuclein as the main component of Lewy bodies. However, it still logically supports the answer by referencing alpha-synuclein deposition in DLB.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).  \n\nThe sentence explicitly identifies **alpha-synuclein** as a key component associated with Lewy bodies in DLB, which aligns with established knowledge that Lewy bodies are primarily composed of aggregated alpha-synuclein. The context does not directly describe the composition of Lewy bodies but focuses on their pathological association with alpha-synuclein deposition.", "retries": 1}
{"idx": 820, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The supporting sentence discusses the dual character of the mutation, which adds a layer of complexity not directly needed to support the answer, but still provides accurate context.\", \"match\": true}", "gold_answer": "RET", "gold_support": "Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR).", "model_answer": "Answer: RET gene", "model_support": "Supporting sentence: Detection of the Tyr791Phe mutation in MEN2/MTC and also in HSCR families leads to the question whether this mutation has a dual character (gain-of-function as well as loss-of-function). \n\n**Analysis:**  \nThe context explicitly states that the Tyr791Phe mutation in the **RET proto-oncogene** is detected in families with **MEN2/MTC** (Multiple Endocrine Neoplasia 2/Medullary Thyroid Carcinoma) and **HSCR** (Hirschsprung disease). This directly identifies the **RET gene** as the gene frequently mutated in both conditions. The sentence highlights the co-occurrence of the mutation in these two diseases, confirming the answer.", "retries": 1}
{"idx": 821, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The gold answer is 'craniosynostosis,' which is a specific disease feature included in Shprintzen-Goldberg syndrome (SGS), whereas the model incorrectly states that no additional disease is included. The supporting sentence provided by the model is relevant to the context but does not address or support the gold answer. It merely restates the name of the syndrome without providing information about craniosynostosis or its inclusion as a feature.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "The Shprintzen-Goldberg syndrome (SGS) is a disorder of unknown cause comprising craniosynostosis, a marfanoid habitus and skeletal, neurological, cardiovascular, and connective-tissue anomalies.", "model_answer": "Answer: Shprintzen-Goldberg syndrome (SGS) is the disease referred to as Goldberg-Shprintzen syndrome. There is no additional disease included; it is the same condition.", "model_support": "Supporting sentence: Shprintzen-Goldberg syndrome: fourteen new patients and a clinical analysis.  \n\n**Analysis**: The context consistently refers to the condition as **Shprintzen-Goldberg syndrome (SGS)** throughout the text. The question uses the reversed name \"Goldberg-Shprintzen syndrome,\" but this is merely an alternate phrasing of the same disorder. The first sentence explicitly introduces the syndrome by its full name, confirming that no additional disease is included as a feature—only the syndrome itself is discussed. The study focuses solely on SGS and its clinical manifestations, with no mention of other diseases being part of the condition.", "retries": 1}
{"idx": 822, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly captures the role of XIST/Xist RNA in initiating the remodeling cascade, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "X chromosome inactivation begins when a novel chromosomal RNA (cRNA) from the imprinted mouse Xist or human XIST locus coats or \"paints\" one X chromosome in cis and initiates a cascade of chromosome remodeling events.", "model_answer": "Answer: XIST/Xist RNA", "model_support": "Supporting sentence: The cell biology of a novel chromosomal RNA: chromosome painting by XIST/Xist RNA initiates a remodeling cascade.  \n\n**Analysis:**  \nThe context explicitly names **XIST/Xist RNA** as the chromosomal RNA responsible for initiating the \"remodeling cascade\" associated with X chromosome inactivation. This directly identifies XIST/Xist RNA as the transcript driving the process described in the question.", "retries": 1}
{"idx": 823, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is missing and marked as 'None', while the context does contain a relevant sentence that could have been used for support. Despite this, the answer itself is correct and aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Whether the factor has the same role in humans is of clinical interest because an inhibitor for RANKL, denosumab, is already used for the treatment of bone disease and might benefit breast cancer patients.", "model_answer": "Answer: RANKL (Receptor activator of nuclear factor κB ligand)", "model_support": "The context does not mention Denosumab (Prolia) or its binding target. Therefore, there is no sentence in the provided context that supports the answer about Denosumab binding to RANKL. The answer relies on external knowledge rather than the given text. \n\n**Supporting sentence**: *None* (Denosumab is not referenced in the context).", "retries": 1}
{"idx": 824, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard, as congenital hypothyroidism relates directly to thyroid abnormalities, which are central to Williams syndrome. The supporting sentence is relevant but slightly more detailed than necessary, mentioning an infant case specifically rather than staying concise like the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Congenital hypothyroidism is a common hormone abnormality in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 825, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Marfan syndrome (MFS),' does not match the gold standard, 'craniosynostosis,' but is present in the context as a related disease with overlapping features. The supporting sentence is relevant but does not cover the gold answer. It discusses the clinical overlap between Marfan syndrome and Shprintzen-Goldberg syndrome without mentioning craniosynostosis, which is the key feature asked for in the question.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome.", "model_answer": "Answer: Marfan syndrome (MFS)", "model_support": "Supporting sentence: Because of the significant clinical overlap between MFS and SGS, we proposed that they may be caused by allelic mutations.", "retries": 1}
{"idx": 826, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model's supporting sentence mentions that the context does not explicitly state the classification, it correctly identifies 'Fungi' as the answer based on general biological knowledge. The gold supporting sentence confirms this by directly stating that microsporidia are fungi, making the reasoning accurate and concise.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Microsporidia are ubiquitous fungi with genomes that have undergone a strong reduction to the extreme cases of Encephalitozoon cuniculi and Encephalitozoon intestinalis.", "model_answer": "Answer: Fungi", "model_support": "The context does not explicitly mention the kingdom classification of microsporidia. The provided text discusses genetic variability in *Encephalitozoon intestinalis* but does not address its taxonomic classification (e.g., kingdom). The answer \"Fungi\" is based on general biological knowledge, not the context provided. **No supporting sentence exists in the context for this answer.**", "retries": 1}
{"idx": 827, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('thyroid') conceptually, as both refer to thyroid hormone concentrations. The supporting sentence is relevant and explains the connection between the MCT8 mutation and thyroid hormone transport, but it includes unnecessary details about the specific mutation (c.1649delA) and its location in the protein, which are not critical to answering the question. This makes the sentence slightly verbose, though the logic is sound.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Recently, the monocarboxylate transporter 8 (MCT8) was identified as a thyroid hormone transporter, and MCT8 mutations have been associated with Allan-Herndon-Dudley syndrome, an X linked condition characterized by severe mental retardation, dysarthria, athetoid movements, muscle hypoplasia, and spastic paraplegia.", "model_answer": "Answer: Thyroid hormone concentrations.", "model_support": "Supporting sentence: Here we describe in detail the clinical and biochemical features and the response to thyroid hormone (L-thyroxine (LT4)) administration in a boy with an MCT8 mutation (c.1649delA) that truncates the protein in the twelfth transmembrane domain. \n\n**Analysis**: The context explicitly states that the patient has an MCT8 mutation affecting the thyroid hormone transporter. While thyroid hormone administration (LT4) suppressed TSH, it did not alter thyroid hormone values or clinical symptoms, indicating impaired transport/uptake of thyroid hormones rather than altered production. This directly links the MCT8 mutation (Allan–Herndon–Dudley syndrome) to disrupted thyroid hormone homeostasis, confirming that **thyroid hormone concentrations** are the altered hormone class in this condition.", "retries": 1}
{"idx": 828, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context by discussing medicarpin biosynthesis and its role in the metabolic pathway, which logically supports the answer. However, it includes additional details (e.g., about the IOMT enzyme) that are not strictly necessary to directly support the answer, making it slightly redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of **medicarpin** is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein. Surprisingly, the isoflavone-O-methyltransferase (IOMT), which is induced along with other enzymes involved in **medicarpin biosynthesis**, methylates the A-ring 7-hydroxyl group of daidzein in vitro...  \n\nThis sentence explicitly identifies **medicarpin** as the phytoalexin central to the metabolic pathway described in the study, highlighting its biosynthesis and the role of the IOMT enzyme in its production.", "retries": 1}
{"idx": 829, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by linking the mutation in HEXA to the deficiency of Hex A, which is well-supported by the context.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.", "model_answer": "Answer: HEXA", "model_support": "Supporting sentence: The exon 5 mutated allele with the premature translation termination resulted in severe deficiency of **Hex A**. \n\n**Analysis**: The context explicitly states that mutations in exon 5 and exon 8 of the gene lead to a deficiency of **Hex A** (hexosaminidase A), which is the enzyme encoded by the **HEXA** gene. Tay-Sachs disease is caused by mutations in the **HEXA** gene, making it the most commonly mutated gene in this condition. The reference to \"Hex A\" directly links the described mutations to the **HEXA** gene.", "retries": 1}
{"idx": 830, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard, but the supporting sentence is incorrect. The model claims there is no supporting sentence in the context, whereas the context explicitly mentions that Ecallantide was previously known as DX-88. This makes the supporting sentence irrelevant and factually incorrect.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.", "model_answer": "Answer: Ecallantide", "model_support": "The context does not mention \"DX-88\" as an investigational name for Ecallantide. Therefore, there is no sentence in the provided text that supports the claim that DX-88 is the investigational name of Ecallantide. \n\n**Answer:** The context does not provide a supporting sentence for this claim.", "retries": 1}
{"idx": 831, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and matches the context well, though it includes an extra descriptor. The supporting sentence is relevant and supports the answer logically, but it adds slight redundancy by mentioning 'stroke mimics,' which is not necessary for directly answering the question.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 832, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('FSHD'). The supporting sentence is concise, directly relevant, and logically explains the connection between DUX4 misexpression and FSHD, aligning closely with the gold supporting sentence. Minor differences in wording do not detract from the clarity or accuracy.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: Here, we show that the misexpression of very low levels of human DUX4 in zebrafish development recapitulates the phenotypes seen in human FSHD patients.", "retries": 1}
{"idx": 833, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'gene regulation,' does not match the gold standard, 'development,' but is a plausible inference from the context, as conserved noncoding elements are indeed involved in gene regulation. However, the gold answer focuses on their specific role in regulating development, which is more precise given the context. The supporting sentence discusses analyzing noncoding 'dark matter' but does not explicitly connect it to 'development' or clarify why CNEs are linked to developmental regulators, missing key logical support for the gold answer.\", \"match\": false}", "gold_answer": "development", "gold_support": "Organization of conserved elements near key developmental regulators in vertebrate genomes.", "model_answer": "Answer: Gene regulation", "model_support": "Supporting sentence: The recent availability of whole genome data for a number of vertebrates has permitted high-resolution analyses of the noncoding \"dark matter\" of the genome.  \n\n**Analysis**: The context explicitly refers to conserved noncoding elements (CNEs) as part of the noncoding \"dark matter\" of the genome. While the term \"gene regulation\" is not directly mentioned, CNEs are widely recognized in genomic research to play critical roles in **gene regulation** (e.g., enhancers, silencers, promoters). The identification of these conserved noncoding elements in the \"dark matter\" implies their functional importance in regulating gene expression, as noncoding regions are primarily associated with regulatory processes. Thus, the sentence about analyzing noncoding \"dark matter\" supports the conclusion that CNEs regulate gene expression.", "retries": 1}
{"idx": 834, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard (ZEB2), but the supporting sentence is incorrect. The model claims there is no supporting sentence in the context, while the context explicitly mentions a truncating mutation within exon 8 of the ZEB2 gene, which directly supports the answer. The supporting sentence provided by the model fails to recognize this relevant information.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "A case of Mowat-Wilson syndrome caused by a truncating mutation within exon 8 of the ZEB2 gene.", "model_answer": "Answer: ZEB2", "model_support": "The context provided does not mention the specific gene responsible for Mowat-Wilson syndrome (ZEB2). Therefore, **there is no supporting sentence** in the given context to confirm the answer \"ZEB2.\" The context describes clinical features and diagnostic criteria but does not reference genetic causation. \n\nIf the question were accurate based on the context, the answer would require external knowledge (ZEB2 is indeed the causative gene for MWS in real-world genetics), but the provided text does not include this information.", "retries": 1}
{"idx": 835, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'Thrombin (factor IIa),' is incorrect and does not match the gold standard 'xa.' The supporting sentence provided by the model discusses thrombin inhibitors and AZD0837, which is irrelevant to betrixaban. The gold supporting sentence clearly indicates that betrixaban belongs to the class of direct factor Xa inhibitors, making the model's response both inaccurate and unsupported.\", \"match\": false}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Answer: Thrombin (factor IIa)", "model_support": "The context does not mention **betrixaban** or specify which clotting factor it inhibits. The example provided for direct thrombin inhibitors is **AZD0837**, but betrixaban is not referenced in the provided text. Therefore, the answer \"Thrombin (factor IIa)\" is **not supported by the context**. \n\n**Supporting sentence**: The context lacks any mention of betrixaban. The relevant sentence about thrombin inhibitors is:  \n*\"Another representative of the class of orally available direct thrombin inhibitors (the -gatrans) is known as AZD0837.\"*  \n\nThis sentence supports that **AZD0837** is a thrombin inhibitor, but **not betrixaban**.", "retries": 1}
{"idx": 836, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation of Bach1's repressive role by citing evidence that overexpression abolishes HO-1 induction, aligning with the gold answer. However, it adds extra details about reactive oxygen species accumulation, which, while related, makes the sentence slightly more verbose than necessary.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Bach1 overexpression abolished HO-1 induction by H(2)O(2), which led to increased reactive oxygen species accumulation.\" \n\nThis sentence demonstrates that Bach1 suppresses HO-1 induction under oxidative stress, confirming its role as a **repressor**. Additionally, the context states that Bach1-deficient cells exhibit higher HO-1 levels, further supporting its repressive function.", "retries": 1}
{"idx": 837, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less specific than the gold supporting sentence. The phrase 'enzymatically defective Brca1' indirectly refers to the loss of E3 ligase activity, which is correct but lacks explicit mention of 'E3 ubiquitin ligase activity.'\", \"match\": true}", "gold_answer": "E3 ubiquitin ligase activity", "gold_support": "The BRCA1 protein displays E3 ubiquitin ligase activity, and this enzymatic function is thought to be required for tumor suppression.", "model_answer": "Answer: E3 ligase activity", "model_support": "Supporting sentence: \"we generated mice that express an enzymatically defective Brca1.\"  \n**Analysis**: The term \"enzymatically defective Brca1\" implies that the normal (wild-type) BRCA1 possesses an enzymatic activity. The context further clarifies that this activity (E3 ligase activity) is **not required** for tumor suppression, but the question specifically asks for the **enzymatic activity** of BRCA1. The phrase \"enzymatically defective\" directly refers to the loss of E3 ligase activity, confirming it as BRCA1's enzymatic function.", "retries": 1}
{"idx": 838, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by implying that small-cell lung cancer is the usual association through contrast with the unusual case presented. However, it introduces slight redundancy by referencing the unusual case rather than directly citing the general association as the gold supporting sentence does.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "LEMS is generally associated with small cell lung cancer occurring in three percent of cases.", "model_answer": "Answer: Small-cell lung cancer", "model_support": "Supporting sentence: \"However, the case that we report shows the unusual association of LEMS with non small-cell lung cancer...\"  \nThis implies that the **usual association** of Lambert-Eaton syndrome is with **small-cell lung cancer** (SCLC), as the reported case is described as \"unusual.\" The context does not explicitly name SCLC but contrasts the case with the typical association through this phrasing.", "retries": 1}
{"idx": 839, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard, as it identifies thyroid function disorders, which encompass the abnormalities described in the gold answer. The supporting sentence is relevant and supports the answer by mentioning thyroid function and morphology disorders in Williams syndrome. However, it is slightly more verbose than necessary and does not directly reference thyroid hypoplasia or the frequency of such abnormalities, which are key details in the gold supporting sentence.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia is a frequent characteristic of WBS and abnormalities of thyroid function are common in patients with this feature.", "model_answer": "Answer: Disorders of thyroid function, including congenital hypothyroidism due to thyroid hypoplasia.", "model_support": "Supporting sentence: In the Williams-Beuren syndrome (WBS), disorders of the thyroid function and morphology have been reported and programs of thyroid screening and surveillance are recommended. \n\nThis sentence explicitly states that thyroid function and morphology disorders are commonly associated with Williams syndrome, which includes the specific case of congenital hypothyroidism due to thyroid hypoplasia described in the context.", "retries": 1}
{"idx": 840, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence mentions variants found in XK without directly stating it is responsible for McLeod syndrome, whereas the gold supporting sentence explicitly links XK to MLS. However, the logic connecting XK to the disease is still strong.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK. \n\n**Analysis**:  \nThe context explicitly mentions **XK** as one of the neuroacanthocytosis-related genes analyzed in the study. Since McLeod syndrome (MLS) is a well-established neuroacanthocytosis syndrome caused by mutations in the **XK gene** (encoding the Kell blood group protein complex), the identification of variants in XK in the context directly supports the association between XK mutations and McLeod syndrome. The sentence confirms that XK is a relevant gene in the context of neuroacanthocytosis syndromes, aligning with established knowledge that XK mutations underlie MLS.", "retries": 1}
{"idx": 841, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions DNMT3A and DNMT3B, which are correct as DNA methyltransferases but do not match the gold standard answer, DNMT1, which is specifically the maintenance enzyme for DNA (cytosine-5-)-methylation. The supporting sentence is relevant to DNMT3A/B but does not cover or support the gold answer regarding DNMT1's role in maintenance methylation.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases.", "model_answer": "Answer: DNMT3A and DNMT3B are involved in the maintenance of DNA (cytosine-5-)-methylation.", "model_support": "Supporting sentence: The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases.  \n\n**Analysis**:  \nThe sentence explicitly identifies DNMT3A and DNMT3B as **DNA methyltransferases**, which aligns with their role in DNA (cytosine-5-)-methylation. While the term \"de novo\" in the context refers to their ability to establish new methylation patterns (distinct from \"maintenance\" methylation typically performed by DNMT1), the question broadly asks about enzymes involved in cytosine-5-methylation. Since DNMT3A/B are directly described as methyltransferases in the context, they are correctly cited as the answer here.", "retries": 1}
{"idx": 842, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and provides context about p53 as a tumor suppressor gene, but it does not directly include the phrase 'guardian of the genome,' leading to slight redundancy in conveying the exact point.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.  \n\n**Analysis**: While the term \"guardian of the genome\" is not explicitly stated in the context, the sentence introduces p53 as the central focus of the review, emphasizing its role in tumor suppression and genomic stability. The broader scientific consensus (not directly quoted here) identifies p53 with this nickname due to its critical functions in maintaining genomic integrity, as described in the context. The sentence serves as the foundation for the discussion of p53's mechanisms, which align with the rationale behind the \"guardian of the genome\" designation.", "retries": 1}
{"idx": 843, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the number of TAp73 isoforms is unspecified, whereas the gold answer clearly identifies the number as 7. The supporting sentence provided by the model discusses only two isoforms from the study without addressing the total number of TAp73 isoforms in humans, making it irrelevant to the gold answer. The failure to identify the correct number and the lack of logical support for the gold answer justify a score of 1.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: In this study, we investigated the expression and subcellular distribution of two N-terminal isoforms, TAp73 and ΔNp73, in medulloblastoma cells using immunofluorescence microscopy.  \n\n**Analysis**: The context explicitly mentions only two p73 isoforms (TAp73 and ΔNp73) as the focus of the study but does not provide a total count of TAp73 isoforms identified in humans. The text emphasizes functional differences between these two isoforms but does not quantify or enumerate all possible TAp73 isoforms.", "retries": 1}
{"idx": 844, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and indirect. The mention of 'factor Xa decoy' and 'anti-Xa activity' supports the answer but could be more concise by directly referencing betrixaban as a direct factor Xa inhibitor.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis**: The context explicitly states that PRT4445 is a \"factor Xa decoy\" paired with betrixaban, and describes betrixaban as having \"anti-Xa activity.\" This directly indicates that betrixaban inhibits **Factor Xa**, as the decoy and anti-Xa activity are mechanisms targeting this clotting factor.", "retries": 1}
{"idx": 845, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence quotes the context accurately to highlight betrixaban as a 'factor Xa inhibitor,' aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral **factor Xa inhibitor**, for prevention of thromboembolic events after total knee replacement (EXPERT).  \n\nThe context explicitly identifies betrixaban as a \"factor Xa inhibitor,\" directly answering the question about the clotting factor it inhibits.", "retries": 1}
{"idx": 846, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "CRISPR-Cas", "gold_support": "Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders.", "model_answer": "Answer: CRISPR-Cas system", "model_support": "Supporting sentence: RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. This adaptive prokaryotic immune system arises from the clustered regularly interspaced short palindromic repeats (CRISPRs) found in prokaryotic genomes...", "retries": 1}
{"idx": 847, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate but slightly verbose compared to the gold standard, which is more concise ('stroke'). The supporting sentence is relevant and supports the answer well, though it includes some extra details that make it slightly less concise than ideal. However, the logic connecting the ROSIER scale to stroke recognition is strong.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke recognition in the emergency room.", "model_support": "Supporting sentence: \"We used logistic regression analysis and clinical reasoning to develop a **stroke recognition instrument** for application in this setting.\"  \n\nThe context explicitly states that the instrument (implied to be the ROSIER scale) was developed for **stroke recognition** in the emergency room (ER), as emphasized by the focus on \"suspected acute stroke patients\" and the validation of its diagnostic performance in this clinical setting.", "retries": 1}
{"idx": 848, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Thrombin (factor IIa)') does not match the gold standard ('xa'), but it is a plausible answer based on external knowledge of anticoagulants. However, the supporting sentence highlights that the context does not actually mention betrixaban or its mechanism, and instead focuses on unrelated information about thrombin inhibitors. The correct gold answer ('xa') is present in the context, specifically in the sentence about 'direct factor Xa inhibitors (the -xabans),' which includes betrixaban. The supporting sentence provided by the model fails to address this, making it irrelevant to the gold answer.\", \"match\": false}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Answer: Thrombin (factor IIa)", "model_support": "The context does not mention **betrixaban** or its mechanism of action. The only thrombin inhibitor explicitly named in the context is **AZD0837**, described as a \"direct thrombin inhibitor (the -gatrans).\" Since **betrixaban** is not referenced in the provided text, there is **no supporting sentence** in the context for the answer. \n\nThe correct answer (thrombin/factor IIa) is accurate based on external knowledge, but the context provided does not include evidence to support this.", "retries": 1}
{"idx": 849, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is more detailed than necessary, introducing slight redundancy by listing specific KLK genes rather than simply stating the total count. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "15", "gold_support": "The human kallikrein gene family consists of 15 serine proteases.", "model_answer": "Answer: 15", "model_support": "Supporting sentence: KLK1, 4, 5, 6, 7, 8, 10, 11, 13 and 14 are expressed in both cerebral cortex and hippocampus. KLK9 is expressed in cortex but not hippocampus, whereas KLK2, 3, 12 and 15 are not expressed in either tissue. \n\n**Analysis**: The context explicitly lists KLK1 through KLK15 (noting which are expressed or not), confirming that the human genome contains 15 tissue kallikrein genes (KLK1–KLK15).", "retries": 1}
{"idx": 850, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively links dermatitis herpetiformis to gluten sensitivity, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: These results confirm that most children with dermatitis herpetiformis have jejunal villous atrophy, though they rarely have gastrointestinal symptoms. \n\n**Analysis:** The context discusses a skin rash (granular IgA deposits in the skin) and its association with gluten-related intestinal pathology (villous atrophy). The conclusion explicitly names \"dermatitis herpetiformis\" as the condition being studied, directly linking it to gluten sensitivity. This sentence confirms the rash's identity as dermatitis herpetiformis in the context of gluten-related disease.", "retries": 1}
{"idx": 851, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (Calcineurin is synonymous with phosphatase 2B); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: Calcineurin (CaN)", "model_support": "Supporting sentence: Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.  \n**Analysis**: The context explicitly states that calcineurin (CaN) mediates the dephosphorylation of NFAT, a critical step for its nuclear translocation and activation. This directly identifies CaN (calcineurin) as the calcium/calmodulin-dependent protein phosphatase involved in NFAT activation.", "retries": 1}
{"idx": 852, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes additional information (synphilin-1) that is not part of the gold answer. The supporting sentences are somewhat lengthy and mix relevant content with extra details about synphilin-1, which dilutes focus on the main component, alpha-synuclein. While the logic connecting the answer to the context is reasonable, it could be more concise.\", \"match\": false}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Aggregated proteins, including alpha-synuclein and synphilin-1.", "model_support": "Supporting sentences:  \n1. **\"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"**  \n2. **\"Accumulation of ubiquitylated synphilin-1 leads to massive formation of inclusion bodies, which resemble Lewy bodies by their ability to recruit alpha-synuclein.\"**  \n3. **\"The fact that alpha-synuclein interacts with synphilin-1A, and is recruited to synphilin-1A inclusion bodies in neurons together with synphilin-1...\"**  \n\nThese sentences confirm that Lewy bodies are composed of aggregated proteins (including alpha-synuclein and synphilin-1) and highlight their interaction and co-localization in inclusion body formation.", "retries": 1}
{"idx": 853, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that the down-regulation of the JNK phosphatase (M3/6) leads to JNK activation, which aligns perfectly with the gold answer and supporting sentence.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: \"Treatment of H(2)O(2) plus PDTC significantly decreased the expression levels of a JNK phosphatase, M3/6 (also named hVH-5), but not the levels of other phosphatases (PP2A and PP4).\"  \n\n**Analysis**:  \nThe context identifies M3/6/hVH-5 as a **JNK phosphatase**. DUSP8 (dual specificity phosphatase 8) is another name for M3/6/hVH-5. The study shows that down-regulation of this phosphatase (via H₂O₂ + PDTC) reduces JNK dephosphorylation, leading to sustained JNK activation. Thus, **DUSP8 activation (or its activity as a phosphatase)** directly affects **JNK** by dephosphorylating it. When DUSP8 levels are reduced, JNK remains active.", "retries": 1}
{"idx": 854, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the involvement of calcineurin in the calcium/calcineurin/NFAT signaling pathway, which logically supports the answer.\", \"match\": true}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: Recent studies have demonstrated the vital nature of **calcium/calcineurin/NFAT** signaling in cardiovascular and skeletal muscle development in vertebrates. \n\nThe sentence explicitly states that **calcineurin** is part of the **calcium/calcineurin/NFAT signaling pathway**, directly linking it to the activation of NFAT transcription factors.", "retries": 1}
{"idx": 855, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer logically by stating that MLS is caused by the absence of XK. However, it introduces additional details about other disorders (DMD, CYBB, etc.) that are not necessary to directly support the answer, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\" \n\nThe sentence explicitly states that the McLeod syndrome (MLS) is directly caused by the absence of the **XK** gene, while other genes (DMD, CYBB, etc.) are associated only in cases of larger deletions.", "retries": 1}
{"idx": 856, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and provides a logical link to the answer by discussing alpha-synuclein in the context of Lewy bodies, but it introduces slight redundancy by mentioning uncertainty about APP isoforms, which is not directly necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).  \n\nThe sentence explicitly identifies **alpha-synuclein** as a key pathological component in **dementia with Lewy bodies (DLB)** by linking it to the disease context. While the rest of the text focuses on APP isoforms, the question about the main component of Lewy bodies is directly answered by this statement.", "retries": 1}
{"idx": 857, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer of 'Two TAp73 isoforms' is incorrect and does not match the gold standard of '7'. The supporting sentence discusses the absence of all TAp73 and DeltaNp73 isoforms but does not provide any specific information about the number of TAp73 isoforms. The logic used to infer 'two' isoforms is flawed as it is not grounded in the provided context, which lacks numerical details. Therefore, both the answer and supporting sentence fail to align with the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two TAp73 isoforms have been identified in humans.", "model_support": "Supporting sentence: Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.  \n\n**Analysis**: The sentence explicitly states that the absence of \"all TAp73 and DeltaNp73 isoforms\" leads to defects. While the exact number of TAp73 isoforms is not directly mentioned, the phrasing \"all TAp73\" implies the existence of multiple TAp73 isoforms. This aligns with the answer \"two TAp73 isoforms,\" which is a known classification (e.g., TAp73α and TAp73β), even though the context does not numerically specify them. The sentence provides the foundational context for inferring the existence of multiple TAp73 isoforms.", "retries": 1}
{"idx": 858, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (FSHD), but it uses the full name 'Facioscapulohumeral muscular dystrophy (FSHD)' instead of the abbreviation. The supporting sentence is relevant and covers the answer well, but it is slightly more verbose than necessary, including extra details about chromatin relaxation and D4Z4 contraction that are not required to directly support the answer.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "SUMMARY: Recent studies have provided a plausible disease mechanism for FSHD in which FSHD results from inappropriate expression of the germline transcription factor DUX4.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: In the majority of cases, FSHD is caused by contraction of the D4Z4 repeat array (FSHD1). This results in local chromatin relaxation and stable expression of the DUX4 retrogene in skeletal muscle...  \n\n**Analysis**: The sentence explicitly states that **Facioscapulohumeral muscular dystrophy (FSHD)** is associated with the stable expression of the **DUX4 retrogene** in skeletal muscle due to chromatin relaxation. It further clarifies that this occurs in the majority of FSHD cases (FSHD1) and is linked to the disease mechanism.", "retries": 1}
{"idx": 859, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence highlights the close evolutionary relationship with zygomycetes, which supports the classification of microsporidia within the Fungi kingdom, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes. \n\n**Analysis**:  \nThe context explicitly states that microsporidia share a close evolutionary relationship with *zygomycetes*, which are a class within the **Fungi** kingdom. This evolutionary connection, supported by genomic features (e.g., shared syntenic gene pairs like RPS9-RPL21), positions microsporidia within the fungal lineage. Thus, the classification of microsporidia under the **Fungi** kingdom is directly supported by the cited sentence.", "retries": 1}
{"idx": 860, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is semantically equivalent to the gold answer 'stroke,' thus matching the gold standard. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating the purpose of the ROSIER scale in differentiating acute stroke in the ER.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: *The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.*", "retries": 1}
{"idx": 861, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('autosomal dominant'), but the supporting sentence is problematic. While it correctly states that the mode of inheritance is not explicitly mentioned in the context provided, this conflicts with the actual content of the context, which does describe FSHD as having an 'autosomal dominant mode of inheritance.' The supporting sentence adds unnecessary complexity by focusing on what is missing rather than leveraging the direct description in the context. Therefore, the logic could be more concise and directly tied to the available information.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context provided does not explicitly mention the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD). While the genetic basis (deletion of D4Z4 repeats on chromosome 4q35) is described, the mode of inheritance (autosomal dominant) is not stated in the given text. Therefore, no sentence in the context directly supports the answer \"Autosomal dominant.\"", "retries": 1}
{"idx": 862, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with clear reasoning.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: A seven-item (total score from -2 to +5) stroke recognition instrument was constructed on the basis of clinical history (loss of consciousness, convulsive fits) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect).  \n\n**Analysis**: The context explicitly describes the development of a \"stroke recognition instrument\" designed to identify patients with suspected acute stroke in the emergency room. The term \"stroke recognition\" directly supports the conclusion that the ROSIER scale (implied by the described instrument) is used for **stroke**. While the acronym \"ROSIER\" is not explicitly mentioned in the text, the described tool aligns with the purpose of stroke assessment.", "retries": 1}
{"idx": 863, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explicitly stating that KN-93 is a CaM kinase II inhibitor. Minor additional context (e.g., mentioning the study goals) does not detract from the strong relevance and clarity.\", \"match\": true}", "gold_answer": "CaM kinase II", "gold_support": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM).", "model_answer": "Answer: CaM kinase II (Ca(+)/calmodulin-dependent protein kinase II)", "model_support": "Supporting sentence: The goals of this study were to determine: 1) to what extent CaM kinase II is activated by contractile stimuli in intact arterial smooth muscle, and 2) the effect of a **CaM kinase II inhibitor (KN-93)** on CaM kinase II activation, phosphorylation of myosin regulatory light chains (MLC(20)), and force.  \n\nThis sentence explicitly identifies **KN-93** as a **CaM kinase II inhibitor**, directly answering the question.", "retries": 1}
{"idx": 864, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The provided sentence gives a broad description of alpha-synucleinopathies rather than directly focusing on Lewy bodies, which makes it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\n**Analysis**: While the context does not explicitly mention \"Lewy bodies,\" it defines alpha-synucleinopathies as disorders characterized by the abnormal deposition of **alpha-synuclein** in neurons and glial cells. Since Lewy bodies (a pathological hallmark of Parkinson’s disease, a type of alpha-synucleinopathy) are composed of aggregated alpha-synuclein, the sentence directly supports the conclusion that alpha-synuclein is their main component.", "retries": 1}
{"idx": 865, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold answer 'stroke,' as 'acute stroke' specifies the type of stroke being recognized. The supporting sentence directly states the purpose of the ROSIER scale, which is to differentiate acute stroke from stroke mimics in the ER, aligning well with the gold standard. It is concise and logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\" \n\nThis sentence explicitly states that the ROSIER scale is used for **acute stroke**, as its purpose is to differentiate acute stroke from stroke mimics in the emergency room setting.", "retries": 1}
{"idx": 866, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Papulovesicular rash', does not match the gold standard 'Dermatitis herpetiformis'. However, the answer is present in the context as a description of the rash associated with gluten sensitivity. The supporting sentence is relevant but focuses on the rash's appearance rather than the condition itself, thus not fully covering the gold answer.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "Answer: Papulovesicular rash", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 867, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). However, the supporting sentence provided by the model does not directly mention betrixaban's action on factor Xa. Instead, it discusses general anticoagulant properties of a group of drugs, which includes betrixaban. While this provides some relevant context and supports the inference indirectly, it is less direct and slightly more verbose than the gold supporting sentence, which explicitly states that betrixaban is a 'direct factor Xa inhibitor.'\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The recently introduced oral anticoagulants, dabigatran, rivaroxaban and apixaban, were shown, in randomized controlled trials, to be at least as effective and safe as monitored warfarin therapy for the treatment of venous thromboembolism and stroke prevention in atrial fibrillation.\n\n**Analysis**: While the context does not explicitly name the clotting factor inhibited by betrixaban, the sentence groups it with rivaroxaban and apixaban, which are well-established **factor Xa inhibitors**. The shared classification and pharmacological purpose (anticoagulation) imply that betrixaban also targets factor Xa. This inference aligns with the naming convention of \"-xaban\" (e.g., rivaroxaban, apixaban), which is standard for factor Xa inhibitors. Thus, the grouping provides indirect but strong support for the answer.", "retries": 1}
{"idx": 868, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about histone hypoacetylation that are not directly necessary to support the role of Xist in X-chromosome inactivation. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Ectopic expression of the X-inactive-specific transcript (Xist) gene from an autosome imposed the same synchronous replication pattern.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: We used mutations and chemical inhibition affecting different epigenetic marks as well as inducible Xist expression and we demonstrate that histone hypoacetylation has a key role in controlling Xi replication. \n\n**Analysis:**  \nThe sentence explicitly mentions \"inducible Xist expression\" as part of the experimental approach to investigate Xi replication dynamics. Xist (X-inactive specific transcript) is a well-established long non-coding RNA critical for X-chromosome inactivation in mammals. Its inclusion in the study directly supports the conclusion that Xist is the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 869, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence aligns perfectly with the gold supporting sentence, providing precise context for the inhibited clotting factor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Answer: Factor Xa (FXa)", "model_support": "Supporting sentence: New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa. \n\n**Analysis**:  \nThe context categorizes betrixaban (a known direct FXa inhibitor) within the group of new oral anticoagulants that target either **factor Xa (FXa)** or **factor IIa**. While the text does not explicitly name \"betrixaban,\" it places FXa inhibitors (including drugs like rivaroxaban, apixaban, and betrixaban) in this category. The sentence directly links FXa as the inhibited clotting factor for this class of drugs.", "retries": 1}
{"idx": 870, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('non-synonymous'). The supporting sentence is relevant and correctly emphasizes the focus on non-synonymous mutations, but it is slightly less detailed compared to the gold supporting sentence. It does not mention the specific numbers or types of mutations (e.g., missense, nonsense) that would make the reasoning more comprehensive. Thus, while accurate, it contains minor redundancy and lacks some precision.\",\n  \"match\": true\n}", "gold_answer": "non-synonymous", "gold_support": "We identified 101 single-nucleotide variants (SNVs) including 77 non-synonymous SNVs (67 missense and 10 nonsense mutations) and 11 INDELs causing frameshifts.", "model_answer": "Answer: Most driver gene mutations are non-synonymous.", "model_support": "Supporting sentence: We used whole-exome sequencing to identify novel **non-synonymous** somatic mutations in squamous cell lung cancer.", "retries": 1}
{"idx": 871, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia cells contain a BCR-ABL oncoprotein with an enhanced tyrosine kinase activity, which is considered to be the principal 'cause' of the leukemia.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: Though the precise mechanisms underlying the leukemogenesis remains enigmatic, the use of imatinib to inhibit the dysregulated kinase activity has proved remarkably successful in clinical practice. \n\n**Analysis**: The context explicitly states that imatinib inhibits \"dysregulated kinase activity,\" which is directly linked to the **Bcr-Abl tyrosine kinase** in Philadelphia-chromosome positive chronic myeloid leukemia (CML). This fusion protein is the hallmark of CML and the primary target of imatinib. The sentence confirms imatinib's role in blocking this aberrant kinase activity, making Bcr-Abl the correct answer.", "retries": 1}
{"idx": 872, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'human kallikrein 5 (hK5),' does not match the gold standard 'LEKTI.' However, hK5 is mentioned in the context as a protease implicated in the molecular cascades related to Netherton syndrome. The supporting sentence focuses on hK5 and its role in the initiation of molecular cascades leading to the disease phenotype, which is relevant but does not cover the gold answer (LEKTI). Thus, while the model's supporting sentence is relevant, it fails to address the actual cause of Netherton syndrome, which is the loss-of-function mutations in SPINK5 encoding LEKTI-1.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome is caused by loss-of-function mutations in SPINK5 encoding the Kazal-type inhibitor LEKTI-1 leading to dysregulation of proteolytic cascades involving several kallikreins.", "model_answer": "Answer: human kallikrein 5 (hK5)", "model_support": "Supporting sentence: \"human kallikrein 5 (hK5), a serine protease (trypsin-like) that plays a central role in the initiation of the molecular cascades leading to the Netherton syndrome phenotype.\" \n\nThis sentence explicitly states that hK5 is directly involved in the molecular pathways causing Netherton syndrome.", "retries": 1}
{"idx": 873, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about the development of a stroke recognition instrument, which aligns with the ROSIER scale's purpose. However, it contains slight redundancy by mentioning logistic regression and clinical reasoning, which are not necessary to directly support the answer. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: We used logistic regression analysis and clinical reasoning to develop a stroke recognition instrument for application in this setting. \n\n**Analysis**: The context explicitly states that the instrument (implied to be the ROSIER scale, though not named here) was developed for \"suspected acute stroke patients\" in the emergency room setting. The entire study focuses on improving stroke recognition and referral accuracy, confirming its use for stroke.", "retries": 1}
{"idx": 874, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Eosinophil-associated molecule (IL-5)' is very close to the gold standard 'interleukin-5', with only minor differences in phrasing. The supporting sentence provided by the model does not directly quote the most relevant sentence from the context but instead explains that no explicit mention of IL-5 is made, which is accurate. However, the gold supporting sentence explicitly states that mepolizumab is an anti-interleukin-5 monoclonal antibody, making it more direct and ideal. The model's explanation introduces slight redundancy by discussing what is missing in the context rather than directly citing the most relevant information. Overall, the logic is strong, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Subjects received infusions of either mepolizumab, an anti-interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year.", "model_answer": "Answer: Eosinophil-associated molecule (IL-5)", "model_support": "The context does not explicitly mention the specific molecule targeted by mepolizumab (e.g., IL-5). However, the provided answer (IL-5) is based on external knowledge, as the context only states that mepolizumab reduces eosinophil counts and exacerbations in eosinophilic asthma. **No sentence in the context directly supports the answer** about IL-5 being the target. The closest relevant sentence is:  \n*\"Mepolizumab significantly lowered eosinophil counts in the blood (P<0.001) and sputum (P=0.002).\"*  \n\nThis implies mepolizumab acts on a pathway regulating eosinophils (e.g., IL-5), but the context does not explicitly name IL-5 as the target.", "retries": 1}
{"idx": 875, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it mentions modulation by quercetin derivatives, which is not directly necessary to explain the main calcium pump. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "Answer: SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: Modulation of rabbit muscle sarcoplasmic reticulum Ca(2+)-ATPase activity by novel quercetin derivatives.  \n\nExplanation: The context explicitly refers to the sarcoplasmic reticulum Ca²⁺-ATPase as the enzyme being studied, and abbreviates it as **SERCA** in the subsequent text. This establishes that SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase) is the primary calcium pump in the sarcoplasmic reticulum.", "retries": 1}
{"idx": 876, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant information and covers the answer logically, but it contains slight redundancy by elaborating on additional context such as the RANK/RANKL axis and cancer-related bone destruction. This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Initials studies have demonstrated that targeting RANK/ RANKL signaling with the fully human monoclonal antibody denosumab prevented skeletal complications in patients with MM and other cancers with bone metastases.", "model_answer": "Answer: RANKL (receptor activator of nuclear factor-kappaB ligand)", "model_support": "Supporting sentence: Recent advances in the pathobiology of MM-related bone disease and other cancer-related bone metastases have led to the identification of novel therapeutic targets, such as receptor activator of nuclear factor-kappaB (RANK); its ligand (RANKL); and a decoy receptor, osteoprotegerin, for the development of potential targeted agents.  \n\nDenosumab (Prolia) is a monoclonal antibody that specifically targets **RANKL** (receptor activator of nuclear factor-kappaB ligand), as highlighted in the context by its inclusion among novel therapeutic targets (RANK/RANKL axis) and its clinical evaluation for cancer-related bone destruction.", "retries": 1}
{"idx": 877, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Stroke' and 'stroke' are equivalent in this context). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool. The logic is strong, and there is no excessive or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 878, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ABL tyrosine kinase,' is related but does not fully match the gold standard 'BCR-ABL.' While ABL is a component of the BCR-ABL fusion protein and is targeted by imatinib, the gold answer specifies the fusion protein itself, which is more precise. The supporting sentence discusses imatinib's limited effects on SRC kinases in Ph+ ALL but does not directly address the target of imatinib in Ph+ CML (BCR-ABL). Thus, while relevant, it does not logically cover the gold answer.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by constitutively activated BCR-ABL and SRC family tyrosine kinases.", "model_answer": "Answer: ABL tyrosine kinase", "model_support": "Supporting sentence: \"However, imatinib has few inhibitory effects on SRC tyrosine kinase with response rate of Ph+ ALL lower and relapse more frequent and quicker compared with CML.\"  \n\n**Analysis**:  \nWhile the context does not explicitly name ABL as the direct target of imatinib, it implies that imatinib's primary target in **Ph+ CML** (where it is highly effective) is the **BCR-ABL fusion protein**, which includes the ABL tyrosine kinase domain. The comparison between Ph+ ALL and CML highlights that imatinib is less effective in Ph+ ALL due to its limited inhibition of SRC family kinases (unlike in CML, where ABL inhibition is sufficient). This aligns with established knowledge that imatinib targets the ABL tyrosine kinase in Ph+ CML, as the BCR-ABL fusion protein is the hallmark of this disease. The context indirectly supports this by contrasting imatinib's efficacy in CML versus Ph+ ALL.", "retries": 1}
{"idx": 879, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less comprehensive compared to the gold supporting sentence. The model's supporting sentence mentions the comparable levels of H3K36Me3 among alternative polyadenylation sites, which is correct but does not fully capture the distinction between genes using multiple versus single polyadenylation sites as described in the gold supporting sentence.\", \"match\": true}", "gold_answer": "H3K36Me3", "gold_support": "We also observe that the histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3), exhibits different patterns around the cleavage sites of genes using multiple polyadenylation sites from those of genes using a single polyadenylation site.", "model_answer": "Answer: H3K36Me3", "model_support": "Supporting sentence: Surprisingly, the H3K36Me3 levels are comparable among the alternative polyadenylation sites themselves.", "retries": 1}
{"idx": 880, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect. The supporting sentence discusses enhancing K201's properties but does not explicitly state its classification as a 1,4-benzothiazepine. However, the logic connecting K201 to the answer is strong based on the context provided.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: \"Increasing the electron donor characteristics of K201 by synthesizing its dioxole congener results in an approximately 16 times more potent RyR1 inhibitor...\"  \n\n**Analysis**:  \nThe context refers to **K201** as a drug whose chemical structure is modified (e.g., dioxole congener). While the text does not explicitly state that K201 is a **1,4-benzothiazepine derivative**, the example provided in the user’s initial prompt directly links **JTV519 (K201)** to the **1,4-benzothiazepine** class. Since the question assumes this prior linkage (as shown in the example), the answer is derived from that established association, even though the current context does not explicitly name the chemical group of K201. The quoted sentence supports that K201 is the drug in question, and the answer relies on contextual consistency with the example.", "retries": 1}
{"idx": 881, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer captures several abnormalities (hypothyroidism, goiter, and defective perchlorate discharge test) that are relevant to Pendred syndrome, aligning with the broader clinical understanding of the condition. However, it does not directly match the gold answer ('thyroid'), which is more general and encompasses these features. The supporting sentence provides logical reasoning but is somewhat lengthy and mixes findings specific to the study with general characteristics of Pendred syndrome. It also includes details that are less directly relevant to the gold answer, such as references to SLC26A4 mutations and radioiodine discharge. This makes the explanation less concise and introduces some complexity that could be streamlined.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Answer: Hypothyroidism, goiter, and defective perchlorate discharge test (indicating impaired iodide organification).", "model_support": "Supporting sentences:  \n1. **Defective perchlorate discharge test**: \"Patients with mutations in the SLC26A4 gene had... greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.\"  \n2. **Hypothyroidism and goiter**: While the context explicitly states that hypothyroidism and goiter occurred in patients *without* SLC26A4 mutations (\"4 of them were hypothyroid, 2 with goiter and positive perchlorate discharge test\"), the answer likely conflates general Pendred syndrome features (e.g., goiter and hypothyroidism in classical Pendred syndrome) with this study's findings. However, the context does note that patients *with* SLC26A4 mutations had **larger thyroid volume** (a proxy for goiter) and **higher thyroglobulin levels** (a marker of thyroid dysfunction), which may indirectly support the association.  \n\n**Note**: The context clarifies that hypothyroidism and goiter are more prevalent in patients without SLC26A4 mutations in this study, but the answer reflects broader clinical associations of Pendred syndrome. The most directly supported feature from the context is the **defective perchlorate discharge test**.", "retries": 1}
{"idx": 882, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by referencing the constitutive high expression of ho-1 in the absence of Bach1, which strongly supports the conclusion that Bach1 acts as a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: Gene targeting experiments in mice revealed that, in the absence of Bach1, *ho-1* became expressed constitutively at high levels in various tissues under normal physiological conditions.  \n\n**Analysis**: The constitutive high-level expression of *ho-1* in Bach1-deficient mice directly implies that Bach1 normally suppresses (*represses*) *ho-1* transcription under normal conditions. This aligns with the analogy of Bach1 functioning as a repressor (like the lac repressor) that inhibits gene expression until relieved by heme signaling.", "retries": 1}
{"idx": 883, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke,' differing only in specificity. The supporting sentence is relevant and directly supports the answer by stating that the ROSIER scale differentiates acute stroke from mimics. However, it could be slightly more concise as the phrase 'in the initial differentiation of acute stroke from stroke mimics in the ER' contains some redundancy.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\" \n\nThis sentence explicitly states that the ROSIER scale is designed to distinguish **acute stroke** from other conditions (stroke mimics) in emergency room settings, directly supporting the answer.", "retries": 1}
{"idx": 884, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that TCR targets the transcribed strand by referencing the role of RNA polymerase in recognizing damage on this strand. The explanation aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands. \n\n**Analysis**: This sentence explicitly states that transcription-coupled repair (TCR) targets \"transcribed strands,\" directly answering the question. The mention of \"stalled RNA polymerase\" as the signaling structure further clarifies that TCR specifically addresses damage on the strand being transcribed.", "retries": 1}
{"idx": 885, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the close evolutionary relationship between microsporidia and zygomycetes, which are part of the fungal kingdom, aligning perfectly with the context and gold answer.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes. \n\n**Analysis**: Zygomycetes are a class within the kingdom Fungi. The context explicitly states that microsporidia share a close evolutionary relationship with zygomycetes, and modern taxonomic classifications place microsporidia within the fungal kingdom based on this phylogenetic evidence.", "retries": 1}
{"idx": 886, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 887, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' vs. 'Xa'). The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning by referencing the category of drugs that include betrixaban as an orally active direct factor Xa inhibitor. Although the model notes that the context does not explicitly mention betrixaban, the sentence provided aligns perfectly with the gold supporting sentence in identifying the mechanism of action.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention **betrixaban** or its mechanism of action (inhibition of Factor Xa). Therefore, there is **no supporting sentence** in the provided text that directly addresses the clotting factor inhibited by betrixaban. The answer \"Factor Xa\" cannot be validated from the given context. \n\n**Note:** Betrixaban is a Factor Xa inhibitor, but this information is not included in the provided text.", "retries": 1}
{"idx": 888, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The use of 'its' in the supporting sentence clearly refers to alpha-synuclein as mentioned in the context.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation... \n\n(Note: The pronoun \"its\" in this sentence refers to **alpha-synuclein**, which is explicitly mentioned earlier in the context as the key protein implicated in the pathogenesis of DLB. This establishes alpha-synuclein as the primary component of Lewy bodies.)", "retries": 1}
{"idx": 889, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'SERCA2a' is very close to the gold answer 'SERCA2', differing only by the 'a' isoform specification, which is still correct in the context of cardiac muscle. The supporting sentence is relevant and highlights the importance of SERCA2a in cardiac function, but it does not explicitly define SERCA2a as the calcium pump of the sarcoplasmic reticulum, making it slightly less precise than the gold supporting sentence.\", \"match\": false}", "gold_answer": "SERCA2", "gold_support": "The calcium pump SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF).", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: Increasing SERCA2a expression in HF models improves cardiac function.  \n\n**Analysis:**  \nThe context repeatedly emphasizes the role of SERCA2a (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase 2a) as the primary calcium pump in cardiac muscle. The study focuses on delivering AAV6-hSERCA2a to enhance SERCA2a expression, directly linking it to improved cardiac function. The sentence \"Increasing SERCA2a expression in HF models improves cardiac function\" explicitly underscores SERCA2a's critical role as the sarcoplasmic reticulum's main calcium pump in the heart.", "retries": 1}
{"idx": 890, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and supports the answer by discussing Tyk2's stabilization of IFNAR1 independently of beta-Trcp, indirectly confirming beta-Trcp's role in ubiquitination. However, it is slightly less direct compared to the gold supporting sentence, which explicitly mentions SCFbeta-Trcp as the E3 ligase mediating IFNAR1 degradation.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: β-Trcp (beta-Trcp)", "model_support": "Supporting sentence: Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination. \n\n**Analysis**:  \nThe sentence implies that **beta-Trcp** (β-Trcp) is a known E3 ubiquitin ligase that could mediate IFNAR1 ubiquitination and degradation under normal conditions. The context states that Tyk2 stabilizes IFNAR1 **independently** of beta-Trcp and ubiquitination, suggesting that beta-Trcp is the E3 ligase typically responsible for ubiquitinating IFNAR1 when Tyk2 is absent or inactive. This inference aligns with the answer (β-Trcp) as the E3 ligase mediating IFNAR1 degradation.", "retries": 1}
{"idx": 891, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by highlighting the close evolutionary relationship between microsporidia and fungi.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \n\n**Analysis**: The context explicitly states that microsporidia are closely related to zygomycetes, which are a group within the **Fungi** kingdom. This evolutionary relationship, along with shared genomic features (e.g., syntenic gene clusters like the sex-related locus), supports the classification of microsporidia within the Fungi kingdom.", "retries": 1}
{"idx": 892, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '1,4-benzothiazepine,' is essentially correct and matches the gold standard, 'benzothiazepine.' The difference in phrasing ('1,4-benzothiazepine' vs. 'benzothiazepine') is minor and does not affect correctness. However, the supporting sentence states that no sentence in the context supports the answer, which is incorrect because the gold supporting sentence explicitly mentions JTV519 as a derivative of 1,4-benzothiazepine. This leads to a slight deduction in score due to the oversight in identifying the relevant supporting sentence.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The provided context does not mention JTV519 or its chemical classification. Therefore, **no sentence in the context supports the answer** to the question about JTV519 being a derivative of 1,4-benzothiazepine. The context focuses on calstabin2 and its role in cardiac arrhythmias, unrelated to JTV519's chemical structure.", "retries": 1}
{"idx": 893, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the supporting sentence is relevant to the context and discusses APOBEC3B's behavior during mitosis, it fails to address the key point from the gold supporting sentence that APOBEC3B becomes nuclear after mitosis. The reasoning focuses on mitotic exclusion but misses the post-mitotic localization, which is critical for the correct answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "Answer: Predominantly cytoplasmic.", "model_support": "Supporting sentence: APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis. \n\n**Analysis:** During mitosis, the nuclear envelope disintegrates, allowing cytoplasmic proteins to access chromatin (nuclear DNA). The exclusion of APOBEC3B from chromatin throughout mitosis indicates it remains in the cytoplasm rather than entering the nuclear compartment, even when the nuclear envelope is absent. This supports its predominant cytoplasmic localization.", "retries": 1}
{"idx": 894, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Parallel heterodimers') does not match the gold standard ('antiparallel'). The supporting sentence is relevant to spectrin assembly but misinterprets the 'side-to-side pairing' as indicative of parallel alignment, whereas the correct interpretation from the context is antiparallel. While the supporting sentence provides logical reasoning, it fails to cover the gold answer.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "The antiparallel side-to-side association of spectrin alpha and beta monomers is a two-step process which occurs in seconds even at 0 degrees C and at low concentrations.", "model_answer": "Answer: Parallel heterodimers.", "model_support": "Supporting sentence: The nucleation sites probably have a specific lock and key structure which defines the unique **side-to-side pairing** of the many homologous segments in both subunits.  \n\n**Analysis**: The term \"side-to-side pairing\" directly indicates that alpha- and beta-spectrin subunits align laterally in a **parallel** orientation (rather than antiparallel) during heterodimer formation. This structural analogy to a zipper further supports a parallel arrangement, as zippers interlock in a unidirectional, parallel manner.", "retries": 1}
{"idx": 895, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard ('thyroid'), though it could be more specific by mentioning 'T3' or 'T4'. The supporting sentence is relevant and accurately describes the syndrome caused by MCT8 mutations but does not explicitly mention the altered transport of thyroid hormones (T3/T4) to neurons, which is central to the gold supporting sentence. While logical, the supporting sentence contains slight redundancy by focusing on the syndrome's neurological aspects rather than directly addressing hormone concentration changes.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Mct8 transports thyroid hormones (T4 and T3), and the Allan-Herndon-Dudley syndrome is likely caused by lack of T3 transport to neurons during critical periods of fetal brain development.", "model_answer": "Answer: Thyroid hormone concentrations.", "model_support": "Supporting sentence: Mutations of the monocarboxylate transporter 8 gene (MCT8, SLC16A2) cause the Allan-Herndon-Dudley syndrome, an X-linked syndrome of severe intellectual deficit and neurological impairment. \n\n**Analysis**: The context explicitly links mutations in the MCT8 gene (which encodes a transporter for thyroid hormones) to Allan-Herndon-Dudley syndrome. Since MCT8 is critical for thyroid hormone (T3/T4) transport across cellular membranes, its dysfunction directly alters thyroid hormone concentrations in target tissues (e.g., the brain). The study further investigates how T4 and T3 interact with MCT8, reinforcing that the syndrome’s pathophysiology involves disrupted thyroid hormone homeostasis.", "retries": 1}
{"idx": 896, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but includes an additional sentence that introduces slight redundancy. The first sentence alone would have been sufficient to support the answer.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways...\"  \nAdditional supporting sentence: \"Orteronel can suppress serum estradiol concentrations... through selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 897, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer logically, but it is slightly indirect compared to the gold supporting sentence. The model's supporting sentence discusses attenuation of repression by IHABP rather than directly stating Bach1's function as a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a transcriptional repressor of heme oxygenase-1 (HO-1) and the beta-globin genes.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner.", "retries": 1}
{"idx": 898, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights SERCA's role as a calcium pump, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "Answer: SERCA (Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase)", "model_support": "Supporting sentence: SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.  \n\n**Analysis**: The context explicitly states that SERCA (Sarcoplasmic/Endoplasmic Reticulum Ca²⁺-ATPase) is the membrane protein responsible for transporting calcium into intracellular stores (i.e., the sarcoplasmic reticulum). This directly identifies SERCA as the primary calcium pump of the sarcoplasmic reticulum.", "retries": 1}
{"idx": 899, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is unnecessarily verbose and explains that the context does not explicitly state the full form, which is incorrect since the gold supporting sentence directly provides the expansion from the text. The correct supporting sentence should have been more concise and directly referenced the relevant part of the context.\", \"match\": true}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Beyond the JAK/signal transducer and activator of transcription network, a wide number of molecular alterations were described in MPN including the fosfatidilinositolo-3-chinasi (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway constitutive activation.", "model_answer": "Answer: Mammalian Target of Rapamycin", "model_support": "The context does not explicitly state the full form of \"mTOR\" (Mammalian Target of Rapamycin). While the term is widely recognized in biomedical literature, the provided text does not include a sentence that directly expands the acronym. The answer relies on general scientific knowledge rather than a specific quote from the context.", "retries": 1}
{"idx": 900, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by referencing collagen's role in the study. However, it includes slight redundancy when discussing deamidation and amphibians, which is unnecessary for justifying the answer.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "(Reports, 13 April 2007, p.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: \"absence of amino acid composition data, lack of evidence for peptide deamidation, and association of alpha1(I) collagen sequences with amphibians rather than birds suggest that T. rex does not.\"  \n\nThe mention of **alpha1(I) collagen sequences** directly identifies collagen as the bone protein analyzed in the study. Collagen is a well-established structural protein in bones used in archaeology for species identification and dating due to its preservation potential and taxonomic specificity.", "retries": 1}
{"idx": 901, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model correctly references prior knowledge to provide a complete explanation.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Romano-Ward syndrome is a subtype of prolonged QT syndrome with autosomal dominant inheritance.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context does not explicitly mention the mode of inheritance of Romano-Ward syndrome. However, based on established medical knowledge, **Romano-Ward syndrome (a form of long QT syndrome)** is inherited in an **autosomal dominant** pattern. The provided text focuses on clinical presentation, treatment, and outcomes, not genetic inheritance. \n\n**Answer:** Autosomal dominant  \n**Supporting sentence:** The context does not include a sentence specifying the mode of inheritance. The answer relies on prior knowledge of Romano-Ward syndrome as an autosomal dominant condition.", "retries": 1}
{"idx": 902, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why cysteine is the most commonly mutated residue in CADASIL syndrome by referencing a 'cysteine-sparing mutation,' which implies cysteine's typical involvement. This aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "cysteine", "gold_support": "Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.", "model_answer": "Answer: Cysteine", "model_support": "Supporting sentence: We describe a 49-year-old woman with a CADASIL-like phenotype, carrying a novel **cysteine-sparing** mutation in exon 29 of the NOTCH3 gene, and discuss the possible pathogenetic role of this molecular variant. \n\n**Analysis**: The phrase \"cysteine-sparing mutation\" indicates that this specific mutation does not alter cysteine residues, which contrasts with the typical CADASIL mutations (which often involve cysteine substitutions or disrupt cysteine-rich domains in NOTCH3). This implies that **cysteine** is the amino acid residue most commonly mutated in CADASIL syndrome.", "retries": 1}
{"idx": 903, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor differences in capitalization ('adempas' vs. 'Adempas') do not affect the correctness.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "retries": 1}
{"idx": 904, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about the mechanism being poorly understood are acceptable as they do not detract from the core logic.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X-chromosome inactivation (XCI) in female mammals depends on the noncoding RNA X inactivation specific transcript (Xist).", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: The mechanism of chromosome-wide silencing by Xist is poorly understood.  \n**Analysis**: The context explicitly states that \"Xist\" is central to the process of chromosome-wide silencing (i.e., X-chromosome inactivation). The entire study focuses on the structural and functional roles of the Xist RNA A-repeat in this process, confirming that Xist RNA is the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 905, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking calcineurin to NFAT regulation through its inhibition by immunosuppressive drugs. However, it contains slight redundancy by mentioning cyclosporin A and FK506, which, while relevant, are not necessary to directly support the role of calcineurin in NFAT activation. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated T cells), a family of transcription factors required for the synthesis of several cytokine genes.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: \"Calcineurin is the target of the immunosuppressive drugs cyclosporin A and FK506 complexed with their cytoplasmic receptors cyclophilin and FKBP12, respectively.\" \n\nThis sentence establishes that calcineurin is the phosphatase inhibited by drugs known to block NFAT activation (cyclosporin A and FK506), directly linking calcineurin to the regulation of NFAT. Additionally, the context later confirms that CHP inhibits calcineurin activity, which in turn impairs NFAT function, further reinforcing the role of calcineurin in NFAT activation.", "retries": 1}
{"idx": 906, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard, specifying 'hypothyroidism' as a common hormone abnormality in Williams syndrome, which is correct and related to the thyroid. However, it does not exactly match the gold answer 'thyroid,' which is broader but still accurate. The supporting sentence is somewhat lengthy and focuses on treatment rather than directly emphasizing the presence of thyroid abnormalities, mixing some extra details. The logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "New case of thyroid dysgenesis and clinical signs of hypothyroidism in Williams syndrome.", "model_answer": "Answer: Hypothyroidism is a common hormone abnormality in Williams syndrome.", "model_support": "Supporting sentence: Moreover, our case shows that clinical manifestations of hypothyroidism may be present and the treatment may be necessary as it is in isolated congenital hypothyroidism.", "retries": 1}
{"idx": 907, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by explaining the construction and purpose of LepChorionDB, which logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 908, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard exactly ('FSHD'). The supporting sentence is relevant and directly ties the ectopic expression of DUX4 to FSHD, but it contains slight redundancy by specifying 'variegated expression in skeletal muscle' which, while accurate, adds a small amount of unnecessary detail compared to the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "Answer: FSHD (Facioscapulohumeral Muscular Dystrophy)", "model_support": "Supporting sentence: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\" \n\nThis sentence explicitly links **ectopic expression of DUX4** (variegated expression in skeletal muscle) to **FSHD (Facioscapulohumeral Muscular Dystrophy)**, establishing the disease association.", "retries": 1}
{"idx": 909, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and correct but slightly less detailed compared to the gold supporting sentence. It mentions the presence of a mutation in the MCT8 gene, which supports the answer, but does not elaborate on the phenotype or elevated T(3) levels that provide richer context. Slight redundancy is present due to the phrasing 'a missense mutation,' but overall, logical support is strong.\",\n  \"match\": true\n}", "gold_answer": "MCT8", "gold_support": "Mutations of the monocarboxylate transporter 8 (MCT8) gene determine a distinct X-linked phenotype of severe psychomotor retardation and consistently elevated T(3) levels.", "model_answer": "Answer: MCT8", "model_support": "Supporting sentence: A missense mutation of the MCT8 gene was present.", "retries": 1}
{"idx": 910, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase', does not fully match the gold standard 'BCR-ABL'. While 'Abl kinase' is related and partially correct (as BCR-ABL contains the Abl kinase domain), it is incomplete. The supporting sentence focuses on mutations in the Abl kinase protein but does not directly state that BCR-ABL is the fusion protein targeted by imatinib. Thus, the supporting sentence is relevant but fails to fully cover the gold answer.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "The fusion gene that results (BCR-ABL) produces a constitutively activated tyrosine kinase that exists in different isoforms depending on BCR break-points.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: \"However, 17% of patients in the chronic phase will either relapse or develop resistance resulting mainly from one or more point mutations affecting at least 30 amino acids within the **Abl kinase protein**.\" \n\nThis sentence directly identifies **Abl kinase** as the target of imatinib, as resistance mechanisms in CML are linked to mutations in the Abl kinase domain of the Bcr-Abl fusion protein, which imatinib inhibits.", "retries": 1}
{"idx": 911, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly verbose and includes more detail than necessary. The key point about medicarpin being the major phytoalexin is covered, though the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis...\" and \"...the kinetics of induction are consistent with the appearance of IFR activity, the accumulation of medicarpin...\" \n\nThe context explicitly states that IFR is part of the **medicarpin biosynthesis** pathway and directly links the induction of IFR activity to the **accumulation of medicarpin**, confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 912, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "retries": 1}
{"idx": 913, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly ('acute stroke' is an acceptable synonym in this context); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"  \n\nThis sentence explicitly states that the ROSIER scale is designed to differentiate **acute stroke** from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 914, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 is often referred to as \"the guardian of the genome\" because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "retries": 1}
{"idx": 915, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose. The reference to cancer patients is not necessary for answering the question about type 1 neurofibromatosis, introducing slight redundancy.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Lysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: \"Mutations of this lysine were detected in samples from a neurofibromatosis patient as well as from cancer patients.\"  \nThis sentence explicitly links lysine 1423 of **neurofibromin (NF1)** to neurofibromatosis, confirming that the **NF1 gene** is mutated in type 1 neurofibromatosis. The entire context focuses on the functional role of NF1 and its mutations, further supporting this conclusion.", "retries": 1}
{"idx": 916, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard, confirming BACH1 as a repressor. However, the supporting sentence is somewhat indirect and mixes relevant information with additional context about hydroxytyrosol, which is not necessary for supporting the answer. While the logic connects BACH1 to its repressive role by referencing the Nrf2/Bach1 balance, it is less concise and clear compared to the gold supporting sentence, which directly states BACH1's role as a repressor of the antioxidant response element.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In HaCaT cells, FB and EC (200 μM) induced nuclear translocation of NRF2 protein after 24 h and reduced nuclear protein levels of BACH1, a repressor of the antioxidant response element.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: We suggest that hydroxytyrosol (HYD) could be a potential bioactive metabolite of PPGs since HYD, in equimolar amounts to PGGs, is able to both activate HO-1 transcription and **modify Nrf2/Bach1 nuclear protein levels**.  \n\nThe context implies that BACH1 functions as a repressor by describing how compounds like hydroxytyrosol modulate the **Nrf2/Bach1 balance** to activate HO-1 transcription. Since Nrf2 is an activator of cytoprotective genes (like HMOX1) and BACH1 antagonizes Nrf2’s activity, the phrase \"modify Nrf2/Bach1 nuclear protein levels\" directly supports the conclusion that BACH1 acts as a repressor in this regulatory system.", "retries": 1}
{"idx": 917, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by pointing to the explicit synonym relationship in the context.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.  \n\nThe synonym is explicitly stated in the first sentence, where \"X-linked dystonia-parkinsonism\" and \"Lubag disease\" are separated by a slash, indicating they refer to the same condition.", "retries": 1}
{"idx": 918, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns well with the gold standard, correctly identifying Groucho as a transcriptional repressor in Drosophila melanogaster. However, it adds extra details about the mechanism (histone deacetylase-dependent increase in nucleosome density), which, while correct and supported by the context, are not necessary to match the gold answer. The supporting sentence provided is relevant and supports the answer logically but contains slight redundancy by referencing multiple mechanisms rather than focusing on the concise interaction with Rpd3 as in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor", "gold_support": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3.", "model_answer": "Answer: The Drosophila melanogaster Groucho protein is a transcriptional repressor that mediates repression through histone deacetylase-dependent mechanisms, including increased nucleosome density.", "model_support": "Supporting sentence: \"Groucho-mediated repression may result from a histone deacetylase-dependent increase in nucleosome density.\"  \nAdditional supporting sentences:  \n- \"We propose a model in which Gro-mediated histone deacetylation results in increased nucleosome density leading to transcriptional repression.\"  \n- \"Gro colocalizes with Rpd3 to the chromatin of a target gene and that this is accompanied by the deacetylation of specific lysines within the N-terminal tails of histones H3 and H4.\"  \n- \"These effects [of Gro overexpression] are reversed by the histone deacetylase inhibitors TSA and HC-Toxin and by the reduction of Rpd3 gene dosage.\"  \n\nThese sentences collectively establish that the **Drosophila melanogaster Groucho (Gro) protein** acts as a **transcriptional repressor** that mediates repression via **histone deacetylase (HDAC)-dependent mechanisms**, including **increased nucleosome density** and **histone deacetylation** (specifically of H3 and H4 tails). The involvement of Rpd3 (a HDAC) and reversal by HDAC inhibitors further confirm the dependency on histone deacetylation.", "retries": 1}
{"idx": 919, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly confirms that gevokizumab interacts with IL-1β, aligning perfectly with the gold answer.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: \"Gevokizumab occupies an allosteric site on IL-1β and complex formation results in a minor reduction of binding affinity to IL-1RI.\" \n\nThis sentence explicitly states that **gevokizumab interacts with IL-1β**, confirming it as the targeted molecule.", "retries": 1}
{"idx": 920, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it focuses on the method of diagnosis (cytologic examination) rather than directly emphasizing the association between small-cell lung cancer and Lambert-Eaton syndrome as the gold supporting sentence does. This makes it slightly less ideal but still logical and relevant.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.", "model_answer": "Answer: Small cell lung cancer (SCLC)", "model_support": "Supporting sentence: Cytologic examination of ultrasound-guided fine needle aspiration disclosed SCLC.", "retries": 1}
{"idx": 921, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence, while relevant, is more focused on gender-specific risks in women rather than directly stating the prevalence ratio. The chosen supporting sentence is somewhat indirect and does not explicitly mention the 5.2:1 ratio, which would have made it more concise and directly aligned with the gold supporting sentence. However, it still logically supports the conclusion that RA is more common in women.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "Supporting sentence: Colombian women with RA are more at risk of having an early age at onset and developing polyautoimmunity and abdominal obesity, and they perform more household duties than their male counterparts. \n\n**Analysis**: While the context does not explicitly state the overall prevalence of RA in men vs. women, the focus on \"Colombian women with RA\" and the identification of gender-specific risks (e.g., earlier onset, polyautoimmunity) in the study imply a significant proportion of women in the RA population. Additionally, the conclusion highlights \"high rates of disability and worse prognosis observed in women with RA,\" further suggesting a higher prevalence or impact in women. However, the most direct supporting sentence is the one explicitly stating gender-specific risks in women, which indirectly reflects a higher prevalence or susceptibility in this group.", "retries": 1}
{"idx": 922, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Interleukin 17 (IL-17)' is very close to the gold standard 'interleukin-17A,' as IL-17A is a specific isoform of IL-17 and the broader term is not incorrect. However, it lacks the specificity of the gold answer. The supporting sentence is relevant and supports the answer with logical reasoning but contains slight redundancy by restating the role of IL-17 in the disease without directly referencing secukinumab's mechanism of action.\", \"match\": false}", "gold_answer": "interleukin-17A", "gold_support": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.", "model_answer": "Answer: Interleukin 17 (IL-17)", "model_support": "Supporting sentence: Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis, the prototypical form of spondyloarthritis.  \n\n**Analysis**: The context explicitly identifies IL-17 as a central inflammatory cytokine in ankylosing spondylitis. While the text does not explicitly state \"secukinumab targets IL-17,\" the logical connection is made through the study's design (testing secukinumab as an alternative to TNF inhibitors) and the established role of IL-17 in the disease mechanism. The drug’s name (\"secukinumab\") also aligns with standard nomenclature for anti-IL-17 monoclonal antibodies (e.g., \"-mab\" suffix denotes a monoclonal antibody, and \"secu-\" implies targeting IL-17).", "retries": 1}
{"idx": 923, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Na⁺/Ca²⁺ exchanger (NCX),' is correct and matches the gold standard ('NCX'). However, the supporting sentence provided by the model does not cover the gold answer adequately because it discusses PPADS instead of SEA0400. The gold supporting sentence explicitly mentions SEA0400 as an inhibitor of NCX(REV), which is crucial to justifying the answer. The model's failure to reference SEA0400 reduces the relevance and accuracy of its supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)", "model_support": "The context does not mention the small molecule **SEA0400** at all. The compounds discussed as inhibitors of the reverse mode of the Na⁺/Ca²⁺ exchanger (NCX) are **PPADS**, **KB-R7943**, and **SN-6**. Since **SEA0400** is not referenced in the provided text, the answer is **incorrect**. The correct response would be: *The context does not provide information about SEA0400.* \n\n**Supporting sentence for the actual discussion of NCX inhibition**:  \n\"PPADS, a P2X receptor antagonist, acts as a NCX(REV) inhibitor in guinea pig tracheal myocytes.\"", "retries": 1}
{"idx": 924, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically. The provided sentence, while not identical to the gold supporting sentence, still establishes Jnk's role as a MAP kinase family member activated by dual phosphorylation, aligning with its function in phosphorylating c-Jun.\", \"match\": true}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "Answer: Jnk", "model_support": "Supporting sentence: Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group that is activated by dual phosphorylation at Tyr and Thr. \n\n**Analysis**:  \nThe context explicitly states that Jnk is a member of the MAP kinase family (despite being termed a \"distant relative\") and highlights its activation mechanism (dual phosphorylation at Tyr and Thr), which aligns with Jnk's known role in phosphorylating c-Jun. While the text does not *explicitly* name Jnk as the kinase for c-Jun, it is implied through the following:  \n1. **c-Jun is listed as a MAP kinase target** (\"These substrates include transcription factors [...] c-Jun\").  \n2. **Jnk is explicitly linked to the MAP kinase group** and its activation mechanism, confirming its role in the pathway.  \n3. **Jnk (c-Jun N-terminal kinase)** is the canonical MAP kinase known to phosphorylate c-Jun in biological systems.  \n\nThus, the final sentence confirms Jnk's classification within the MAP kinase family, supporting its role in phosphorylating c-Jun.", "retries": 1}
{"idx": 925, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, β-TrCP, is correct but slightly less specific than the gold answer, SCF(β-TrCP). The supporting sentence is relevant and provides good reasoning by linking β-TrCP to IκB degradation. However, it does not explicitly mention the full form SCF(β-TrCP), which would make it more precise. The logic is strong, but the omission of 'SCF' makes the answer and supporting sentence slightly less complete compared to the gold standard.\", \"match\": false}", "gold_answer": "SCF(β-TrCP)", "gold_support": "IKK activation and IκB degradation involve different ubiquitination modes; the latter is mediated by a specific E3 ubiquitin ligase SCF(β-TrCP) .", "model_answer": "Answer: β-TrCP", "model_support": "Supporting sentence: In vivo ablation of β-TrCP results in accumulation of all the IκBs and complete NF-κB inhibition. \n\n**Analysis**:  \nThe sentence demonstrates that β-TrCP is essential for the degradation of IκBs (inhibitors of NF-κB). When β-TrCP is absent (ablated), IκBs accumulate instead of being degraded, blocking NF-κB activation. This directly implicates β-TrCP as the E3 ubiquitin ligase responsible for ubiquitinating IκBs, marking them for proteasomal degradation. The context further supports this by highlighting β-TrCP's role in IκB-β-TrCP interactions and its therapeutic relevance in NF-κB pathways.", "retries": 1}
{"idx": 926, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Iron deficiency') is correct in general medical knowledge and matches the gold standard ('iron') in meaning, though not exactly in form. However, the supporting sentence provided by the model is incorrect because it explicitly states that no sentence in the context supports the answer, which is untrue. The gold supporting sentence directly references 'iron deficiency' as a cause of RLS within the context, demonstrating that relevant support exists. Thus, while the answer is present in the context, the supporting sentence fails to logically cover the gold answer.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS), aging, pregnancy, uraemia, iron deficiency, polyneuropathy are some of the common causes of secondary PLMD.", "model_answer": "Answer: Iron deficiency", "model_support": "The context does not mention iron deficiency or its association with restless leg syndrome (RLS). The provided text discusses **periodic limb movement disorder (PLMD)** and its clinical/polysomnographic features but does not address RLS or iron deficiency. Therefore, **no sentence in the context supports the answer**. \n\n**Note:** While iron deficiency is a known cause of RLS in general medical knowledge, the specific context provided here does not discuss this relationship.", "retries": 1}
{"idx": 927, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is somewhat verbose and includes additional details not directly necessary to support the answer. The logic is clear, but it could be more concise.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700)... In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity...", "retries": 1}
{"idx": 928, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard (NCX), but the supporting sentence is incorrect and does not support the gold answer. The model incorrectly identifies PPADS as the inhibitor instead of SEA0400, which is mentioned in the gold supporting sentence. The correct supporting sentence should have referenced SEA0400 as a selective inhibitor of NCX(REV).\", \"match\": true}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: Na⁺/Ca²⁺ exchanger (NCX)", "model_support": "The answer provided is incorrect based on the context. The context discusses **PPADS** as the inhibitor of the Na⁺/Ca²⁺ exchanger (NCX), not **SEA0400**. The correct answer is **PPADS**, and the supporting sentence is:\n\n**Supporting sentence:** \"We found that PPADS, a P2X receptor antagonist, acts as a NCX(REV) inhibitor in guinea pig tracheal myocytes.\"\n\nThe context does not mention **SEA0400** at all.", "retries": 1}
{"idx": 929, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Thyroid hormone synthesis abnormalities,' is not incorrect but does not directly match the gold answer, 'thyroid.' The supporting sentence is relevant and explains a consequence of the lack of pendrin, which relates to abnormal thyroid hormone synthesis. However, it does not directly support the specific gold answer ('thyroid') and contains unnecessary details about oxidative stress and cell destruction. The connection between the model's supporting sentence and the gold answer is weak, leading to a lower score.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "CONTEXT: Pendred syndrome is caused by mutations in the gene coding for pendrin, an apical Cl-/I- exchanger.", "model_answer": "Answer: Thyroid hormone synthesis abnormalities.", "model_support": "Supporting sentence: In more affected follicles, Duox and TPO are relocated in the cytosol, leading to abnormal intracellular thyroid hormone synthesis, which results in cell destruction presumably because intracellular OS cannot be buffered by antioxidant defenses.", "retries": 1}
{"idx": 930, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and provides correct information about the KFERQ motif's role in CMA. However, it includes additional details (e.g., 'six KFERQ motifs') that are not necessary to directly support the answer, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.", "model_answer": "Answer: Chaperone-mediated autophagy (CMA)", "model_support": "Supporting sentence: In silico analysis also revealed that the RyR2 sequence harbours six KFERQ motifs which are required for the recognition Hsc70 and its degradation via CMA.", "retries": 1}
{"idx": 931, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The inverse regulation of HO-1 and Bach1 provides strong support for Bach1 being a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Expression of HO-1 and Bach1 is inversely regulated.  \n**Analysis**: The context explicitly states that HO-1 and Bach1 expression are inversely regulated, meaning when Bach1 levels increase (e.g., under hypoxia, interferon-gamma, or iron chelation), HO-1 expression decreases. This inverse relationship confirms that **Bach1 acts as a repressor** of HO-1 transcription.", "retries": 1}
{"idx": 932, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard and is correct based on general knowledge. However, the supporting sentence provided does not directly cover the answer as it discusses TCR being a subpathway of NER but does not specify that TCR targets the transcribed strand. The logic is reasonable, but the supporting sentence could be more concise and directly relevant.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: It has been clearly demonstrated to be a subpathway of nucleotide excision repair (NER) in E. coli, yeast and mammalian cells.  \n\n**Analysis**: The context does not explicitly state which DNA strand is targeted by transcription-coupled repair (TCR). While the answer \"the transcribed strand\" is correct based on general knowledge (TCR specifically repairs the DNA strand being transcribed by RNA polymerase to prevent transcriptional blockage), the provided context does **not** include a sentence directly confirming this. The example format assumes a direct quote, but in this case, the supporting sentence is absent from the given text.", "retries": 1}
{"idx": 933, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' closely matches the gold standard 'stroke,' as 'acute stroke' is a specific type of stroke and contextually appropriate. The supporting sentence is concise, directly relevant, and logically explains that the ROSIER scale differentiates acute stroke from stroke mimics, which aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence explicitly states that the ROSIER scale is used for distinguishing **acute stroke** from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 934, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer logically, but it is slightly verbose and does not directly mention the MR CLEAN study, which is a key detail in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "Answer: Acute ischemic stroke", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 935, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the connection between gluten ingestion and dermatitis herpetiformis as the typical rash, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "Answer: Dermatitis herpetiformis", "model_support": "Supporting sentence: **Tolerance to oats in dermatitis herpetiformis.**  \n\nThis sentence directly associates **dermatitis herpetiformis** with gluten-related conditions, as the context focuses on the relationship between gluten intake (via oats) and this rash. The study examines whether oats (a gluten-containing grain) trigger the rash in patients with dermatitis herpetiformis, confirming that the rash is not activated by oats, thus reinforcing that the typical gluten-associated rash is dermatitis herpetiformis.", "retries": 1}
{"idx": 936, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's answer 'Acute stroke' aligns with the gold answer 'stroke,' and the supporting sentence clearly explains the purpose of the ROSIER scale in identifying acute stroke.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence explicitly states that the ROSIER scale is used for identifying **acute stroke** in emergency room settings, distinguishing it from other conditions (stroke mimics).", "retries": 1}
{"idx": 937, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly ('stroke' is synonymous with 'acute stroke' in this context); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: **\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**  \n\nThis sentence directly states that the ROSIER scale is used for **acute stroke**, as its purpose is to distinguish acute stroke from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 938, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by highlighting the incorporation of [(14)C]phenylalanine into medicarpin during elicitation, but it contains slight redundancy by mentioning conjugation, which is not directly needed to support the answer.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.", "retries": 1}
{"idx": 939, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It highlights the selective inhibition of CYP17A1 activity by orteronel, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through **selective inhibition of CYP17A1 activity**, suggesting that orteronel might be effective for hormone-dependent breast cancers and estrogen-dependent diseases.", "retries": 1}
{"idx": 940, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Papulovesicular rash') does not match the gold standard ('Dermatitis herpetiformis'), but it is present in the context as a characteristic of the condition. The supporting sentence is relevant but focuses on the rash rather than directly supporting the gold answer, which is the name of the disease itself.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "Answer: Papulovesicular rash", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.  \n**Analysis**: The context explicitly states that dermatitis herpetiformis (DH), a gluten-associated condition, presents as a **papulovesicular rash**, directly linking the rash type to gluten-related pathology.", "retries": 1}
{"idx": 941, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct than the gold supporting sentence. It mentions heme binding to Bach1 and regulating its DNA-binding activity, which indirectly supports its role as a repressor, but does not explicitly state that Bach1 functions as a repressor of MARE like the gold standard does.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the Maf recognition element (MARE) by forming antagonizing hetero-oligomers with the small Maf family proteins.", "model_answer": "Answer: A repressor.", "model_support": "Supporting sentence: We show here that heme binds specifically to Bach1 and regulates its DNA-binding activity. \n\nThe context explicitly refers to Bach1 as a \"transcription repressor\" in the first sentence (\"Heme controls expression of genes... We show here that heme binds specifically to **transcription repressor Bach1**...\"). This directly identifies BACH1 as a repressor.", "retries": 1}
{"idx": 942, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer, 'Ser129', matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of Ser129 phosphorylation in the formation of Lewy bodies, aligning well with the gold supporting sentence. Minor additional context in the supporting sentence is acceptable as it strengthens the logical connection.\",\n  \"match\": true\n}", "gold_answer": "Parkinson", "gold_support": "Approximately 90% of α-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129).", "model_answer": "Answer: Ser129", "model_support": "Supporting sentence: \"This suggests that the accumulation of Ser129-phosphorylated α-syn leads to the formation of Lewy bodies and dopaminergic neurodegeneration in Parkinson's disease.\"", "retries": 1}
{"idx": 943, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's supporting sentence introduces additional experimental context ('engineered minimal selenoprotein mRNAs') that is not directly necessary to explain the answer, making it slightly verbose compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "The machinery comprises the tRNA(Sec), a 3'-UTR mRNA stem-loop termed SElenoCysteine Insertion Sequence (SECIS), which is mandatory for recoding UGA as a Sec codon, the SECIS Binding Protein 2 (SBP2), and other proteins.", "model_answer": "Answer: SECIS", "model_support": "Supporting sentence: Here, we developed a novel approach using instead engineered minimal selenoprotein mRNAs containing **SECIS elements** derivatized with photoreactive groups. \n\n**Explanation**: The context explicitly refers to \"SECIS elements\" as part of the mRNA structure involved in selenocysteine incorporation. The SECIS (Selenocysteine Insertion Sequence) element is a conserved stem-loop structure located in the 3' untranslated region (UTR) of mammalian selenoprotein mRNAs, as described in the study.", "retries": 1}
{"idx": 944, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer '1,4-benzothiazepine' does not match the gold standard 'benzothiazepine,' but it is present in the context as a specific subgroup. The supporting sentence discusses diltiazem as a 1,5-benzothiazepine derivative, which does not directly support the model's answer or the gold answer. While the model answer is somewhat accurate, the supporting sentence fails to properly justify either the model's or the gold answer.\", \"match\": false}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n**Analysis**: The context does not explicitly state that JTV519 is a 1,4-benzothiazepine derivative. Instead, it only mentions diltiazem as a 1,5-benzothiazepine derivative for comparison. The answer provided (1,4-benzothiazepine) cannot be directly supported by the sentences in this context. The correct classification of JTV519 as a 1,4-benzothiazepine derivative would require a different context (e.g., the example provided earlier in the history).", "retries": 1}
{"idx": 945, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's supporting sentence provides a detailed description of the deletions found in the patients but could be more concise. The core point about XK gene involvement is made clearly, aligning well with the gold answer and supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "It is caused by XK gene defects and may include large deletions in the Xp21 region.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Analysis of three unrelated McLeod patients for the presence of the XK, DMD, CYBB, ETX1, RPGR and OTC loci, as well as for the DXS709 marker, revealed deletions from the 39th exon of DMD to the ETX1 locus (patient Be), from the XK to RPGR loci (patient Bi) and from the XK to CYBB loci (patient Lh). \n\n**Explanation**: The deletions in all three patients overlap with the **XK gene** (patients Bi and Lh show deletions starting at the XK locus). The XK gene encodes the Kx protein, which is directly associated with McLeod syndrome. The study's focus on XK deletions and their correlation with the syndrome confirms its role.", "retries": 1}
{"idx": 946, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (H3K4). The supporting sentence acknowledges that the context does not explicitly mention the specific histone residue methylated by MLL1 but correctly identifies the answer as a well-known fact. Although the supporting sentence is slightly verbose, it logically explains the absence of direct evidence in the context while affirming the correctness of the answer. This reasoning aligns with the scoring reference for a score of 5.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "While androgen suppresses EZH2 in CRPC cells, in LNCaP cells, physiological concentrations of androgen stimulate expression of PRC2 genes (EZH2, SUZ12, and EED), which is mediated by androgen-induced ANCCA and involves E2F and histone H3K4me3 methylase MLL1 complex.", "model_answer": "Answer: Lysine 4 of histone H3 (H3K4)", "model_support": "The context does not explicitly mention the histone residue methylated by MLL1 (e.g., H3K4). While the title refers to the \"MLL histone methylase complex,\" the provided text focuses on the regulation of ANCCA and EZH2 in prostate development and cancer, without specifying the exact histone residue targeted by MLL1. The answer (H3K4) is a well-established fact from external knowledge, but **no sentence in the given context directly supports this claim**. \n\n**Analysis:**  \nThe conclusion and implications in the context discuss the role of ANCCA and EZH2 in prostate development and cancer, but there is no mention of MLL1's enzymatic activity or its specific histone substrates (e.g., H3K4). The reference to \"MLL histone methylase complex\" in the title is too vague to infer the exact residue without additional context.", "retries": 1}
{"idx": 947, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'Autologous epidural blood patch (AEBP),' is functionally equivalent to the gold answer, 'epidural blood patch,' as AEBP is a specific type of epidural blood patch and matches the intended treatment. However, the supporting sentence, 'Complications of AEBP are rare,' is relevant but does not directly explain why AEBP is the definitive treatment. It lacks the clear reasoning provided in the gold supporting sentence, which explicitly states when and why the epidural blood patch should be performed. The model's supporting sentence contains some redundancy by focusing on complications rather than directly addressing its role as the definitive treatment.\", \"match\": true}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch should be performed within 24-48 h of dural puncture.", "model_answer": "Answer: Autologous epidural blood patch (AEBP)", "model_support": "Supporting sentence: Complications of AEBP are rare.  \n**Analysis**: The context does not explicitly state that autologous epidural blood patch (AEBP) is the definitive treatment for low-pressure headache (PDPH). However, the phrase \"Complications of AEBP are rare\" implies that AEBP is a recognized and commonly used intervention for PDPH, as it is discussed in the context of managing the condition. The absence of alternative treatments in the text further supports this inference.", "retries": 1}
{"idx": 948, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly indicating that the ROSIER scale is used as a stroke recognition tool.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 949, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'Calcitonin gene-related peptide receptor' is effectively equivalent to 'calcitonin gene-related peptide' in this context. The supporting sentence is relevant and supports the answer well, but it contains slight redundancy by including additional descriptors like 'oral' and 'antagonist,' which are accurate but not strictly necessary for identifying the targeted receptor.\",\n  \"match\": true\n}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is a novel, orally active, and selective calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.", "model_answer": "Answer: Calcitonin gene-related peptide receptor", "model_support": "Supporting sentence: Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral **calcitonin gene-related peptide receptor antagonist**, in adults.  \n\nThe phrase \"calcitonin gene-related peptide receptor antagonist\" in the context explicitly identifies the receptor targeted by telcagepant.", "retries": 1}
{"idx": 950, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the use of flumazenil in benzodiazepine overdose, but it contains slight redundancy by including additional details about the study groups and efficacy categorization, which are not necessary to directly support the answer. The logic is strong, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "STUDY OBJECTIVE: To develop clinical rules for the safe and effective use of flumazenil in suspected benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: Group A (low-risk) patients had a clinical picture compatible with uncomplicated benzodiazepine intoxication... **Efficacy of flumazenil** was categorized as complete awakening...  \n\n**Analysis**: The study evaluates the use of flumazenil in comatose patients with suspected drug overdose, specifically addressing its efficacy in reversing benzodiazepine intoxication. The phrase \"Efficacy of flumazenil was categorized...\" directly links flumazenil to the treatment of benzodiazepine overdose, confirming its role as an antidote. While the term \"antidote\" is not explicitly used, the context and clinical application of flumazenil in this scenario align with its established role as the antidote for benzodiazepine overdose.", "retries": 1}
{"idx": 951, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by quoting the title instead of focusing on the specific sentence that establishes the synonymy. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Regional and global metabolic rates for glucose (rCMRGlc and GMR) were estimated using [18F]fluorodeoxyglucose and positron emission tomography in 3 patients with Filipino X-linked dystonia-parkinsonism (lubag).", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Positron emission tomographic findings in Filipino X-linked dystonia-parkinsonism.  \n\nThe context explicitly refers to the condition as \"Filipino X-linked dystonia-parkinsonism\" in the title and later identifies the patients as having \"lubag,\" establishing the synonymy.", "retries": 1}
{"idx": 952, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX'), though it includes extra clarification ('Na+/Ca²+ exchanger'). The supporting sentence is relevant and covers the role of SEA0400 in inhibiting NCX, but it is slightly verbose and less direct than the gold supporting sentence. It discusses additional outcomes (e.g., arrhythmias) not necessary for answering the question directly, which adds some redundancy.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.", "model_answer": "Answer: Na+/Ca²+ exchanger (NCX)", "model_support": "Supporting sentence: It is concluded that the selective inhibition of NCX may be effective to preserve high-energy phosphates and to improve cardiac function after reperfusion, but may not be able to prevent fatal arrhythmias.", "retries": 1}
{"idx": 953, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "RET", "gold_support": "The RET proto-oncogene is involved in neural crest disorders.", "model_answer": "Answer: RET proto-oncogene", "model_support": "Supporting sentence: Direct fluorescent sequencing of genomic DNA revealed a heterozygous mutation in the RET proto-oncogene in exon 10 at codon C609Y in both persons tested.  \n**Analysis**: The context explicitly identifies the *RET proto-oncogene* as the gene mutated in this family with familial medullary thyroid carcinoma (FMTC) and Hirschsprung disease (HSCR). The conclusion further links this mutation to the broader association with MEN2A/FMTC-HSCR, confirming the *RET* gene's role in both conditions.", "retries": 1}
{"idx": 954, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' with only a minor difference in specificity. The supporting sentence is relevant and provides clear reasoning that the ROSIER scale is used for differentiating acute stroke in the ER, aligning well with the gold standard context. However, it includes slight redundancy by emphasizing 'acute' when 'stroke' alone would suffice.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\" \n\nThis sentence explicitly states that the ROSIER scale is used for differentiating **acute stroke** from other conditions (stroke mimics) in the emergency room setting.", "retries": 1}
{"idx": 955, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by referencing p53 and its regulatory mechanisms.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain. \n\n**Analysis**: While the context does not explicitly use the phrase \"guardian of the genome,\" it focuses on the structural and functional roles of **p53**, a well-established tumor suppressor known by that nickname in broader scientific literature. The first sentence directly references p53 and its regulatory mechanisms, providing contextual support for identifying p53 as the tumor suppressor in question.", "retries": 1}
{"idx": 956, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard but is based on external knowledge not present in the context. The supporting sentence provided by the model incorrectly states that there is no mention of PBT2 in the context, while the gold supporting sentence clearly includes PBT2 as a treatment for Alzheimer's disease. The model's supporting sentence does not cover the gold answer and lacks relevance to the context.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective.", "model_answer": "Answer: Alzheimer's disease", "model_support": "The context does not mention PBT2 or its association with any disorder. Therefore, there is no supporting sentence in the provided text to confirm that PBT2 has been tested for Alzheimer's disease. The answer appears to be based on external knowledge not included in the given context.", "retries": 1}
{"idx": 957, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'The transcribed DNA strand' is synonymous with 'the transcribed strand.' The supporting sentence is relevant and provides context about the complexity of TCR and its reliance on RNA polymerase, which indirectly supports why the transcribed strand is targeted. However, it does not explicitly state that TCR targets the transcribed strand, making it slightly less direct than the gold supporting sentence. This results in a minor loss of precision.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Answer: The transcribed DNA strand.", "model_support": "Supporting sentence: Genetic and biochemical studies indicate that it is a highly complex process and requires the participation of the NER pathway, the RNA polymerase complex and additional factors.  \n\n**Analysis**: While the context does not explicitly state \"transcribed DNA strand,\" the involvement of the **RNA polymerase complex** directly implies coupling with transcription. Transcription-coupled repair (TCR) specifically targets the DNA strand being transcribed (the transcribed strand) because RNA polymerase stalls at lesions on this strand, triggering repair. The sentence highlights the requirement of RNA polymerase for TCR, which is consistent with the known mechanism of targeting the transcribed strand.", "retries": 1}
{"idx": 958, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Thrombin (Factor IIa),' does not match the gold standard 'xa' (Factor Xa). However, the supporting sentence correctly identifies that betrixaban belongs to a category of anticoagulants mentioned in the context, though it incorrectly associates betrixaban with thrombin inhibitors rather than Factor Xa inhibitors. The supporting sentence is relevant but fails to cover the gold answer accurately.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "X (rivaroxaban, apixaban, edoxaban, betrixaban)", "model_answer": "Answer: Thrombin (Factor IIa)", "model_support": "The context provided does not mention **betrixaban** or specify its mechanism of action. Therefore, there is no supporting sentence in the given context to directly answer the question about betrixaban's target clotting factor. \n\nHowever, based on general pharmacological knowledge, **betrixaban** is a direct **thrombin (Factor IIa)** inhibitor. This aligns with the context's mention of \"inhibitors of activated factor II (dabigatran, AZD0837)\" as examples of direct thrombin inhibitors. While the context does not explicitly list betrixaban, it categorizes direct thrombin inhibitors as a clinically advanced class, which includes drugs like dabigatran. Thus, the answer is inferred from the broader category described in the context. \n\n**Answer:** Thrombin (Factor IIa)  \n**Supporting sentence (inferred from context):** \"Inhibitors of activated factor II (dabigatran, AZD0837), [...] Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.\"", "retries": 1}
{"idx": 959, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant as it acknowledges the existence of multiple isoforms; however, it does not cover the gold answer (7) and lacks precision regarding the exact number of TAp73 isoforms in humans.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial.  \nAnalysis: The context uses the phrase \"various p73 isoforms\" to indicate the existence of multiple TAp73-related isoforms but does not explicitly state how many have been identified in humans. No specific numerical value or direct reference to the total number of human TAp73 isoforms is provided in the text.", "retries": 1}
{"idx": 960, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a clear explanation of the RANKL-RANK-OPG pathway, which includes RANKL as the ligand targeted by Denosumab. However, the supporting sentence contains additional information about shared signaling pathways between the skeletal and immune systems, making it slightly verbose compared to the gold supporting sentence, which directly addresses Denosumab's mechanism of action.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Denosumab, an anti-RANKL monoclonal antibody with proven antiosteoclast activity, may suppress immune responses.", "model_answer": "Answer: RANKL (Receptor Activator of Nuclear Factor-κB Ligand)", "model_support": "Supporting sentence: The skeletal and immune systems share various cytokines, receptors, and transcription factors that regulate signal transduction pathways involved in osteoclastogenesis and immune system activation, including the receptor activator of nuclear factor-κΒ ligand/receptor activator of nuclear factor-κΒ/osteoprotegerin (RANKL-RANK-OPG) pathway. \n\n**Analysis**: Denosumab is a monoclonal antibody that targets RANKL (Receptor Activator of Nuclear Factor-κB Ligand). The context explicitly identifies RANKL as part of the RANKL-RANK-OPG pathway, which is central to bone remodeling and immune regulation. While the context does not directly name Denosumab, it establishes the relevance of RANKL as the ligand in this pathway, aligning with the known mechanism of Denosumab.", "retries": 1}
{"idx": 961, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('AUS') but is present in the context as a treatment option. The supporting sentence is relevant and highlights the effectiveness of BAUS, but it does not cover the gold answer ('AUS') or mention that BAUS compares favorably with AUS, which is critical to identifying the gold standard.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "Answer: The gold standard treatment for iatrogenic male incontinence is the bone-anchored sub-urethral sling (BAUS).", "model_support": "Supporting sentence: **CONCLUSIONS: BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.**  \n\nThis sentence directly positions the bone-anchored sub-urethral sling (BAUS) as a **safe and effective** treatment for iatrogenic male incontinence caused by intrinsic sphincter deficiency (ISD), which aligns with the claim of it being the \"gold standard\" in the answer. While the term \"gold standard\" is not explicitly used, the conclusion emphasizes its efficacy and minimal invasiveness, implicitly suggesting it is the most recommended approach.", "retries": 1}
{"idx": 962, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional. \n\nThis sentence explicitly identifies the **XK gene** as the locus of the mutation (E327K) linked to the McLeod syndrome phenotype.", "retries": 1}
{"idx": 963, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes additional information about the automatic device (BVM 6500), which is not required by the gold answer. The supporting sentence provides relevant information and mentions both techniques, but it is somewhat lengthy and introduces details (e.g., measurement differences, limitations of the BVM 6500) that are not necessary to directly support the gold answer. The logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "ultrasound", "gold_support": "To compare repeatability and agreement of conventional ultrasound bladder wall thickness (BWT) measurements with automatically obtained BWT measurements by the BVM 6500 device.", "model_answer": "Answer: Bladder wall thickness is measured using conventional ultrasound and an automatic measurement device (BVM 6500).", "model_support": "Supporting sentence: Mean difference between the two techniques was 0.11 - 0.23 mm and did not differ significantly. The BVM 6500 device was not able to correctly measure BWTs above 4 mm. \n\n**Analysis:**  \nThe sentence explicitly references the **BVM 6500 device** (automatic measurement) and implies the **manual method** (conventional ultrasound) as the \"two techniques\" compared in the study. The prior context in the **Methods** section also states that repeatability was assessed for \"each method,\" confirming that both manual (conventional ultrasound) and automatic (BVM 6500) approaches were used.", "retries": 1}
{"idx": 964, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 965, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly support the answer, the gold supporting sentence directly confirms the answer with concise and relevant information, fulfilling the criteria for a perfect score.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.", "model_answer": "Answer: Interleukin-17A (IL-17A)", "model_support": "The context provided does not explicitly mention the molecular target (Interleukin-17A/IL-17A) of Secukinumab. While the answer \"Interleukin-17A (IL-17A)\" is factually correct based on external knowledge, **no sentence in the given context directly supports this answer**. The context focuses on efficacy, safety, and usability of Secukinumab in psoriasis but does not discuss its mechanism of action or target. \n\n**Conclusion**: The provided context lacks the supporting sentence for the stated answer.", "retries": 1}
{"idx": 966, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Xist (X-inactive specific transcript),' matches the gold standard. However, the supporting sentence does not cover the gold answer adequately. The context provided does include a relevant sentence mentioning XIST/Xist, which directly supports the gold answer. The model incorrectly claims that the context does not mention Xist, leading to a lower score despite the correct answer.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "Answer: Xist (X-inactive specific transcript)", "model_support": "The context provided does not mention the **Xist (X-inactive specific transcript)** or any specific transcript directly responsible for X-chromosome inactivation. While the passage discusses mechanisms and loci (e.g., Xce, XIC) involved in X-inactivation, it does not identify a specific transcript like **Xist** as the answer. \n\n**Answer:** The context does not explicitly name the transcript responsible for X-chromosome inactivation.  \n**Supporting sentence:** None of the sentences in the context explicitly mention \"Xist\" or any specific transcript.", "retries": 1}
{"idx": 967, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains some redundancy by elaborating on mutant p53 functions rather than directly referencing its role as 'the guardian of the genome.' While logical, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Not only do such mutations result in the abrogation of wild-type p53 activity, but the expressed p53 mutant proteins also tend to gain oncogenic functions, such as interference with wild-type p53-independent apoptosis. \n\n**Analysis:** The context explicitly discusses p53's role as a tumor suppressor (wild-type p53 activity) and its loss/gain of function in cancer, which aligns with the well-established scientific designation of p53 as \"the guardian of the genome.\" While the phrase \"guardian of the genome\" is not directly quoted in the context, the detailed focus on p53's tumor suppressor functions and its critical role in apoptosis and cancer prevention strongly supports the answer. The first sentence establishes p53 as the central subject, linking it to its canonical role in genomic stability.", "retries": 1}
{"idx": 968, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but it introduces additional details about phosphorylated alpha-synuclein that are not necessary for answering the question. The logic is sound, but slight redundancy is present.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: The central amygdaloid nucleus contained **anti-alpha-synuclein-** and **-phosphorylated alpha-synuclein-positive dystrophic axonal terminals**, the degree of which was greater for cases with granular staining in the putamen... \n\nThis sentence explicitly states that antibodies against **alpha-synuclein** (and its phosphorylated form) were used for immunostaining to detect Lewy body-related pathology.", "retries": 1}
{"idx": 969, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about mutations are acceptable as they support the explanation without being excessive.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "It is caused by de novo heterozygous mutations or deletions of the ZFHX1B gene located at 2q22.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Over 100 mutations have been described in patients with clinically typical MWS, who almost always have whole gene deletions or truncating mutations (nonsense or frameshift) of **ZFHX1B**, suggesting that haploinsufficiency is the basis of MWS pathology.", "retries": 1}
{"idx": 970, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence highlights the necessity of the SET domain for active HMTase, which aligns perfectly with the gold standard context.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "The fly complex contains a catalytic SET domain subunit, E(Z), plus three noncatalytic subunits, SU(Z)12, ESC, and NURF-55.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: \"the E(Z) SET domain requires multiple partner inputs to produce active HMTase.\" \n\n**Analysis:**  \nThe context identifies the **SET domain** (Su(var)3-9, Enhancer of zeste, Trithorax) as the conserved catalytic domain in the E(Z) subunit of the fly Polycomb group complex, which is essential for histone methyltransferase (HMTase) activity. This directly links the SET domain to the characteristic domain of histone methyltransferases. While other domains (e.g., CXC, VEFS) are mentioned in accessory subunits, the **SET domain** is explicitly highlighted as the core functional domain for enzymatic activity in E(Z), a prototypical histone methyltransferase.", "retries": 1}
{"idx": 971, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively conveys the interaction between FANCA and the SWI/SNF complex, which includes BRG1 as specified in the context.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: FANCA was demonstrated to associate with the endogenous SWI/SNF complex.  \n**Analysis**: The sentence explicitly states that FANCA interacts with the SWI/SNF complex. The context further identifies **BRG1** as a subunit of the SWI/SNF complex (\"BRG1 is a subunit of the SWI/SNF complex\"), establishing that BRG1 is the specific subunit involved in this interaction.", "retries": 1}
{"idx": 972, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the number of TAp73 isoforms is unspecified, whereas the gold answer clearly identifies 7. The supporting sentence discusses alternative splicing and p73 isoforms but does not directly address the specific count of TAp73 isoforms in humans. The model fails to extract or infer the correct information from the context, rendering both the answer and supporting sentence irrelevant.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "The context does not specify the number of TAp73 isoforms identified in humans.  \n**Supporting sentence**: \"In addition to alternative splicing at the carboxyl terminus which yields several p73 isoforms, a p73 variant lacking the N-terminal transactivation domain (Delta Np73) was described in mice.\"  \n\nThe text mentions \"several p73 isoforms\" due to alternative splicing but does not provide a specific number for TAp73 isoforms in humans.", "retries": 1}
{"idx": 973, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard ('PLN'), but the supporting sentence is somewhat lengthy and includes details about other regulatory proteins (e.g., HRC, HAX1) that are not directly necessary to support the role of PLN as the main regulatory molecule. While the logic is reasonable and the information provided is relevant, it could be more concise and focused on PLN specifically, as in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: \"Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport. These include the inhibitor-1 (I-1) of protein phosphatase 1 (PP1), the small heat shock protein 20 (Hsp20) and the HS-1 associated protein X-1 (HAX1). In addition, the intra-luminal histidine-rich calcium binding protein (HRC) has been shown to interact with both SERCA2a and triadin. Notably, there is physical and direct interaction between these protein players, mediating a fine-cross talk between SR Ca-uptake, storage and release.\"\n\n**Analysis**: The context explicitly states that phospholamban (PLN) is the central regulatory molecule in the SERCA2A interactome. The phrase \"PLN/SERCA interactome\" and the description of PLN-associated proteins (e.g., HRC, HAX1) directly link PLN to the regulation of SERCA2A function in cardiac muscle. Additionally, the introduction of the article (\"Phospholamban interactome...\") and the focus on PLN's role in modulating SR calcium cycling further confirm this relationship.", "retries": 1}
{"idx": 974, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA),' which is not part of the gold answer. The supporting sentence provides relevant context and covers the answer reasonably well, though it is somewhat lengthy and indirectly references the gold answer through additional details about the study objective and reference standard. Logic is sound but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: OBJECTIVE: To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke. \n\nAdditionally, the reference standard explicitly states: \"Reference standard A consensus diagnosis of stroke or transient ischaemic attack (TIA)...\" which confirms the disorders the ROSIER scale is designed to identify.", "retries": 1}
{"idx": 975, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (BCR-ABL). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking imatinib's role in treating Philadelphia chromosome-positive CML to its mechanism of targeting BCR-ABL tyrosine kinase. Although the supporting sentence does not explicitly quote the gold supporting sentence, it provides sufficient context from both the given text and general biomedical knowledge.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "All 1,063 patients selected met the following inclusion criteria: aged 18 or older and in chronic phase at the time of diagnosis, Philadelphia chromosome and/or BCR-ABL positive, received first-line treatment with imatinib, and not enrolled in a randomized clinical trial during the period of retrospective review.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: *Among patients treated with first-line imatinib...*  \n**Analysis**: While the context does not explicitly name the **BCR-ABL tyrosine kinase** as the target of imatinib, the question relies on established biomedical knowledge. Imatinib is a well-documented tyrosine kinase inhibitor targeting the **BCR-ABL fusion protein**, which is the hallmark of Philadelphia chromosome-positive CML. The context implicitly supports this by discussing imatinib's use in treating CML, a disease defined by the Philadelphia chromosome translocation that produces the BCR-ABL oncogene. Thus, the answer is grounded in both the context (imatinib's role in CML) and general knowledge of its mechanism of action.", "retries": 1}
{"idx": 976, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about alpha-synuclein and its degradation via autophagy, which indirectly supports its role as the main component of Lewy bodies. However, it does not explicitly mention Lewy bodies, making it slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence indicates that macroautophagy (hereafter referred to as autophagy) is involved in alpha-synuclein degradation. \n\n**Analysis**: While the context does not explicitly mention Lewy bodies, it directly links alpha-synuclein to Parkinson's disease pathogenesis by stating that autophagy is involved in its degradation. This aligns with established biomedical knowledge that Lewy bodies, the pathological hallmark of Parkinson's disease, are primarily composed of aggregated alpha-synuclein. The sentence provides the necessary contextual support for the answer.", "retries": 1}
{"idx": 977, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose and includes details about B-raf and Drwms2 that are not necessary for directly supporting the role of Xist in X-chromosome inactivation.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Xist (X-inactive specific transcript) is a major effector of the X-inactivation process, and X-linked genes are highly expressed in brain tissue and consistent with a role in brain developments.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: By microarray, upregulation of Xist, B-raf and Drwms2 were detected. Especially, mRNA expression of Xist was increased in a concentration-dependent manner in male and female mice. \n\n**Analysis**: The context explicitly identifies *Xist* as a gene whose expression is altered in response to diesel exhaust exposure. Since Xist (X-inactive specific transcript) is a well-established long non-coding RNA directly responsible for initiating X-chromosome inactivation (XCI), this sentence directly supports the conclusion that Xist is the transcript involved in XCI. The study further contextualizes Xist’s role in XCI mechanisms by contrasting it with Tsix (its antisense partner) and noting that other X-linked genes remain unaffected.", "retries": 1}
{"idx": 978, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model's supporting sentence initially claims there is no mention of benserazide in the context, the actual context does include a relevant sentence mentioning benserazide co-administration with L-dopa. Despite this confusion in reasoning, the provided gold supporting sentence directly supports the correct answer and is concise and relevant. Therefore, the answer is accurate and supported properly by the gold sentence.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "The administration of L-dopa (20 and 60 mg/kg p.o.) + benserazide (15 mg/kg p.o.) resulted in dose-dependent increase of dialysate levels of L-dopa and 3-O-methyl-DOPA.", "model_answer": "Answer: L-dopa", "model_support": "The context does not mention **benserazide** at all. The question and answer provided are unrelated to the content of the context, which focuses on **tolcapone**, a catechol-O-methyltransferase inhibitor. Since **benserazide** is not discussed in the text, there is **no supporting sentence** in the context for the answer \"L-dopa.\" \n\n**Note:** While benserazide is indeed clinically co-administered with L-dopa (as a peripheral aromatic amino acid decarboxylase inhibitor to prevent peripheral conversion of L-dopa to dopamine), this information is **not present** in the provided context.", "retries": 1}
{"idx": 979, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly (H3K4). The supporting sentence, while noting that the context does not explicitly mention H3K4, correctly identifies that external knowledge is required and aligns with the gold supporting sentence in spirit by referencing histone methylation. It is concise and logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Trimethylation of histone H3 Lys4 (H3K4) is associated with transcriptional activation.", "model_answer": "Answer: Lysine 4 of histone H3 (H3K4)", "model_support": "Supporting sentence: The context does not explicitly mention the specific histone residue (e.g., Lysine 4 of histone H3) methylated by MLL1. The provided text only states that MLL core components regulate histone methylation but does not specify the residue. The answer (H3K4) relies on external knowledge, not the given context. \n\n**Analysis**: The example assumes a direct quote from the context, but in this case, the context lacks the specific detail about the histone residue. The correct answer (H3K4) is biologically accurate but not supported by the provided text.", "retries": 1}
{"idx": 980, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'BCR-ABL tyrosine kinase' is very close to the gold standard 'BCR-ABL,' with only slight additional detail that does not detract from correctness. The supporting sentence is relevant and accurate but contains some redundancy compared to the gold supporting sentence, which is more concise while still covering the essential reasoning.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: Chronic myeloid leukemia (CML) is caused by the BCR-ABL oncogene.  \n\nExplanation: The context explicitly states that CML is driven by the **BCR-ABL oncogene**, which encodes a constitutively active **BCR-ABL tyrosine kinase**. Imatinib (Gleevec) is described as targeting \"tyrosyl phosphorylation of the protein related to the cell signaling,\" which directly refers to inhibiting the BCR-ABL tyrosine kinase activity. This establishes BCR-ABL as the molecular target of imatinib in Philadelphia chromosome-positive CML.", "retries": 1}
{"idx": 981, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of modified forms of AS does not detract from the correctness or relevance.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "Answer: α-Synuclein (AS)", "model_support": "Supporting sentence: Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS. \n\nThis sentence explicitly states that α-synuclein (AS) is a major component of Lewy bodies, even though it specifies the modified forms (phosphorylated, nitrated, monoubiquitinated). The context directly links AS to the composition of Lewy bodies, confirming it as their primary constituent.", "retries": 1}
{"idx": 982, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a paradigm for neoplasias that are defined by a unique genetic aberration, the BCR-ABL1 fusion gene.", "model_answer": "Answer: BCR-ABL1 fusion protein", "model_support": "Supporting sentence: ...oncogenic signaling pathways downstreams of the BCR-ABL1 fusion gene product.  \n\n**Analysis:**  \nThe context states that imatinib is a **protein tyrosine kinase inhibitor** used in CML therapy. While it does not explicitly name BCR-ABL1 as the target, the **BCR-ABL1 fusion gene product** is directly tied to CML pathogenesis (via the Philadelphia chromosome), and imatinib’s mechanism aligns with inhibiting its tyrosine kinase activity. The sentence mentioning \"downstreams of the BCR-ABL1 fusion gene product\" implicitly confirms BCR-ABL1 as the primary target of imatinib.", "retries": 1}
{"idx": 983, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Catalytic domain in the C-terminus') does not match the gold standard ('SET domain'), but the supporting sentence is relevant and accurate in describing the involvement of the C-terminus in catalysis. However, it does not cover the specific gold answer (SET domain), which is a more precise characteristic domain associated with histone methyltransferases like G9a.\", \"match\": false}", "gold_answer": "SET domain", "gold_support": "Murine G9a is a 1263 amino acid H3-K9 methyltransferase that possesses characteristic SET domain and ANK repeats.", "model_answer": "Answer: Catalytic domain in the C-terminus.", "model_support": "Supporting sentence: Furthermore, mutation of conserved amino acids R1097A, W1103A, Y1120A, Y1138A and R1162A, or the metal binding C1168A in the catalytic region, resulted in catalytically impaired enzymes, thereby confirming the involvement of the C-terminus of G9a in catalysis. \n\n**Analysis:** This sentence directly identifies the C-terminus of G9a as the region containing the catalytic domain, as mutations in conserved residues within this region impair enzymatic activity. The conclusion in the final sentence explicitly links the C-terminus to catalytic function, supporting the answer that histone methyltransferases like G9a have a catalytic domain in the C-terminus.", "retries": 1}
{"idx": 984, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning the broader SWI/SNF complex rather than directly specifying BRG1. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: FANCA was demonstrated to associate with the endogenous SWI/SNF complex. \n\n**Analysis**: The sentence explicitly states that FANCA interacts with the SWI/SNF complex. Since BRG1 is identified earlier in the context as a subunit of this complex (\"BRG1 is a subunit of the SWI/SNF complex\"), the interaction between FANCA and the SWI/SNF complex implies that BRG1 (as a core subunit) is the specific subunit involved.", "retries": 1}
{"idx": 985, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by elaborating on the stalled RNA polymerase complex, which is not necessary to directly support the answer. The logic is strong, but the additional details make it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage. The stalled RNA polymerase complex may then mediate recruitment of repair proteins to damage in the transcribed strand.", "retries": 1}
{"idx": 986, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in meaning, though it is slightly more verbose. The supporting sentence provided by the model is relevant and supports the answer, but it is somewhat indirect and includes additional information about the study objectives rather than directly stating that betrixaban inhibits factor Xa. The gold supporting sentence is more concise and directly mentions factor Xa inhibitors including betrixaban. Thus, the model's supporting sentence has slight redundancy but still provides logical support.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors.", "retries": 1}
{"idx": 987, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context clearly mentions that HSP70 is upregulated during HSP90 inhibition, but the model incorrectly states that no specific heat shock protein is mentioned. The supporting sentence is also flawed as it misrepresents the context by claiming no relevant information exists, whereas the context explicitly discusses the induction of HSP70. Both the answer and supporting sentence fail to address the correct information.\",\n  \"match\": false\n}", "gold_answer": "HSP70", "gold_support": "Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro.", "model_answer": "Answer: The context does not mention any specific heat shock protein being upregulated during HSP90 inhibition.", "model_support": "The context does not mention any specific heat shock protein being upregulated during HSP90 inhibition. The study focuses on the effects of HSP90 inhibition on signaling pathways (e.g., Akt, Erk, STAT3) and liver regeneration, but no other heat shock proteins are discussed in relation to upregulation. \n\n**Supporting sentence**: \"The context does not mention any specific heat shock protein being upregulated during HSP90 inhibition.\" (This is inferred from the absence of relevant information in the provided text.)", "retries": 1}
{"idx": 988, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect. The supporting sentence refers to a 'factor Xa decoy' and its role as a reversal agent rather than directly stating that betrixaban inhibits Factor Xa. While logical and correct, it introduces slight redundancy by referencing the decoy instead of focusing solely on betrixaban's mechanism.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445... may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" \n\n**Analysis**: The context explicitly associates betrixaban with anticoagulants that target **Factor Xa** (via the term \"anti-Xa activity\") and pairs it with a Factor Xa decoy (PRT4445). This implies that betrixaban inhibits Factor Xa, as its mechanism aligns with other anticoagulants in this class (e.g., rivaroxaban, apixaban). While the text does not directly state \"betrixaban inhibits Factor Xa,\" the pharmacologic context and the reference to a Factor Xa-specific reversal agent provide strong indirect evidence.", "retries": 1}
{"idx": 989, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' is correct and matches the gold standard 'Xa'. The supporting sentence is relevant and explains the connection between betrixaban and Factor Xa, but it includes slight redundancy by mentioning the study name 'Explore-Xa', which is not necessary for answering the question. The logic is sound, but the extra detail makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: **Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa).**  \nThe study name \"Explore-Xa\" explicitly indicates that betrixaban targets **Factor Xa**, a key clotting factor in the coagulation cascade.", "retries": 1}
{"idx": 990, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence accurately reflects the context provided in the gold supporting sentence, being concise and directly relevant while covering the answer with clear reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly mention that JTV519 is a derivative of **1,4-benzothiazepine**. While the drug's effects on calcium regulation and heart failure are described, there is no sentence in the text that identifies its chemical classification. The previous example (not this context) included the statement: *\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative...\"*—which is absent here. Therefore, the answer **cannot be directly supported** by the provided context. \n\n**Note:** The answer may rely on external knowledge or prior information not included in the given text.", "retries": 1}
{"idx": 991, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'). The supporting sentence is relevant and provides accurate information about SEA0400 blocking Ca²⁺ influx, which aligns with the inhibition of the Na+/Ca²⁺ exchanger. However, it does not explicitly mention the broader effects like the blocking of SNP-induced phosphorylation or cytotoxicity, which are included in the gold supporting sentence. This makes the model's supporting sentence slightly less comprehensive but still logically sound.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific NCX inhibitor SEA0400 blocked SNP-induced phosphorylation of ERK, JNK and p38 MAPK, and decrease in cell viability.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: This increase in (45)Ca²⁺ influx was blocked by SEA0400, but not the Ca²⁺ channel blocker nifedipine. \n\n**Analysis**: The sentence explicitly states that SEA0400 blocks the calcium influx observed in the experiment, while nifedipine (a Ca²⁺ channel blocker) does not. Since the study attributes this calcium influx to the **Na⁺/Ca²⁺ exchanger (NCX)** activity (as noted in the context's first paragraph), this directly identifies SEA0400 as an inhibitor of the NCX. The distinction from nifedipine (which targets voltage-gated Ca²⁺ channels) further confirms that SEA0400 acts on a different mechanism—the NCX.", "retries": 1}
{"idx": 992, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'Factor Xa' correctly identifies the clotting factor inhibited by betrixaban, matching the gold answer 'xa'. The supporting sentence provided by the model is relevant but includes unnecessary details about the study's objectives, which are not directly needed to answer the question. The gold supporting sentence is more concise and directly mentions betrixaban as one of the factor Xa inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors.  \n**Analysis**: The context explicitly identifies betrixaban as one of the four oral direct **factor Xa** inhibitors (alongside rivaroxaban, apixaban, and edoxaban). This classification directly answers the question about the clotting factor inhibited by betrixaban.", "retries": 1}
{"idx": 993, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Xist RNA' is essentially the same as the gold standard 'Xist,' with only a minor difference in phrasing that does not affect correctness. The supporting sentence directly mentions Xist RNA and its role in X-chromosome inactivation, aligning closely with the gold supporting sentence while remaining concise and logically clear.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The process is mediated by the non-coding RNA X inactive specific transcript (Xist) that binds in cis and propagates along the inactive X chromosome elect, triggering chromosome-wide silencing.", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: The mechanisms by which **Xist RNA** binds and spreads along the chromosome, and initiates Xist-mediated chromosome silencing remain poorly understood. \n\nThis sentence explicitly identifies **Xist RNA** as the transcript responsible for X-chromosome inactivation (XCI).", "retries": 1}
{"idx": 994, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Insulin receptor' does not match the gold standard 'insulin'. While the supporting sentence correctly identifies the insulin receptor and its mutation as relevant to Donohue syndrome, it does not cover the gold answer 'insulin', which is more specific to the hormone rather than the receptor. The answer is present in the context but does not align with the gold standard.\", \"match\": false}", "gold_answer": "insulin", "gold_support": "Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.", "model_answer": "Answer: Insulin receptor", "model_support": "Supporting sentence: A novel homozygous missense mutation p.Leu795Pro was found, located in the extracellular portion of the β subunit of the **insulin receptor**.  \n**OR**  \nSupporting sentence: Treatment with rhIGF-I partially reversed severe progressive HOCM and renal tubular dysfunction in a patient with Donohue syndrome associated with a novel p.Leu795Pro **INSR gene mutation** causing a severe decrease in **IR autophosphorylation**.  \n\nBoth sentences explicitly link Donohue syndrome to mutations in the **insulin receptor (INSR)** and its functional impairment.", "retries": 1}
{"idx": 995, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence accurately reflects the gold supporting sentence by demonstrating that Bach1 represses ho-1 expression, as evidenced by the increased expression of ho-1 in the absence of Bach1.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Gene targeting experiments in mice revealed that, in the absence of Bach1, *ho-1* became expressed constitutively at high levels in various tissues under normal physiological conditions.  \n\n**Analysis**: The absence of Bach1 leads to constitutive high-level expression of *ho-1*, indicating that Bach1 normally suppresses (*represses*) *ho-1* expression. This directly demonstrates that Bach1 functions as a **repressor** of *ho-1*.", "retries": 1}
{"idx": 996, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant. The phrase 'antiparallel spectrin heterodimers' directly supports the answer, yet the mention of 'forced unfolding' adds unnecessary context that doesn't contribute to explaining the parallel or antiparallel nature.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Answer: antiparallel", "model_support": "Supporting sentence: Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.", "retries": 1}
{"idx": 997, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard ('iron deficiency' vs. 'iron'), which is acceptable as it implies the same deficiency. However, the supporting sentence is somewhat convoluted and includes unnecessary commentary about the context lacking explicit information on restless leg syndrome, which was not required. The logic is reasonable but could be more concise, as the gold supporting sentence demonstrates by simply stating that iron deficiency can cause these symptoms.\", \"match\": true}", "gold_answer": "iron", "gold_support": "That iron deficiency, per se, can cause these symptoms is poorly recognized.", "model_answer": "Answer: Iron deficiency", "model_support": "The context does not mention **restless leg syndrome (RLS)** or its association with iron deficiency. While iron deficiency is a known cause of RLS in clinical practice, the provided text only discusses symptoms like **fatigability, cold intolerance, and poor effort intolerance** in the context of iron deficiency anemia and CKD. There is **no sentence in the given context** that explicitly links iron deficiency to restless leg syndrome. \n\n**Answer:** Iron deficiency  \n**Supporting sentence:** *Not present in the provided context.*  \n\nTo accurately answer this question using the context, the text would need to explicitly state a connection between iron deficiency and RLS.", "retries": 1}
{"idx": 998, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The context explicitly mentions 5-aminolevulinic acid in relation to Gliolan, making the support strong and accurate.\", \"match\": true}", "gold_answer": "5-aminolevulinic acid", "gold_support": "OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(®)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6).", "model_answer": "Answer: 5-aminolevulinic acid", "model_support": "Supporting sentence: Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).  \n\n**Analysis**:  \nThe context directly refers to **5-aminolevulinic acid (5-ALA)** as the substance studied. While the term \"Gliolan\" is not explicitly mentioned in the text, it is a well-established brand name for **5-aminolevulinic acid** in clinical practice (used for fluorescence-guided resection of malignant gliomas). The supporting sentence from the context confirms the generic name of the drug under investigation, which aligns with the known identity of Gliolan.", "retries": 1}
{"idx": 999, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and explains the reasoning by referencing general biomedical knowledge about imatinib targeting BCR-ABL in Philadelphia chromosome-positive CML. Although the context lacks an explicit statement, the explanation logically connects the question to the correct answer without unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is a genetically associated malignancy of haematopoietic stem cells, characterized by a t(9;22) translocation that forms the Philadelphia chromosome and creates a novel fusion gene, BCR-ABL.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The context does not explicitly mention the specific tyrosine kinase (BCR-ABL) targeted by imatinib. However, the question relies on general biomedical knowledge, as imatinib is a well-established BCR-ABL inhibitor in Philadelphia chromosome-positive CML. The provided context discusses imatinib resistance in CML but does not include a direct statement about the target kinase.", "retries": 1}
